data_1ilo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ilo _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.452 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 111.395 0.146 . . . . 0.0 111.395 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.463 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -80.55 116.23 20.48 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.865 0.364 . . . . 0.0 111.317 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -79.85 101.08 8.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.981 0.419 . . . . 0.0 109.95 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.496 HD13 ' CE2' ' A' ' 34' ' ' PHE . 2.0 mt -109.95 124.92 67.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.579 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.424 ' CB ' HD11 ' A' ' 37' ' ' ILE . 3.2 mp0 -110.47 133.74 53.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.146 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.433 ' CG2' ' CB ' ' A' ' 14' ' ' CYS . 42.0 mt -114.45 109.64 29.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.109 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.885 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 66.5 m-85 -95.78 125.3 40.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.072 0.463 . . . . 0.0 111.556 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.446 ' HA3' ' HB1' ' A' ' 12' ' ' ALA . . . 122.46 -70.42 0.42 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.287 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.47 -70.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.821 0.343 . . . . 0.0 111.469 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.36 -97.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.643 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.44 -29.44 61.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.76 0.314 . . . . 0.0 111.134 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.446 ' HB1' ' HA3' ' A' ' 8' ' ' GLY . . . -68.65 120.49 14.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.996 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -76.24 21.25 0.18 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.433 ' CB ' ' CG2' ' A' ' 6' ' ' ILE . 6.1 m -55.21 -21.61 14.51 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.694 0.283 . . . . 0.0 111.374 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.62 -39.48 11.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 mtp -63.68 -62.69 1.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.642 0.258 . . . . 0.0 111.257 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.418 ' HB3' ' CG2' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -67.22 -19.54 65.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.781 0.324 . . . . 0.0 110.724 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -60.29 -50.36 73.95 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.345 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -70.28 -45.87 65.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.713 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -60.76 -38.6 85.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.008 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.408 ' HB1' ' CD1' ' A' ' 17' ' ' LEU . . . -63.47 -45.91 88.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.296 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 5.6 mtt-85 -57.71 -53.15 61.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -65.58 -50.19 66.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.523 -179.336 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.12 -51.91 64.66 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 32' ' ' ALA . 4.4 p -53.77 -55.09 15.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.446 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.473 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 36.6 mtpt -65.34 -49.56 68.93 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.676 0.274 . . . . 0.0 111.2 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 46.8 tp10 -60.01 -39.28 85.27 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.721 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.02 -15.93 1.68 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.751 0.31 . . . . 0.0 111.175 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.05 26.16 3.9 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.546 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.513 HG21 HD12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -163.26 109.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 0.0 110.628 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 1' ' ' MET . 2.8 m-20 -60.71 156.49 16.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . . . -145.29 140.06 27.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -103.94 117.12 33.56 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.044 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 15.7 m-85 -98.48 109.3 22.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.331 0.586 . . . . 0.0 112.068 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.51 126.51 55.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.287 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.85 150.65 30.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.148 0.499 . . . . 0.0 111.068 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.744 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -124.2 80.73 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.408 -179.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.04 75.03 6.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.132 0.491 . . . . 0.0 111.378 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.572 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.4 OUTLIER 173.95 119.02 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.704 179.385 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.513 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 1.2 ptp -54.02 -33.11 56.32 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.45 0.167 . . . . 0.0 111.089 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.26 -37.38 46.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -86.74 -33.86 19.84 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.185 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.885 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 26.8 mt -61.41 -55.95 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.061 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.412 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.06 -36.65 84.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.826 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -56.85 -24.56 52.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.993 0.425 . . . . 0.0 110.319 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.403 ' HB1' ' CD1' ' A' ' 48' ' ' LEU . . . -72.14 -40.08 68.31 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.574 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.53 -10.75 11.4 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.506 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.545 HD21 ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -71.87 152.07 42.89 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 117.444 0.622 . . . . 0.0 111.017 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 t -104.35 -9.41 18.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.931 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -104.06 -177.93 3.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.422 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -81.67 -64.09 0.28 Allowed Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.418 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 51' ' ' LEU . 56.2 Cg_endo -70.29 56.48 1.62 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.371 2.047 . . . . 0.0 113.41 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -73.06 143.48 33.35 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.903 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.27 102.7 5.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.565 0.221 . . . . 0.0 110.432 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -104.95 124.47 49.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 111.581 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.432 HG13 HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.27 138.4 44.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.39 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 46.99 25.39 0.47 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.296 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.98 22.64 44.67 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.128 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.46 ' O ' ' CG ' ' A' ' 59' ' ' GLU . 4.6 pt-20 -137.28 108.19 6.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.216 0.531 . . . . 0.0 110.852 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -85.4 131.32 34.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.887 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.84 2.49 2.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.546 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.532 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 9.7 mt -128.24 122.39 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.664 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.502 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 2.4 mpp? -145.74 130.81 18.33 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.474 ' N ' ' CB ' ' A' ' 50' ' ' ALA . . . 73.6 6.79 72.34 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.176 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 178.81 101.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.761 0.315 . . . . 0.0 110.616 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.418 ' CG2' ' HB3' ' A' ' 17' ' ' LEU . 3.3 p -57.83 148.35 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.644 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.37 173.74 2.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.935 0.398 . . . . 0.0 111.434 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.11 158.97 17.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.607 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -48.48 65.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.319 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.14 -34.32 77.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.922 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.54 -42.57 91.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.5 mm -56.23 -55.1 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.986 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.434 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 3.4 mtt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.674 0.273 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.502 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -77.23 113.56 15.11 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.891 0.377 . . . . 0.0 111.095 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.55 100.38 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.467 HD13 ' CE2' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -106.51 125.51 62.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.026 -179.085 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.551 ' HB3' HD12 ' A' ' 37' ' ' ILE . 3.3 mm-40 -107.11 126.23 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.169 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.409 ' CG2' ' HB2' ' A' ' 14' ' ' CYS . 2.9 mp -107.86 102.65 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.737 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 80.6 m-85 -88.94 124.26 34.07 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.924 0.392 . . . . 0.0 110.755 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.1 -85.36 0.19 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.299 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t 40.29 86.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.879 0.371 . . . . 0.0 111.778 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.42 -61.92 0.56 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.517 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.1 m -118.62 -2.57 10.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.526 0.203 . . . . 0.0 111.497 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.77 135.08 42.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.82 0.343 . . . . 0.0 111.154 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -76.55 20.1 0.24 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.023 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.45 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 3.8 p -57.15 -19.85 22.73 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.675 0.274 . . . . 0.0 111.509 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.08 -38.49 38.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.653 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.416 ' CB ' HG13 ' A' ' 66' ' ' VAL . 1.1 mpp? -64.65 -52.64 56.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.564 ' HB2' HG11 ' A' ' 66' ' ' VAL . 30.9 tp -66.78 -28.75 68.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.067 0.46 . . . . 0.0 110.143 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.01 -47.47 80.78 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.386 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -46.17 61.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.867 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -56.6 -53.02 62.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.044 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.43 -43.06 71.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.892 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.476 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 5.5 mtt180 -57.61 -43.71 84.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.665 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 61.6 tt0 -74.34 -50.75 17.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.368 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.28 -49.84 72.45 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.499 ' CG1' ' HB3' ' A' ' 32' ' ' ALA . 3.2 p -54.38 -53.9 26.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.613 0.244 . . . . 0.0 110.44 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.494 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 51.7 mttt -67.01 -50.09 63.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.784 0.326 . . . . 0.0 110.849 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 19.4 tt0 -57.82 -39.78 78.45 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.077 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.6 tp -52.14 -21.14 3.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.781 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.76 32.55 2.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.618 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pt -169.09 121.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.862 0.363 . . . . 0.0 111.222 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.434 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -61.36 164.0 6.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.167 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -150.62 140.07 21.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -100.72 111.17 23.35 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.386 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.476 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 68.9 m-85 -94.88 109.18 21.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.505 0.669 . . . . 0.0 111.966 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.31 128.36 54.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.374 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -78.69 149.95 32.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.113 0.483 . . . . 0.0 110.806 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.69 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -115.7 76.62 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.687 -178.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.3 75.16 2.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.993 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.502 ' O ' HG13 ' A' ' 43' ' ' ILE . 2.6 mm-40 167.9 124.12 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.669 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.558 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -59.24 -20.31 53.05 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.213 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.46 -43.33 62.07 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -87.41 -34.8 18.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.475 178.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.737 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 16.9 mt -61.36 -54.94 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.345 0.593 . . . . 0.0 111.036 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -35.84 77.04 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.612 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -56.35 -34.05 66.23 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.158 0.504 . . . . 0.0 109.818 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.55 -42.67 51.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.875 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.99 30.61 31.12 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.561 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.536 ' HG ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -51.61 -41.75 61.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.443 0.621 . . . . 0.0 110.919 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 48' ' ' LEU . 5.6 p 90.64 7.23 0.08 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.241 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.465 ' CB ' ' HG2' ' A' ' 63' ' ' MET . . . -153.65 -157.27 0.76 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.948 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.582 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.4 mp -99.19 -61.15 0.11 Allowed Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 25.9 Cg_exo -62.94 52.85 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.843 2.362 . . . . 0.0 113.879 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.536 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -81.68 137.37 17.31 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.285 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -136.41 101.51 4.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.673 0.273 . . . . 0.0 110.499 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -104.45 133.53 49.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.81 0.338 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.412 ' CG1' HG21 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.59 141.45 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.183 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 50.83 23.18 1.33 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.595 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.43 31.02 23.15 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.257 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.7 106.59 5.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.118 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -83.18 130.08 35.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.016 179.23 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -138.23 1.23 2.2 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 pp -150.25 124.21 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.051 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.465 ' HG2' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.5 150.5 36.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.534 179.319 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.548 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 56.42 16.74 16.43 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.992 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -165.66 94.65 0.6 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.863 0.363 . . . . 0.0 110.531 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.564 HG11 ' HB2' ' A' ' 17' ' ' LEU . 2.0 t -60.48 120.05 5.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.736 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.11 126.77 28.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.33 169.74 1.56 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -60.52 -58.29 9.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.766 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -60.79 -33.16 72.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.24 -37.75 75.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 mt -69.24 -52.68 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.919 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.972 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 2.1 mtt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.46 ' HB3' HD13 ' A' ' 4' ' ' ILE . 1.1 mpp? -86.67 119.29 26.75 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.334 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.94 111.46 18.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.621 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.46 HD13 ' HB3' ' A' ' 2' ' ' MET . 3.7 mp -116.91 123.1 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.212 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.592 ' CB ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -110.59 127.88 55.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.598 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.489 HG13 ' HA ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -110.37 113.01 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.869 0.366 . . . . 0.0 110.924 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.702 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 90.6 m-85 -91.91 111.91 23.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.22 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.421 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 136.66 -96.9 0.25 Allowed Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.195 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.96 -65.23 0.3 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.827 0.346 . . . . 0.0 111.463 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.68 -57.51 9.47 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.822 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.0 p -111.92 -35.46 5.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 110.982 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.421 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -65.63 124.73 23.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.071 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -76.5 16.67 0.46 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 p -59.24 -19.5 46.21 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.784 0.325 . . . . 0.0 111.337 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -24.98 5.25 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.872 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.5 mtp -63.26 -62.19 1.86 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.791 0.329 . . . . 0.0 110.475 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 67' ' ' ALA . 5.6 tt -65.67 -20.37 66.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.512 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -57.61 -51.45 69.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.129 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -69.15 -51.32 39.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.609 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -54.7 -40.34 69.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.594 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.72 -45.93 90.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.442 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.527 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -54.88 -38.48 67.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.718 0.294 . . . . 0.0 111.273 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 35.1 tp10 -73.4 -50.41 21.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.019 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.63 79.59 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.563 ' CG1' ' HB3' ' A' ' 32' ' ' ALA . 14.0 p -53.62 -56.05 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.626 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.42 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.16 -40.34 82.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.692 0.282 . . . . 0.0 110.741 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 6.0 tp10 -59.27 -47.44 85.38 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.958 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -54.06 -20.22 6.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.76 42.79 0.84 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.43 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -175.35 113.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.375 . . . . 0.0 111.054 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.8 OUTLIER -61.57 164.08 6.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.257 179.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.563 ' HB3' ' CG1' ' A' ' 25' ' ' VAL . . . -146.0 165.91 27.62 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -126.48 109.78 12.56 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.527 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 15.0 m-85 -98.71 108.67 21.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.38 0.609 . . . . 0.0 112.071 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -117.39 133.32 56.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.56 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.489 ' HA ' HG13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -79.69 151.81 30.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.211 0.529 . . . . 0.0 111.396 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.692 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -127.77 78.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.616 -178.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 37.4 tptt -82.02 75.12 8.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.968 0.413 . . . . 0.0 111.191 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.507 ' O ' HG13 ' A' ' 43' ' ' ILE . 22.7 tp10 177.03 120.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.79 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.51 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 46.5 ttp -53.11 -32.21 46.14 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 121.268 -0.173 . . . . 0.0 110.942 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.55 -37.56 50.13 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.69 -34.22 19.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.113 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.702 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 29.0 mt -60.45 -55.21 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.055 0 CA-C-O 121.198 0.523 . . . . 0.0 111.29 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -39.13 93.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.855 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -54.44 -25.26 23.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.056 0.455 . . . . 0.0 110.347 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' HB1' ' CZ ' ' A' ' 7' ' ' TYR . . . -71.6 -39.24 70.63 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.714 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.0 -8.22 25.33 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.644 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.546 ' N ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -80.31 167.1 20.68 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.693 0.282 . . . . 0.0 110.947 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.88 14.29 5.82 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.433 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -114.68 172.57 6.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.623 0.249 . . . . 0.0 110.75 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.524 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 2.9 mt -71.15 -72.32 0.23 Allowed Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 51' ' ' LEU . 74.2 Cg_endo -72.23 60.23 3.18 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.195 1.93 . . . . 0.0 112.425 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -79.54 147.46 29.75 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.963 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.4 tt -144.95 110.27 5.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.885 0.374 . . . . 0.0 111.075 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -98.6 126.29 44.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.563 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.419 ' CG1' ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -120.78 139.75 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.283 0.563 . . . . 0.0 111.936 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 47.24 26.83 0.75 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.183 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.03 27.32 53.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.524 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -148.26 98.05 2.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.967 0.413 . . . . 0.0 110.435 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -77.29 141.76 39.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.203 0.525 . . . . 0.0 111.317 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.18 8.25 1.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.216 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.484 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 1.3 mp -119.36 123.1 70.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.427 ' CG ' ' HB2' ' A' ' 48' ' ' LEU . 32.3 mtp -146.49 115.31 6.87 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.478 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 85.45 -5.87 81.96 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.64 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.441 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER 173.65 104.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.708 0.289 . . . . 0.0 110.591 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.3 m -50.62 158.62 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.875 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.432 ' N ' HD12 ' A' ' 17' ' ' LEU . . . -80.47 174.26 11.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.052 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -93.73 167.27 11.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.824 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -53.82 -38.38 64.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.2 -36.99 74.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.725 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -68.86 -51.04 44.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.3 tt -59.15 -41.5 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 46.7 tttm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.736 179.858 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 31' ' ' ASP . 10.3 ttp . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.524 0.202 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.519 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 12.2 mmt -87.82 116.15 25.77 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.407 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -71.19 104.95 3.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.174 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.467 ' CG1' ' CG1' ' A' ' 56' ' ' VAL . 2.8 mp -112.55 120.77 63.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.361 0.601 . . . . 0.0 111.833 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.43 ' CB ' ' CD1' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -111.72 131.22 55.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.835 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 pt -110.8 115.1 48.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-O 120.822 0.344 . . . . 0.0 111.097 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.728 ' CE1' HG13 ' A' ' 37' ' ' ILE . 85.2 m-85 -99.1 107.11 19.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.98 0.419 . . . . 0.0 111.095 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 175.74 -106.12 0.21 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.491 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 m 68.48 88.24 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 111.122 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.49 -74.73 0.43 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.529 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 55.5 m -106.56 -26.87 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.407 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -76.25 127.99 34.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.305 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -76.91 20.69 0.24 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.189 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.419 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.4 p -52.0 -25.44 8.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.958 0.409 . . . . 0.0 111.116 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -36.22 65.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.181 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -51.92 63.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.875 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.423 ' HB2' HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -68.9 -22.01 64.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.994 0.426 . . . . 0.0 110.553 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -60.62 -54.25 47.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.558 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -48.64 65.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.73 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -55.09 -49.88 70.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.834 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.401 ' HB3' ' CD1' ' A' ' 17' ' ' LEU . . . -58.72 -41.51 86.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.797 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.548 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 11.5 mtp180 -57.55 -46.18 84.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 111.373 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.7 pt-20 -72.6 -50.3 26.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.558 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.76 -49.37 75.28 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.493 ' CG1' ' N ' ' A' ' 26' ' ' LYS . 3.8 p -53.56 -55.17 14.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.614 0.245 . . . . 0.0 110.883 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.493 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -69.56 -44.35 71.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.233 179.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 2.7 tt0 -56.68 -45.19 81.88 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.138 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.19 -22.1 3.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.907 0.384 . . . . 0.0 110.591 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.74 34.61 1.68 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.394 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.4 pt -162.74 116.73 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 0.0 111.288 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -61.32 164.69 5.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.159 179.348 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -151.23 161.98 41.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -121.37 111.65 17.58 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.548 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 58.0 m-85 -98.01 108.86 21.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.481 0.657 . . . . 0.0 112.038 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.419 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -117.81 133.85 55.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.481 178.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.5 151.34 29.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.04 0.447 . . . . 0.0 111.027 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.728 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -126.32 91.34 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.696 -179.071 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.18 75.76 6.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.979 0.419 . . . . 0.0 111.229 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.546 ' O ' HG13 ' A' ' 43' ' ' ILE . 2.8 tt0 173.69 121.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.903 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.55 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -54.65 -33.92 61.38 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.222 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.36 -36.34 42.66 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -86.55 -31.67 21.11 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.032 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.697 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 46.1 mt -63.05 -56.32 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.039 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.492 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.75 -34.73 77.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.182 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -21.71 59.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.909 0.385 . . . . 0.0 110.488 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -76.93 -35.8 57.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.3 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.18 -8.94 22.85 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.619 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.587 ' N ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -74.33 152.27 39.64 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 117.326 0.563 . . . . 0.0 111.382 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.7 p -108.02 -19.91 13.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.647 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -87.39 -171.58 3.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.393 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.563 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 2.0 mp -86.16 -73.78 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.563 ' CD ' ' CB ' ' A' ' 51' ' ' LEU . 38.3 Cg_endo -66.12 63.78 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.361 2.04 . . . . 0.0 112.609 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.432 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -84.93 143.78 20.71 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.993 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 tt -134.86 109.57 8.6 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.16 123.15 42.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.021 0.439 . . . . 0.0 110.901 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.467 ' CG1' ' CG1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -115.95 138.8 45.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.354 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 46.16 27.91 0.6 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.482 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.92 34.32 48.15 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.399 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.98 101.09 3.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.838 0.351 . . . . 0.0 111.099 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -45.81 130.2 9.38 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.159 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -118.33 -19.29 8.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.701 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -145.09 143.0 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 111.973 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.541 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -146.16 115.11 6.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.483 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.536 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 63.6 13.67 51.87 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.085 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.67 94.45 0.5 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.843 0.354 . . . . 0.0 110.77 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 17' ' ' LEU . 2.0 t -60.54 126.08 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.242 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.77 142.58 58.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.836 0.351 . . . . 0.0 111.067 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.68 169.07 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.74 -49.83 76.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.975 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.99 -36.48 81.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -58.81 -49.7 76.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.2 mm -60.51 -54.28 37.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.008 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.421 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 33.5 ttm . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.566 0.222 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.518 ' HB3' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -83.65 114.03 21.27 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.045 0.45 . . . . 0.0 110.808 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -69.52 116.35 9.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.007 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.518 HD13 ' HB3' ' A' ' 2' ' ' MET . 2.5 mp -124.25 128.29 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.47 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.576 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 0.8 OUTLIER -111.16 143.02 42.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.6 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.449 HD13 HG23 ' A' ' 6' ' ' ILE . 7.6 pt -127.31 110.25 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 110.395 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.733 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 8.1 m-30 -100.15 110.67 22.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.726 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.56 -66.34 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.525 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 m 74.63 79.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.793 0.33 . . . . 0.0 111.284 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.58 -62.76 1.9 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.846 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -50.47 -70.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.353 . . . . 0.0 111.235 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.36 147.78 24.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.021 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.4 17.06 0.4 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 p -55.43 -21.96 18.21 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.729 0.3 . . . . 0.0 111.228 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -37.45 74.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.326 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -62.43 1.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.886 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.404 ' HA ' ' ND2' ' A' ' 20' ' ' ASN . 1.6 tm? -59.31 -36.02 74.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.616 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.87 -41.0 77.22 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.7 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -73.46 -51.94 15.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.969 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 30.7 p30 -64.61 -36.23 83.58 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.88 0.372 . . . . 0.0 111.025 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.465 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . -62.49 -44.38 96.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.61 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.573 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 1.4 mtp180 -58.55 -45.12 89.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.748 0.308 . . . . 0.0 111.253 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.2 pt-20 -71.67 -47.57 53.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.076 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.99 73.0 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.442 ' CG1' ' HB2' ' A' ' 32' ' ' ALA . 9.1 p -53.3 -55.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 121.26 -0.176 . . . . 0.0 110.821 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.437 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.68 -40.77 79.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.5 0.191 . . . . 0.0 110.988 179.208 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 47.9 tt0 -60.27 -48.06 83.33 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.363 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.4 mt -53.84 -19.56 4.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.723 0.297 . . . . 0.0 110.966 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.74 42.93 0.84 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.433 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -175.65 106.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 111.21 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' O ' ' CA ' ' A' ' 1' ' ' MET . 28.5 t0 -61.26 164.35 5.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.105 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 2' ' ' MET . . . -148.0 179.28 7.85 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.58 110.95 9.66 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.573 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 17.7 m-85 -98.0 109.63 22.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.408 0.623 . . . . 0.0 111.982 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -109.97 124.61 51.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.35 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HA ' HG13 ' A' ' 6' ' ' ILE . 2.9 tmmt? -92.38 144.2 25.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.579 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.733 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -118.49 172.28 5.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.374 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -155.7 75.35 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.277 0.56 . . . . 0.0 109.944 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER 157.5 136.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.418 -179.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.753 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -54.03 -20.6 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 -179.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -51.38 -45.12 62.35 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -86.44 -31.77 21.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.3 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.753 ' HB ' ' HA ' ' A' ' 40' ' ' MET . 62.7 mt -63.59 -56.07 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-O 121.549 0.69 . . . . 0.0 111.503 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -36.52 83.64 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.086 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -55.76 -24.13 33.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.103 0.478 . . . . 0.0 110.362 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.591 ' CB ' ' HE2' ' A' ' 7' ' ' TYR . . . -77.61 -41.86 37.11 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.525 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.89 -7.64 23.69 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.558 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.588 HD22 ' N ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -78.1 157.21 29.57 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.887 0.375 . . . . 0.0 110.933 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.89 -22.76 9.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.856 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 63' ' ' MET . . . -79.7 170.49 16.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.049 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.5 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 2.7 mp -71.96 -70.08 0.31 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.793 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 51' ' ' LEU . 47.8 Cg_endo -69.92 60.13 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.056 1.837 . . . . 0.0 112.234 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -83.68 128.82 8.77 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.415 ' CD1' ' CG2' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -121.97 107.93 12.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.759 0.314 . . . . 0.0 110.244 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.74 124.5 43.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.199 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.432 ' CG1' ' CG1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.85 139.59 40.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.193 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.49 26.78 0.54 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.823 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.75 35.19 46.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.317 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -144.94 103.24 3.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.944 0.402 . . . . 0.0 111.132 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.455 ' N ' HD13 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -54.5 132.71 45.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.494 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.6 -5.21 1.57 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.544 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 0.7 OUTLIER -154.17 124.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.919 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.54 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -145.73 134.55 22.4 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.367 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.467 ' N ' ' HB2' ' A' ' 50' ' ' ALA . . . 80.2 -1.5 80.36 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.884 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -178.35 100.43 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.779 0.323 . . . . 0.0 110.582 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.415 ' CG2' ' CD1' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -65.09 137.28 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.065 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.73 164.38 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.33 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.8 p -92.16 -179.76 5.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.136 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.424 ' O ' HG22 ' A' ' 72' ' ' ILE . 16.5 pttm -64.14 -49.28 72.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.673 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -71.82 -30.23 65.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.722 0.296 . . . . 0.0 111.142 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.69 -51.33 23.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.373 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.465 HD13 HG21 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -55.65 -45.87 79.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.139 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.418 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 13.4 tttt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.834 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.443 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 2.2 tpp . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.559 0.219 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.514 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 8.2 tpp -80.65 112.01 17.61 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -70.12 118.3 12.78 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.028 0.442 . . . . 0.0 110.94 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 2' ' ' MET . 2.3 mp -126.14 124.95 66.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.941 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 3.7 mt-30 -110.36 139.1 45.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.945 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.5 mp -119.86 113.46 40.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.08 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.845 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 83.7 m-85 -104.71 115.94 31.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.249 0.547 . . . . 0.0 112.465 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.459 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 128.93 -66.91 0.56 Allowed Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.649 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 53.53 -84.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.608 0.242 . . . . 0.0 111.502 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 8' ' ' GLY . . . -58.96 -53.85 42.95 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.492 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.3 m -98.71 33.67 2.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.459 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -155.0 126.22 7.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -76.05 7.57 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.666 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.1 p -55.98 -20.38 16.17 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.735 0.303 . . . . 0.0 111.402 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.39 -25.46 6.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.511 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.7 mtt -63.49 -62.14 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.728 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.3 tp -64.46 -24.03 67.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.782 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.75 -51.78 67.55 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.411 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -67.62 -47.39 69.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.818 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -56.51 -39.66 73.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.913 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.73 -46.97 87.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.605 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.476 ' CG ' ' CD1' ' A' ' 34' ' ' PHE . 41.8 mtp180 -54.63 -38.05 66.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.803 0.335 . . . . 0.0 111.14 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.8 tt0 -73.57 -49.92 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.8 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -60.55 -50.93 71.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.786 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.452 ' CG1' ' HB3' ' A' ' 32' ' ' ALA . 13.8 p -53.23 -56.05 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.631 0.253 . . . . 0.0 110.64 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.439 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 0.7 OUTLIER -65.48 -47.64 75.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 0.0 110.923 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 17.8 tp10 -56.03 -48.07 76.67 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.283 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -53.32 -21.92 6.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.809 0.338 . . . . 0.0 110.765 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.62 47.41 0.63 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.597 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.6 tt -179.23 128.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.305 0.574 . . . . 0.0 111.471 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' O ' ' CA ' ' A' ' 1' ' ' MET . 17.0 t0 -69.68 164.32 23.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.604 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.514 ' HA ' ' N ' ' A' ' 2' ' ' MET . . . -147.21 175.47 10.72 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.23 107.72 9.19 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.071 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.479 ' CD2' ' HB ' ' A' ' 4' ' ' ILE . 25.2 m-85 -101.38 108.58 20.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.346 0.594 . . . . 0.0 111.179 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -118.73 124.74 48.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.67 143.68 26.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.206 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.826 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -110.08 -178.02 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.333 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.488 ' N ' HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -158.92 75.37 0.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.106 0.479 . . . . 0.0 110.62 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.479 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER 158.14 130.05 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.96 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.493 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -52.63 -27.28 16.47 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 121.245 -0.182 . . . . 0.0 111.153 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.48 -39.0 56.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -86.75 -35.87 18.94 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.974 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.845 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 20.9 mt -60.76 -54.82 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.077 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.425 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.405 HD22 ' O ' ' A' ' 40' ' ' MET . 0.2 OUTLIER -58.7 -37.33 75.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.768 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.18 -25.27 31.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 110.565 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' HB2' HD12 ' A' ' 48' ' ' LEU . . . -73.64 -34.75 65.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.996 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.12 -5.17 35.95 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.018 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.624 ' N ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -74.1 157.11 36.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.084 0.469 . . . . 0.0 111.512 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.6 p -112.41 -8.73 13.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.21 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.452 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -102.38 -175.41 2.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.41 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.614 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -86.1 -64.21 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.63 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.614 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 11.7 Cg_exo -69.53 59.87 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.254 1.969 . . . . 0.0 111.82 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.442 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -87.44 141.41 17.37 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.226 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.42 ' HB3' ' CG1' ' A' ' 62' ' ' ILE . 4.8 tt -135.27 111.45 9.64 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.32 124.42 42.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.934 0.397 . . . . 0.0 111.123 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.431 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -113.6 139.4 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.06 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 49.56 24.71 1.21 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.598 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.75 28.55 56.81 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.318 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -143.25 104.2 4.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.859 0.361 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.409 HD23 ' HB2' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -46.07 131.77 9.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.921 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.84 -13.84 7.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.985 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.42 ' CG1' ' HB3' ' A' ' 54' ' ' LEU . 2.7 pp -152.98 146.88 14.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.553 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 1.6 mtp -146.24 125.53 13.05 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.889 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.599 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 89.06 -17.17 53.07 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.034 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 178.22 109.77 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.4 m -49.51 174.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.88 0.371 . . . . 0.0 111.445 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.402 ' N ' HG23 ' A' ' 62' ' ' ILE . . . -92.61 -165.67 1.39 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.046 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.2 m -113.4 163.16 15.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.812 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -55.75 -42.79 75.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -65.85 -32.63 74.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.804 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.47 -48.98 29.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.046 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.407 HG21 ' N ' ' A' ' 73' ' ' LYS . 16.9 tt -62.46 -46.74 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.204 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.407 ' N ' HG21 ' A' ' 72' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.896 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.434 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.825 0.345 . . . . 0.0 111.284 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.482 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -83.99 116.11 22.66 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.83 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -69.12 118.34 11.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.016 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 4.3 mt -128.8 123.03 58.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.094 0.473 . . . . 0.0 111.88 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -111.96 142.84 43.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.314 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.427 HG12 ' HA ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -120.55 106.23 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.767 0.318 . . . . 0.0 110.766 179.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.888 ' CD2' ' HA ' ' A' ' 43' ' ' ILE . 59.2 m-85 -91.77 109.68 21.01 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.069 0.461 . . . . 0.0 111.412 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.17 -100.1 0.14 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.269 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 51.86 100.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.874 0.369 . . . . 0.0 111.411 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.17 18.49 26.48 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.697 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.63 -41.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.346 . . . . 0.0 110.818 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.12 132.5 39.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.174 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -76.56 20.4 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.06 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.413 ' HA ' HG11 ' A' ' 66' ' ' VAL . 3.4 p -54.1 -24.06 16.2 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.953 0.406 . . . . 0.0 111.206 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.27 -32.79 64.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.111 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 23.0 ttt -63.61 -62.07 1.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.752 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.408 HD11 ' N ' ' A' ' 67' ' ' ALA . 1.2 tt -64.69 -20.05 66.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 110.637 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -58.88 -54.35 48.06 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.303 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -50.09 43.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -54.83 -49.19 71.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.072 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.02 -40.88 74.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.517 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.513 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -57.32 -41.02 79.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.259 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -74.39 -50.4 18.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.106 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.22 73.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.77 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.557 ' CG1' ' HB3' ' A' ' 32' ' ' ALA . 6.2 p -53.64 -55.53 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.154 -0.218 . . . . 0.0 110.614 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.474 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -64.65 -48.99 72.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 178.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -57.85 -42.85 85.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.51 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -53.58 -20.01 4.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.811 0.339 . . . . 0.0 110.883 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.98 41.95 0.88 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.49 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.0 tt -179.22 120.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.24 0.543 . . . . 0.0 111.058 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.434 ' O ' ' CA ' ' A' ' 1' ' ' MET . 5.0 t70 -62.64 163.97 8.33 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.762 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.557 ' HB3' ' CG1' ' A' ' 25' ' ' VAL . . . -157.77 141.04 15.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.641 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -103.83 119.58 39.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.561 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.533 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 13.3 m-85 -103.17 109.59 21.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.349 0.595 . . . . 0.0 111.906 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -108.64 122.45 47.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.824 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.427 ' HA ' HG12 ' A' ' 6' ' ' ILE . 1.9 mtpt -90.21 141.37 28.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.059 0.457 . . . . 0.0 111.13 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.781 HG13 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -108.8 175.31 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.594 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -160.06 74.93 0.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.892 0.377 . . . . 0.0 110.896 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.544 ' O ' HG13 ' A' ' 43' ' ' ILE . 3.2 mt-10 157.0 127.29 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.311 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.54 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -53.96 -26.67 26.84 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.924 -0.126 . . . . 0.0 111.111 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.66 -39.84 58.92 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -86.62 -33.15 20.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.206 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.888 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 13.1 mt -63.18 -55.87 20.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.547 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.402 HD22 ' O ' ' A' ' 40' ' ' MET . 0.4 OUTLIER -61.02 -35.89 78.06 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.681 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.86 -22.51 59.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.102 0.477 . . . . 0.0 110.234 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.451 ' HB1' ' CZ ' ' A' ' 7' ' ' TYR . . . -73.42 -36.35 65.95 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.913 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 121.13 -15.08 9.45 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.583 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.533 HD21 ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.85 158.79 32.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.361 0.58 . . . . 0.0 111.689 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 t -105.78 -28.07 10.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.458 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.42 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -81.93 -177.62 6.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.063 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.508 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -89.89 -55.57 0.29 Allowed Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.486 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 51' ' ' LEU . 14.6 Cg_exo -69.65 56.89 1.38 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.511 2.141 . . . . 0.0 112.473 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -81.46 142.25 22.73 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.475 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.2 105.32 7.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.95 122.13 40.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.987 0.422 . . . . 0.0 111.507 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.408 ' CG1' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -119.53 139.28 47.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.192 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.48 27.49 0.97 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.659 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.92 33.2 55.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.269 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.94 101.71 3.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.938 0.399 . . . . 0.0 111.171 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.44 127.42 22.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.608 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -125.72 -13.47 6.43 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.49 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 6.5 mt -139.63 130.55 32.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.523 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.509 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 4.0 mpp? -146.72 134.62 21.33 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.963 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.441 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 86.74 -10.61 67.04 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.575 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 3.8 ttp180 176.85 104.96 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.719 0.295 . . . . 0.0 110.436 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.416 ' HA ' ' CG2' ' A' ' 62' ' ' ILE . 2.1 p -59.28 142.84 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.839 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.408 ' N ' HD11 ' A' ' 17' ' ' LEU . . . -67.43 170.79 6.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.806 0.336 . . . . 0.0 111.349 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.67 172.04 7.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.79 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.02 -38.02 69.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.281 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -73.29 -39.39 65.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 111.106 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -69.23 -49.69 54.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.198 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.457 HD11 HG23 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -57.22 -46.72 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.253 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.8 tttm . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.866 179.919 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.424 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.498 0.189 . . . . 0.0 111.266 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.515 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -76.54 112.56 13.21 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.762 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 100.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.042 0.449 . . . . 0.0 110.126 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.477 ' CG2' ' CD2' ' A' ' 34' ' ' PHE . 4.3 mt -110.61 130.26 64.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.51 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.474 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 14.3 mt-30 -110.81 144.36 39.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.19 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.436 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -128.2 107.96 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-O 120.82 0.343 . . . . 0.0 110.975 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.742 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 6.1 m-30 -100.11 112.8 25.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.125 0.488 . . . . 0.0 111.469 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.57 -104.51 0.24 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.572 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 62.37 136.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 0.0 111.063 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.52 25.67 42.97 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -175.99 -67.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 110.685 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.5 137.89 50.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -76.27 13.82 0.85 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.156 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.403 ' HB2' HG21 ' A' ' 6' ' ' ILE . 4.6 p -56.22 -29.22 60.67 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.915 0.388 . . . . 0.0 111.209 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.34 -35.26 60.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.45 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 tpt -64.78 -62.65 1.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.346 . . . . 0.0 111.127 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.431 ' CB ' ' HB ' ' A' ' 66' ' ' VAL . 3.5 tm? -66.37 -24.18 66.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.767 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.17 -49.82 74.78 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.22 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.1 -46.09 82.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.43 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -54.91 -45.53 74.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.551 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.74 -41.51 82.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.473 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.511 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 3.9 mtm180 -55.68 -41.68 74.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.038 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 13.9 tt0 -73.77 -49.85 23.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.186 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -62.28 -51.88 65.93 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' A' ' 26' ' ' LYS . 2.9 p -53.3 -53.98 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.418 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.487 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 3.4 mtpm? -65.46 -48.88 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.82 0.343 . . . . 0.0 110.841 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.411 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 4.4 tm-20 -58.13 -42.87 86.75 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.535 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -51.35 -21.36 2.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.878 0.37 . . . . 0.0 110.955 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.76 34.37 1.71 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.226 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -169.37 113.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.429 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 2.2 t0 -61.07 164.13 5.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.213 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 2' ' ' MET . . . -150.87 167.56 27.14 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -125.86 115.14 19.51 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.26 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.511 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 12.4 m-85 -100.2 108.72 20.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.337 0.589 . . . . 0.0 111.093 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -110.57 112.24 24.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.696 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 mtmt -82.23 141.36 33.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.243 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.742 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -112.3 159.75 12.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.29 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -139.92 75.34 1.51 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.325 0.583 . . . . 0.0 110.123 179.197 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 0.3 OUTLIER 157.59 134.66 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.566 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.641 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 3.6 ttm -56.39 -16.91 6.47 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -51.17 -45.94 61.93 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.48 -31.62 21.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.299 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.663 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 30.4 mt -64.57 -54.73 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 121.504 0.668 . . . . 0.0 111.383 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -36.26 83.3 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.007 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 28.6 tt0 -54.88 -26.19 33.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.209 0.528 . . . . 0.0 110.041 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.618 ' CB ' ' HE2' ' A' ' 7' ' ' TYR . . . -74.59 -46.73 36.73 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.084 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.63 -7.76 13.51 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.528 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.572 HD22 ' N ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -76.26 155.22 34.55 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.774 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.82 -26.07 9.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.788 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.516 ' CB ' ' HB2' ' A' ' 63' ' ' MET . . . -75.73 179.66 5.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.59 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.476 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -81.69 -68.59 0.19 Allowed Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.117 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 51' ' ' LEU . 45.0 Cg_endo -70.01 57.33 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.201 1.934 . . . . 0.0 113.809 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.454 ' HA2' ' HB3' ' A' ' 63' ' ' MET . . . -72.2 141.52 31.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.033 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 62' ' ' ILE . 0.1 OUTLIER -130.76 104.07 6.96 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.483 ' CB ' HD11 ' A' ' 60' ' ' LEU . . . -98.39 123.48 42.53 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.102 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.463 ' CG1' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -120.8 141.04 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.657 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 47.19 26.92 0.74 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.938 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.38 29.52 55.83 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.404 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -140.92 103.7 4.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.912 0.386 . . . . 0.0 110.84 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.499 HD11 ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -72.87 126.53 30.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.161 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -147.16 10.18 0.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 54' ' ' LEU . 5.2 mt -147.1 103.9 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.989 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.516 ' HB2' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.37 149.92 35.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.132 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.511 ' N ' ' HB1' ' A' ' 50' ' ' ALA . . . 84.53 -5.94 79.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.978 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.427 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER 165.4 105.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.431 ' HB ' ' CB ' ' A' ' 17' ' ' LEU . 10.3 m -61.14 163.89 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 111.193 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.27 169.18 16.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.063 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 m -82.96 178.2 8.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.911 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -65.35 -53.4 44.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.264 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -33.22 72.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.343 . . . . 0.0 110.931 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -72.62 -48.13 42.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.054 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -42.21 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.996 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.635 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.444 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 2.7 ttp . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.448 0.166 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.496 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 2.3 mmt -81.11 113.03 19.01 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.947 0.403 . . . . 0.0 110.824 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 120.14 14.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.068 0.461 . . . . 0.0 110.767 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.451 ' CG2' ' CD2' ' A' ' 34' ' ' PHE . 2.1 mp -129.09 124.82 61.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.454 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -111.1 141.98 43.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.257 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.429 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -130.28 113.44 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 0.0 110.608 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.359 ' CD2' ' CE2' ' A' ' 7' ' ' TYR . 27.5 m-85 -100.51 113.02 25.48 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.298 0.571 . . . . 0.0 112.042 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 171.24 -100.62 0.16 Allowed Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.412 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.91 103.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.786 0.326 . . . . 0.0 111.302 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.48 -28.62 11.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.711 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.8 p -138.57 -48.36 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 111.134 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.436 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -73.45 132.7 43.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -76.56 19.73 0.25 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.196 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.5 p -55.62 -23.06 25.53 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.808 0.337 . . . . 0.0 111.234 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -33.79 72.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.174 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 38.1 ttp -64.58 -62.09 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.372 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.451 ' CD1' ' HB1' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -60.97 -33.21 72.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.694 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -56.47 -39.84 73.88 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.666 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -73.52 -52.4 13.69 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.849 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 30.7 p30 -64.22 -34.02 77.14 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.849 0.357 . . . . 0.0 110.803 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.451 ' HB1' ' CD1' ' A' ' 17' ' ' LEU . . . -62.07 -49.28 76.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.026 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 2.2 mtm-85 -54.76 -39.04 67.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.716 0.293 . . . . 0.0 111.007 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -72.18 -50.26 29.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.079 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.43 -50.52 71.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.682 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.477 ' CG1' ' HB1' ' A' ' 32' ' ' ALA . 11.1 p -53.54 -55.8 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.607 0.241 . . . . 0.0 110.473 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.456 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 11.8 mtpt -64.15 -49.36 72.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.755 0.312 . . . . 0.0 110.682 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -55.72 -47.15 77.38 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.349 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -51.64 -22.3 3.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.856 0.36 . . . . 0.0 110.872 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.8 36.12 1.44 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.336 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -168.55 112.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.041 0.448 . . . . 0.0 111.103 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.453 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 30.5 t70 -61.44 164.61 5.52 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.49 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.496 ' HA ' ' N ' ' A' ' 2' ' ' MET . . . -148.65 171.72 15.72 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -128.51 110.23 12.1 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.957 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.492 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 15.1 m-85 -100.46 108.96 21.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.323 0.583 . . . . 0.0 111.374 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -113.17 121.05 43.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.789 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.414 ' HA ' HG12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -94.45 139.63 30.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.075 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.826 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -106.98 179.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.124 -179.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.438 ' N ' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -155.34 74.92 0.92 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.116 0.484 . . . . 0.0 110.884 179.114 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER 162.25 126.62 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.006 179.676 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.499 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 15.2 mtt -52.55 -29.24 24.42 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.569 0.223 . . . . 0.0 110.764 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.93 -38.13 55.2 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.884 ' O ' ' CE2' ' A' ' 7' ' ' TYR . 7.4 mt-30 -86.6 -34.94 19.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.083 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.872 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 10.7 mt -62.84 -54.67 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.512 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.58 -34.26 77.42 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.924 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.04 -23.58 62.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.919 0.39 . . . . 0.0 110.427 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.438 ' CB ' HD11 ' A' ' 48' ' ' LEU . . . -73.11 -36.52 66.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.707 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.76 -9.05 14.57 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.842 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.514 HD23 ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -69.21 150.08 47.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.495 0.648 . . . . 0.0 111.243 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.31 -19.36 19.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.431 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.437 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -100.92 -173.37 2.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.212 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.512 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.0 OUTLIER -86.87 -57.4 0.32 Allowed Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.643 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 17.0 Cg_exo -67.87 58.19 0.83 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.618 2.212 . . . . 0.0 112.38 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.417 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -74.88 148.32 37.94 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.559 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -137.24 100.1 4.16 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.92 119.43 36.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.188 0.518 . . . . 0.0 111.217 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.44 ' CG1' ' CG1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -115.03 138.74 44.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.888 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 47.25 27.25 0.82 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.497 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.53 35.43 47.01 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.284 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -148.47 100.66 3.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 0.0 111.268 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.75 129.45 14.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.974 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.42 -13.16 4.39 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.407 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 4.8 mm -139.59 135.84 39.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.754 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.466 ' CG ' ' HB2' ' A' ' 48' ' ' LEU . 1.4 mpp? -146.48 133.28 20.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.52 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.503 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 83.23 -6.34 72.46 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.273 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 173.44 103.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.4 HG23 ' CB ' ' A' ' 17' ' ' LEU . 9.0 p -48.47 155.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.337 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.77 178.74 0.57 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.894 0.378 . . . . 0.0 111.158 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 74.3 m -110.17 169.57 8.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.008 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.404 ' O ' HG23 ' A' ' 72' ' ' ILE . 46.0 tttm -58.38 -45.86 87.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.239 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -73.1 -29.8 63.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 0.0 111.052 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -73.39 -46.69 47.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.376 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.465 HG22 HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -61.71 -46.18 97.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.139 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 0.0 110.816 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.456 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 9.1 ptp . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.361 0.124 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.47 ' CB ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -81.35 109.74 16.13 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.796 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -69.26 103.55 1.98 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.132 0.491 . . . . 0.0 110.664 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.429 HG13 ' CG1' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -101.64 116.65 45.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.107 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.464 ' CB ' HD12 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -110.11 115.04 29.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.017 179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.41 HG13 ' HA ' ' A' ' 36' ' ' LYS . 15.8 pt -100.41 109.26 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-O 121.086 0.47 . . . . 0.0 111.847 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.704 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 90.3 m-85 -90.44 125.91 35.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.93 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.79 -82.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.514 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p 51.85 78.36 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 111.285 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.14 -84.01 0.18 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.542 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.9 m -93.99 -29.99 14.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.798 0.332 . . . . 0.0 110.926 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.42 133.28 53.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.384 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -76.63 20.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.083 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.2 p -53.03 -23.47 7.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.893 0.378 . . . . 0.0 111.287 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -39.45 71.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 16.9 ttt -68.08 -51.36 47.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.507 ' HB2' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -69.04 -25.89 64.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.987 0.423 . . . . 0.0 110.389 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -58.78 -52.92 63.67 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.243 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -65.79 -44.71 84.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.829 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -58.12 -54.32 48.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.165 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.443 ' CB ' ' HE2' ' A' ' 34' ' ' PHE . . . -53.02 -36.3 60.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.32 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.593 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -60.4 -48.87 79.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.319 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.2 pt-20 -71.59 -47.83 52.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.298 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.03 -49.88 72.88 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.484 ' CG1' ' N ' ' A' ' 26' ' ' LYS . 4.9 p -53.48 -54.99 15.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.919 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.484 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 5.7 mtmm -70.04 -49.03 55.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.265 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 22.9 tt0 -51.81 -46.68 64.34 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.732 0.301 . . . . 0.0 111.172 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.47 -23.66 4.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.978 0.418 . . . . 0.0 110.487 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.53 37.57 1.3 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.572 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -167.97 117.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.987 0.422 . . . . 0.0 111.642 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.456 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -61.42 165.53 4.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.895 178.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.47 ' HB3' ' CB ' ' A' ' 2' ' ' MET . . . -148.31 179.2 7.95 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -129.45 113.98 15.57 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.593 ' CZ ' ' HA ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -100.31 109.75 21.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.279 0.561 . . . . 0.0 111.659 -178.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -126.21 128.55 47.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.073 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.41 ' HA ' HG13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -79.76 151.94 30.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.961 0.41 . . . . 0.0 110.762 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.689 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -123.27 78.35 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.938 -178.271 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.9 tttt -77.47 75.77 4.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.14 0.495 . . . . 0.0 110.825 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.07 127.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.414 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.624 ' HA ' HG21 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -63.92 -27.21 68.99 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.031 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.402 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 2.1 t0 -51.48 -36.76 45.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.22 -33.41 18.13 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.893 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.704 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -68.51 -45.22 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.073 0.463 . . . . 0.0 111.432 -179.195 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.42 ' N ' ' CG1' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -65.48 -37.96 88.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.178 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -60.59 -22.06 63.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.243 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.47 -35.4 53.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.0 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.87 -8.35 21.6 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.628 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.443 ' HB2' ' HG3' ' A' ' 63' ' ' MET . 0.0 OUTLIER -81.46 158.8 24.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.431 0.616 . . . . 0.0 111.597 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 t -114.92 -31.87 5.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.587 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.23 -159.73 0.1 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.23 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.484 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.6 OUTLIER -101.87 -56.28 0.12 Allowed Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.483 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.548 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 21.1 Cg_exo -65.55 57.81 0.36 Allowed 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.477 2.118 . . . . 0.0 113.561 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -88.48 136.03 13.44 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.164 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.422 ' HG ' ' CD1' ' A' ' 17' ' ' LEU . 3.4 tm? -138.31 114.78 10.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.741 0.305 . . . . 0.0 110.77 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.455 ' CB ' ' CD2' ' A' ' 60' ' ' LEU . . . -109.55 131.34 55.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.03 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.429 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -117.85 139.9 43.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.111 0.482 . . . . 0.0 111.013 179.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 46.58 27.9 0.7 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.6 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.87 42.05 17.46 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.378 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.14 100.58 3.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.455 ' CD2' ' CB ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -69.01 128.17 35.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.916 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.29 7.75 1.03 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.56 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 11.0 mm -143.72 110.57 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.791 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.443 ' HG3' ' HB2' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -145.52 141.45 28.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.926 0.393 . . . . 0.0 111.509 -179.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.548 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 67.39 11.45 59.42 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.858 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -178.09 103.63 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.821 0.343 . . . . 0.0 110.621 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.507 HG11 ' HB2' ' A' ' 17' ' ' LEU . 0.9 OUTLIER -56.45 144.49 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.618 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.25 147.28 34.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.102 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.8 p -90.47 168.32 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -55.65 -41.78 74.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.13 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -69.37 -40.55 77.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.976 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -63.94 -45.91 87.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.013 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.8 mt -65.93 -50.44 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.964 179.941 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.447 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 6.9 mtp . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.731 0.3 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.468 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.05 114.54 17.03 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.828 0.347 . . . . 0.0 110.672 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.47 106.07 2.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.106 0.479 . . . . 0.0 110.105 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.458 HD13 ' CE2' ' A' ' 34' ' ' PHE . 7.3 mt -117.13 127.75 74.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.478 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.418 ' O ' ' CD2' ' A' ' 54' ' ' LEU . 2.9 mp0 -110.39 144.08 39.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.354 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.72 108.24 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.793 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.845 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 56.9 m-85 -96.94 115.64 27.79 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.289 0.566 . . . . 0.0 111.586 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 159.88 -88.87 0.11 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.331 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.8 p 49.54 96.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.843 0.354 . . . . 0.0 111.43 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.9 -78.88 0.31 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.392 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 t -85.76 -39.57 17.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.781 0.324 . . . . 0.0 110.762 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.419 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -79.45 125.77 29.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.926 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -76.49 19.95 0.24 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.131 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 p -58.77 -19.92 45.11 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.696 0.284 . . . . 0.0 111.611 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.95 -31.62 60.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.405 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.09 -52.83 61.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.673 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.428 ' CB ' HG23 ' A' ' 66' ' ' VAL . 5.6 tt -69.09 -29.87 68.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.753 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -55.55 -40.6 72.12 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.899 0.381 . . . . 0.0 110.416 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -73.03 -52.33 14.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.918 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 31.9 p30 -64.49 -33.73 76.58 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.816 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.471 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . -60.74 -47.06 88.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.941 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.534 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 12.6 mtp180 -56.89 -42.32 79.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.651 0.262 . . . . 0.0 110.905 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -47.94 49.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.055 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.97 -51.73 65.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.691 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 32' ' ' ALA . 9.8 p -53.55 -55.12 14.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.456 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -62.97 -49.15 75.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.651 178.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.11 -45.84 86.56 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.301 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -52.12 -20.69 2.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.991 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.11 46.61 0.64 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.623 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 7.9 tt 177.14 124.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.11 0.481 . . . . 0.0 111.192 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.447 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -66.08 162.64 19.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.704 179.51 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.529 ' HB3' ' CG1' ' A' ' 25' ' ' VAL . . . -154.32 142.8 20.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -104.48 114.41 28.62 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.273 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.534 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 17.8 m-85 -97.58 109.29 22.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.317 0.58 . . . . 0.0 111.471 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -110.06 114.71 28.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.62 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.51 138.54 31.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.245 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.845 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -107.29 177.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.443 ' N ' HG12 ' A' ' 37' ' ' ILE . 13.6 pttm -156.75 75.28 0.84 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.157 0.503 . . . . 0.0 110.889 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.498 ' O ' HG13 ' A' ' 43' ' ' ILE . 9.8 pt-20 157.31 130.77 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.839 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.46 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 2.2 ptt? -52.31 -25.35 9.32 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.804 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.5 -39.44 57.62 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -87.31 -38.8 15.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.166 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.837 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 8.5 mt -60.68 -55.59 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.561 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -34.83 77.42 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.879 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -57.21 -24.92 57.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.102 0.477 . . . . 0.0 110.248 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . . . -71.97 -37.24 69.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.726 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.05 -14.62 10.34 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.703 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.515 HD21 ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.86 161.18 25.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.028 0.442 . . . . 0.0 111.289 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t -110.59 -24.58 10.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.997 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.17 -179.74 7.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.417 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.549 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.6 mt -88.13 -60.08 0.25 Allowed Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.855 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 17.2 Cg_exo -66.52 49.6 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.637 2.224 . . . . 0.0 113.769 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.99 146.74 35.42 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.571 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.418 ' CD2' ' O ' ' A' ' 5' ' ' GLN . 2.8 tm? -136.55 102.4 4.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -97.9 123.68 41.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 111.335 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.45 140.67 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.181 0.515 . . . . 0.0 111.487 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 t0 48.48 25.66 0.98 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.086 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.17 25.72 50.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.413 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -139.9 104.49 4.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.891 0.377 . . . . 0.0 110.601 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -90.43 128.72 36.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.696 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -146.43 3.22 0.87 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.141 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 54' ' ' LEU . 19.5 mm -128.67 103.31 9.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.989 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -146.45 162.46 38.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.632 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . 80.9 -7.61 58.86 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.246 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER 170.37 103.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.428 HG23 ' CB ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -67.68 151.93 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.821 0.343 . . . . 0.0 111.389 -179.14 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.9 179.58 7.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.341 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 m -104.26 -170.18 1.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.932 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.41 ' O ' HG21 ' A' ' 72' ' ' ILE . 25.7 tttt -65.55 -54.51 27.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.008 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.17 -29.8 70.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.906 0.384 . . . . 0.0 110.652 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.45 -51.14 18.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.04 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.441 HG23 ' N ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -60.76 -42.85 93.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.858 0.361 . . . . 0.0 110.964 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.441 ' N ' HG23 ' A' ' 72' ' ' ILE . 16.6 tptm . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.706 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.426 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 8.6 ttp . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.554 0.216 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.491 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 1.4 mtt -77.73 113.61 15.76 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.951 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -69.35 100.8 1.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.012 0.434 . . . . 0.0 109.958 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.446 HG12 ' CG1' ' A' ' 56' ' ' VAL . 3.5 mt -109.95 135.66 48.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.998 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.443 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 22.2 mm-40 -111.36 143.98 41.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.376 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.464 ' CG2' ' HB2' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -127.3 100.34 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 120.972 0.415 . . . . 0.0 110.349 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.753 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 8.3 m-30 -94.19 116.31 28.69 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.3 0.572 . . . . 0.0 112.155 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.16 -90.52 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.213 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 m 48.57 29.71 2.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.76 0.314 . . . . 0.0 111.528 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.86 108.85 0.23 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.499 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t 59.78 27.17 16.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 110.994 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 14' ' ' CYS . . . -124.73 132.47 53.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.896 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -76.12 20.74 0.19 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.699 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.464 ' HB2' ' CG2' ' A' ' 6' ' ' ILE . 1.8 p -51.51 -28.96 15.0 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.953 0.406 . . . . 0.0 111.128 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -36.18 73.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.008 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 14.3 mtt -68.62 -50.67 49.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.354 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.44 ' N ' HG12 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -71.09 -31.19 67.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.994 0.426 . . . . 0.0 110.628 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -58.48 -42.36 87.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.617 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.45 -42.4 62.01 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 36.1 p30 -74.96 -34.62 62.07 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.734 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.499 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . -66.28 -50.44 63.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.558 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.563 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -59.91 -44.46 94.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.583 0.23 . . . . 0.0 111.457 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 41.7 tp10 -72.69 -50.17 26.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.622 0.248 . . . . 0.0 110.966 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -62.34 -51.8 66.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.692 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.478 ' CG1' ' HB2' ' A' ' 32' ' ' ALA . 4.0 p -53.3 -54.91 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.914 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.476 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 11.1 mtmm -67.27 -46.6 73.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.636 0.255 . . . . 0.0 111.112 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.435 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -58.57 -46.24 87.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.359 -179.576 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -52.01 -21.83 3.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.924 0.393 . . . . 0.0 110.851 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.79 50.3 0.52 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.528 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 6.8 tt 178.03 122.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.238 0.542 . . . . 0.0 111.371 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.426 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -62.94 164.54 8.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.373 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.491 ' HA ' ' N ' ' A' ' 2' ' ' MET . . . -153.59 151.52 29.84 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -111.91 113.47 25.8 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.05 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.563 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 69.0 m-85 -99.85 108.81 21.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.281 0.563 . . . . 0.0 111.634 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -107.24 110.63 22.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.257 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -84.44 136.83 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.69 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.753 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -113.0 164.37 8.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.064 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -140.62 75.43 1.51 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.992 0.425 . . . . 0.0 110.73 179.553 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 1.4 mm-40 155.26 132.81 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.828 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.508 ' HA ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -57.02 -28.43 62.49 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.709 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.5 -33.58 32.17 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -86.93 -33.07 19.81 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.356 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.704 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 0.9 OUTLIER -71.19 -50.82 39.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 CA-C-O 121.083 0.468 . . . . 0.0 111.601 -179.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.492 ' N ' ' CG1' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -57.22 -36.21 70.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.58 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -53.73 -25.42 18.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.973 0.416 . . . . 0.0 110.173 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.516 ' CB ' ' HE2' ' A' ' 7' ' ' TYR . . . -78.67 -46.33 19.39 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.387 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.93 -20.6 4.52 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.518 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.532 HD23 ' N ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.0 155.67 39.95 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.895 0.379 . . . . 0.0 111.068 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.86 -16.22 12.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.394 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.407 ' HB2' ' N ' ' A' ' 64' ' ' GLY . . . -89.19 -179.14 5.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.791 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.594 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.6 mp -83.72 -63.95 0.24 Allowed Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 16.4 Cg_exo -67.45 51.58 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.392 2.061 . . . . 0.0 112.927 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.74 116.75 4.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.22 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.05 107.19 18.06 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.28 123.53 42.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.038 0.447 . . . . 0.0 111.632 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.446 ' CG1' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.37 139.01 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.919 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.8 t70 46.68 27.81 0.71 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.355 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.87 37.55 50.68 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.233 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -150.09 101.84 3.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 111.304 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.407 HD11 ' CB ' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -46.0 133.37 8.87 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.015 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.79 -16.8 2.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.994 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.458 HD12 HG21 ' A' ' 62' ' ' ILE . 15.6 mt -154.34 111.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.586 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -145.64 150.91 37.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.021 0.439 . . . . 0.0 111.627 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . 83.4 -5.18 78.73 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.544 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 45.2 ttp85 174.25 106.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.743 0.306 . . . . 0.0 110.423 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 17' ' ' LEU . 2.6 t -54.34 141.06 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.651 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.83 142.27 27.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.043 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.4 t -63.66 156.95 25.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.1 -30.4 25.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.284 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -42.2 96.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.837 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -67.18 -41.87 85.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.995 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.7 mm -58.88 -53.19 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 tptm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.842 179.952 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.437 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.452 0.168 . . . . 0.0 111.179 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.46 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -82.64 112.84 19.88 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.08 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.6 104.9 2.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.128 0.489 . . . . 0.0 110.253 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.478 ' CD1' ' CZ ' ' A' ' 34' ' ' PHE . 2.2 mp -108.57 127.57 64.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.39 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.425 ' CB ' HD12 ' A' ' 37' ' ' ILE . 2.0 mt-30 -110.29 125.6 53.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.016 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.435 ' CG2' ' HB2' ' A' ' 14' ' ' CYS . 3.3 mp -103.93 98.3 6.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.324 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.733 ' CE1' HG13 ' A' ' 37' ' ' ILE . 93.8 m-85 -93.5 116.92 29.46 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 120.926 0.393 . . . . 0.0 111.2 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 118.37 -1.99 16.21 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.088 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 t -40.05 120.1 1.12 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 111.668 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.3 -54.43 0.54 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.338 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.1 m -101.98 -33.01 9.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.917 0.389 . . . . 0.0 110.73 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.431 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -86.32 152.3 22.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.015 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -75.95 8.99 2.66 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.7 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.435 ' HB2' ' CG2' ' A' ' 6' ' ' ILE . 3.4 p -54.19 -30.99 51.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.998 0.427 . . . . 0.0 111.273 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -36.59 42.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.601 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 10.4 tpp -63.77 -62.44 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.092 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.447 ' CB ' ' HB ' ' A' ' 66' ' ' VAL . 6.5 tp -65.66 -24.7 67.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.697 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -55.7 -50.42 70.35 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.849 0.357 . . . . 0.0 110.136 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -47.07 76.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.693 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -56.11 -44.62 79.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.16 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.48 -40.84 83.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.805 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.57 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -59.11 -46.81 87.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.659 0.266 . . . . 0.0 111.245 -179.604 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 10.8 pt-20 -71.95 -47.33 53.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.226 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.5 -50.74 70.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.484 ' CG1' ' N ' ' A' ' 26' ' ' LYS . 5.9 p -53.62 -55.74 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.591 0.234 . . . . 0.0 110.763 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.484 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 21.3 mtpp -66.99 -49.9 63.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.38 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 2.0 tt0 -52.86 -48.19 67.26 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.59 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mt -52.46 -21.26 3.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.86 0.362 . . . . 0.0 110.719 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.55 30.68 2.56 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.311 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -156.75 107.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.963 0.411 . . . . 0.0 111.075 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.437 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.7 OUTLIER -61.56 164.16 6.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.042 179.331 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 2' ' ' MET . . . -152.53 175.66 12.52 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -129.6 114.14 15.69 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.57 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 40.8 m-85 -102.13 108.94 20.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.553 0.692 . . . . 0.0 112.278 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -118.38 129.45 55.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.008 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.98 153.09 30.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.103 0.478 . . . . 0.0 111.127 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.733 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -128.14 76.56 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.463 -178.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.53 75.65 4.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.061 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.461 ' O ' HG22 ' A' ' 43' ' ' ILE . 6.5 pt-20 171.47 125.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.609 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.574 ' HA ' ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -59.92 -30.48 69.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.58 0.229 . . . . 0.0 110.973 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -51.23 -33.75 29.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.409 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 28.3 mm100 -87.91 -34.57 18.1 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.984 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.653 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 2.5 pt -61.86 -51.37 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.056 0.455 . . . . 0.0 111.029 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.487 ' N ' ' CG1' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -62.84 -41.34 99.3 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.022 179.56 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -58.98 -22.41 60.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.945 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' CB ' ' CZ ' ' A' ' 7' ' ' TYR . . . -75.27 -39.76 59.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.729 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 123.4 -20.43 7.44 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.084 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.477 ' HG ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -77.28 163.75 26.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.1 m -115.58 -23.35 8.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.902 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.522 ' HB3' ' CB ' ' A' ' 63' ' ' MET . . . -78.84 173.26 12.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.47 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.621 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -78.72 -64.75 0.35 Allowed Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.292 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.621 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 15.4 Cg_exo -67.17 59.14 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.406 2.071 . . . . 0.0 112.426 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.477 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -80.9 136.83 17.01 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.602 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 tp -127.1 98.2 5.22 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.426 ' CB ' HD12 ' A' ' 60' ' ' LEU . . . -97.38 122.72 40.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.087 0.47 . . . . 0.0 111.079 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.442 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -112.94 139.98 35.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.989 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 45.5 27.05 0.36 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.726 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.2 39.44 31.81 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.31 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -149.03 100.9 3.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 111.314 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.426 HD12 ' CB ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -51.31 131.4 28.34 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.798 179.456 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.05 -16.79 4.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.015 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.46 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 2.1 mt -152.69 131.8 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.987 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.522 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.96 135.19 22.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.392 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.476 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 92.85 -10.56 73.74 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.474 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 165.69 106.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.447 ' HB ' ' CB ' ' A' ' 17' ' ' LEU . 5.8 m -53.05 166.09 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.793 0.33 . . . . 0.0 111.186 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.5 -173.98 4.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.151 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.0 t -97.77 168.85 10.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -58.1 -54.4 47.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -56.24 -39.49 72.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.982 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -56.94 -43.0 81.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.4 mm -57.9 -55.22 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.972 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.906 179.928 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.408 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.567 0.222 . . . . 0.0 111.291 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.475 ' HB3' HD11 ' A' ' 4' ' ' ILE . 3.1 ttt -82.68 114.04 20.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.917 0.389 . . . . 0.0 110.97 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.39 118.87 17.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.938 0.399 . . . . 0.0 110.576 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.491 HG13 ' CG1' ' A' ' 56' ' ' VAL . 2.7 mp -125.61 118.1 51.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.092 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.455 ' CB ' HD11 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -111.14 122.57 48.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.799 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.8 pt -104.63 110.72 31.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 CA-C-O 120.848 0.356 . . . . 0.0 111.08 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.735 ' CE1' HG13 ' A' ' 37' ' ' ILE . 93.7 m-85 -90.74 122.88 33.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.038 0.447 . . . . 0.0 111.431 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.439 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 127.83 -65.85 0.57 Allowed Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.182 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.3 m 66.07 -73.1 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.734 0.302 . . . . 0.0 111.64 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.75 -96.37 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.853 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.8 -23.55 7.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.654 0.264 . . . . 0.0 111.508 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.439 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -82.8 121.89 27.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.913 0.387 . . . . 0.0 111.357 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -76.77 21.34 0.21 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.859 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.493 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.7 p -52.83 -24.43 8.99 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.89 0.376 . . . . 0.0 111.363 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.63 -28.02 3.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.506 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -62.51 1.51 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.836 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.425 ' HB3' HG21 ' A' ' 66' ' ' VAL . 4.0 tp -68.38 -20.05 64.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.806 0.336 . . . . 0.0 110.508 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -59.12 -49.91 76.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.251 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -50.05 24.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.812 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -56.28 -50.82 70.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.114 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.6 -41.87 77.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.574 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.482 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 3.0 mtm180 -60.73 -44.43 96.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.578 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 24' ' ' ALA . 14.8 pt-20 -73.33 -45.95 52.27 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.925 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' A' ' 23' ' ' GLU . . . -64.01 -49.23 73.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.467 HG12 ' HB2' ' A' ' 32' ' ' ALA . 14.0 p -53.44 -55.52 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.458 0.171 . . . . 0.0 110.842 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.422 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.09 -43.03 79.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.549 0.214 . . . . 0.0 110.926 179.208 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 13.4 tt0 -58.57 -47.0 85.72 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.731 0.3 . . . . 0.0 110.971 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.44 -20.43 7.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.9 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.57 41.72 0.93 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.554 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -173.89 110.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.42 . . . . 0.0 111.288 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.408 ' O ' ' CA ' ' A' ' 1' ' ' MET . 38.6 t70 -61.38 163.63 6.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.375 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 25' ' ' VAL . . . -145.39 174.8 10.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -131.85 109.02 9.81 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.482 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 18.7 m-85 -100.85 108.84 20.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.503 0.668 . . . . 0.0 112.018 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -119.77 131.17 55.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.94 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.3 141.94 35.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.006 0.431 . . . . 0.0 110.646 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.735 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -116.76 70.62 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.481 -179.335 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 75.39 1.91 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.18 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.518 ' O ' HG13 ' A' ' 43' ' ' ILE . 1.3 mt-10 174.85 119.78 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.699 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.464 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 17.0 ptp -53.05 -27.76 21.39 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.467 0.175 . . . . 0.0 110.927 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -51.55 -39.87 58.6 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.43 ' HB3' HG21 ' A' ' 37' ' ' ILE . 1.9 mm-40 -87.74 -35.53 17.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.531 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.662 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 11.7 mt -62.06 -54.91 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.154 0.502 . . . . 0.0 111.216 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.88 -32.33 69.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.209 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -59.38 -38.65 81.06 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB2' ' CD1' ' A' ' 48' ' ' LEU . . . -68.71 -40.67 79.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.59 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.46 26.0 55.53 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.116 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.518 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -47.19 -87.43 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.25 0.525 . . . . 0.0 111.061 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.495 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 1.5 m 147.67 -25.52 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.563 0.745 . . . . 0.0 109.4 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -122.15 -166.79 1.45 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.838 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.55 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -83.7 -59.52 0.36 Allowed Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.575 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 11.9 Cg_exo -70.06 57.76 1.64 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.5 2.133 . . . . 0.0 112.524 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -81.44 139.45 20.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.699 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.426 HD11 ' HA ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -137.03 110.77 8.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.723 0.297 . . . . 0.0 110.944 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -99.55 123.27 43.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.035 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.491 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -115.48 137.21 49.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.307 0.575 . . . . 0.0 111.836 -179.116 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 46.62 27.45 0.65 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.738 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.8 33.41 37.6 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.315 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -148.27 97.88 2.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.863 0.363 . . . . 0.0 111.081 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 2.0 mp -60.74 134.64 57.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.03 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 2.52 1.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.475 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 3.9 mp -137.78 127.6 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.632 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.448 ' CG ' ' HB2' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -147.34 126.79 13.18 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.543 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 77.06 4.57 83.63 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.506 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 178.36 108.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.741 0.271 . . . . 0.0 110.504 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.493 ' CG2' ' HA ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -59.54 139.12 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.659 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.416 ' CB ' HD11 ' A' ' 17' ' ' LEU . . . -63.93 168.2 5.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.811 0.339 . . . . 0.0 111.346 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.4 t -103.28 -174.77 2.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.148 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.39 -57.26 13.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.137 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -53.46 -33.96 56.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.143 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.87 -37.71 88.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.2 mt -64.98 -55.07 22.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.977 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.433 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 2.6 mtm . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.616 0.246 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.483 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -76.45 113.32 13.93 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.987 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.29 118.59 12.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.411 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.51 ' CG2' ' CD2' ' A' ' 34' ' ' PHE . 7.4 mt -129.18 119.59 49.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.078 0.466 . . . . 0.0 112.117 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -112.0 123.89 51.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.333 178.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.423 ' C ' HD11 ' A' ' 37' ' ' ILE . 2.9 mp -101.74 111.82 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.661 0.267 . . . . 0.0 111.32 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.908 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 98.2 m-85 -95.17 108.59 20.72 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.073 0.463 . . . . 0.0 111.525 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.449 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 140.47 -82.3 0.24 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.468 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 m 69.68 -68.71 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 0.0 111.397 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.15 -92.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.635 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 m -54.47 -28.73 46.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 111.129 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.449 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -90.62 117.21 29.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.149 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -76.24 15.71 0.54 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.9 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.445 ' CB ' HG12 ' A' ' 66' ' ' VAL . 2.5 p -57.53 -19.92 28.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.742 0.306 . . . . 0.0 111.419 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -47.39 -28.79 2.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.572 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -60.29 3.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.73 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.421 ' HA ' ' ND2' ' A' ' 20' ' ' ASN . 0.5 OUTLIER -59.45 -37.84 79.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.383 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -54.37 -36.06 63.47 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.883 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -71.48 -52.45 18.3 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.531 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 28.4 p30 -62.68 -33.01 74.21 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.782 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.471 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . -58.89 -44.47 91.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.081 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.567 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 13.1 mtp180 -58.32 -52.64 64.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.292 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.41 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 2.7 pp20? -68.06 -50.12 57.15 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.378 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -60.87 -51.53 68.93 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 26' ' ' LYS . 3.9 p -53.66 -55.64 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.883 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.498 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 7.1 mttt -66.41 -50.25 64.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.689 0.28 . . . . 0.0 111.441 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -57.68 -41.48 81.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.384 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 1.7 mm? -53.57 -19.15 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.914 0.387 . . . . 0.0 110.899 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.76 26.23 3.96 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.409 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -156.5 112.25 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.785 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.433 ' O ' ' CA ' ' A' ' 1' ' ' MET . 2.3 m-20 -61.67 159.89 12.56 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.483 ' HA ' ' N ' ' A' ' 2' ' ' MET . . . -152.03 153.72 34.57 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -114.91 114.97 26.18 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.218 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.567 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 18.1 m-85 -98.75 108.94 21.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.361 0.601 . . . . 0.0 111.431 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -110.76 110.73 21.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.1 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 137.54 34.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.877 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.782 HG13 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -102.9 176.58 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.666 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 4.3 pttt -160.1 75.49 0.6 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.883 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.495 ' O ' HG13 ' A' ' 43' ' ' ILE . 1.4 mt-10 158.14 128.53 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.564 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.485 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -56.58 -29.81 62.47 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 121.366 -0.134 . . . . 0.0 110.867 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.46 -36.37 43.92 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -86.67 -36.94 18.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.95 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.908 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 40.4 mt -58.95 -55.49 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.731 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.35 -36.74 81.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.631 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.79 -25.39 40.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.019 0.438 . . . . 0.0 110.335 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . . . -70.93 -34.84 71.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.792 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.39 -17.87 9.57 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.745 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.506 ' N ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -83.2 169.35 15.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.936 0.398 . . . . 0.0 111.324 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.4 p -124.07 -30.1 3.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.91 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.2 -178.62 1.08 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.216 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.585 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.5 mp -86.39 -63.59 0.22 Allowed Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.658 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.585 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 17.0 Cg_exo -66.27 63.92 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.033 1.822 . . . . 0.0 111.709 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -104.04 145.52 16.11 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.098 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -150.33 129.8 13.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.0 0.429 . . . . 0.0 110.165 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.417 ' CB ' ' CD1' ' A' ' 60' ' ' LEU . . . -103.55 125.03 49.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.021 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.485 ' CG1' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -112.62 135.45 52.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.194 0.521 . . . . 0.0 111.45 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 48.12 27.35 1.23 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.257 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.75 38.64 31.12 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.344 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -154.98 99.52 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.827 0.346 . . . . 0.0 111.148 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.417 ' CD1' ' CB ' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -43.79 126.93 4.91 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.057 179.72 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.95 -17.68 9.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.91 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.423 ' CD1' ' HB3' ' A' ' 54' ' ' LEU . 1.3 pt -137.33 140.42 42.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.068 0.461 . . . . 0.0 112.103 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.413 ' HG3' ' HB2' ' A' ' 48' ' ' LEU . 1.6 ttm -145.98 114.63 6.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.606 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.557 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 88.75 -14.26 60.58 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 119.688 -1.244 . . . . 0.0 112.866 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -178.44 114.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.648 0.261 . . . . 0.0 110.355 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.445 HG12 ' CB ' ' A' ' 14' ' ' CYS . 28.8 m -54.21 -173.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.12 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.94 143.21 30.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.92 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.2 m -65.9 162.43 19.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -59.04 -47.59 84.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -67.14 -29.91 69.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.508 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -74.03 -42.0 60.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.067 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 73' ' ' LYS . 1.1 tt -73.74 -48.47 39.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.346 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.414 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.384 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.4 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 6.2 mtp . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.652 0.263 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.475 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -73.26 115.46 12.64 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.68 179.588 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.09 106.65 2.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.98 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.48 HD12 ' CZ ' ' A' ' 34' ' ' PHE . 3.5 mt -122.45 124.88 71.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.743 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.424 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 2.5 mm-40 -110.75 138.9 46.57 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.856 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.408 ' C ' HD11 ' A' ' 37' ' ' ILE . 22.4 mt -114.24 104.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.914 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 94.5 m-85 -92.78 109.27 20.7 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.986 0.422 . . . . 0.0 111.369 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 10' ' ' GLY . . . 134.55 -44.16 1.21 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.679 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 p 52.73 -85.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 8' ' ' GLY . . . -94.71 -52.4 1.82 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.709 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 m -53.1 -26.38 16.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 111.098 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.55 147.23 35.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.143 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -76.29 15.32 0.6 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.953 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 66' ' ' VAL . 2.3 p -57.3 -19.88 24.82 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.707 0.289 . . . . 0.0 111.493 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.62 -32.08 7.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.403 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 mtt -63.31 -62.08 1.92 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.559 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.0 tt -63.92 -19.81 65.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.644 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -59.35 -54.13 50.32 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.56 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -71.9 -40.23 69.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.262 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -64.54 -41.69 96.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.195 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.49 -45.89 90.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.814 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.508 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -57.39 -42.52 82.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.617 0.246 . . . . 0.0 111.238 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 14.9 pt-20 -73.88 -49.22 25.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.321 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.8 -50.4 69.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 26' ' ' LYS . 4.2 p -53.57 -52.84 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.357 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.463 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.23 -41.83 80.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.724 0.297 . . . . 0.0 110.742 178.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.421 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 1.1 tp10 -62.07 -43.79 98.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.418 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.0 -19.49 1.87 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.791 0.329 . . . . 0.0 111.027 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.52 44.58 0.7 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.8 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.2 tt 175.88 121.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.264 0.554 . . . . 0.0 111.158 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.423 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 3.6 t0 -62.53 163.81 8.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.849 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HA ' ' N ' ' A' ' 2' ' ' MET . . . -151.09 152.51 33.52 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.549 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -112.72 118.39 34.87 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.317 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.508 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 22.2 m-85 -101.78 109.39 21.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.339 0.59 . . . . 0.0 111.707 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -105.42 114.67 28.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.003 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -82.11 139.17 34.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.089 0.471 . . . . 0.0 110.813 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.799 HG13 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -104.49 175.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.682 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 7.0 ptmt -160.36 75.32 0.57 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.017 0.437 . . . . 0.0 110.916 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.507 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER 157.63 127.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.405 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.474 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 17.7 mtp -54.77 -28.51 49.3 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.987 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.34 -37.82 49.9 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -86.95 -36.52 18.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.952 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.914 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 25.9 mt -60.01 -55.26 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.767 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.79 -34.5 76.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.719 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -60.64 -21.91 63.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 0.0 110.084 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.417 ' HB1' ' CZ ' ' A' ' 7' ' ' TYR . . . -71.9 -34.76 69.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.615 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.402 ' HA3' HD22 ' A' ' 60' ' ' LEU . . . 124.22 -20.42 7.07 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.874 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.487 HD21 ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -83.32 176.69 8.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 111.026 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.3 m -126.59 -34.94 2.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.223 0.535 . . . . 0.0 110.486 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.11 -173.11 0.35 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.707 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.568 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.4 mp -92.48 -63.55 0.16 Allowed Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.456 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.616 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 28.6 Cg_exo -60.78 63.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.218 1.945 . . . . 0.0 112.645 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -103.84 147.17 16.56 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.973 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.6 tt -144.58 118.26 9.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.827 0.346 . . . . 0.0 110.862 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.4 ' CB ' ' CD1' ' A' ' 60' ' ' LEU . . . -99.57 122.65 42.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.037 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.49 136.35 53.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.511 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 46.75 28.17 0.78 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.898 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.47 30.39 58.46 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.433 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -142.97 103.95 4.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.892 0.377 . . . . 0.0 110.949 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.402 HD22 ' HA3' ' A' ' 47' ' ' GLY . 1.0 OUTLIER -54.98 127.32 28.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.06 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.68 -9.15 4.52 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.787 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.457 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 1.6 mp -134.4 127.73 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.573 0.225 . . . . 0.0 110.408 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 19.2 tmm? -146.81 116.51 7.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.83 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.616 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 70.19 3.27 44.82 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.121 -1.038 . . . . 0.0 113.651 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.97 96.6 0.21 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.919 0.359 . . . . 0.0 110.504 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.408 ' CB ' ' HA ' ' A' ' 14' ' ' CYS . 0.3 OUTLIER -68.27 129.62 32.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.813 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.79 166.04 7.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 111.345 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.9 m -98.29 173.02 7.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -57.06 -47.34 81.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.79 -36.12 76.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.966 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.42 -38.18 90.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.038 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.0 mm -61.63 -55.17 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.185 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.255 -179.793 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 2.4 mpp? . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.432 0.158 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.515 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 2.1 ttt -80.05 112.5 17.41 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.861 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -69.78 114.69 8.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.638 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 2' ' ' MET . 2.3 mp -123.24 120.7 61.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.674 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -110.83 128.28 55.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.321 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 14' ' ' CYS . 1.0 OUTLIER -113.39 109.0 26.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.683 0.277 . . . . 0.0 111.474 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.892 ' CD2' ' HA ' ' A' ' 43' ' ' ILE . 40.2 m-85 -93.69 119.2 32.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.952 0.406 . . . . 0.0 110.636 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.402 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . -173.71 -85.77 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.498 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.7 m 56.61 77.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 0.0 110.794 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.02 117.66 3.54 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.068 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 78.89 -56.97 0.44 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.69 0.281 . . . . 0.0 110.934 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.402 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -54.73 122.08 9.92 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.916 0.389 . . . . 0.0 111.053 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -76.38 20.87 0.2 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.171 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.431 ' HB2' ' HB ' ' A' ' 6' ' ' ILE . 3.3 p -52.15 -25.98 10.26 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.004 0.43 . . . . 0.0 111.181 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -31.93 72.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.643 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.5 mtp -63.52 -62.67 1.52 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.307 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.428 ' CB ' ' CG2' ' A' ' 66' ' ' VAL . 1.1 tm? -67.79 -21.48 65.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.8 0.333 . . . . 0.0 110.629 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -57.81 -48.3 80.14 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.229 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -71.54 -46.41 59.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.768 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -59.28 -36.27 75.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.149 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . . . -66.86 -50.4 62.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.108 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 20.8 ttt180 -55.66 -37.83 68.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.519 0.199 . . . . 0.0 111.406 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 23.7 pt-20 -74.24 -48.31 29.57 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.111 -0.236 . . . . 0.0 111.229 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.77 -50.95 67.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.492 HG12 ' HB1' ' A' ' 32' ' ' ALA . 8.9 p -53.8 -55.42 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.717 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.463 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 5.6 mtpm? -66.94 -49.49 65.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.108 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.454 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 45.6 tp10 -56.29 -43.77 79.19 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 110.762 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.7 tp -53.11 -22.12 5.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.557 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.65 44.73 0.75 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.442 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.0 tt 179.76 124.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.308 0.575 . . . . 0.0 111.505 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -67.66 165.22 17.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.472 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.515 ' HA ' ' N ' ' A' ' 2' ' ' MET . . . -146.12 178.26 8.35 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.78 106.39 8.66 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.861 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 66.0 m-85 -99.4 109.0 21.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.424 0.63 . . . . 0.0 111.947 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.429 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.9 OUTLIER -119.36 136.48 54.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.556 179.068 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -89.37 153.64 20.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.12 0.486 . . . . 0.0 111.112 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.793 HG13 ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -126.47 83.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.307 -179.073 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.55 75.35 9.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.138 0.494 . . . . 0.0 111.636 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.581 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER 173.07 118.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.789 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.507 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 6.2 ptt? -53.53 -35.31 60.56 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.945 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.42 -35.78 40.77 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -86.63 -35.2 19.52 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.98 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.892 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 23.3 mt -60.32 -55.9 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.553 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.02 -34.35 77.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.2 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -60.21 -21.26 61.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.406 . . . . 0.0 110.155 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.451 ' CB ' ' CZ ' ' A' ' 7' ' ' TYR . . . -72.61 -38.38 67.81 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.704 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.35 -14.62 7.76 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.473 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.552 HD21 ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.02 158.0 35.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.364 0.582 . . . . 0.0 111.119 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.5 t -107.42 -10.33 15.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.04 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.471 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -102.51 -175.28 2.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.304 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.449 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -89.64 -54.49 0.31 Allowed Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.616 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.624 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 11.1 Cg_exo -70.29 52.16 1.14 Allowed 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 122.626 2.218 . . . . 0.0 112.414 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -71.95 156.9 52.78 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.253 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.36 101.49 2.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.844 0.354 . . . . 0.0 110.779 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -100.3 126.09 46.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.809 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.451 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -118.05 140.62 40.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.141 0.496 . . . . 0.0 111.572 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 44.91 27.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.252 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.75 34.68 30.47 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.443 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.32 99.84 3.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 0.6 OUTLIER -69.9 131.31 44.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.019 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -146.09 11.45 1.2 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.719 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.487 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 3.2 mp -133.31 123.92 48.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.512 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 2.4 mtm -146.62 123.51 11.32 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.624 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 70.81 7.33 61.59 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.825 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.55 100.43 0.06 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.868 0.366 . . . . 0.0 110.588 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.457 ' HA ' HG22 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -56.34 141.84 12.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.96 -179.623 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.66 172.35 2.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.902 0.382 . . . . 0.0 111.152 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -109.43 157.81 18.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.7 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.09 -41.18 71.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.206 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -60.14 -40.77 90.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -64.6 -37.45 87.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.2 mm -59.72 -54.86 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.984 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.5 tttm . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.033 179.949 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.442 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 15.2 mmt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.463 0.173 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.488 ' O ' ' CB ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -81.31 112.36 18.54 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.836 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.408 ' CG ' ' HA ' ' A' ' 57' ' ' ASP . 17.3 ptpt -68.72 115.05 7.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.992 0.425 . . . . 0.0 110.583 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.461 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 1.5 mt -121.23 121.97 66.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.45 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -110.54 134.87 51.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.604 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.401 ' HA ' HD23 ' A' ' 54' ' ' LEU . 1.6 mp -119.93 113.71 41.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.398 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.88 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 48.9 m-85 -104.27 116.59 32.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.448 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 138.42 -78.36 0.31 Allowed Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.493 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m 69.27 -66.41 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 111.209 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.58 -96.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.708 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.6 m -63.73 -46.14 86.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 0.0 111.187 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.448 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -54.44 118.99 4.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.285 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -76.34 14.91 0.66 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.989 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.3 p -57.36 -19.83 25.33 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.755 0.312 . . . . 0.0 111.511 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -35.5 34.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.194 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.4 mmt -63.84 -62.07 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.793 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.25 -30.03 69.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.66 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -54.7 -47.75 73.31 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.149 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -65.04 -39.78 93.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.481 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -60.14 -51.04 71.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.753 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.459 ' CB ' ' HE2' ' A' ' 34' ' ' PHE . . . -54.01 -37.54 64.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.201 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.627 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 2.6 mtm-85 -59.92 -50.4 73.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 111.207 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.472 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 10.8 pt-20 -71.67 -47.75 52.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.075 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.13 -51.93 67.01 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 26' ' ' LYS . 4.5 p -53.24 -55.54 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.684 0.278 . . . . 0.0 110.737 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.503 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 7.5 mttm -67.51 -49.59 62.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.305 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 4.9 tt0 -53.99 -48.03 70.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.355 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -51.0 -22.47 2.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 110.671 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.57 34.64 1.7 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.648 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.8 pt -161.98 112.85 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.872 0.368 . . . . 0.0 111.574 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.442 ' O ' ' CA ' ' A' ' 1' ' ' MET . 4.2 t70 -61.51 164.24 6.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 2' ' ' MET . . . -150.44 178.14 9.33 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -128.75 114.67 16.88 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.127 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.627 ' CZ ' ' HA ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -102.06 109.34 21.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.209 0.528 . . . . 0.0 111.218 -178.738 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -116.09 115.72 26.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.035 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.6 mtpt -90.19 140.32 29.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.975 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.88 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -111.98 179.14 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.477 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.447 ' N ' HG12 ' A' ' 37' ' ' ILE . 2.7 tmtt? -157.25 75.56 0.81 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.138 0.494 . . . . 0.0 110.452 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.499 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.7 OUTLIER 160.43 128.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.064 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.493 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -52.49 -27.41 16.2 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 121.25 -0.18 . . . . 0.0 110.831 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.7 -39.27 58.04 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -86.54 -37.7 17.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.024 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.855 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 16.4 mt -58.98 -55.36 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.094 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.411 HD21 ' O ' ' A' ' 40' ' ' MET . 0.1 OUTLIER -61.24 -40.97 96.02 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.702 179.699 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -53.02 -26.13 14.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.972 0.415 . . . . 0.0 110.372 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -70.36 -36.57 74.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.753 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.3 -13.37 16.15 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.907 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.529 HD21 ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.3 162.96 26.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.904 0.352 . . . . 0.0 111.124 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.63 -17.83 11.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 111.67 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -87.48 175.61 7.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.654 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.601 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.7 mt -79.64 -63.88 0.35 Allowed Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.962 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 11.0 Cg_exo -70.04 58.91 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.278 1.985 . . . . 0.0 111.919 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -79.01 147.75 30.83 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.475 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 0.3 OUTLIER -139.85 104.01 4.78 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -98.47 124.72 43.35 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.975 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.425 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -120.68 139.51 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.182 0.515 . . . . 0.0 112.218 -179.267 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.408 ' HA ' ' CG ' ' A' ' 3' ' ' LYS . 1.8 m-20 43.03 28.3 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.687 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.29 32.95 37.05 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.714 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.48 98.56 2.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.921 0.391 . . . . 0.0 110.468 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.424 ' CD2' HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -70.2 133.75 47.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.827 -179.6 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.29 6.68 1.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.72 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.432 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 1.2 mp -127.88 125.78 65.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.662 0.268 . . . . 0.0 110.94 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.429 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 7.8 mtt -146.51 116.16 7.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.652 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.547 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 88.98 -13.24 63.65 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.134 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 179.46 114.42 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.423 ' HA ' ' CG1' ' A' ' 62' ' ' ILE . 3.6 m -52.11 179.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.392 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -91.71 177.31 6.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.1 p -99.67 158.49 15.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.806 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -52.64 -39.32 61.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.118 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -67.37 -38.78 85.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.01 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.47 -32.29 72.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.048 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.2 mm -71.08 -52.63 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.078 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.833 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.483 ' HA ' ' HA ' ' A' ' 32' ' ' ALA . 10.8 mtt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.316 0.103 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.511 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 33.2 mmm -83.5 111.12 18.78 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.163 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.05 100.8 2.58 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.154 0.502 . . . . 0.0 110.44 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.515 HG13 ' CG1' ' A' ' 56' ' ' VAL . 1.7 mp -99.86 114.64 38.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.998 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.415 ' CB ' HD13 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -101.64 119.67 39.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.466 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.3 mm -104.59 101.63 12.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 120.697 0.284 . . . . 0.0 111.574 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.713 ' CE1' HG13 ' A' ' 37' ' ' ILE . 79.4 m-85 -90.6 103.23 15.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.046 0.451 . . . . 0.0 110.739 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.39 -84.55 0.12 Allowed Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.986 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 t 40.44 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 112.001 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.07 -62.3 0.29 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.138 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 t -87.79 -30.79 19.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.98 0.419 . . . . 0.0 110.545 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.17 134.89 52.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.811 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.22 15.09 0.61 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 p -57.85 -20.13 34.06 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.67 0.271 . . . . 0.0 111.524 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -20.99 36.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.534 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.2 mtt -63.31 -62.43 1.7 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.771 0.319 . . . . 0.0 110.858 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.0 tp -64.08 -22.45 66.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.34 . . . . 0.0 110.581 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -56.18 -54.17 48.36 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.354 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.55 -46.73 78.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.95 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -54.78 -51.32 66.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.62 -36.73 69.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.806 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.528 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 44.2 mtp180 -57.26 -48.0 79.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 111.117 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 8.0 tt0 -72.39 -50.26 27.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.183 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.05 -51.08 71.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.5 ' CG1' ' N ' ' A' ' 26' ' ' LYS . 2.4 p -53.64 -55.41 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.59 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.5 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 6.0 mttm -67.22 -50.36 61.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.681 0.277 . . . . 0.0 111.113 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 8.8 tt0 -52.01 -45.63 64.64 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.381 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -52.99 -19.33 2.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.882 0.372 . . . . 0.0 110.608 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 30' ' ' ILE . . . 113.37 21.31 5.89 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.599 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.405 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -147.76 110.88 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.861 0.363 . . . . 0.0 110.899 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -64.92 162.81 15.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.345 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.511 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -149.27 -169.33 3.35 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -142.42 113.96 7.88 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.048 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.528 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 11.8 m-85 -105.75 109.13 20.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.569 0.699 . . . . 0.0 112.249 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -127.65 134.87 49.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.456 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.24 155.71 28.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.022 0.439 . . . . 0.0 110.905 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.713 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -126.21 80.34 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.663 -178.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -82.21 75.56 9.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.087 0.47 . . . . 0.0 111.143 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.531 ' O ' HG13 ' A' ' 43' ' ' ILE . 3.0 mm-40 173.52 121.7 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.67 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.518 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 1.6 tpt -53.88 -31.58 50.32 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.843 -0.162 . . . . 0.0 111.059 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.57 -37.96 52.19 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -86.9 -34.21 19.48 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.192 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.699 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 47.5 mt -59.76 -55.21 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.348 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.16 -38.37 90.9 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.048 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -56.11 -24.3 39.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.535 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.437 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -74.22 -34.78 63.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.974 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.43 -6.43 31.86 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.198 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.594 ' HB2' ' HG2' ' A' ' 63' ' ' MET . 0.0 OUTLIER -79.53 160.44 26.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.161 0.48 . . . . 0.0 111.643 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.0 t -112.06 -30.09 7.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.743 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.447 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -77.58 -177.78 4.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.229 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.571 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.3 mp -87.98 -62.47 0.22 Allowed Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.912 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 16.9 Cg_exo -67.38 59.66 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.264 1.976 . . . . 0.0 112.255 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.422 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -84.8 139.52 17.92 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.574 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.442 ' CD1' HG22 ' A' ' 4' ' ' ILE . 16.3 tp -129.58 103.13 6.69 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -100.79 125.33 47.27 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.321 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.515 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.92 139.38 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.078 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 47.06 26.94 0.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.587 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.61 34.79 48.47 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.325 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -144.7 103.31 3.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.386 . . . . 0.0 111.197 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.415 ' CD2' HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -46.31 133.32 9.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.234 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.63 -23.7 6.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.532 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 66' ' ' VAL . 2.8 pp -154.62 154.91 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.594 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 2.0 mtp -146.78 129.13 15.81 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.432 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.466 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 94.41 -20.51 47.77 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.369 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -179.79 112.18 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.785 0.326 . . . . 0.0 110.364 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.448 ' HA ' ' CD1' ' A' ' 62' ' ' ILE . 15.8 m -51.29 161.54 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.278 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.1 -166.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.954 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.9 t -118.94 171.17 8.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.962 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -55.57 -56.64 17.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.066 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -59.77 -30.54 68.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.822 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -61.89 -46.38 89.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.5 mm -59.71 -54.25 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.882 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 179.858 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.437 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 4.8 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.523 0.201 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.547 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 5.2 mmt -77.56 113.51 15.46 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.986 0.422 . . . . 0.0 110.808 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.81 100.51 1.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.084 0.468 . . . . 0.0 110.52 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.447 ' CG1' ' CG1' ' A' ' 56' ' ' VAL . 2.8 mp -109.24 128.79 64.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.933 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -110.89 142.45 42.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.878 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 6' ' ' ILE . 19.9 mt -122.09 115.0 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.196 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.844 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 86.6 m-85 -106.1 110.82 23.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.302 0.572 . . . . 0.0 112.134 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.435 ' HA3' ' HB1' ' A' ' 12' ' ' ALA . . . 155.78 -78.61 0.19 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.235 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 p 49.22 33.3 4.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.791 0.329 . . . . 0.0 111.584 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.38 -71.81 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.39 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.08 27.96 8.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 110.737 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.435 ' HB1' ' HA3' ' A' ' 8' ' ' GLY . . . -124.57 130.05 51.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.083 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -76.36 20.46 0.21 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.756 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.414 ' H ' ' C ' ' A' ' 12' ' ' ALA . 2.6 p -55.45 -19.86 10.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.796 0.332 . . . . 0.0 111.557 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.03 -41.47 47.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.787 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.0 mtp -63.74 -62.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.764 0.316 . . . . 0.0 111.218 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.44 ' CD1' ' HB3' ' A' ' 21' ' ' ALA . 0.7 OUTLIER -59.47 -31.85 69.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.825 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -40.05 81.45 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -73.28 -46.93 46.95 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.454 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 34.4 p30 -69.17 -34.3 74.74 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.151 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.454 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . -63.06 -47.33 83.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.467 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -57.69 -47.5 82.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.712 0.291 . . . . 0.0 111.294 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.442 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 22.2 tp10 -72.75 -50.45 24.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.42 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.58 -49.1 76.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.483 ' CG1' ' HB1' ' A' ' 32' ' ' ALA . 3.8 p -53.36 -54.66 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.451 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.476 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.52 -43.43 76.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.619 0.247 . . . . 0.0 110.702 178.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 35.3 tt0 -57.28 -43.92 83.56 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.154 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.7 -19.12 2.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.8 0.333 . . . . 0.0 110.769 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.91 25.91 4.03 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.671 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.42 HG21 HD12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -159.64 117.0 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.943 0.401 . . . . 0.0 111.443 179.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.44 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -61.46 164.79 5.35 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.242 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 2' ' ' MET . . . -148.78 165.74 30.53 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -125.13 110.05 13.64 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.042 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.489 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 30.3 m-85 -97.08 108.94 21.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.253 0.549 . . . . 0.0 111.418 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -112.97 115.58 28.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.809 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 136.62 33.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.032 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.844 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -101.66 -178.24 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.291 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.484 ' N ' HG12 ' A' ' 37' ' ' ILE . 3.3 ptmt -158.5 75.37 0.72 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.168 0.509 . . . . 0.0 110.651 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 0.2 OUTLIER 155.37 131.68 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.886 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 0.493 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 3.1 mpp? -52.61 -25.11 9.72 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.2 -0.2 . . . . 0.0 111.136 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -51.51 -39.82 58.39 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -86.54 -36.4 18.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.037 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.813 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 17.4 mt -59.67 -54.96 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.324 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -38.58 91.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.835 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -55.63 -24.61 34.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.99 0.424 . . . . 0.0 110.294 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.438 ' HB1' ' CZ ' ' A' ' 7' ' ' TYR . . . -72.62 -35.31 67.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.771 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.0 -11.76 24.67 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.973 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.514 ' N ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.48 161.72 23.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.076 0.438 . . . . 0.0 111.36 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.6 p -114.32 -25.48 8.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.16 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.526 ' HB3' ' CB ' ' A' ' 63' ' ' MET . . . -77.88 171.92 14.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.579 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.61 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.5 mp -77.99 -64.12 0.42 Allowed Pre-proline 0 C--N 1.332 -0.188 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.486 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.61 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 14.8 Cg_exo -67.9 58.13 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.239 1.959 . . . . 0.0 112.365 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -84.26 137.69 16.23 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.926 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -129.06 103.83 7.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.447 ' CB ' HD11 ' A' ' 60' ' ' LEU . . . -97.82 121.7 40.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.026 0.441 . . . . 0.0 111.422 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.447 ' CG1' ' CG1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -112.95 139.16 39.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.826 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 47.96 26.41 0.96 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.553 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.13 33.16 50.51 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.502 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.09 102.27 3.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.827 0.346 . . . . 0.0 111.158 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.447 HD11 ' CB ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -48.78 126.56 12.25 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.856 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -115.6 -21.9 9.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.7 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.468 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -154.95 133.65 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.284 -179.392 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.526 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.88 138.02 25.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.355 178.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.505 ' N ' ' CB ' ' A' ' 50' ' ' ALA . . . 81.54 -3.54 77.94 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.816 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 179.61 100.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.34 . . . . 0.0 110.482 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -65.5 141.3 18.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.961 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.93 -173.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.23 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.02 179.96 4.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.825 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.7 -46.19 87.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.212 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.61 -41.76 95.43 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.018 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -56.85 -44.05 81.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.075 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.412 ' CG1' HD21 ' A' ' 17' ' ' LEU . 40.3 mm -64.86 -55.1 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.935 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 1.678 ' HE2' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 1 N--CA 1.362 -4.861 0 N-CA-C 113.763 1.023 . . . . 3.1099999999999999 113.763 . . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 1.672 ' HE2' ' SD ' ' A' ' 2' ' ' MET . 1.7 mtt -80.54 113.76 18.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.594 -0.442 . . . . 2.1600000000000001 110.938 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 1.671 ' HZ1' ' CE ' ' A' ' 3' ' ' LYS . 96.3 mttt -70.72 107.89 4.17 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.142 0.496 . . . . 2.6499999999999999 110.406 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 1.399 HD13 ' CG1' ' A' ' 4' ' ' ILE . 3.6 mt -114.65 122.68 69.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.124 0.487 . . . . 1.3400000000000001 111.535 -179.274 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 1.589 ' HG2' ' CB ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -109.1 133.67 52.7 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 115.867 -0.606 . . . . 1.8200000000000001 110.632 179.626 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 1.604 HG12 ' CB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -115.03 108.91 26.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.832 0.349 . . . . 2.04 111.188 -179.915 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 1.419 ' CZ ' ' CD1' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -96.09 113.91 25.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.281 0.562 . . . . 2.1699999999999999 111.591 -179.383 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.479 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 154.79 -83.8 0.15 Allowed Glycine 1 C--O 1.114 -7.378 0 CA-C-N 115.833 -0.621 . . . . 0.70999999999999996 113.678 -179.865 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 1.576 HG23 ' CB ' ' A' ' 9' ' ' THR . 0.2 OUTLIER 61.18 69.21 0.68 Allowed 'General case' 2 C--O 0.484 -39.237 1 CA-C-O 149.367 13.937 . . . . 2.1299999999999999 111.866 179.918 . . . . . . . . 5 4 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 1.284 ' CA ' ' O ' ' A' ' 9' ' ' THR . . . 142.4 -71.18 0.41 Allowed Glycine 3 C--N 0.807 -28.808 3 O-C-N 50.769 -44.957 . . . . 1.4199999999999999 115.301 179.83 . . . . . . . . 4 3 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.457 ' HG ' ' CB ' ' A' ' 11' ' ' CYS . 1.1 m -90.58 -20.82 22.17 Favored 'General case' 2 C--N 1.078 -11.201 2 O-C-N 108.323 -8.751 . . . . 2.5099999999999998 111.781 -179.946 . . . . . . . . 4 3 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 1.006 ' HB2' ' CA ' ' A' ' 12' ' ' ALA . . . -89.86 129.9 36.17 Favored 'General case' 1 C--N 1.184 -6.624 1 O-C-N 115.274 -4.641 . . . . 1.1299999999999999 111.247 179.969 . . . . . . . . 4 3 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 1.388 ' OD1' ' CB ' ' A' ' 13' ' ' ASN . 68.6 m-20 -76.36 17.9 0.34 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.36 0.504 . . . . 2.0499999999999998 112.36 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.0 p -54.7 -23.21 16.56 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.286 0.565 . . . . 1.29 111.936 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.85 -33.89 51.69 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.811 -0.631 . . . . 1.5600000000000001 111.799 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 1.679 ' HG3' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -64.38 -59.14 4.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.161 0.505 . . . . 2.75 110.889 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 1.493 ' CD2' ' CB ' ' A' ' 17' ' ' LEU . 2.7 tm? -64.57 -25.8 68.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.187 0.517 . . . . 2.3700000000000001 110.907 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.56 -48.95 77.94 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.981 -0.554 . . . . 1.78 110.623 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 1.64 ' HZ3' ' CE ' ' A' ' 19' ' ' LYS . 25.6 tttt -69.05 -47.81 64.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.113 0.482 . . . . 2.8199999999999998 111.316 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -43.81 92.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.086 -0.506 . . . . 1.9199999999999999 111.176 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.993 ' HB3' ' CB ' ' A' ' 21' ' ' ALA . . . -58.94 -42.71 90.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.123 -0.489 . . . . 1.0800000000000001 111.714 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 1.436 ' HE ' ' CZ ' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -57.68 -45.62 85.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.816 0.341 . . . . 3.21 111.467 -179.638 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 1.514 ' HG2' ' CB ' ' A' ' 23' ' ' GLU . 0.6 OUTLIER -71.9 -49.33 38.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.407 -0.36 . . . . 2.1800000000000002 111.296 -179.636 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.989 ' HB1' ' CA ' ' A' ' 24' ' ' ALA . . . -62.4 -50.43 71.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.877 0.325 . . . . 1.1200000000000001 111.877 -179.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.974 HG21 ' CB ' ' A' ' 25' ' ' VAL . 5.4 p -53.72 -54.86 16.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.643 0.258 . . . . 1.1299999999999999 110.743 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 1.495 ' HZ1' ' CE ' ' A' ' 26' ' ' LYS . 21.7 mttm -67.55 -47.23 70.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.734 0.302 . . . . 2.8199999999999998 110.995 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 86.1 tt0 -57.12 -43.88 82.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 1.95 111.35 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 1.636 HD23 ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -52.39 -20.94 3.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.997 0.427 . . . . 2.5099999999999998 110.903 179.551 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.92 36.22 1.41 Allowed Glycine 0 C--O 1.22 -0.738 0 C-N-CA 120.798 -0.715 . . . . 0.65000000000000002 112.474 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 1.589 HG12 ' CD1' ' A' ' 30' ' ' ILE . 17.7 pt -170.37 117.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.117 0.484 . . . . 2.2400000000000002 111.434 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 1.423 ' OD1' ' CB ' ' A' ' 31' ' ' ASP . 0.4 OUTLIER -62.4 163.61 8.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.937 -0.574 . . . . 1.6200000000000001 110.228 179.379 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.984 ' HB2' ' CA ' ' A' ' 32' ' ' ALA . . . -149.43 164.7 34.26 Favored 'General case' 0 C--O 1.188 -2.167 0 N-CA-C 109.584 -0.525 . . . . 1.0900000000000001 109.584 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 1.449 ' HG3' ' CB ' ' A' ' 33' ' ' GLU . 1.2 mt-10 -122.0 113.15 19.17 Favored 'General case' 0 C--N 1.281 -2.398 0 O-C-N 121.008 -1.057 . . . . 2.1800000000000002 110.17 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 1.431 ' CZ ' ' CD1' ' A' ' 34' ' ' PHE . 22.3 m-85 -98.93 109.4 22.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.398 0.618 . . . . 2.1600000000000001 111.824 -178.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 1.571 ' HG2' ' CB ' ' A' ' 35' ' ' GLU . 1.8 mt-10 -115.64 122.9 46.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.169 -0.923 . . . . 2.2999999999999998 110.278 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 1.627 ' HZ1' ' CE ' ' A' ' 36' ' ' LYS . 14.7 mttt -84.42 144.95 28.44 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.437 -0.347 . . . . 2.6800000000000002 110.507 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 1.568 HD13 ' CG1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -115.01 136.57 51.27 Favored 'Isoleucine or valine' 1 C--O 0.985 -12.837 0 CA-C-O 123.872 1.796 . . . . 2.29 110.205 -179.568 . . . . . . . . 4 4 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 1.611 ' HD2' ' CG ' ' A' ' 38' ' ' LYS . 53.1 pttt -124.71 75.3 1.41 Allowed 'General case' 1 C--N 1.132 -8.889 2 O-C-N 109.725 -8.11 . . . . 3.6499999999999999 110.94 -179.98 . . . . . . . . 4 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 1.483 ' HG3' ' CB ' ' A' ' 39' ' ' GLU . 0.7 OUTLIER 163.4 128.29 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.339 -0.846 . . . . 2.4399999999999999 110.7 179.839 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' MET . . . . . 1.689 ' HE2' ' SD ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -56.21 -26.52 51.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.573 0.225 . . . . 2.9700000000000002 111.065 -179.871 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 1.165 ' OD2' ' CB ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -51.5 -38.7 55.28 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.899 -0.778 . . . . 1.7 108.899 178.645 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 1.467 HE21 ' CG ' ' A' ' 42' ' ' GLN . 6.3 mm-40 -87.02 -34.95 19.04 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.093 -0.958 . . . . 2.5099999999999998 110.302 178.316 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 1.443 HG22 ' CB ' ' A' ' 43' ' ' ILE . 5.2 mt -62.61 -52.76 55.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-O 121.108 0.48 . . . . 1.5700000000000001 111.375 -179.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 1.007 HD22 ' CG ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -63.38 -36.85 85.08 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.97 -0.559 . . . . 1.26 110.866 179.877 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 1.26 ' HG3' ' CD ' ' A' ' 45' ' ' GLU . 24.5 tt0 -57.14 -25.61 59.16 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.348 -0.387 . . . . 2.0099999999999998 110.17 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 1.015 ' HB3' ' CA ' ' A' ' 46' ' ' ALA . . . -74.72 -38.07 62.39 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 115.951 -0.568 . . . . 1.1699999999999999 109.75 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.43 -3.48 28.0 Favored Glycine 0 C--O 1.195 -2.293 0 C-N-CA 120.773 -0.727 . . . . 0.92000000000000004 114.867 179.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 1.168 HD11 ' CG ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -74.03 160.19 31.63 Favored 'General case' 1 C--O 0.896 -17.525 0 CA-C-O 121.69 0.757 . . . . 1.4099999999999999 112.073 179.96 . . . . . . . . 4 4 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 1.524 HG22 ' CB ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -115.55 -17.56 11.14 Favored 'General case' 2 C--N 1.111 -9.768 3 O-C-N 109.08 -8.513 . . . . 2.3700000000000001 112.481 179.761 . . . . . . . . 5 4 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 1.011 ' HB2' ' CA ' ' A' ' 50' ' ' ALA . . . -97.01 -172.71 2.51 Favored 'General case' 1 C--N 1.208 -5.549 0 O-C-N 117.698 -3.126 . . . . 1.1399999999999999 110.348 179.503 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 1.625 HD21 ' CG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -89.01 -63.65 0.2 Allowed Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 112.13 0.419 . . . . 2.04 112.13 -179.572 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.555 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 6.3 Cg_exo -67.78 59.68 0.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.239 1.959 . . . . 0.83999999999999997 112.829 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -86.9 144.44 19.47 Favored Glycine 0 C--O 1.21 -1.355 0 C-N-CA 120.642 -0.79 . . . . 0.53000000000000003 112.862 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 1.499 ' HG ' ' CB ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -136.73 109.22 7.4 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 122.52 -0.4 . . . . 2.3599999999999999 110.708 179.889 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 1.002 ' HB3' ' CA ' ' A' ' 55' ' ' ALA . . . -101.02 125.15 47.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.909 0.385 . . . . 1.1200000000000001 111.269 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.994 HG12 ' CB ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -116.82 139.12 45.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.073 -0.512 . . . . 1.24 111.306 -179.91 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 1.3 ' OD1' ' CB ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER 47.11 27.06 0.73 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.605 -0.725 . . . . 1.5900000000000001 110.715 -179.575 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.58 32.89 44.86 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.864 -0.684 . . . . 0.62 112.527 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.529 ' HG3' ' CB ' ' A' ' 59' ' ' GLU . 3.9 mt-10 -145.75 102.27 3.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.856 0.36 . . . . 2.21 111.041 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 1.616 HD22 ' CD1' ' A' ' 60' ' ' LEU . 2.1 mm? -58.92 131.95 52.53 Favored 'General case' 0 CA--C 1.482 -1.668 0 CA-C-N 116.094 -0.503 . . . . 2.3700000000000001 111.32 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 1.612 ' HD3' ' CG ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -131.47 -8.71 3.69 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 114.678 1.362 . . . . 2.9500000000000002 114.678 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 1.587 HG23 ' CB ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -142.08 130.78 22.18 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.908 0 C-N-CA 120.253 -0.579 . . . . 2.7000000000000002 111.795 -179.881 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 1.709 ' HE2' ' SD ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -146.62 131.04 17.63 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 112.742 0.645 . . . . 2.6600000000000001 112.742 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.554 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 77.46 -2.93 60.93 Favored Glycine 0 C--O 1.192 -2.512 0 C-N-CA 120.297 -0.954 . . . . 0.65000000000000002 113.676 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 1.614 ' HG2' ' CB ' ' A' ' 65' ' ' ARG . 1.7 ttp180 -177.21 101.9 0.05 Allowed 'General case' 0 C--O 1.2 -1.549 0 CA-C-N 117.48 0.64 . . . . 4.1600000000000001 112.7 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 1.637 HG13 ' CB ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -57.95 148.58 5.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 116.579 -0.282 . . . . 1.8500000000000001 111.476 -179.666 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 1.021 ' HB3' ' CA ' ' A' ' 67' ' ' ALA . . . -75.54 167.44 21.89 Favored 'General case' 0 C--O 1.19 -2.047 0 CA-C-O 120.816 0.341 . . . . 1.3200000000000001 111.511 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 1.049 ' OG ' ' CA ' ' A' ' 68' ' ' SER . 0.5 OUTLIER -97.21 170.72 8.91 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 122.085 -0.384 . . . . 1.9399999999999999 111.297 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 1.612 ' HG3' ' CD ' ' A' ' 69' ' ' LYS . 2.7 pttt -57.54 -46.5 83.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.405 -0.361 . . . . 3.1499999999999999 111.125 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 1.615 ' HG2' ' CB ' ' A' ' 70' ' ' GLU . 1.4 tt0 -64.7 -34.95 79.52 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.88 0.371 . . . . 2.4199999999999999 111.135 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 1.357 ' HG2' ' CD ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -66.4 -45.05 81.31 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.2 -0.454 . . . . 1.95 110.921 -179.885 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 1.607 HG21 ' CB ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -62.17 -50.54 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 116.098 -0.501 . . . . 2.2200000000000002 111.086 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 1.619 ' HZ2' ' CE ' ' A' ' 73' ' ' LYS . 17.6 tttt . . . . . 0 N--CA 1.438 -1.046 0 CA-C-N 116.295 -0.411 . . . . 2.71 110.836 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.452 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 111.395 0.146 . . . . 0.0 111.395 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.463 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -80.55 116.23 20.48 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.865 0.364 . . . . 0.0 111.317 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -79.85 101.08 8.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.981 0.419 . . . . 0.0 109.95 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.496 HD13 ' CE2' ' A' ' 34' ' ' PHE . 2.0 mt -109.95 124.92 67.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.579 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.424 ' CB ' HD11 ' A' ' 37' ' ' ILE . 3.2 mp0 -110.47 133.74 53.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.146 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.433 ' CG2' ' CB ' ' A' ' 14' ' ' CYS . 42.0 mt -114.45 109.64 29.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.109 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.885 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 66.5 m-85 -95.78 125.3 40.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.072 0.463 . . . . 0.0 111.556 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.446 ' HA3' ' HB1' ' A' ' 12' ' ' ALA . . . 122.46 -70.42 0.42 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.287 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.47 -70.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.821 0.343 . . . . 0.0 111.469 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.36 -97.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.643 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.44 -29.44 61.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.76 0.314 . . . . 0.0 111.134 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.446 ' HB1' ' HA3' ' A' ' 8' ' ' GLY . . . -68.65 120.49 14.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.996 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -76.24 21.25 0.18 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.433 ' CB ' ' CG2' ' A' ' 6' ' ' ILE . 6.1 m -55.21 -21.61 14.51 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.694 0.283 . . . . 0.0 111.374 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.62 -39.48 11.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 mtp -63.68 -62.69 1.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.642 0.258 . . . . 0.0 111.257 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.418 ' HB3' ' CG2' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -67.22 -19.54 65.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.781 0.324 . . . . 0.0 110.724 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -60.29 -50.36 73.95 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.345 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -70.28 -45.87 65.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.713 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -60.76 -38.6 85.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.008 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.408 ' HB1' ' CD1' ' A' ' 17' ' ' LEU . . . -63.47 -45.91 88.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.296 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 5.6 mtt-85 -57.71 -53.15 61.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -65.58 -50.19 66.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.523 -179.336 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.12 -51.91 64.66 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 32' ' ' ALA . 4.4 p -53.77 -55.09 15.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.446 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.473 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 36.6 mtpt -65.34 -49.56 68.93 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.676 0.274 . . . . 0.0 111.2 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 46.8 tp10 -60.01 -39.28 85.27 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.721 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.02 -15.93 1.68 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.751 0.31 . . . . 0.0 111.175 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.05 26.16 3.9 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.546 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.513 HG21 HD12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -163.26 109.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 0.0 110.628 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.452 ' O ' ' CB ' ' A' ' 1' ' ' MET . 2.8 m-20 -60.71 156.49 16.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HB2' ' CE1' ' A' ' 34' ' ' PHE . . . -145.29 140.06 27.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -103.94 117.12 33.56 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.044 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 15.7 m-85 -98.48 109.3 22.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.331 0.586 . . . . 0.0 112.068 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.51 126.51 55.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.287 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.85 150.65 30.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.148 0.499 . . . . 0.0 111.068 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.744 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -124.2 80.73 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.408 -179.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.04 75.03 6.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.132 0.491 . . . . 0.0 111.378 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.572 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.4 OUTLIER 173.95 119.02 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.704 179.385 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.513 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 1.2 ptp -54.02 -33.11 56.32 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.45 0.167 . . . . 0.0 111.089 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.26 -37.38 46.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -86.74 -33.86 19.84 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.185 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.885 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 26.8 mt -61.41 -55.95 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.061 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.412 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.06 -36.65 84.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.826 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -56.85 -24.56 52.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.993 0.425 . . . . 0.0 110.319 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.403 ' HB1' ' CD1' ' A' ' 48' ' ' LEU . . . -72.14 -40.08 68.31 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.574 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.53 -10.75 11.4 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.506 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.545 HD21 ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -71.87 152.07 42.89 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 117.444 0.622 . . . . 0.0 111.017 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 t -104.35 -9.41 18.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.931 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -104.06 -177.93 3.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.422 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -81.67 -64.09 0.28 Allowed Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.418 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 51' ' ' LEU . 56.2 Cg_endo -70.29 56.48 1.62 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.371 2.047 . . . . 0.0 113.41 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.532 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -73.06 143.48 33.35 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.903 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.27 102.7 5.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.565 0.221 . . . . 0.0 110.432 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -104.95 124.47 49.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 111.581 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.432 HG13 HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.27 138.4 44.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.39 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 46.99 25.39 0.47 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.296 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.98 22.64 44.67 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.128 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.46 ' O ' ' CG ' ' A' ' 59' ' ' GLU . 4.6 pt-20 -137.28 108.19 6.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.216 0.531 . . . . 0.0 110.852 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -85.4 131.32 34.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.887 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.84 2.49 2.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.546 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.532 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 9.7 mt -128.24 122.39 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.664 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.502 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 2.4 mpp? -145.74 130.81 18.33 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.474 ' N ' ' CB ' ' A' ' 50' ' ' ALA . . . 73.6 6.79 72.34 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.176 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 178.81 101.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.761 0.315 . . . . 0.0 110.616 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.418 ' CG2' ' HB3' ' A' ' 17' ' ' LEU . 3.3 p -57.83 148.35 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.644 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.37 173.74 2.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.935 0.398 . . . . 0.0 111.434 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.11 158.97 17.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.607 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -48.48 65.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.319 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.14 -34.32 77.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.922 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.54 -42.57 91.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.5 mm -56.23 -55.1 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.986 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -58.63 -37.23 75.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -31.76 62.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.22 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -76.05 -29.78 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.989 0.423 . . . . 0.0 110.697 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tp -108.01 -74.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.014 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.906 -179.934 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.434 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 3.4 mtt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.674 0.273 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.502 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -77.23 113.56 15.11 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.891 0.377 . . . . 0.0 111.095 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.55 100.38 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.467 HD13 ' CE2' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -106.51 125.51 62.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.026 -179.085 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.551 ' HB3' HD12 ' A' ' 37' ' ' ILE . 3.3 mm-40 -107.11 126.23 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.169 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.409 ' CG2' ' HB2' ' A' ' 14' ' ' CYS . 2.9 mp -107.86 102.65 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.737 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 80.6 m-85 -88.94 124.26 34.07 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.924 0.392 . . . . 0.0 110.755 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.1 -85.36 0.19 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.299 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t 40.29 86.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.879 0.371 . . . . 0.0 111.778 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.42 -61.92 0.56 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.517 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.1 m -118.62 -2.57 10.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.526 0.203 . . . . 0.0 111.497 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.77 135.08 42.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.82 0.343 . . . . 0.0 111.154 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.9 m-20 -76.55 20.1 0.24 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.023 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.45 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 3.8 p -57.15 -19.85 22.73 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.675 0.274 . . . . 0.0 111.509 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.08 -38.49 38.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.653 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.416 ' CB ' HG13 ' A' ' 66' ' ' VAL . 1.1 mpp? -64.65 -52.64 56.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.564 ' HB2' HG11 ' A' ' 66' ' ' VAL . 30.9 tp -66.78 -28.75 68.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.067 0.46 . . . . 0.0 110.143 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.01 -47.47 80.78 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.386 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -46.17 61.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.867 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -56.6 -53.02 62.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.044 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.43 -43.06 71.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.892 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.476 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 5.5 mtt180 -57.61 -43.71 84.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.665 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 61.6 tt0 -74.34 -50.75 17.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.368 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.28 -49.84 72.45 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.499 ' CG1' ' HB3' ' A' ' 32' ' ' ALA . 3.2 p -54.38 -53.9 26.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.613 0.244 . . . . 0.0 110.44 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.494 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 51.7 mttt -67.01 -50.09 63.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.784 0.326 . . . . 0.0 110.849 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 19.4 tt0 -57.82 -39.78 78.45 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.077 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.6 tp -52.14 -21.14 3.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.781 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.76 32.55 2.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.618 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 pt -169.09 121.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.862 0.363 . . . . 0.0 111.222 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.434 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -61.36 164.0 6.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.167 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -150.62 140.07 21.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -100.72 111.17 23.35 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.386 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.476 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 68.9 m-85 -94.88 109.18 21.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.505 0.669 . . . . 0.0 111.966 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.31 128.36 54.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.374 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -78.69 149.95 32.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.113 0.483 . . . . 0.0 110.806 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.69 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -115.7 76.62 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.687 -178.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.3 75.16 2.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.993 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.502 ' O ' HG13 ' A' ' 43' ' ' ILE . 2.6 mm-40 167.9 124.12 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.669 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.558 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -59.24 -20.31 53.05 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.213 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.46 -43.33 62.07 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -87.41 -34.8 18.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.475 178.296 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.737 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 16.9 mt -61.36 -54.94 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.345 0.593 . . . . 0.0 111.036 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -35.84 77.04 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.612 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -56.35 -34.05 66.23 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.158 0.504 . . . . 0.0 109.818 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.55 -42.67 51.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.875 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.99 30.61 31.12 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.561 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.536 ' HG ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -51.61 -41.75 61.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.443 0.621 . . . . 0.0 110.919 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' ' 48' ' ' LEU . 5.6 p 90.64 7.23 0.08 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.241 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.465 ' CB ' ' HG2' ' A' ' 63' ' ' MET . . . -153.65 -157.27 0.76 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.948 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.582 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.4 mp -99.19 -61.15 0.11 Allowed Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 25.9 Cg_exo -62.94 52.85 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.843 2.362 . . . . 0.0 113.879 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.536 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -81.68 137.37 17.31 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.285 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -136.41 101.51 4.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.673 0.273 . . . . 0.0 110.499 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -104.45 133.53 49.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.81 0.338 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.412 ' CG1' HG21 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.59 141.45 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.183 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 50.83 23.18 1.33 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.595 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.43 31.02 23.15 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.257 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.7 106.59 5.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.118 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -83.18 130.08 35.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.016 179.23 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -138.23 1.23 2.2 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 pp -150.25 124.21 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.051 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.465 ' HG2' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.5 150.5 36.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.534 179.319 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.548 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 56.42 16.74 16.43 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.992 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -165.66 94.65 0.6 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.863 0.363 . . . . 0.0 110.531 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.564 HG11 ' HB2' ' A' ' 17' ' ' LEU . 2.0 t -60.48 120.05 5.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.736 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.11 126.77 28.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.33 169.74 1.56 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -60.52 -58.29 9.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.766 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -60.79 -33.16 72.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.24 -37.75 75.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 mt -69.24 -52.68 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.919 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -31.95 73.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.972 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.91 -30.13 62.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.822 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.0 mt -75.79 -37.84 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.143 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.14 8.52 43.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.309 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.989 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 2.1 mtt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.46 ' HB3' HD13 ' A' ' 4' ' ' ILE . 1.1 mpp? -86.67 119.29 26.75 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.334 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.94 111.46 18.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.621 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.46 HD13 ' HB3' ' A' ' 2' ' ' MET . 3.7 mp -116.91 123.1 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.212 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.592 ' CB ' HD12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -110.59 127.88 55.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.598 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.489 HG13 ' HA ' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -110.37 113.01 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.869 0.366 . . . . 0.0 110.924 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.702 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 90.6 m-85 -91.91 111.91 23.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.22 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.421 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 136.66 -96.9 0.25 Allowed Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.195 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.96 -65.23 0.3 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.827 0.346 . . . . 0.0 111.463 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.68 -57.51 9.47 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.822 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.0 p -111.92 -35.46 5.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 110.982 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.421 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -65.63 124.73 23.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.071 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -76.5 16.67 0.46 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 p -59.24 -19.5 46.21 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.784 0.325 . . . . 0.0 111.337 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -24.98 5.25 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.872 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.5 mtp -63.26 -62.19 1.86 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.791 0.329 . . . . 0.0 110.475 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 67' ' ' ALA . 5.6 tt -65.67 -20.37 66.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.512 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -57.61 -51.45 69.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.129 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -69.15 -51.32 39.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.609 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -54.7 -40.34 69.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.594 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.72 -45.93 90.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.442 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.527 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -54.88 -38.48 67.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.718 0.294 . . . . 0.0 111.273 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 35.1 tp10 -73.4 -50.41 21.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.019 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.63 79.59 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.563 ' CG1' ' HB3' ' A' ' 32' ' ' ALA . 14.0 p -53.62 -56.05 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.626 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.42 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.16 -40.34 82.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.692 0.282 . . . . 0.0 110.741 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 6.0 tp10 -59.27 -47.44 85.38 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.958 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -54.06 -20.22 6.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.76 42.79 0.84 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.43 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -175.35 113.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.375 . . . . 0.0 111.054 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.8 OUTLIER -61.57 164.08 6.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.257 179.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.563 ' HB3' ' CG1' ' A' ' 25' ' ' VAL . . . -146.0 165.91 27.62 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -126.48 109.78 12.56 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.527 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 15.0 m-85 -98.71 108.67 21.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.38 0.609 . . . . 0.0 112.071 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -117.39 133.32 56.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.56 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.489 ' HA ' HG13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -79.69 151.81 30.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.211 0.529 . . . . 0.0 111.396 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.692 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -127.77 78.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.616 -178.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 37.4 tptt -82.02 75.12 8.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.968 0.413 . . . . 0.0 111.191 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.507 ' O ' HG13 ' A' ' 43' ' ' ILE . 22.7 tp10 177.03 120.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.79 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.51 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 46.5 ttp -53.11 -32.21 46.14 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 121.268 -0.173 . . . . 0.0 110.942 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.55 -37.56 50.13 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.69 -34.22 19.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.113 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.702 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 29.0 mt -60.45 -55.21 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.055 0 CA-C-O 121.198 0.523 . . . . 0.0 111.29 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -39.13 93.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.855 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -54.44 -25.26 23.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.056 0.455 . . . . 0.0 110.347 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' HB1' ' CZ ' ' A' ' 7' ' ' TYR . . . -71.6 -39.24 70.63 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.714 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.0 -8.22 25.33 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.644 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.546 ' N ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -80.31 167.1 20.68 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.693 0.282 . . . . 0.0 110.947 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.88 14.29 5.82 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.433 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -114.68 172.57 6.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.623 0.249 . . . . 0.0 110.75 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.524 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 2.9 mt -71.15 -72.32 0.23 Allowed Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 51' ' ' LEU . 74.2 Cg_endo -72.23 60.23 3.18 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.195 1.93 . . . . 0.0 112.425 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -79.54 147.46 29.75 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.963 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.4 tt -144.95 110.27 5.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.885 0.374 . . . . 0.0 111.075 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -98.6 126.29 44.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.563 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.419 ' CG1' ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -120.78 139.75 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.283 0.563 . . . . 0.0 111.936 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 47.24 26.83 0.75 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.183 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.03 27.32 53.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.524 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -148.26 98.05 2.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.967 0.413 . . . . 0.0 110.435 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -77.29 141.76 39.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.203 0.525 . . . . 0.0 111.317 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.18 8.25 1.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.216 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.484 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 1.3 mp -119.36 123.1 70.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.427 ' CG ' ' HB2' ' A' ' 48' ' ' LEU . 32.3 mtp -146.49 115.31 6.87 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.478 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 85.45 -5.87 81.96 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.64 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.441 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER 173.65 104.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.708 0.289 . . . . 0.0 110.591 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.3 m -50.62 158.62 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.875 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.432 ' N ' HD12 ' A' ' 17' ' ' LEU . . . -80.47 174.26 11.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.052 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -93.73 167.27 11.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.824 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -53.82 -38.38 64.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.2 -36.99 74.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.725 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -68.86 -51.04 44.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.3 tt -59.15 -41.5 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -62.21 -31.91 72.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.736 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -73.84 -31.79 63.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.811 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 54.5 mt -75.71 -38.1 37.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.35 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.5 mt -62.42 -44.28 96.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.942 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.968 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 31' ' ' ASP . 10.3 ttp . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.524 0.202 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.519 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 12.2 mmt -87.82 116.15 25.77 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.407 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -71.19 104.95 3.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.174 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.467 ' CG1' ' CG1' ' A' ' 56' ' ' VAL . 2.8 mp -112.55 120.77 63.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.361 0.601 . . . . 0.0 111.833 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.43 ' CB ' ' CD1' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -111.72 131.22 55.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.835 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.0 pt -110.8 115.1 48.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-O 120.822 0.344 . . . . 0.0 111.097 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.728 ' CE1' HG13 ' A' ' 37' ' ' ILE . 85.2 m-85 -99.1 107.11 19.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.98 0.419 . . . . 0.0 111.095 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 175.74 -106.12 0.21 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.491 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 m 68.48 88.24 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 111.122 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.49 -74.73 0.43 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.529 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 55.5 m -106.56 -26.87 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.407 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -76.25 127.99 34.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.305 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -76.91 20.69 0.24 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.189 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.419 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.4 p -52.0 -25.44 8.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.958 0.409 . . . . 0.0 111.116 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -36.22 65.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.181 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -51.92 63.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.875 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.423 ' HB2' HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -68.9 -22.01 64.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.994 0.426 . . . . 0.0 110.553 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -60.62 -54.25 47.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.558 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -48.64 65.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.73 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -55.09 -49.88 70.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.834 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.401 ' HB3' ' CD1' ' A' ' 17' ' ' LEU . . . -58.72 -41.51 86.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.797 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.548 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 11.5 mtp180 -57.55 -46.18 84.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 111.373 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.7 pt-20 -72.6 -50.3 26.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.558 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.76 -49.37 75.28 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.493 ' CG1' ' N ' ' A' ' 26' ' ' LYS . 3.8 p -53.56 -55.17 14.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.614 0.245 . . . . 0.0 110.883 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.493 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -69.56 -44.35 71.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.233 179.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 2.7 tt0 -56.68 -45.19 81.88 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.138 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.19 -22.1 3.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.907 0.384 . . . . 0.0 110.591 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.74 34.61 1.68 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.394 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.4 pt -162.74 116.73 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 0.0 111.288 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -61.32 164.69 5.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.159 179.348 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -151.23 161.98 41.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -121.37 111.65 17.58 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.548 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 58.0 m-85 -98.01 108.86 21.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.481 0.657 . . . . 0.0 112.038 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.419 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.6 OUTLIER -117.81 133.85 55.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.481 178.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.5 151.34 29.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.04 0.447 . . . . 0.0 111.027 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.728 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -126.32 91.34 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.696 -179.071 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.18 75.76 6.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.979 0.419 . . . . 0.0 111.229 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.546 ' O ' HG13 ' A' ' 43' ' ' ILE . 2.8 tt0 173.69 121.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.903 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.55 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -54.65 -33.92 61.38 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.222 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.36 -36.34 42.66 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -86.55 -31.67 21.11 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.032 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.697 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 46.1 mt -63.05 -56.32 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.039 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.492 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.75 -34.73 77.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.182 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.01 -21.71 59.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.909 0.385 . . . . 0.0 110.488 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -76.93 -35.8 57.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.3 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.18 -8.94 22.85 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.619 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.587 ' N ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -74.33 152.27 39.64 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 117.326 0.563 . . . . 0.0 111.382 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.7 p -108.02 -19.91 13.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.647 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -87.39 -171.58 3.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.393 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.563 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 2.0 mp -86.16 -73.78 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.563 ' CD ' ' CB ' ' A' ' 51' ' ' LEU . 38.3 Cg_endo -66.12 63.78 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.361 2.04 . . . . 0.0 112.609 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.432 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -84.93 143.78 20.71 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.993 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.7 tt -134.86 109.57 8.6 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.16 123.15 42.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.021 0.439 . . . . 0.0 110.901 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.467 ' CG1' ' CG1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -115.95 138.8 45.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.354 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 46.16 27.91 0.6 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.482 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.92 34.32 48.15 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.399 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.98 101.09 3.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.838 0.351 . . . . 0.0 111.099 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -45.81 130.2 9.38 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.159 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -118.33 -19.29 8.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.701 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -145.09 143.0 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 111.973 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.541 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -146.16 115.11 6.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.483 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.536 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 63.6 13.67 51.87 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.085 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.67 94.45 0.5 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.843 0.354 . . . . 0.0 110.77 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 17' ' ' LEU . 2.0 t -60.54 126.08 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.242 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.77 142.58 58.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.836 0.351 . . . . 0.0 111.067 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.68 169.07 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.74 -49.83 76.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.975 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.99 -36.48 81.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -58.81 -49.7 76.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.2 mm -60.51 -54.28 37.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.008 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -39.34 75.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -74.09 -31.73 62.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.061 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.4 mm -76.04 -36.79 32.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.009 0.433 . . . . 0.0 110.389 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mt -73.76 -35.69 65.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.055 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.7 p . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.895 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.421 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 33.5 ttm . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.566 0.222 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.518 ' HB3' HD13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -83.65 114.03 21.27 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.045 0.45 . . . . 0.0 110.808 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -69.52 116.35 9.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.007 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.518 HD13 ' HB3' ' A' ' 2' ' ' MET . 2.5 mp -124.25 128.29 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.47 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.576 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 0.8 OUTLIER -111.16 143.02 42.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.6 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.449 HD13 HG23 ' A' ' 6' ' ' ILE . 7.6 pt -127.31 110.25 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 110.395 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.733 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 8.1 m-30 -100.15 110.67 22.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.726 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.56 -66.34 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.525 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 m 74.63 79.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.793 0.33 . . . . 0.0 111.284 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.58 -62.76 1.9 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.846 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -50.47 -70.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.353 . . . . 0.0 111.235 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.36 147.78 24.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.021 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.4 17.06 0.4 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 p -55.43 -21.96 18.21 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.729 0.3 . . . . 0.0 111.228 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -37.45 74.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.326 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -62.43 1.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.886 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.404 ' HA ' ' ND2' ' A' ' 20' ' ' ASN . 1.6 tm? -59.31 -36.02 74.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.616 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -56.87 -41.0 77.22 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.7 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -73.46 -51.94 15.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.969 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 30.7 p30 -64.61 -36.23 83.58 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.88 0.372 . . . . 0.0 111.025 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.465 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . -62.49 -44.38 96.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.61 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.573 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 1.4 mtp180 -58.55 -45.12 89.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.748 0.308 . . . . 0.0 111.253 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.2 pt-20 -71.67 -47.57 53.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.076 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.64 -49.99 73.0 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.442 ' CG1' ' HB2' ' A' ' 32' ' ' ALA . 9.1 p -53.3 -55.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 121.26 -0.176 . . . . 0.0 110.821 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.437 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.68 -40.77 79.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.5 0.191 . . . . 0.0 110.988 179.208 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 47.9 tt0 -60.27 -48.06 83.33 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.363 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.4 mt -53.84 -19.56 4.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.723 0.297 . . . . 0.0 110.966 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.74 42.93 0.84 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.433 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -175.65 106.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 111.21 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' O ' ' CA ' ' A' ' 1' ' ' MET . 28.5 t0 -61.26 164.35 5.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.105 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 2' ' ' MET . . . -148.0 179.28 7.85 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.58 110.95 9.66 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.573 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 17.7 m-85 -98.0 109.63 22.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.408 0.623 . . . . 0.0 111.982 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -109.97 124.61 51.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.35 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HA ' HG13 ' A' ' 6' ' ' ILE . 2.9 tmmt? -92.38 144.2 25.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.579 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.733 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -118.49 172.28 5.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.374 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -155.7 75.35 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.277 0.56 . . . . 0.0 109.944 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER 157.5 136.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.418 -179.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.753 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -54.03 -20.6 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 -179.413 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -51.38 -45.12 62.35 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -86.44 -31.77 21.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.3 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.753 ' HB ' ' HA ' ' A' ' 40' ' ' MET . 62.7 mt -63.59 -56.07 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-O 121.549 0.69 . . . . 0.0 111.503 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.91 -36.52 83.64 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.086 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -55.76 -24.13 33.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.103 0.478 . . . . 0.0 110.362 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.591 ' CB ' ' HE2' ' A' ' 7' ' ' TYR . . . -77.61 -41.86 37.11 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.525 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.89 -7.64 23.69 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.558 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.588 HD22 ' N ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -78.1 157.21 29.57 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.887 0.375 . . . . 0.0 110.933 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.89 -22.76 9.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.856 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 63' ' ' MET . . . -79.7 170.49 16.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.049 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.5 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 2.7 mp -71.96 -70.08 0.31 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.793 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 51' ' ' LEU . 47.8 Cg_endo -69.92 60.13 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.056 1.837 . . . . 0.0 112.234 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -83.68 128.82 8.77 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.415 ' CD1' ' CG2' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -121.97 107.93 12.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.759 0.314 . . . . 0.0 110.244 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.74 124.5 43.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.199 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.432 ' CG1' ' CG1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.85 139.59 40.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.193 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.49 26.78 0.54 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.823 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.75 35.19 46.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.317 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -144.94 103.24 3.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.944 0.402 . . . . 0.0 111.132 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.455 ' N ' HD13 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -54.5 132.71 45.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.494 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.6 -5.21 1.57 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.544 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 0.7 OUTLIER -154.17 124.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.919 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.54 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -145.73 134.55 22.4 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.367 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.467 ' N ' ' HB2' ' A' ' 50' ' ' ALA . . . 80.2 -1.5 80.36 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.884 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -178.35 100.43 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.779 0.323 . . . . 0.0 110.582 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.415 ' CG2' ' CD1' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -65.09 137.28 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.065 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.73 164.38 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.33 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.8 p -92.16 -179.76 5.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.136 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.424 ' O ' HG22 ' A' ' 72' ' ' ILE . 16.5 pttm -64.14 -49.28 72.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.673 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -71.82 -30.23 65.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.722 0.296 . . . . 0.0 111.142 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.69 -51.33 23.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.373 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.465 HD13 HG21 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -55.65 -45.87 79.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.139 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.418 ' N ' ' CG2' ' A' ' 72' ' ' ILE . 13.4 tttt -60.35 -37.09 79.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.834 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -74.06 -30.16 62.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.169 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.423 HD13 ' N ' ' A' ' 75' ' ' ILE . 1.4 mp -75.92 -29.69 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.375 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.81 -31.54 40.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.869 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.932 -179.937 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.443 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 2.2 tpp . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.559 0.219 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.514 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 8.2 tpp -80.65 112.01 17.61 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -70.12 118.3 12.78 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.028 0.442 . . . . 0.0 110.94 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 2' ' ' MET . 2.3 mp -126.14 124.95 66.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.941 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 3.7 mt-30 -110.36 139.1 45.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.945 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.5 mp -119.86 113.46 40.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.08 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.845 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 83.7 m-85 -104.71 115.94 31.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.249 0.547 . . . . 0.0 112.465 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.459 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 128.93 -66.91 0.56 Allowed Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.649 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 53.53 -84.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.608 0.242 . . . . 0.0 111.502 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 8' ' ' GLY . . . -58.96 -53.85 42.95 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.492 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.3 m -98.71 33.67 2.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.459 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -155.0 126.22 7.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -76.05 7.57 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.666 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.1 p -55.98 -20.38 16.17 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.735 0.303 . . . . 0.0 111.402 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.39 -25.46 6.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.511 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.7 mtt -63.49 -62.14 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.728 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.3 tp -64.46 -24.03 67.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.782 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.75 -51.78 67.55 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.411 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -67.62 -47.39 69.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.818 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -56.51 -39.66 73.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.913 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.73 -46.97 87.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.605 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.476 ' CG ' ' CD1' ' A' ' 34' ' ' PHE . 41.8 mtp180 -54.63 -38.05 66.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.803 0.335 . . . . 0.0 111.14 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.8 tt0 -73.57 -49.92 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.8 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -60.55 -50.93 71.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.786 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.452 ' CG1' ' HB3' ' A' ' 32' ' ' ALA . 13.8 p -53.23 -56.05 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.631 0.253 . . . . 0.0 110.64 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.439 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 0.7 OUTLIER -65.48 -47.64 75.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 0.0 110.923 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 17.8 tp10 -56.03 -48.07 76.67 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.283 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -53.32 -21.92 6.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.809 0.338 . . . . 0.0 110.765 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.62 47.41 0.63 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.597 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.6 tt -179.23 128.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.305 0.574 . . . . 0.0 111.471 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.443 ' O ' ' CA ' ' A' ' 1' ' ' MET . 17.0 t0 -69.68 164.32 23.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.604 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.514 ' HA ' ' N ' ' A' ' 2' ' ' MET . . . -147.21 175.47 10.72 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.23 107.72 9.19 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.071 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.479 ' CD2' ' HB ' ' A' ' 4' ' ' ILE . 25.2 m-85 -101.38 108.58 20.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.346 0.594 . . . . 0.0 111.179 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -118.73 124.74 48.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.67 143.68 26.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.206 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.826 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -110.08 -178.02 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.333 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.488 ' N ' HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -158.92 75.37 0.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.106 0.479 . . . . 0.0 110.62 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.479 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER 158.14 130.05 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.96 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.493 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -52.63 -27.28 16.47 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 121.245 -0.182 . . . . 0.0 111.153 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.48 -39.0 56.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -86.75 -35.87 18.94 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.974 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.845 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 20.9 mt -60.76 -54.82 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.077 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.425 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.405 HD22 ' O ' ' A' ' 40' ' ' MET . 0.2 OUTLIER -58.7 -37.33 75.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.768 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.18 -25.27 31.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 110.565 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.454 ' HB2' HD12 ' A' ' 48' ' ' LEU . . . -73.64 -34.75 65.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.996 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.12 -5.17 35.95 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.018 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.624 ' N ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -74.1 157.11 36.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.084 0.469 . . . . 0.0 111.512 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.6 p -112.41 -8.73 13.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.21 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.452 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -102.38 -175.41 2.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.41 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.614 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -86.1 -64.21 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.63 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.614 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 11.7 Cg_exo -69.53 59.87 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.254 1.969 . . . . 0.0 111.82 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.442 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -87.44 141.41 17.37 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.226 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.42 ' HB3' ' CG1' ' A' ' 62' ' ' ILE . 4.8 tt -135.27 111.45 9.64 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.32 124.42 42.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.934 0.397 . . . . 0.0 111.123 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.431 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -113.6 139.4 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.06 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 49.56 24.71 1.21 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.598 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.75 28.55 56.81 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.318 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -143.25 104.2 4.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.859 0.361 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.409 HD23 ' HB2' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -46.07 131.77 9.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.921 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.84 -13.84 7.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.985 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.42 ' CG1' ' HB3' ' A' ' 54' ' ' LEU . 2.7 pp -152.98 146.88 14.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.553 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 1.6 mtp -146.24 125.53 13.05 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.889 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.599 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 89.06 -17.17 53.07 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.034 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 178.22 109.77 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.4 m -49.51 174.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.88 0.371 . . . . 0.0 111.445 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.402 ' N ' HG23 ' A' ' 62' ' ' ILE . . . -92.61 -165.67 1.39 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.046 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.2 m -113.4 163.16 15.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.812 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.0 pttp -55.75 -42.79 75.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -65.85 -32.63 74.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.804 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.47 -48.98 29.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.046 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.407 HG21 ' N ' ' A' ' 73' ' ' LYS . 16.9 tt -62.46 -46.74 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.204 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.407 ' N ' HG21 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.27 -37.69 75.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.896 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -40.16 95.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.767 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.8 mp -75.93 -37.7 34.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.467 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.12 -45.17 68.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.111 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 91.1 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.901 -179.931 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.434 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.825 0.345 . . . . 0.0 111.284 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.482 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -83.99 116.11 22.66 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.83 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -69.12 118.34 11.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.016 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.533 ' O ' ' HA ' ' A' ' 34' ' ' PHE . 4.3 mt -128.8 123.03 58.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.094 0.473 . . . . 0.0 111.88 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -111.96 142.84 43.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.314 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.427 HG12 ' HA ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -120.55 106.23 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.767 0.318 . . . . 0.0 110.766 179.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.888 ' CD2' ' HA ' ' A' ' 43' ' ' ILE . 59.2 m-85 -91.77 109.68 21.01 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.069 0.461 . . . . 0.0 111.412 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 174.17 -100.1 0.14 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.269 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 51.86 100.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.874 0.369 . . . . 0.0 111.411 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.17 18.49 26.48 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.697 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.63 -41.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.346 . . . . 0.0 110.818 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -95.12 132.5 39.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.174 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -76.56 20.4 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.06 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.413 ' HA ' HG11 ' A' ' 66' ' ' VAL . 3.4 p -54.1 -24.06 16.2 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.953 0.406 . . . . 0.0 111.206 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.27 -32.79 64.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.111 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 23.0 ttt -63.61 -62.07 1.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.752 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.408 HD11 ' N ' ' A' ' 67' ' ' ALA . 1.2 tt -64.69 -20.05 66.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 110.637 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -58.88 -54.35 48.06 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.303 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -50.09 43.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -54.83 -49.19 71.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.072 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.02 -40.88 74.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.517 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.513 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -57.32 -41.02 79.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.259 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -74.39 -50.4 18.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.106 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.22 73.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.77 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.557 ' CG1' ' HB3' ' A' ' 32' ' ' ALA . 6.2 p -53.64 -55.53 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.154 -0.218 . . . . 0.0 110.614 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.474 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -64.65 -48.99 72.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 178.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -57.85 -42.85 85.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.51 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -53.58 -20.01 4.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.811 0.339 . . . . 0.0 110.883 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.98 41.95 0.88 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.49 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.0 tt -179.22 120.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.24 0.543 . . . . 0.0 111.058 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.434 ' O ' ' CA ' ' A' ' 1' ' ' MET . 5.0 t70 -62.64 163.97 8.33 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.762 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.557 ' HB3' ' CG1' ' A' ' 25' ' ' VAL . . . -157.77 141.04 15.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.641 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -103.83 119.58 39.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.561 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.533 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 13.3 m-85 -103.17 109.59 21.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.349 0.595 . . . . 0.0 111.906 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -108.64 122.45 47.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.824 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.427 ' HA ' HG12 ' A' ' 6' ' ' ILE . 1.9 mtpt -90.21 141.37 28.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.059 0.457 . . . . 0.0 111.13 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.781 HG13 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -108.8 175.31 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.594 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -160.06 74.93 0.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.892 0.377 . . . . 0.0 110.896 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.544 ' O ' HG13 ' A' ' 43' ' ' ILE . 3.2 mt-10 157.0 127.29 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.311 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.54 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -53.96 -26.67 26.84 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.924 -0.126 . . . . 0.0 111.111 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.66 -39.84 58.92 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -86.62 -33.15 20.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.206 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.888 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 13.1 mt -63.18 -55.87 20.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.547 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.402 HD22 ' O ' ' A' ' 40' ' ' MET . 0.4 OUTLIER -61.02 -35.89 78.06 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.681 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.86 -22.51 59.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.102 0.477 . . . . 0.0 110.234 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.451 ' HB1' ' CZ ' ' A' ' 7' ' ' TYR . . . -73.42 -36.35 65.95 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.913 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 121.13 -15.08 9.45 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.583 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.533 HD21 ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.85 158.79 32.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.361 0.58 . . . . 0.0 111.689 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 t -105.78 -28.07 10.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.458 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.42 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -81.93 -177.62 6.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.063 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.508 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -89.89 -55.57 0.29 Allowed Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.486 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 51' ' ' LEU . 14.6 Cg_exo -69.65 56.89 1.38 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.511 2.141 . . . . 0.0 112.473 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -81.46 142.25 22.73 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.475 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.2 105.32 7.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.95 122.13 40.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.987 0.422 . . . . 0.0 111.507 -179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.408 ' CG1' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -119.53 139.28 47.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.192 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.48 27.49 0.97 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.659 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.92 33.2 55.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.269 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.94 101.71 3.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.938 0.399 . . . . 0.0 111.171 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.44 127.42 22.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.608 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -125.72 -13.47 6.43 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.49 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 6.5 mt -139.63 130.55 32.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.523 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.509 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 4.0 mpp? -146.72 134.62 21.33 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.963 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.441 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 86.74 -10.61 67.04 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.575 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 3.8 ttp180 176.85 104.96 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.719 0.295 . . . . 0.0 110.436 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.416 ' HA ' ' CG2' ' A' ' 62' ' ' ILE . 2.1 p -59.28 142.84 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.839 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.408 ' N ' HD11 ' A' ' 17' ' ' LEU . . . -67.43 170.79 6.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.806 0.336 . . . . 0.0 111.349 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.67 172.04 7.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.79 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.02 -38.02 69.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.281 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -73.29 -39.39 65.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 111.106 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -69.23 -49.69 54.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.198 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.457 HD11 HG23 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -57.22 -46.72 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.253 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.8 tttm -60.57 -37.42 81.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.866 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.15 -29.33 61.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.229 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -75.9 -28.91 19.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.945 0.402 . . . . 0.0 110.676 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.32 -32.66 20.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.983 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.2 p . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.943 179.917 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.424 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.498 0.189 . . . . 0.0 111.266 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.515 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -76.54 112.56 13.21 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.762 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 100.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.042 0.449 . . . . 0.0 110.126 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.477 ' CG2' ' CD2' ' A' ' 34' ' ' PHE . 4.3 mt -110.61 130.26 64.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.51 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.474 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 14.3 mt-30 -110.81 144.36 39.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.19 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.436 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -128.2 107.96 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-O 120.82 0.343 . . . . 0.0 110.975 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.742 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 6.1 m-30 -100.11 112.8 25.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.125 0.488 . . . . 0.0 111.469 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.57 -104.51 0.24 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.572 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 62.37 136.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 0.0 111.063 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.52 25.67 42.97 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -175.99 -67.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 110.685 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.5 137.89 50.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -76.27 13.82 0.85 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.156 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.403 ' HB2' HG21 ' A' ' 6' ' ' ILE . 4.6 p -56.22 -29.22 60.67 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.915 0.388 . . . . 0.0 111.209 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.34 -35.26 60.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.45 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 tpt -64.78 -62.65 1.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.346 . . . . 0.0 111.127 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.431 ' CB ' ' HB ' ' A' ' 66' ' ' VAL . 3.5 tm? -66.37 -24.18 66.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.767 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -57.17 -49.82 74.78 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.22 179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.1 -46.09 82.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.43 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -54.91 -45.53 74.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.551 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.74 -41.51 82.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.473 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.511 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 3.9 mtm180 -55.68 -41.68 74.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.038 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 13.9 tt0 -73.77 -49.85 23.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.186 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -62.28 -51.88 65.93 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' A' ' 26' ' ' LYS . 2.9 p -53.3 -53.98 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.418 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.487 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 3.4 mtpm? -65.46 -48.88 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.82 0.343 . . . . 0.0 110.841 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.411 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 4.4 tm-20 -58.13 -42.87 86.75 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.535 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -51.35 -21.36 2.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.878 0.37 . . . . 0.0 110.955 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.76 34.37 1.71 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.226 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -169.37 113.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.429 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 2.2 t0 -61.07 164.13 5.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.213 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 2' ' ' MET . . . -150.87 167.56 27.14 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -125.86 115.14 19.51 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.26 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.511 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 12.4 m-85 -100.2 108.72 20.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.337 0.589 . . . . 0.0 111.093 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -110.57 112.24 24.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.696 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 mtmt -82.23 141.36 33.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.243 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.742 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -112.3 159.75 12.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.29 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -139.92 75.34 1.51 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.325 0.583 . . . . 0.0 110.123 179.197 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 0.3 OUTLIER 157.59 134.66 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.566 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.641 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 3.6 ttm -56.39 -16.91 6.47 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -51.17 -45.94 61.93 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.48 -31.62 21.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.299 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.663 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 30.4 mt -64.57 -54.73 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 121.504 0.668 . . . . 0.0 111.383 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.52 -36.26 83.3 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.007 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 28.6 tt0 -54.88 -26.19 33.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.209 0.528 . . . . 0.0 110.041 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.618 ' CB ' ' HE2' ' A' ' 7' ' ' TYR . . . -74.59 -46.73 36.73 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.084 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.63 -7.76 13.51 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.528 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.572 HD22 ' N ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -76.26 155.22 34.55 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.774 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.82 -26.07 9.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.788 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.516 ' CB ' ' HB2' ' A' ' 63' ' ' MET . . . -75.73 179.66 5.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.59 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.476 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -81.69 -68.59 0.19 Allowed Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.117 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 51' ' ' LEU . 45.0 Cg_endo -70.01 57.33 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.201 1.934 . . . . 0.0 113.809 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.454 ' HA2' ' HB3' ' A' ' 63' ' ' MET . . . -72.2 141.52 31.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.033 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 62' ' ' ILE . 0.1 OUTLIER -130.76 104.07 6.96 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.483 ' CB ' HD11 ' A' ' 60' ' ' LEU . . . -98.39 123.48 42.53 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.102 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.463 ' CG1' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -120.8 141.04 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.657 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 47.19 26.92 0.74 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.938 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.38 29.52 55.83 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.404 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -140.92 103.7 4.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.912 0.386 . . . . 0.0 110.84 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.499 HD11 ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -72.87 126.53 30.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.161 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -147.16 10.18 0.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 54' ' ' LEU . 5.2 mt -147.1 103.9 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.989 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.516 ' HB2' ' CB ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.37 149.92 35.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.132 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.511 ' N ' ' HB1' ' A' ' 50' ' ' ALA . . . 84.53 -5.94 79.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.978 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.427 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER 165.4 105.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.431 ' HB ' ' CB ' ' A' ' 17' ' ' LEU . 10.3 m -61.14 163.89 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 111.193 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.27 169.18 16.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.063 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 m -82.96 178.2 8.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.911 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -65.35 -53.4 44.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.264 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -33.22 72.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.343 . . . . 0.0 110.931 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -72.62 -48.13 42.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.054 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.405 ' CD1' ' CD1' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -61.86 -42.21 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.996 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.11 -31.88 73.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.635 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -69.74 -30.6 68.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.08 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 tp -75.51 -28.3 19.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.678 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.405 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -67.94 -55.09 14.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.836 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.929 179.994 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 2.7 ttp . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.448 0.166 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.496 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 2.3 mmt -81.11 113.03 19.01 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.947 0.403 . . . . 0.0 110.824 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 120.14 14.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.068 0.461 . . . . 0.0 110.767 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.451 ' CG2' ' CD2' ' A' ' 34' ' ' PHE . 2.1 mp -129.09 124.82 61.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.454 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -111.1 141.98 43.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.257 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.429 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -130.28 113.44 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 0.0 110.608 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.359 ' CD2' ' CE2' ' A' ' 7' ' ' TYR . 27.5 m-85 -100.51 113.02 25.48 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.298 0.571 . . . . 0.0 112.042 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.436 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 171.24 -100.62 0.16 Allowed Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.412 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.91 103.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.786 0.326 . . . . 0.0 111.302 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.48 -28.62 11.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.711 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.8 p -138.57 -48.36 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 111.134 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.436 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -73.45 132.7 43.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -76.56 19.73 0.25 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.196 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.5 p -55.62 -23.06 25.53 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.808 0.337 . . . . 0.0 111.234 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -33.79 72.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.174 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 38.1 ttp -64.58 -62.09 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.372 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.451 ' CD1' ' HB1' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -60.97 -33.21 72.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.694 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -56.47 -39.84 73.88 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.666 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -73.52 -52.4 13.69 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.849 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 30.7 p30 -64.22 -34.02 77.14 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.849 0.357 . . . . 0.0 110.803 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.451 ' HB1' ' CD1' ' A' ' 17' ' ' LEU . . . -62.07 -49.28 76.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.026 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.492 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 2.2 mtm-85 -54.76 -39.04 67.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.716 0.293 . . . . 0.0 111.007 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -72.18 -50.26 29.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.079 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.43 -50.52 71.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.682 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.477 ' CG1' ' HB1' ' A' ' 32' ' ' ALA . 11.1 p -53.54 -55.8 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.607 0.241 . . . . 0.0 110.473 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.456 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 11.8 mtpt -64.15 -49.36 72.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.755 0.312 . . . . 0.0 110.682 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -55.72 -47.15 77.38 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.349 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -51.64 -22.3 3.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.856 0.36 . . . . 0.0 110.872 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.8 36.12 1.44 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.336 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 pt -168.55 112.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.041 0.448 . . . . 0.0 111.103 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.453 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 30.5 t70 -61.44 164.61 5.52 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.49 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.496 ' HA ' ' N ' ' A' ' 2' ' ' MET . . . -148.65 171.72 15.72 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -128.51 110.23 12.1 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.957 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.492 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 15.1 m-85 -100.46 108.96 21.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.323 0.583 . . . . 0.0 111.374 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -113.17 121.05 43.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.789 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.414 ' HA ' HG12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -94.45 139.63 30.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.075 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.826 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -106.98 179.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.124 -179.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.438 ' N ' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -155.34 74.92 0.92 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.116 0.484 . . . . 0.0 110.884 179.114 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.509 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER 162.25 126.62 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.006 179.676 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.499 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 15.2 mtt -52.55 -29.24 24.42 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.569 0.223 . . . . 0.0 110.764 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.93 -38.13 55.2 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.884 ' O ' ' CE2' ' A' ' 7' ' ' TYR . 7.4 mt-30 -86.6 -34.94 19.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.083 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.872 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 10.7 mt -62.84 -54.67 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.512 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.58 -34.26 77.42 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.924 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.04 -23.58 62.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.919 0.39 . . . . 0.0 110.427 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.438 ' CB ' HD11 ' A' ' 48' ' ' LEU . . . -73.11 -36.52 66.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.707 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.76 -9.05 14.57 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.842 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.514 HD23 ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -69.21 150.08 47.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.495 0.648 . . . . 0.0 111.243 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.31 -19.36 19.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.431 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.437 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -100.92 -173.37 2.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.212 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.512 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.0 OUTLIER -86.87 -57.4 0.32 Allowed Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.643 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 17.0 Cg_exo -67.87 58.19 0.83 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.618 2.212 . . . . 0.0 112.38 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.417 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -74.88 148.32 37.94 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.559 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -137.24 100.1 4.16 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.92 119.43 36.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.188 0.518 . . . . 0.0 111.217 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.44 ' CG1' ' CG1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -115.03 138.74 44.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.888 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 47.25 27.25 0.82 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.497 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.53 35.43 47.01 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.284 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -148.47 100.66 3.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 0.0 111.268 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.75 129.45 14.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.974 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.42 -13.16 4.39 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.407 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 4.8 mm -139.59 135.84 39.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.754 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.466 ' CG ' ' HB2' ' A' ' 48' ' ' LEU . 1.4 mpp? -146.48 133.28 20.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.52 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.503 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 83.23 -6.34 72.46 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.273 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 173.44 103.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.4 HG23 ' CB ' ' A' ' 17' ' ' LEU . 9.0 p -48.47 155.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.337 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.77 178.74 0.57 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.894 0.378 . . . . 0.0 111.158 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 74.3 m -110.17 169.57 8.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.008 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.404 ' O ' HG23 ' A' ' 72' ' ' ILE . 46.0 tttm -58.38 -45.86 87.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.239 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -73.1 -29.8 63.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 0.0 111.052 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -73.39 -46.69 47.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.376 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.465 HG22 HD13 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -61.71 -46.18 97.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.139 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.46 -32.76 74.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 0.0 110.816 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -27.99 61.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.9 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.6 mm -75.85 -35.54 30.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.019 0.438 . . . . 0.0 110.171 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -33.68 57.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.833 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.816 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.456 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 9.1 ptp . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.361 0.124 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.47 ' CB ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -81.35 109.74 16.13 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.796 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -69.26 103.55 1.98 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.132 0.491 . . . . 0.0 110.664 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.429 HG13 ' CG1' ' A' ' 56' ' ' VAL . 1.0 OUTLIER -101.64 116.65 45.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.107 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.464 ' CB ' HD12 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -110.11 115.04 29.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.017 179.58 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.41 HG13 ' HA ' ' A' ' 36' ' ' LYS . 15.8 pt -100.41 109.26 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-O 121.086 0.47 . . . . 0.0 111.847 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.704 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 90.3 m-85 -90.44 125.91 35.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.93 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.79 -82.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.514 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p 51.85 78.36 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 111.285 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.14 -84.01 0.18 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.542 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.9 m -93.99 -29.99 14.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.798 0.332 . . . . 0.0 110.926 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.42 133.28 53.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.384 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -76.63 20.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.083 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.2 p -53.03 -23.47 7.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.893 0.378 . . . . 0.0 111.287 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -39.45 71.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 16.9 ttt -68.08 -51.36 47.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.507 ' HB2' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -69.04 -25.89 64.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.987 0.423 . . . . 0.0 110.389 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -58.78 -52.92 63.67 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.243 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -65.79 -44.71 84.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.829 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -58.12 -54.32 48.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.165 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.443 ' CB ' ' HE2' ' A' ' 34' ' ' PHE . . . -53.02 -36.3 60.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.32 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.593 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -60.4 -48.87 79.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.319 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.2 pt-20 -71.59 -47.83 52.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.298 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.03 -49.88 72.88 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.484 ' CG1' ' N ' ' A' ' 26' ' ' LYS . 4.9 p -53.48 -54.99 15.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.919 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.484 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 5.7 mtmm -70.04 -49.03 55.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.265 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 22.9 tt0 -51.81 -46.68 64.34 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.732 0.301 . . . . 0.0 111.172 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.47 -23.66 4.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.978 0.418 . . . . 0.0 110.487 179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.53 37.57 1.3 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.572 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -167.97 117.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.987 0.422 . . . . 0.0 111.642 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.456 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -61.42 165.53 4.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.895 178.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.47 ' HB3' ' CB ' ' A' ' 2' ' ' MET . . . -148.31 179.2 7.95 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -129.45 113.98 15.57 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.593 ' CZ ' ' HA ' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -100.31 109.75 21.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.279 0.561 . . . . 0.0 111.659 -178.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -126.21 128.55 47.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.073 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.41 ' HA ' HG13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -79.76 151.94 30.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.961 0.41 . . . . 0.0 110.762 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.689 ' CD1' ' N ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -123.27 78.35 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.938 -178.271 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.9 tttt -77.47 75.77 4.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.14 0.495 . . . . 0.0 110.825 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 172.07 127.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.414 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.624 ' HA ' HG21 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -63.92 -27.21 68.99 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.031 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.402 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 2.1 t0 -51.48 -36.76 45.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.22 -33.41 18.13 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.893 178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.704 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -68.51 -45.22 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.073 0.463 . . . . 0.0 111.432 -179.195 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.42 ' N ' ' CG1' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -65.48 -37.96 88.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.178 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -60.59 -22.06 63.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.243 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.47 -35.4 53.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.0 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.87 -8.35 21.6 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.628 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.443 ' HB2' ' HG3' ' A' ' 63' ' ' MET . 0.0 OUTLIER -81.46 158.8 24.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.431 0.616 . . . . 0.0 111.597 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 t -114.92 -31.87 5.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.587 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.23 -159.73 0.1 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.23 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.484 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.6 OUTLIER -101.87 -56.28 0.12 Allowed Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.483 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.548 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 21.1 Cg_exo -65.55 57.81 0.36 Allowed 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.477 2.118 . . . . 0.0 113.561 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -88.48 136.03 13.44 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.164 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.422 ' HG ' ' CD1' ' A' ' 17' ' ' LEU . 3.4 tm? -138.31 114.78 10.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.741 0.305 . . . . 0.0 110.77 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.455 ' CB ' ' CD2' ' A' ' 60' ' ' LEU . . . -109.55 131.34 55.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.03 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.429 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -117.85 139.9 43.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.111 0.482 . . . . 0.0 111.013 179.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 46.58 27.9 0.7 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.6 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.87 42.05 17.46 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.378 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.14 100.58 3.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.455 ' CD2' ' CB ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -69.01 128.17 35.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.916 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.29 7.75 1.03 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.56 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 11.0 mm -143.72 110.57 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.791 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.443 ' HG3' ' HB2' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -145.52 141.45 28.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.926 0.393 . . . . 0.0 111.509 -179.478 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.548 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 67.39 11.45 59.42 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.858 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -178.09 103.63 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.821 0.343 . . . . 0.0 110.621 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.507 HG11 ' HB2' ' A' ' 17' ' ' LEU . 0.9 OUTLIER -56.45 144.49 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.618 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -78.25 147.28 34.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.102 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.8 p -90.47 168.32 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -55.65 -41.78 74.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.13 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -69.37 -40.55 77.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.976 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -63.94 -45.91 87.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.013 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.8 mt -65.93 -50.44 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -57.78 -31.81 66.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.964 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -72.02 -38.81 69.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.0 mt -75.73 -38.41 37.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.509 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 mp -64.0 -53.31 52.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.001 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.903 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.447 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 6.9 mtp . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.731 0.3 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.468 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.05 114.54 17.03 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.828 0.347 . . . . 0.0 110.672 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.47 106.07 2.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.106 0.479 . . . . 0.0 110.105 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.458 HD13 ' CE2' ' A' ' 34' ' ' PHE . 7.3 mt -117.13 127.75 74.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.478 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.418 ' O ' ' CD2' ' A' ' 54' ' ' LEU . 2.9 mp0 -110.39 144.08 39.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.354 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.72 108.24 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.793 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.845 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 56.9 m-85 -96.94 115.64 27.79 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.289 0.566 . . . . 0.0 111.586 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 159.88 -88.87 0.11 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.331 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.8 p 49.54 96.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.843 0.354 . . . . 0.0 111.43 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.9 -78.88 0.31 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.392 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 t -85.76 -39.57 17.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.781 0.324 . . . . 0.0 110.762 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.419 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -79.45 125.77 29.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.926 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -76.49 19.95 0.24 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.131 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.2 p -58.77 -19.92 45.11 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.696 0.284 . . . . 0.0 111.611 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.95 -31.62 60.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.405 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.09 -52.83 61.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.673 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.428 ' CB ' HG23 ' A' ' 66' ' ' VAL . 5.6 tt -69.09 -29.87 68.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.753 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -55.55 -40.6 72.12 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.899 0.381 . . . . 0.0 110.416 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -73.03 -52.33 14.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.918 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 31.9 p30 -64.49 -33.73 76.58 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.816 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . -60.74 -47.06 88.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.941 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.534 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 12.6 mtp180 -56.89 -42.32 79.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.651 0.262 . . . . 0.0 110.905 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -47.94 49.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.055 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.97 -51.73 65.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.691 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 32' ' ' ALA . 9.8 p -53.55 -55.12 14.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.456 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -62.97 -49.15 75.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.651 178.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.11 -45.84 86.56 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.301 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -52.12 -20.69 2.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.991 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.11 46.61 0.64 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.623 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 7.9 tt 177.14 124.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.11 0.481 . . . . 0.0 111.192 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.447 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -66.08 162.64 19.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.704 179.51 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.529 ' HB3' ' CG1' ' A' ' 25' ' ' VAL . . . -154.32 142.8 20.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -104.48 114.41 28.62 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.273 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.534 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 17.8 m-85 -97.58 109.29 22.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.317 0.58 . . . . 0.0 111.471 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -110.06 114.71 28.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.62 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.51 138.54 31.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.245 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.845 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -107.29 177.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.443 ' N ' HG12 ' A' ' 37' ' ' ILE . 13.6 pttm -156.75 75.28 0.84 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.157 0.503 . . . . 0.0 110.889 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.498 ' O ' HG13 ' A' ' 43' ' ' ILE . 9.8 pt-20 157.31 130.77 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.839 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.46 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 2.2 ptt? -52.31 -25.35 9.32 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.804 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.5 -39.44 57.62 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -87.31 -38.8 15.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.166 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.837 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 8.5 mt -60.68 -55.59 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.561 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -34.83 77.42 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.879 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -57.21 -24.92 57.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.102 0.477 . . . . 0.0 110.248 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . . . -71.97 -37.24 69.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.726 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.05 -14.62 10.34 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.703 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.515 HD21 ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.86 161.18 25.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.028 0.442 . . . . 0.0 111.289 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t -110.59 -24.58 10.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.997 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.17 -179.74 7.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.417 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.549 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.6 mt -88.13 -60.08 0.25 Allowed Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.855 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 17.2 Cg_exo -66.52 49.6 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.637 2.224 . . . . 0.0 113.769 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.99 146.74 35.42 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.571 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.418 ' CD2' ' O ' ' A' ' 5' ' ' GLN . 2.8 tm? -136.55 102.4 4.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -97.9 123.68 41.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 111.335 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.45 140.67 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.181 0.515 . . . . 0.0 111.487 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 t0 48.48 25.66 0.98 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.086 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.17 25.72 50.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.413 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -139.9 104.49 4.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.891 0.377 . . . . 0.0 110.601 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -90.43 128.72 36.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.696 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -146.43 3.22 0.87 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.141 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.402 ' HB ' ' HB3' ' A' ' 54' ' ' LEU . 19.5 mm -128.67 103.31 9.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.989 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -146.45 162.46 38.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.632 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . 80.9 -7.61 58.86 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.246 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER 170.37 103.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.428 HG23 ' CB ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -67.68 151.93 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.821 0.343 . . . . 0.0 111.389 -179.14 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.9 179.58 7.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.341 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 m -104.26 -170.18 1.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.932 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.41 ' O ' HG21 ' A' ' 72' ' ' ILE . 25.7 tttt -65.55 -54.51 27.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.008 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.17 -29.8 70.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.906 0.384 . . . . 0.0 110.652 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.45 -51.14 18.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.04 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.441 HG23 ' N ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -60.76 -42.85 93.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.858 0.361 . . . . 0.0 110.964 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.441 ' N ' HG23 ' A' ' 72' ' ' ILE . 16.6 tptm -65.52 -31.68 72.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.706 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -71.79 -29.15 64.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.75 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.4 mt -75.63 -37.21 36.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.144 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.11 -55.6 4.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.912 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.917 -179.99 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.426 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 8.6 ttp . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.554 0.216 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.491 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 1.4 mtt -77.73 113.61 15.76 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.951 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -69.35 100.8 1.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.012 0.434 . . . . 0.0 109.958 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.446 HG12 ' CG1' ' A' ' 56' ' ' VAL . 3.5 mt -109.95 135.66 48.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.998 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.443 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 22.2 mm-40 -111.36 143.98 41.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.376 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.464 ' CG2' ' HB2' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -127.3 100.34 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 120.972 0.415 . . . . 0.0 110.349 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.753 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 8.3 m-30 -94.19 116.31 28.69 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.3 0.572 . . . . 0.0 112.155 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.16 -90.52 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.213 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 m 48.57 29.71 2.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.76 0.314 . . . . 0.0 111.528 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.86 108.85 0.23 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.499 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t 59.78 27.17 16.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 110.994 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 14' ' ' CYS . . . -124.73 132.47 53.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.896 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -76.12 20.74 0.19 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.699 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.464 ' HB2' ' CG2' ' A' ' 6' ' ' ILE . 1.8 p -51.51 -28.96 15.0 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.953 0.406 . . . . 0.0 111.128 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -36.18 73.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.008 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 14.3 mtt -68.62 -50.67 49.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.354 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.44 ' N ' HG12 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -71.09 -31.19 67.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.994 0.426 . . . . 0.0 110.628 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -58.48 -42.36 87.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.617 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.45 -42.4 62.01 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 36.1 p30 -74.96 -34.62 62.07 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.734 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.499 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . -66.28 -50.44 63.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.558 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.563 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -59.91 -44.46 94.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.583 0.23 . . . . 0.0 111.457 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 41.7 tp10 -72.69 -50.17 26.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.622 0.248 . . . . 0.0 110.966 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -62.34 -51.8 66.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.692 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.478 ' CG1' ' HB2' ' A' ' 32' ' ' ALA . 4.0 p -53.3 -54.91 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.914 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.476 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 11.1 mtmm -67.27 -46.6 73.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.636 0.255 . . . . 0.0 111.112 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.435 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -58.57 -46.24 87.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.359 -179.576 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -52.01 -21.83 3.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.924 0.393 . . . . 0.0 110.851 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.79 50.3 0.52 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.528 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 6.8 tt 178.03 122.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.238 0.542 . . . . 0.0 111.371 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.426 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -62.94 164.54 8.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.373 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.491 ' HA ' ' N ' ' A' ' 2' ' ' MET . . . -153.59 151.52 29.84 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -111.91 113.47 25.8 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.05 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.563 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 69.0 m-85 -99.85 108.81 21.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.281 0.563 . . . . 0.0 111.634 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -107.24 110.63 22.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.257 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -84.44 136.83 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.69 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.753 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -113.0 164.37 8.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.064 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -140.62 75.43 1.51 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.992 0.425 . . . . 0.0 110.73 179.553 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 1.4 mm-40 155.26 132.81 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.828 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.508 ' HA ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -57.02 -28.43 62.49 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.709 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -51.5 -33.58 32.17 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -86.93 -33.07 19.81 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.356 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.704 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 0.9 OUTLIER -71.19 -50.82 39.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 CA-C-O 121.083 0.468 . . . . 0.0 111.601 -179.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.492 ' N ' ' CG1' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -57.22 -36.21 70.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.58 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -53.73 -25.42 18.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.973 0.416 . . . . 0.0 110.173 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.516 ' CB ' ' HE2' ' A' ' 7' ' ' TYR . . . -78.67 -46.33 19.39 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.387 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.93 -20.6 4.52 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.518 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.532 HD23 ' N ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -69.0 155.67 39.95 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.895 0.379 . . . . 0.0 111.068 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.86 -16.22 12.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.394 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.407 ' HB2' ' N ' ' A' ' 64' ' ' GLY . . . -89.19 -179.14 5.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.791 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.594 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.6 mp -83.72 -63.95 0.24 Allowed Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 16.4 Cg_exo -67.45 51.58 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.392 2.061 . . . . 0.0 112.927 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.74 116.75 4.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.22 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.05 107.19 18.06 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -98.28 123.53 42.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.038 0.447 . . . . 0.0 111.632 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.446 ' CG1' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.37 139.01 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.919 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.8 t70 46.68 27.81 0.71 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.355 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.87 37.55 50.68 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.233 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -150.09 101.84 3.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 111.304 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.407 HD11 ' CB ' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -46.0 133.37 8.87 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.015 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.79 -16.8 2.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.994 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.458 HD12 HG21 ' A' ' 62' ' ' ILE . 15.6 mt -154.34 111.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.586 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -145.64 150.91 37.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.021 0.439 . . . . 0.0 111.627 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . 83.4 -5.18 78.73 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.544 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.437 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 45.2 ttp85 174.25 106.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.743 0.306 . . . . 0.0 110.423 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 17' ' ' LEU . 2.6 t -54.34 141.06 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.651 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -87.83 142.27 27.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.043 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.4 t -63.66 156.95 25.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.1 -30.4 25.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.284 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -42.2 96.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.837 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -67.18 -41.87 85.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.995 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.7 mm -58.88 -53.19 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -61.37 -34.23 74.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.842 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -73.73 -30.87 63.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.0 mm -76.1 -36.78 31.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.978 0.418 . . . . 0.0 110.237 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.65 -33.23 35.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.955 -179.952 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.437 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.452 0.168 . . . . 0.0 111.179 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.46 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -82.64 112.84 19.88 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.08 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.6 104.9 2.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.128 0.489 . . . . 0.0 110.253 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.478 ' CD1' ' CZ ' ' A' ' 34' ' ' PHE . 2.2 mp -108.57 127.57 64.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.39 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.425 ' CB ' HD12 ' A' ' 37' ' ' ILE . 2.0 mt-30 -110.29 125.6 53.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.016 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.435 ' CG2' ' HB2' ' A' ' 14' ' ' CYS . 3.3 mp -103.93 98.3 6.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.324 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.733 ' CE1' HG13 ' A' ' 37' ' ' ILE . 93.8 m-85 -93.5 116.92 29.46 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 120.926 0.393 . . . . 0.0 111.2 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.431 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 118.37 -1.99 16.21 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.088 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 t -40.05 120.1 1.12 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 111.668 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.3 -54.43 0.54 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.338 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.1 m -101.98 -33.01 9.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.917 0.389 . . . . 0.0 110.73 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.431 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -86.32 152.3 22.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.015 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -75.95 8.99 2.66 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.7 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.435 ' HB2' ' CG2' ' A' ' 6' ' ' ILE . 3.4 p -54.19 -30.99 51.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.998 0.427 . . . . 0.0 111.273 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -36.59 42.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.601 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 10.4 tpp -63.77 -62.44 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.092 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.447 ' CB ' ' HB ' ' A' ' 66' ' ' VAL . 6.5 tp -65.66 -24.7 67.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.697 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -55.7 -50.42 70.35 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.849 0.357 . . . . 0.0 110.136 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -47.07 76.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.693 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -56.11 -44.62 79.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.16 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.48 -40.84 83.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.805 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.57 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -59.11 -46.81 87.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.659 0.266 . . . . 0.0 111.245 -179.604 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 10.8 pt-20 -71.95 -47.33 53.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.226 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.5 -50.74 70.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.484 ' CG1' ' N ' ' A' ' 26' ' ' LYS . 5.9 p -53.62 -55.74 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.591 0.234 . . . . 0.0 110.763 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.484 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 21.3 mtpp -66.99 -49.9 63.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.38 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 2.0 tt0 -52.86 -48.19 67.26 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.59 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mt -52.46 -21.26 3.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.86 0.362 . . . . 0.0 110.719 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.55 30.68 2.56 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.311 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -156.75 107.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.963 0.411 . . . . 0.0 111.075 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.437 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.7 OUTLIER -61.56 164.16 6.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.042 179.331 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 2' ' ' MET . . . -152.53 175.66 12.52 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -129.6 114.14 15.69 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.57 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 40.8 m-85 -102.13 108.94 20.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.553 0.692 . . . . 0.0 112.278 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -118.38 129.45 55.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.008 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.98 153.09 30.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.103 0.478 . . . . 0.0 111.127 -178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.733 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -128.14 76.56 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.463 -178.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.53 75.65 4.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.061 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.461 ' O ' HG22 ' A' ' 43' ' ' ILE . 6.5 pt-20 171.47 125.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.609 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.574 ' HA ' ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -59.92 -30.48 69.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.58 0.229 . . . . 0.0 110.973 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -51.23 -33.75 29.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.409 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 28.3 mm100 -87.91 -34.57 18.1 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.984 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.653 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 2.5 pt -61.86 -51.37 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.056 0.455 . . . . 0.0 111.029 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.487 ' N ' ' CG1' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -62.84 -41.34 99.3 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.022 179.56 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -58.98 -22.41 60.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.945 178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.454 ' CB ' ' CZ ' ' A' ' 7' ' ' TYR . . . -75.27 -39.76 59.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.729 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 123.4 -20.43 7.44 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.084 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.477 ' HG ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -77.28 163.75 26.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.1 m -115.58 -23.35 8.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.902 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.522 ' HB3' ' CB ' ' A' ' 63' ' ' MET . . . -78.84 173.26 12.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.47 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.621 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -78.72 -64.75 0.35 Allowed Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.292 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.621 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 15.4 Cg_exo -67.17 59.14 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.406 2.071 . . . . 0.0 112.426 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.477 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -80.9 136.83 17.01 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.602 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.1 tp -127.1 98.2 5.22 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.426 ' CB ' HD12 ' A' ' 60' ' ' LEU . . . -97.38 122.72 40.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.087 0.47 . . . . 0.0 111.079 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.442 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -112.94 139.98 35.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.989 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 45.5 27.05 0.36 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.726 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.2 39.44 31.81 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.31 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -149.03 100.9 3.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 111.314 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.426 HD12 ' CB ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -51.31 131.4 28.34 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.798 179.456 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.05 -16.79 4.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.015 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.46 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 2.1 mt -152.69 131.8 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.987 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.522 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.96 135.19 22.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.392 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.476 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 92.85 -10.56 73.74 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.474 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 165.69 106.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.447 ' HB ' ' CB ' ' A' ' 17' ' ' LEU . 5.8 m -53.05 166.09 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.793 0.33 . . . . 0.0 111.186 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -82.5 -173.98 4.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.151 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.0 t -97.77 168.85 10.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -58.1 -54.4 47.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -56.24 -39.49 72.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.982 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -56.94 -43.0 81.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 47.4 mm -57.9 -55.22 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.972 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -61.48 -36.4 80.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.906 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.16 -28.98 61.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.6 mm -76.01 -35.76 30.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.308 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.41 -31.98 48.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.047 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.2 p . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.953 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.567 0.222 . . . . 0.0 111.291 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.475 ' HB3' HD11 ' A' ' 4' ' ' ILE . 3.1 ttt -82.68 114.04 20.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.917 0.389 . . . . 0.0 110.97 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.39 118.87 17.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.938 0.399 . . . . 0.0 110.576 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.491 HG13 ' CG1' ' A' ' 56' ' ' VAL . 2.7 mp -125.61 118.1 51.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.092 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.455 ' CB ' HD11 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -111.14 122.57 48.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.799 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.8 pt -104.63 110.72 31.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 CA-C-O 120.848 0.356 . . . . 0.0 111.08 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.735 ' CE1' HG13 ' A' ' 37' ' ' ILE . 93.7 m-85 -90.74 122.88 33.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.038 0.447 . . . . 0.0 111.431 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.439 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 127.83 -65.85 0.57 Allowed Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.182 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.3 m 66.07 -73.1 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.734 0.302 . . . . 0.0 111.64 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.75 -96.37 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.853 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.8 -23.55 7.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.654 0.264 . . . . 0.0 111.508 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.439 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -82.8 121.89 27.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.913 0.387 . . . . 0.0 111.357 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -76.77 21.34 0.21 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.859 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.493 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.7 p -52.83 -24.43 8.99 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.89 0.376 . . . . 0.0 111.363 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.63 -28.02 3.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.506 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -62.51 1.51 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.836 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.425 ' HB3' HG21 ' A' ' 66' ' ' VAL . 4.0 tp -68.38 -20.05 64.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.806 0.336 . . . . 0.0 110.508 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -59.12 -49.91 76.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.251 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -50.05 24.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.812 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -56.28 -50.82 70.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.114 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.6 -41.87 77.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.574 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.482 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 3.0 mtm180 -60.73 -44.43 96.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.578 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 24' ' ' ALA . 14.8 pt-20 -73.33 -45.95 52.27 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.925 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.472 ' N ' ' HG3' ' A' ' 23' ' ' GLU . . . -64.01 -49.23 73.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.467 HG12 ' HB2' ' A' ' 32' ' ' ALA . 14.0 p -53.44 -55.52 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.458 0.171 . . . . 0.0 110.842 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.422 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.09 -43.03 79.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.549 0.214 . . . . 0.0 110.926 179.208 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 13.4 tt0 -58.57 -47.0 85.72 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.731 0.3 . . . . 0.0 110.971 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.44 -20.43 7.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.9 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.57 41.72 0.93 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.554 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -173.89 110.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.42 . . . . 0.0 111.288 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.408 ' O ' ' CA ' ' A' ' 1' ' ' MET . 38.6 t70 -61.38 163.63 6.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.375 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.467 ' HB2' HG12 ' A' ' 25' ' ' VAL . . . -145.39 174.8 10.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -131.85 109.02 9.81 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.482 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 18.7 m-85 -100.85 108.84 20.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.503 0.668 . . . . 0.0 112.018 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -119.77 131.17 55.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.94 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.3 141.94 35.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.006 0.431 . . . . 0.0 110.646 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.735 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -116.76 70.62 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.481 -179.335 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 75.39 1.91 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.18 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.518 ' O ' HG13 ' A' ' 43' ' ' ILE . 1.3 mt-10 174.85 119.78 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.699 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.464 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 17.0 ptp -53.05 -27.76 21.39 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.467 0.175 . . . . 0.0 110.927 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -51.55 -39.87 58.6 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.43 ' HB3' HG21 ' A' ' 37' ' ' ILE . 1.9 mm-40 -87.74 -35.53 17.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.531 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.662 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 11.7 mt -62.06 -54.91 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.154 0.502 . . . . 0.0 111.216 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.88 -32.33 69.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.209 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -59.38 -38.65 81.06 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HB2' ' CD1' ' A' ' 48' ' ' LEU . . . -68.71 -40.67 79.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.59 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.46 26.0 55.53 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.116 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.518 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -47.19 -87.43 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.25 0.525 . . . . 0.0 111.061 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.495 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 1.5 m 147.67 -25.52 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.563 0.745 . . . . 0.0 109.4 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -122.15 -166.79 1.45 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.838 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.55 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -83.7 -59.52 0.36 Allowed Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.575 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 11.9 Cg_exo -70.06 57.76 1.64 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.5 2.133 . . . . 0.0 112.524 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -81.44 139.45 20.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.699 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.426 HD11 ' HA ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -137.03 110.77 8.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.723 0.297 . . . . 0.0 110.944 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -99.55 123.27 43.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.035 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.491 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -115.48 137.21 49.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.307 0.575 . . . . 0.0 111.836 -179.116 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 46.62 27.45 0.65 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.738 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.8 33.41 37.6 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.315 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -148.27 97.88 2.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.863 0.363 . . . . 0.0 111.081 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 2.0 mp -60.74 134.64 57.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.03 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 2.52 1.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.475 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 3.9 mp -137.78 127.6 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.632 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.448 ' CG ' ' HB2' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -147.34 126.79 13.18 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.543 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 77.06 4.57 83.63 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.506 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 178.36 108.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.741 0.271 . . . . 0.0 110.504 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.493 ' CG2' ' HA ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -59.54 139.12 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.659 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.416 ' CB ' HD11 ' A' ' 17' ' ' LEU . . . -63.93 168.2 5.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.811 0.339 . . . . 0.0 111.346 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.4 t -103.28 -174.77 2.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.148 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.39 -57.26 13.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.137 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -53.46 -33.96 56.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.143 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.87 -37.71 88.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.2 mt -64.98 -55.07 22.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.977 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -34.41 72.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -74.1 -31.66 62.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.947 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 mm -76.14 -36.46 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.293 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.69 -31.78 61.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.003 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.4 t . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.909 -179.899 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.433 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 2.6 mtm . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.616 0.246 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.483 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -76.45 113.32 13.93 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.987 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.29 118.59 12.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.411 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.51 ' CG2' ' CD2' ' A' ' 34' ' ' PHE . 7.4 mt -129.18 119.59 49.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.078 0.466 . . . . 0.0 112.117 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -112.0 123.89 51.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.333 178.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.423 ' C ' HD11 ' A' ' 37' ' ' ILE . 2.9 mp -101.74 111.82 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.661 0.267 . . . . 0.0 111.32 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.908 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 98.2 m-85 -95.17 108.59 20.72 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.073 0.463 . . . . 0.0 111.525 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.449 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 140.47 -82.3 0.24 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.468 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.8 m 69.68 -68.71 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 0.0 111.397 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.15 -92.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.635 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 m -54.47 -28.73 46.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 111.129 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.449 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -90.62 117.21 29.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.149 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -76.24 15.71 0.54 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.9 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.445 ' CB ' HG12 ' A' ' 66' ' ' VAL . 2.5 p -57.53 -19.92 28.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.742 0.306 . . . . 0.0 111.419 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -47.39 -28.79 2.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.572 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -60.29 3.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.73 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.421 ' HA ' ' ND2' ' A' ' 20' ' ' ASN . 0.5 OUTLIER -59.45 -37.84 79.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.383 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -54.37 -36.06 63.47 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.883 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -71.48 -52.45 18.3 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.531 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 28.4 p30 -62.68 -33.01 74.21 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.782 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . -58.89 -44.47 91.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.081 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.567 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 13.1 mtp180 -58.32 -52.64 64.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.292 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.41 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 2.7 pp20? -68.06 -50.12 57.15 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.378 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -60.87 -51.53 68.93 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.498 ' CG1' ' N ' ' A' ' 26' ' ' LYS . 3.9 p -53.66 -55.64 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.883 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.498 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 7.1 mttt -66.41 -50.25 64.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.689 0.28 . . . . 0.0 111.441 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -57.68 -41.48 81.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.384 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 1.7 mm? -53.57 -19.15 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.914 0.387 . . . . 0.0 110.899 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.76 26.23 3.96 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.409 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -156.5 112.25 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.785 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.433 ' O ' ' CA ' ' A' ' 1' ' ' MET . 2.3 m-20 -61.67 159.89 12.56 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.483 ' HA ' ' N ' ' A' ' 2' ' ' MET . . . -152.03 153.72 34.57 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -114.91 114.97 26.18 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.218 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.567 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 18.1 m-85 -98.75 108.94 21.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.361 0.601 . . . . 0.0 111.431 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -110.76 110.73 21.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.1 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.37 137.54 34.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.877 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.782 HG13 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -102.9 176.58 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.666 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 4.3 pttt -160.1 75.49 0.6 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.883 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.495 ' O ' HG13 ' A' ' 43' ' ' ILE . 1.4 mt-10 158.14 128.53 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.564 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.485 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -56.58 -29.81 62.47 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 121.366 -0.134 . . . . 0.0 110.867 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.46 -36.37 43.92 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -86.67 -36.94 18.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.95 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.908 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 40.4 mt -58.95 -55.49 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.731 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.35 -36.74 81.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.631 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.79 -25.39 40.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.019 0.438 . . . . 0.0 110.335 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 7' ' ' TYR . . . -70.93 -34.84 71.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.792 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.39 -17.87 9.57 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.745 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.506 ' N ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -83.2 169.35 15.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.936 0.398 . . . . 0.0 111.324 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.4 p -124.07 -30.1 3.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.91 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.2 -178.62 1.08 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.216 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.585 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.5 mp -86.39 -63.59 0.22 Allowed Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.658 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.585 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 17.0 Cg_exo -66.27 63.92 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.033 1.822 . . . . 0.0 111.709 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -104.04 145.52 16.11 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.098 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 5' ' ' GLN . 0.1 OUTLIER -150.33 129.8 13.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.0 0.429 . . . . 0.0 110.165 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.417 ' CB ' ' CD1' ' A' ' 60' ' ' LEU . . . -103.55 125.03 49.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.021 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.485 ' CG1' HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -112.62 135.45 52.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.194 0.521 . . . . 0.0 111.45 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 48.12 27.35 1.23 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.257 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.75 38.64 31.12 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.344 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -154.98 99.52 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.827 0.346 . . . . 0.0 111.148 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.417 ' CD1' ' CB ' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -43.79 126.93 4.91 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.057 179.72 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.95 -17.68 9.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.91 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.423 ' CD1' ' HB3' ' A' ' 54' ' ' LEU . 1.3 pt -137.33 140.42 42.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.068 0.461 . . . . 0.0 112.103 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.413 ' HG3' ' HB2' ' A' ' 48' ' ' LEU . 1.6 ttm -145.98 114.63 6.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.606 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.557 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 88.75 -14.26 60.58 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 119.688 -1.244 . . . . 0.0 112.866 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -178.44 114.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.648 0.261 . . . . 0.0 110.355 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.445 HG12 ' CB ' ' A' ' 14' ' ' CYS . 28.8 m -54.21 -173.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.12 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.94 143.21 30.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.92 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.2 m -65.9 162.43 19.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -59.04 -47.59 84.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -67.14 -29.91 69.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.508 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 2.4 tp10 -74.03 -42.0 60.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.067 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 73' ' ' LYS . 1.1 tt -73.74 -48.47 39.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.346 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.414 ' N ' HG22 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -59.94 -39.7 86.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.384 -179.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -74.08 -27.83 61.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.978 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.2 mt -75.71 -36.79 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.12 0.486 . . . . 0.0 109.997 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.15 -30.77 60.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.943 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.967 -179.974 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.4 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 6.2 mtp . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.652 0.263 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.475 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -73.26 115.46 12.64 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.68 179.588 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.09 106.65 2.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.98 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.48 HD12 ' CZ ' ' A' ' 34' ' ' PHE . 3.5 mt -122.45 124.88 71.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.743 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.424 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 2.5 mm-40 -110.75 138.9 46.57 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.856 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.408 ' C ' HD11 ' A' ' 37' ' ' ILE . 22.4 mt -114.24 104.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.914 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 94.5 m-85 -92.78 109.27 20.7 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.986 0.422 . . . . 0.0 111.369 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' A' ' 10' ' ' GLY . . . 134.55 -44.16 1.21 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.679 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 p 52.73 -85.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 8' ' ' GLY . . . -94.71 -52.4 1.82 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.709 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 m -53.1 -26.38 16.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 111.098 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.55 147.23 35.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.143 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -76.29 15.32 0.6 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.953 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 66' ' ' VAL . 2.3 p -57.3 -19.88 24.82 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.707 0.289 . . . . 0.0 111.493 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.62 -32.08 7.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.403 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 mtt -63.31 -62.08 1.92 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.559 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.0 tt -63.92 -19.81 65.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.644 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -59.35 -54.13 50.32 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.56 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -71.9 -40.23 69.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.262 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -64.54 -41.69 96.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.195 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.49 -45.89 90.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.814 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.508 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -57.39 -42.52 82.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.617 0.246 . . . . 0.0 111.238 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 14.9 pt-20 -73.88 -49.22 25.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.321 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.8 -50.4 69.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 26' ' ' LYS . 4.2 p -53.57 -52.84 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.357 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.463 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.23 -41.83 80.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.724 0.297 . . . . 0.0 110.742 178.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.421 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 1.1 tp10 -62.07 -43.79 98.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.418 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.0 -19.49 1.87 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.791 0.329 . . . . 0.0 111.027 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.52 44.58 0.7 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.8 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.2 tt 175.88 121.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.264 0.554 . . . . 0.0 111.158 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.423 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 3.6 t0 -62.53 163.81 8.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.849 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.475 ' HA ' ' N ' ' A' ' 2' ' ' MET . . . -151.09 152.51 33.52 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.549 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -112.72 118.39 34.87 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.317 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.508 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 22.2 m-85 -101.78 109.39 21.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.339 0.59 . . . . 0.0 111.707 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -105.42 114.67 28.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.003 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -82.11 139.17 34.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.089 0.471 . . . . 0.0 110.813 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.799 HG13 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -104.49 175.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.682 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 7.0 ptmt -160.36 75.32 0.57 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.017 0.437 . . . . 0.0 110.916 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.507 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER 157.63 127.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.405 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.474 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 17.7 mtp -54.77 -28.51 49.3 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.987 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.34 -37.82 49.9 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -86.95 -36.52 18.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.952 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.914 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 25.9 mt -60.01 -55.26 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.767 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.79 -34.5 76.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.719 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -60.64 -21.91 63.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 0.0 110.084 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.417 ' HB1' ' CZ ' ' A' ' 7' ' ' TYR . . . -71.9 -34.76 69.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.615 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.402 ' HA3' HD22 ' A' ' 60' ' ' LEU . . . 124.22 -20.42 7.07 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.874 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.487 HD21 ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -83.32 176.69 8.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 111.026 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.3 m -126.59 -34.94 2.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.223 0.535 . . . . 0.0 110.486 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.11 -173.11 0.35 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.707 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.568 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.4 mp -92.48 -63.55 0.16 Allowed Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.456 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.616 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 28.6 Cg_exo -60.78 63.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.218 1.945 . . . . 0.0 112.645 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -103.84 147.17 16.56 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.973 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.6 tt -144.58 118.26 9.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.827 0.346 . . . . 0.0 110.862 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.4 ' CB ' ' CD1' ' A' ' 60' ' ' LEU . . . -99.57 122.65 42.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.037 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.49 136.35 53.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.511 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 46.75 28.17 0.78 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.898 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.47 30.39 58.46 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.433 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -142.97 103.95 4.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.892 0.377 . . . . 0.0 110.949 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.402 HD22 ' HA3' ' A' ' 47' ' ' GLY . 1.0 OUTLIER -54.98 127.32 28.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.06 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.68 -9.15 4.52 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.787 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.457 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 1.6 mp -134.4 127.73 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.573 0.225 . . . . 0.0 110.408 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 19.2 tmm? -146.81 116.51 7.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.83 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.616 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 70.19 3.27 44.82 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.121 -1.038 . . . . 0.0 113.651 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.97 96.6 0.21 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.919 0.359 . . . . 0.0 110.504 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.408 ' CB ' ' HA ' ' A' ' 14' ' ' CYS . 0.3 OUTLIER -68.27 129.62 32.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.813 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.79 166.04 7.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 111.345 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.9 m -98.29 173.02 7.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -57.06 -47.34 81.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.79 -36.12 76.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.966 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.42 -38.18 90.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.038 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.0 mm -61.63 -55.17 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.185 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -52.48 -34.82 50.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.255 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -74.2 -41.5 61.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.236 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -76.01 -24.46 16.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 110.872 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.73 -26.98 15.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.065 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.816 -179.955 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 2.4 mpp? . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.432 0.158 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.515 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 2.1 ttt -80.05 112.5 17.41 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.861 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -69.78 114.69 8.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.638 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 2' ' ' MET . 2.3 mp -123.24 120.7 61.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.674 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -110.83 128.28 55.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.321 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' A' ' 14' ' ' CYS . 1.0 OUTLIER -113.39 109.0 26.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.683 0.277 . . . . 0.0 111.474 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.892 ' CD2' ' HA ' ' A' ' 43' ' ' ILE . 40.2 m-85 -93.69 119.2 32.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.952 0.406 . . . . 0.0 110.636 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.402 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . -173.71 -85.77 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.498 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.7 m 56.61 77.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 0.0 110.794 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.02 117.66 3.54 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.068 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 78.89 -56.97 0.44 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.69 0.281 . . . . 0.0 110.934 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.402 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -54.73 122.08 9.92 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.916 0.389 . . . . 0.0 111.053 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -76.38 20.87 0.2 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.171 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.431 ' HB2' ' HB ' ' A' ' 6' ' ' ILE . 3.3 p -52.15 -25.98 10.26 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.004 0.43 . . . . 0.0 111.181 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -31.93 72.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.643 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.5 mtp -63.52 -62.67 1.52 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.307 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.428 ' CB ' ' CG2' ' A' ' 66' ' ' VAL . 1.1 tm? -67.79 -21.48 65.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.8 0.333 . . . . 0.0 110.629 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -57.81 -48.3 80.14 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.229 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -71.54 -46.41 59.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.768 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -59.28 -36.27 75.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.149 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HB3' ' CE2' ' A' ' 34' ' ' PHE . . . -66.86 -50.4 62.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.108 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 20.8 ttt180 -55.66 -37.83 68.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.519 0.199 . . . . 0.0 111.406 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 23.7 pt-20 -74.24 -48.31 29.57 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.111 -0.236 . . . . 0.0 111.229 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.77 -50.95 67.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.492 HG12 ' HB1' ' A' ' 32' ' ' ALA . 8.9 p -53.8 -55.42 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.717 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.463 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 5.6 mtpm? -66.94 -49.49 65.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.108 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.454 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 45.6 tp10 -56.29 -43.77 79.19 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 110.762 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.7 tp -53.11 -22.12 5.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.557 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.65 44.73 0.75 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.442 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.0 tt 179.76 124.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.308 0.575 . . . . 0.0 111.505 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -67.66 165.22 17.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.472 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.515 ' HA ' ' N ' ' A' ' 2' ' ' MET . . . -146.12 178.26 8.35 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.78 106.39 8.66 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.861 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.507 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 66.0 m-85 -99.4 109.0 21.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.424 0.63 . . . . 0.0 111.947 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.429 ' O ' HD11 ' A' ' 37' ' ' ILE . 0.9 OUTLIER -119.36 136.48 54.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.556 179.068 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -89.37 153.64 20.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.12 0.486 . . . . 0.0 111.112 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.793 HG13 ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -126.47 83.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.307 -179.073 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.55 75.35 9.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.138 0.494 . . . . 0.0 111.636 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.581 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER 173.07 118.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.789 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.507 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 6.2 ptt? -53.53 -35.31 60.56 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.945 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.42 -35.78 40.77 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -86.63 -35.2 19.52 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.98 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.892 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 23.3 mt -60.32 -55.9 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.553 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.02 -34.35 77.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.2 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -60.21 -21.26 61.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.406 . . . . 0.0 110.155 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.451 ' CB ' ' CZ ' ' A' ' 7' ' ' TYR . . . -72.61 -38.38 67.81 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.704 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.35 -14.62 7.76 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.473 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.552 HD21 ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.02 158.0 35.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.364 0.582 . . . . 0.0 111.119 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.5 t -107.42 -10.33 15.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.04 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.471 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -102.51 -175.28 2.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.304 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.449 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -89.64 -54.49 0.31 Allowed Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.616 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.624 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 11.1 Cg_exo -70.29 52.16 1.14 Allowed 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 122.626 2.218 . . . . 0.0 112.414 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -71.95 156.9 52.78 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.253 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.36 101.49 2.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.844 0.354 . . . . 0.0 110.779 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -100.3 126.09 46.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.809 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.451 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -118.05 140.62 40.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.141 0.496 . . . . 0.0 111.572 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 44.91 27.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.252 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.75 34.68 30.47 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.443 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.32 99.84 3.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 55' ' ' ALA . 0.6 OUTLIER -69.9 131.31 44.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.019 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -146.09 11.45 1.2 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.719 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.487 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 3.2 mp -133.31 123.92 48.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.512 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 2.4 mtm -146.62 123.51 11.32 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.624 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 70.81 7.33 61.59 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.825 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.55 100.43 0.06 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.868 0.366 . . . . 0.0 110.588 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.457 ' HA ' HG22 ' A' ' 62' ' ' ILE . 0.5 OUTLIER -56.34 141.84 12.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.96 -179.623 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.66 172.35 2.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.902 0.382 . . . . 0.0 111.152 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -109.43 157.81 18.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.7 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.09 -41.18 71.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.206 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -60.14 -40.77 90.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -64.6 -37.45 87.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.2 mm -59.72 -54.86 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.984 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -57.21 -33.31 67.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.033 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.52 -40.21 80.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.028 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.2 mt -75.98 -38.2 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.362 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 43.6 mt -94.3 10.62 33.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.454 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.149 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.442 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 15.2 mmt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.463 0.173 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.488 ' O ' ' CB ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -81.31 112.36 18.54 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.836 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.408 ' CG ' ' HA ' ' A' ' 57' ' ' ASP . 17.3 ptpt -68.72 115.05 7.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.992 0.425 . . . . 0.0 110.583 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.461 HD11 ' CZ ' ' A' ' 34' ' ' PHE . 1.5 mt -121.23 121.97 66.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.45 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -110.54 134.87 51.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.604 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.401 ' HA ' HD23 ' A' ' 54' ' ' LEU . 1.6 mp -119.93 113.71 41.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.398 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.88 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 48.9 m-85 -104.27 116.59 32.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.448 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 138.42 -78.36 0.31 Allowed Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.493 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m 69.27 -66.41 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 111.209 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.58 -96.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.708 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.6 m -63.73 -46.14 86.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 0.0 111.187 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.448 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -54.44 118.99 4.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.285 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -76.34 14.91 0.66 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.989 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.3 p -57.36 -19.83 25.33 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.755 0.312 . . . . 0.0 111.511 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -35.5 34.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.194 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.4 mmt -63.84 -62.07 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.793 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.25 -30.03 69.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.66 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -54.7 -47.75 73.31 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.149 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -65.04 -39.78 93.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.481 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -60.14 -51.04 71.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.753 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.459 ' CB ' ' HE2' ' A' ' 34' ' ' PHE . . . -54.01 -37.54 64.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.201 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.627 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 2.6 mtm-85 -59.92 -50.4 73.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 111.207 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.472 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 10.8 pt-20 -71.67 -47.75 52.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.075 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.13 -51.93 67.01 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' A' ' 26' ' ' LYS . 4.5 p -53.24 -55.54 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.684 0.278 . . . . 0.0 110.737 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.503 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 7.5 mttm -67.51 -49.59 62.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.305 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 4.9 tt0 -53.99 -48.03 70.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.355 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -51.0 -22.47 2.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 110.671 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.57 34.64 1.7 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.648 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.8 pt -161.98 112.85 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.872 0.368 . . . . 0.0 111.574 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.442 ' O ' ' CA ' ' A' ' 1' ' ' MET . 4.2 t70 -61.51 164.24 6.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 2' ' ' MET . . . -150.44 178.14 9.33 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -128.75 114.67 16.88 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.127 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.627 ' CZ ' ' HA ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -102.06 109.34 21.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.209 0.528 . . . . 0.0 111.218 -178.738 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -116.09 115.72 26.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.035 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.6 mtpt -90.19 140.32 29.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.975 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.88 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -111.98 179.14 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.477 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.447 ' N ' HG12 ' A' ' 37' ' ' ILE . 2.7 tmtt? -157.25 75.56 0.81 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.138 0.494 . . . . 0.0 110.452 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.499 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.7 OUTLIER 160.43 128.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.064 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.493 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -52.49 -27.41 16.2 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 121.25 -0.18 . . . . 0.0 110.831 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -51.7 -39.27 58.04 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -86.54 -37.7 17.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.024 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.855 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 16.4 mt -58.98 -55.36 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.094 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.411 HD21 ' O ' ' A' ' 40' ' ' MET . 0.1 OUTLIER -61.24 -40.97 96.02 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.702 179.699 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -53.02 -26.13 14.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.972 0.415 . . . . 0.0 110.372 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -70.36 -36.57 74.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.753 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.3 -13.37 16.15 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.907 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.529 HD21 ' CG2' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.3 162.96 26.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.904 0.352 . . . . 0.0 111.124 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.63 -17.83 11.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 111.67 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -87.48 175.61 7.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.654 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.601 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.7 mt -79.64 -63.88 0.35 Allowed Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.962 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 11.0 Cg_exo -70.04 58.91 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.278 1.985 . . . . 0.0 111.919 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.432 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -79.01 147.75 30.83 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.475 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 0.3 OUTLIER -139.85 104.01 4.78 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -98.47 124.72 43.35 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.975 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.425 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -120.68 139.51 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.182 0.515 . . . . 0.0 112.218 -179.267 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.408 ' HA ' ' CG ' ' A' ' 3' ' ' LYS . 1.8 m-20 43.03 28.3 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.687 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.29 32.95 37.05 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.714 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.48 98.56 2.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.921 0.391 . . . . 0.0 110.468 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.424 ' CD2' HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -70.2 133.75 47.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.827 -179.6 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.29 6.68 1.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.72 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.432 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 1.2 mp -127.88 125.78 65.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.662 0.268 . . . . 0.0 110.94 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.429 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 7.8 mtt -146.51 116.16 7.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.652 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.547 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 88.98 -13.24 63.65 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.134 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 179.46 114.42 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.423 ' HA ' ' CG1' ' A' ' 62' ' ' ILE . 3.6 m -52.11 179.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.392 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -91.71 177.31 6.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.1 p -99.67 158.49 15.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.806 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -52.64 -39.32 61.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.118 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -67.37 -38.78 85.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.01 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.47 -32.29 72.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.048 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.2 mm -71.08 -52.63 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.078 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -34.25 73.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.833 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -33.34 66.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.76 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 9.0 mm -76.05 -36.8 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.227 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.56 -30.9 64.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.9 p . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.815 179.938 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.483 ' HA ' ' HA ' ' A' ' 32' ' ' ALA . 10.8 mtt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.316 0.103 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.511 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 33.2 mmm -83.5 111.12 18.78 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.163 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.05 100.8 2.58 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.154 0.502 . . . . 0.0 110.44 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.515 HG13 ' CG1' ' A' ' 56' ' ' VAL . 1.7 mp -99.86 114.64 38.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.998 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.415 ' CB ' HD13 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -101.64 119.67 39.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.466 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.3 mm -104.59 101.63 12.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 120.697 0.284 . . . . 0.0 111.574 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.713 ' CE1' HG13 ' A' ' 37' ' ' ILE . 79.4 m-85 -90.6 103.23 15.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.046 0.451 . . . . 0.0 110.739 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.39 -84.55 0.12 Allowed Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.986 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 t 40.44 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 112.001 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.07 -62.3 0.29 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.138 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 t -87.79 -30.79 19.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.98 0.419 . . . . 0.0 110.545 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -111.17 134.89 52.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.811 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.22 15.09 0.61 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 p -57.85 -20.13 34.06 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.67 0.271 . . . . 0.0 111.524 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -20.99 36.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.534 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.2 mtt -63.31 -62.43 1.7 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.771 0.319 . . . . 0.0 110.858 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.0 tp -64.08 -22.45 66.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.34 . . . . 0.0 110.581 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -56.18 -54.17 48.36 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.354 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.55 -46.73 78.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.95 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -54.78 -51.32 66.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.62 -36.73 69.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.806 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.528 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 44.2 mtp180 -57.26 -48.0 79.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 111.117 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 8.0 tt0 -72.39 -50.26 27.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.183 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.05 -51.08 71.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.5 ' CG1' ' N ' ' A' ' 26' ' ' LYS . 2.4 p -53.64 -55.41 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.59 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.5 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 6.0 mttm -67.22 -50.36 61.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.681 0.277 . . . . 0.0 111.113 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 8.8 tt0 -52.01 -45.63 64.64 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.381 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -52.99 -19.33 2.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.882 0.372 . . . . 0.0 110.608 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' O ' ' CD1' ' A' ' 30' ' ' ILE . . . 113.37 21.31 5.89 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.599 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.405 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -147.76 110.88 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.861 0.363 . . . . 0.0 110.899 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -64.92 162.81 15.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.345 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.511 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -149.27 -169.33 3.35 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -142.42 113.96 7.88 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.048 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.528 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 11.8 m-85 -105.75 109.13 20.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.569 0.699 . . . . 0.0 112.249 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -127.65 134.87 49.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.456 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.24 155.71 28.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.022 0.439 . . . . 0.0 110.905 -179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.713 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -126.21 80.34 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.663 -178.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -82.21 75.56 9.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.087 0.47 . . . . 0.0 111.143 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.531 ' O ' HG13 ' A' ' 43' ' ' ILE . 3.0 mm-40 173.52 121.7 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.67 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.518 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 1.6 tpt -53.88 -31.58 50.32 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.843 -0.162 . . . . 0.0 111.059 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.57 -37.96 52.19 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -86.9 -34.21 19.48 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.192 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.699 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 47.5 mt -59.76 -55.21 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.348 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.16 -38.37 90.9 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.048 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -56.11 -24.3 39.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.535 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.437 ' CB ' HD12 ' A' ' 48' ' ' LEU . . . -74.22 -34.78 63.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.974 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.43 -6.43 31.86 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.198 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.594 ' HB2' ' HG2' ' A' ' 63' ' ' MET . 0.0 OUTLIER -79.53 160.44 26.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.161 0.48 . . . . 0.0 111.643 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.0 t -112.06 -30.09 7.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.743 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.447 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -77.58 -177.78 4.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.229 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.571 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.3 mp -87.98 -62.47 0.22 Allowed Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.912 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 16.9 Cg_exo -67.38 59.66 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.264 1.976 . . . . 0.0 112.255 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.422 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -84.8 139.52 17.92 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.574 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.442 ' CD1' HG22 ' A' ' 4' ' ' ILE . 16.3 tp -129.58 103.13 6.69 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -100.79 125.33 47.27 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.321 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.515 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.92 139.38 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.078 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 47.06 26.94 0.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.587 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.61 34.79 48.47 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.325 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -144.7 103.31 3.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.386 . . . . 0.0 111.197 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.415 ' CD2' HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -46.31 133.32 9.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.234 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.63 -23.7 6.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.532 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 66' ' ' VAL . 2.8 pp -154.62 154.91 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.594 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 2.0 mtp -146.78 129.13 15.81 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.432 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.466 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 94.41 -20.51 47.77 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.369 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -179.79 112.18 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.785 0.326 . . . . 0.0 110.364 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.448 ' HA ' ' CD1' ' A' ' 62' ' ' ILE . 15.8 m -51.29 161.54 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.278 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.1 -166.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.954 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.9 t -118.94 171.17 8.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.962 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -55.57 -56.64 17.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.066 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -59.77 -30.54 68.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.822 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -61.89 -46.38 89.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.5 mm -59.71 -54.25 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.882 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -58.76 -33.27 70.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -71.84 -36.78 70.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.3 mt -75.83 -38.36 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.34 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.4 mt -88.07 0.05 56.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.452 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.6 t . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.975 -179.967 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.437 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 4.8 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.523 0.201 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.547 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 5.2 mmt -77.56 113.51 15.46 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.986 0.422 . . . . 0.0 110.808 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.81 100.51 1.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.084 0.468 . . . . 0.0 110.52 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.447 ' CG1' ' CG1' ' A' ' 56' ' ' VAL . 2.8 mp -109.24 128.79 64.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.933 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 13.3 mm-40 -110.89 142.45 42.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.878 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 6' ' ' ILE . 19.9 mt -122.09 115.0 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.196 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.844 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 86.6 m-85 -106.1 110.82 23.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.302 0.572 . . . . 0.0 112.134 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.435 ' HA3' ' HB1' ' A' ' 12' ' ' ALA . . . 155.78 -78.61 0.19 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.235 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 p 49.22 33.3 4.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.791 0.329 . . . . 0.0 111.584 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.38 -71.81 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.39 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.08 27.96 8.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 110.737 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.435 ' HB1' ' HA3' ' A' ' 8' ' ' GLY . . . -124.57 130.05 51.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.083 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -76.36 20.46 0.21 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.756 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.414 ' H ' ' C ' ' A' ' 12' ' ' ALA . 2.6 p -55.45 -19.86 10.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.796 0.332 . . . . 0.0 111.557 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.03 -41.47 47.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.787 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.0 mtp -63.74 -62.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.764 0.316 . . . . 0.0 111.218 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.44 ' CD1' ' HB3' ' A' ' 21' ' ' ALA . 0.7 OUTLIER -59.47 -31.85 69.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.825 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -40.05 81.45 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -73.28 -46.93 46.95 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.454 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 34.4 p30 -69.17 -34.3 74.74 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.151 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.454 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . -63.06 -47.33 83.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.467 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.489 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -57.69 -47.5 82.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.712 0.291 . . . . 0.0 111.294 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.442 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 22.2 tp10 -72.75 -50.45 24.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.42 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.58 -49.1 76.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.483 ' CG1' ' HB1' ' A' ' 32' ' ' ALA . 3.8 p -53.36 -54.66 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.451 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.476 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.52 -43.43 76.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.619 0.247 . . . . 0.0 110.702 178.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 35.3 tt0 -57.28 -43.92 83.56 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.154 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.7 -19.12 2.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.8 0.333 . . . . 0.0 110.769 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.91 25.91 4.03 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.671 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.42 HG21 HD12 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -159.64 117.0 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.943 0.401 . . . . 0.0 111.443 179.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.44 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -61.46 164.79 5.35 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.242 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 2' ' ' MET . . . -148.78 165.74 30.53 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -125.13 110.05 13.64 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.042 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.489 ' CE1' ' HA ' ' A' ' 22' ' ' ARG . 30.3 m-85 -97.08 108.94 21.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.253 0.549 . . . . 0.0 111.418 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -112.97 115.58 28.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.809 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 136.62 33.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.032 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.844 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -101.66 -178.24 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.291 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.484 ' N ' HG12 ' A' ' 37' ' ' ILE . 3.3 ptmt -158.5 75.37 0.72 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.168 0.509 . . . . 0.0 110.651 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 0.2 OUTLIER 155.37 131.68 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.886 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 0.493 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 3.1 mpp? -52.61 -25.11 9.72 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.2 -0.2 . . . . 0.0 111.136 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -51.51 -39.82 58.39 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -86.54 -36.4 18.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.037 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.813 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 17.4 mt -59.67 -54.96 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.324 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -38.58 91.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.835 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -55.63 -24.61 34.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.99 0.424 . . . . 0.0 110.294 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.438 ' HB1' ' CZ ' ' A' ' 7' ' ' TYR . . . -72.62 -35.31 67.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.771 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.0 -11.76 24.67 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.973 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.514 ' N ' HD21 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -81.48 161.72 23.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.076 0.438 . . . . 0.0 111.36 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.6 p -114.32 -25.48 8.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.16 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.526 ' HB3' ' CB ' ' A' ' 63' ' ' MET . . . -77.88 171.92 14.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.579 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.61 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.5 mp -77.99 -64.12 0.42 Allowed Pre-proline 0 C--N 1.332 -0.188 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.486 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.61 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 14.8 Cg_exo -67.9 58.13 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.239 1.959 . . . . 0.0 112.365 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -84.26 137.69 16.23 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.926 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -129.06 103.83 7.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.447 ' CB ' HD11 ' A' ' 60' ' ' LEU . . . -97.82 121.7 40.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.026 0.441 . . . . 0.0 111.422 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.447 ' CG1' ' CG1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -112.95 139.16 39.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.826 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 47.96 26.41 0.96 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.553 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.13 33.16 50.51 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.502 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.09 102.27 3.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.827 0.346 . . . . 0.0 111.158 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.447 HD11 ' CB ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -48.78 126.56 12.25 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.856 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -115.6 -21.9 9.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.7 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.468 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -154.95 133.65 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.284 -179.392 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.526 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.88 138.02 25.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.355 178.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.505 ' N ' ' CB ' ' A' ' 50' ' ' ALA . . . 81.54 -3.54 77.94 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.816 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 179.61 100.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.34 . . . . 0.0 110.482 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -65.5 141.3 18.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.961 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.93 -173.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.23 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.02 179.96 4.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.825 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.7 -46.19 87.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.212 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.61 -41.76 95.43 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.018 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -56.85 -44.05 81.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.075 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.412 ' CG1' HD21 ' A' ' 17' ' ' LEU . 40.3 mm -64.86 -55.1 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -36.21 73.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.935 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -74.4 -31.77 62.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.031 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.0 mt -75.51 -37.54 37.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.284 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.3 mt -87.42 -29.32 21.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.9 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 1.678 ' HE2' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 1 N--CA 1.362 -4.861 0 N-CA-C 113.763 1.023 . . . . 3.1099999999999999 113.763 . . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 1.672 ' HE2' ' SD ' ' A' ' 2' ' ' MET . 1.7 mtt -80.54 113.76 18.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.594 -0.442 . . . . 2.1600000000000001 110.938 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 1.671 ' HZ1' ' CE ' ' A' ' 3' ' ' LYS . 96.3 mttt -70.72 107.89 4.17 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.142 0.496 . . . . 2.6499999999999999 110.406 179.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 1.399 HD13 ' CG1' ' A' ' 4' ' ' ILE . 3.6 mt -114.65 122.68 69.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.124 0.487 . . . . 1.3400000000000001 111.535 -179.274 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 1.589 ' HG2' ' CB ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -109.1 133.67 52.7 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 115.867 -0.606 . . . . 1.8200000000000001 110.632 179.626 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 1.604 HG12 ' CB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -115.03 108.91 26.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.832 0.349 . . . . 2.04 111.188 -179.915 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 1.419 ' CZ ' ' CD1' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -96.09 113.91 25.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.281 0.562 . . . . 2.1699999999999999 111.591 -179.383 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.479 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 154.79 -83.8 0.15 Allowed Glycine 1 C--O 1.114 -7.378 0 CA-C-N 115.833 -0.621 . . . . 0.70999999999999996 113.678 -179.865 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 1.576 HG23 ' CB ' ' A' ' 9' ' ' THR . 0.2 OUTLIER 61.18 69.21 0.68 Allowed 'General case' 2 C--O 0.484 -39.237 1 CA-C-O 149.367 13.937 . . . . 2.1299999999999999 111.866 179.918 . . . . . . . . 5 4 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 1.284 ' CA ' ' O ' ' A' ' 9' ' ' THR . . . 142.4 -71.18 0.41 Allowed Glycine 3 C--N 0.807 -28.808 3 O-C-N 50.769 -44.957 . . . . 1.4199999999999999 115.301 179.83 . . . . . . . . 4 3 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.457 ' HG ' ' CB ' ' A' ' 11' ' ' CYS . 1.1 m -90.58 -20.82 22.17 Favored 'General case' 2 C--N 1.078 -11.201 2 O-C-N 108.323 -8.751 . . . . 2.5099999999999998 111.781 -179.946 . . . . . . . . 4 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 1.006 ' HB2' ' CA ' ' A' ' 12' ' ' ALA . . . -89.86 129.9 36.17 Favored 'General case' 1 C--N 1.184 -6.624 1 O-C-N 115.274 -4.641 . . . . 1.1299999999999999 111.247 179.969 . . . . . . . . 4 3 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 1.388 ' OD1' ' CB ' ' A' ' 13' ' ' ASN . 68.6 m-20 -76.36 17.9 0.34 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.36 0.504 . . . . 2.0499999999999998 112.36 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.0 p -54.7 -23.21 16.56 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.286 0.565 . . . . 1.29 111.936 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.85 -33.89 51.69 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.811 -0.631 . . . . 1.5600000000000001 111.799 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 1.679 ' HG3' ' SD ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -64.38 -59.14 4.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.161 0.505 . . . . 2.75 110.889 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 1.493 ' CD2' ' CB ' ' A' ' 17' ' ' LEU . 2.7 tm? -64.57 -25.8 68.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.187 0.517 . . . . 2.3700000000000001 110.907 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -57.56 -48.95 77.94 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.981 -0.554 . . . . 1.78 110.623 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 1.64 ' HZ3' ' CE ' ' A' ' 19' ' ' LYS . 25.6 tttt -69.05 -47.81 64.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.113 0.482 . . . . 2.8199999999999998 111.316 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -43.81 92.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.086 -0.506 . . . . 1.9199999999999999 111.176 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.993 ' HB3' ' CB ' ' A' ' 21' ' ' ALA . . . -58.94 -42.71 90.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.123 -0.489 . . . . 1.0800000000000001 111.714 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 1.436 ' HE ' ' CZ ' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -57.68 -45.62 85.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.816 0.341 . . . . 3.21 111.467 -179.638 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 1.514 ' HG2' ' CB ' ' A' ' 23' ' ' GLU . 0.6 OUTLIER -71.9 -49.33 38.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.407 -0.36 . . . . 2.1800000000000002 111.296 -179.636 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.989 ' HB1' ' CA ' ' A' ' 24' ' ' ALA . . . -62.4 -50.43 71.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.877 0.325 . . . . 1.1200000000000001 111.877 -179.515 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.974 HG21 ' CB ' ' A' ' 25' ' ' VAL . 5.4 p -53.72 -54.86 16.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.643 0.258 . . . . 1.1299999999999999 110.743 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 1.495 ' HZ1' ' CE ' ' A' ' 26' ' ' LYS . 21.7 mttm -67.55 -47.23 70.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.734 0.302 . . . . 2.8199999999999998 110.995 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 86.1 tt0 -57.12 -43.88 82.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 1.95 111.35 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 1.636 HD23 ' CD1' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -52.39 -20.94 3.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.997 0.427 . . . . 2.5099999999999998 110.903 179.551 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.92 36.22 1.41 Allowed Glycine 0 C--O 1.22 -0.738 0 C-N-CA 120.798 -0.715 . . . . 0.65000000000000002 112.474 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 1.589 HG12 ' CD1' ' A' ' 30' ' ' ILE . 17.7 pt -170.37 117.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.117 0.484 . . . . 2.2400000000000002 111.434 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 1.423 ' OD1' ' CB ' ' A' ' 31' ' ' ASP . 0.4 OUTLIER -62.4 163.61 8.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.937 -0.574 . . . . 1.6200000000000001 110.228 179.379 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.984 ' HB2' ' CA ' ' A' ' 32' ' ' ALA . . . -149.43 164.7 34.26 Favored 'General case' 0 C--O 1.188 -2.167 0 N-CA-C 109.584 -0.525 . . . . 1.0900000000000001 109.584 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 1.449 ' HG3' ' CB ' ' A' ' 33' ' ' GLU . 1.2 mt-10 -122.0 113.15 19.17 Favored 'General case' 0 C--N 1.281 -2.398 0 O-C-N 121.008 -1.057 . . . . 2.1800000000000002 110.17 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 1.431 ' CZ ' ' CD1' ' A' ' 34' ' ' PHE . 22.3 m-85 -98.93 109.4 22.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.398 0.618 . . . . 2.1600000000000001 111.824 -178.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 1.571 ' HG2' ' CB ' ' A' ' 35' ' ' GLU . 1.8 mt-10 -115.64 122.9 46.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.169 -0.923 . . . . 2.2999999999999998 110.278 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 1.627 ' HZ1' ' CE ' ' A' ' 36' ' ' LYS . 14.7 mttt -84.42 144.95 28.44 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.437 -0.347 . . . . 2.6800000000000002 110.507 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 1.568 HD13 ' CG1' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -115.01 136.57 51.27 Favored 'Isoleucine or valine' 1 C--O 0.985 -12.837 0 CA-C-O 123.872 1.796 . . . . 2.29 110.205 -179.568 . . . . . . . . 4 4 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 1.611 ' HD2' ' CG ' ' A' ' 38' ' ' LYS . 53.1 pttt -124.71 75.3 1.41 Allowed 'General case' 1 C--N 1.132 -8.889 2 O-C-N 109.725 -8.11 . . . . 3.6499999999999999 110.94 -179.98 . . . . . . . . 4 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 1.483 ' HG3' ' CB ' ' A' ' 39' ' ' GLU . 0.7 OUTLIER 163.4 128.29 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.339 -0.846 . . . . 2.4399999999999999 110.7 179.839 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' MET . . . . . 1.689 ' HE2' ' SD ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -56.21 -26.52 51.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.573 0.225 . . . . 2.9700000000000002 111.065 -179.871 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 1.165 ' OD2' ' CB ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -51.5 -38.7 55.28 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.899 -0.778 . . . . 1.7 108.899 178.645 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 1.467 HE21 ' CG ' ' A' ' 42' ' ' GLN . 6.3 mm-40 -87.02 -34.95 19.04 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.093 -0.958 . . . . 2.5099999999999998 110.302 178.316 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 1.443 HG22 ' CB ' ' A' ' 43' ' ' ILE . 5.2 mt -62.61 -52.76 55.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-O 121.108 0.48 . . . . 1.5700000000000001 111.375 -179.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 1.007 HD22 ' CG ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -63.38 -36.85 85.08 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.97 -0.559 . . . . 1.26 110.866 179.877 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 1.26 ' HG3' ' CD ' ' A' ' 45' ' ' GLU . 24.5 tt0 -57.14 -25.61 59.16 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.348 -0.387 . . . . 2.0099999999999998 110.17 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 1.015 ' HB3' ' CA ' ' A' ' 46' ' ' ALA . . . -74.72 -38.07 62.39 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 115.951 -0.568 . . . . 1.1699999999999999 109.75 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.43 -3.48 28.0 Favored Glycine 0 C--O 1.195 -2.293 0 C-N-CA 120.773 -0.727 . . . . 0.92000000000000004 114.867 179.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 1.168 HD11 ' CG ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -74.03 160.19 31.63 Favored 'General case' 1 C--O 0.896 -17.525 0 CA-C-O 121.69 0.757 . . . . 1.4099999999999999 112.073 179.96 . . . . . . . . 4 4 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 1.524 HG22 ' CB ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -115.55 -17.56 11.14 Favored 'General case' 2 C--N 1.111 -9.768 3 O-C-N 109.08 -8.513 . . . . 2.3700000000000001 112.481 179.761 . . . . . . . . 5 4 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 1.011 ' HB2' ' CA ' ' A' ' 50' ' ' ALA . . . -97.01 -172.71 2.51 Favored 'General case' 1 C--N 1.208 -5.549 0 O-C-N 117.698 -3.126 . . . . 1.1399999999999999 110.348 179.503 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 1.625 HD21 ' CG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -89.01 -63.65 0.2 Allowed Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 112.13 0.419 . . . . 2.04 112.13 -179.572 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.555 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 6.3 Cg_exo -67.78 59.68 0.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.239 1.959 . . . . 0.83999999999999997 112.829 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -86.9 144.44 19.47 Favored Glycine 0 C--O 1.21 -1.355 0 C-N-CA 120.642 -0.79 . . . . 0.53000000000000003 112.862 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 1.499 ' HG ' ' CB ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -136.73 109.22 7.4 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 122.52 -0.4 . . . . 2.3599999999999999 110.708 179.889 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 1.002 ' HB3' ' CA ' ' A' ' 55' ' ' ALA . . . -101.02 125.15 47.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.909 0.385 . . . . 1.1200000000000001 111.269 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.994 HG12 ' CB ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -116.82 139.12 45.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.073 -0.512 . . . . 1.24 111.306 -179.91 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 1.3 ' OD1' ' CB ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER 47.11 27.06 0.73 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.605 -0.725 . . . . 1.5900000000000001 110.715 -179.575 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.58 32.89 44.86 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.864 -0.684 . . . . 0.62 112.527 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.529 ' HG3' ' CB ' ' A' ' 59' ' ' GLU . 3.9 mt-10 -145.75 102.27 3.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.856 0.36 . . . . 2.21 111.041 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 1.616 HD22 ' CD1' ' A' ' 60' ' ' LEU . 2.1 mm? -58.92 131.95 52.53 Favored 'General case' 0 CA--C 1.482 -1.668 0 CA-C-N 116.094 -0.503 . . . . 2.3700000000000001 111.32 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 1.612 ' HD3' ' CG ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -131.47 -8.71 3.69 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 114.678 1.362 . . . . 2.9500000000000002 114.678 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 1.587 HG23 ' CB ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -142.08 130.78 22.18 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.908 0 C-N-CA 120.253 -0.579 . . . . 2.7000000000000002 111.795 -179.881 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 1.709 ' HE2' ' SD ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -146.62 131.04 17.63 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 112.742 0.645 . . . . 2.6600000000000001 112.742 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.554 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 77.46 -2.93 60.93 Favored Glycine 0 C--O 1.192 -2.512 0 C-N-CA 120.297 -0.954 . . . . 0.65000000000000002 113.676 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 1.614 ' HG2' ' CB ' ' A' ' 65' ' ' ARG . 1.7 ttp180 -177.21 101.9 0.05 Allowed 'General case' 0 C--O 1.2 -1.549 0 CA-C-N 117.48 0.64 . . . . 4.1600000000000001 112.7 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 1.637 HG13 ' CB ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -57.95 148.58 5.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 116.579 -0.282 . . . . 1.8500000000000001 111.476 -179.666 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 1.021 ' HB3' ' CA ' ' A' ' 67' ' ' ALA . . . -75.54 167.44 21.89 Favored 'General case' 0 C--O 1.19 -2.047 0 CA-C-O 120.816 0.341 . . . . 1.3200000000000001 111.511 -179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 1.049 ' OG ' ' CA ' ' A' ' 68' ' ' SER . 0.5 OUTLIER -97.21 170.72 8.91 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 122.085 -0.384 . . . . 1.9399999999999999 111.297 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 1.612 ' HG3' ' CD ' ' A' ' 69' ' ' LYS . 2.7 pttt -57.54 -46.5 83.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.405 -0.361 . . . . 3.1499999999999999 111.125 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 1.615 ' HG2' ' CB ' ' A' ' 70' ' ' GLU . 1.4 tt0 -64.7 -34.95 79.52 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.88 0.371 . . . . 2.4199999999999999 111.135 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 1.357 ' HG2' ' CD ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -66.4 -45.05 81.31 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.2 -0.454 . . . . 1.95 110.921 -179.885 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 1.607 HG21 ' CB ' ' A' ' 72' ' ' ILE . 0.2 OUTLIER -62.17 -50.54 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 116.098 -0.501 . . . . 2.2200000000000002 111.086 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 1.619 ' HZ2' ' CE ' ' A' ' 73' ' ' LYS . 17.6 tttt -59.26 -35.03 72.98 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 116.295 -0.411 . . . . 2.71 110.836 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 1.629 ' HD3' ' CE ' ' A' ' 74' ' ' LYS . 4.8 tttt -71.8 -33.12 68.3 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.42 -0.354 . . . . 3.0499999999999998 111.136 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 1.588 HD11 ' CG1' ' A' ' 75' ' ' ILE . 0.7 OUTLIER -76.3 -34.28 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 116.177 -0.465 . . . . 2.0800000000000001 110.414 179.686 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 1.526 ' CD2' ' CB ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -79.16 -35.53 41.85 Favored 'General case' 0 C--O 1.162 -3.517 0 CA-C-N 116.167 -0.47 . . . . 3.1600000000000001 111.678 -179.926 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 1.653 ' HG ' ' CA ' ' A' ' 77' ' ' SER 1.471 0.0 OUTLIER . . . . . 2 C--O 0.09 -59.94 2 N-CA-C 166.842 20.682 . . . . 2.9700000000000002 166.842 179.996 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.452 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 111.395 0.146 . . . . 0.0 111.395 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.712 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -80.55 116.23 20.48 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.865 0.364 . . . . 0.0 111.317 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -79.85 101.08 8.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.981 0.419 . . . . 0.0 109.95 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.884 HD12 ' CZ ' ' A' ' 34' ' ' PHE . 2.0 mt -109.95 124.92 67.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.579 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.407 ' O ' HD22 ' A' ' 54' ' ' LEU . 3.2 mp0 -110.47 133.74 53.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.146 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.433 ' CG2' ' CB ' ' A' ' 14' ' ' CYS . 42.0 mt -114.45 109.64 29.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.109 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.914 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 66.5 m-85 -95.78 125.3 40.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.072 0.463 . . . . 0.0 111.556 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.46 -70.42 0.42 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.287 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.47 -70.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.821 0.343 . . . . 0.0 111.469 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.36 -97.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.643 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.44 -29.44 61.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.76 0.314 . . . . 0.0 111.134 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.468 ' HB1' ' SG ' ' A' ' 14' ' ' CYS . . . -68.65 120.49 14.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.996 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -76.24 21.25 0.18 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.486 ' HA ' HG21 ' A' ' 66' ' ' VAL . 6.1 m -55.21 -21.61 14.51 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.694 0.283 . . . . 0.0 111.374 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.62 -39.48 11.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 mtp -63.68 -62.69 1.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.642 0.258 . . . . 0.0 111.257 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.04 HD11 HD11 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -67.22 -19.54 65.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.781 0.324 . . . . 0.0 110.724 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -60.29 -50.36 73.95 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.345 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -70.28 -45.87 65.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.713 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -60.76 -38.6 85.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.008 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -63.47 -45.91 88.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.296 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 5.6 mtt-85 -57.71 -53.15 61.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -65.58 -50.19 66.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.523 -179.336 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' O ' HD12 ' A' ' 28' ' ' LEU . . . -63.12 -51.91 64.66 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.924 HG11 ' HB3' ' A' ' 32' ' ' ALA . 4.4 p -53.77 -55.09 15.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.446 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.516 ' N ' HG13 ' A' ' 25' ' ' VAL . 36.6 mtpt -65.34 -49.56 68.93 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.676 0.274 . . . . 0.0 111.2 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 46.8 tp10 -60.01 -39.28 85.27 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.721 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -54.02 -15.93 1.68 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.751 0.31 . . . . 0.0 111.175 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.646 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 114.05 26.16 3.9 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.546 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.718 ' N ' HD13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -163.26 109.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 0.0 110.628 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.489 ' HA ' ' HG2' ' A' ' 26' ' ' LYS . 2.8 m-20 -60.71 156.49 16.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.924 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -145.29 140.06 27.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -103.94 117.12 33.56 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.044 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.884 ' CZ ' HD12 ' A' ' 4' ' ' ILE . 15.7 m-85 -98.48 109.3 22.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.331 0.586 . . . . 0.0 112.068 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.51 126.51 55.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.287 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.838 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -79.85 150.65 30.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.148 0.499 . . . . 0.0 111.068 -179.163 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.847 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -124.2 80.73 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.408 -179.002 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.04 75.03 6.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.132 0.491 . . . . 0.0 111.378 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.589 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.4 OUTLIER 173.95 119.02 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.704 179.385 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.516 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 1.2 ptp -54.02 -33.11 56.32 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.45 0.167 . . . . 0.0 111.089 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.26 -37.38 46.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 34.9 mm-40 -86.74 -33.86 19.84 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.185 178.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.027 HG22 HD21 ' A' ' 48' ' ' LEU . 26.8 mt -61.41 -55.95 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.061 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.412 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -63.06 -36.65 84.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.826 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.478 ' H ' HD23 ' A' ' 44' ' ' LEU . 3.6 tt0 -56.85 -24.56 52.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.993 0.425 . . . . 0.0 110.319 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.776 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -72.14 -40.08 68.31 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.574 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.512 ' HA3' HD11 ' A' ' 60' ' ' LEU . . . 119.53 -10.75 11.4 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.506 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.027 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -71.87 152.07 42.89 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 117.444 0.622 . . . . 0.0 111.017 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 t -104.35 -9.41 18.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.931 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' A' ' 63' ' ' MET . . . -104.06 -177.93 3.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.422 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -81.67 -64.09 0.28 Allowed Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.418 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.445 ' HG2' ' CA ' ' A' ' 64' ' ' GLY . 56.2 Cg_endo -70.29 56.48 1.62 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.371 2.047 . . . . 0.0 113.41 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -73.06 143.48 33.35 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.903 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.703 HD11 ' CG2' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -134.27 102.7 5.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.565 0.221 . . . . 0.0 110.432 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -104.95 124.47 49.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 111.581 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.873 HG12 HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.27 138.4 44.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.39 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 46.99 25.39 0.47 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.296 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.98 22.64 44.67 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.128 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 59' ' ' GLU . 4.6 pt-20 -137.28 108.19 6.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.216 0.531 . . . . 0.0 110.852 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.647 HD21 ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -85.4 131.32 34.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.887 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.84 2.49 2.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.546 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.597 HG21 ' HA ' ' A' ' 66' ' ' VAL . 9.7 mt -128.24 122.39 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.664 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.565 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 2.4 mpp? -145.74 130.81 18.33 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.474 ' N ' ' CB ' ' A' ' 50' ' ' ALA . . . 73.6 6.79 72.34 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.176 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.414 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 1.9 ttp85 178.81 101.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.761 0.315 . . . . 0.0 110.616 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.597 ' HA ' HG21 ' A' ' 62' ' ' ILE . 3.3 p -57.83 148.35 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.644 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.675 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -65.37 173.74 2.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.935 0.398 . . . . 0.0 111.434 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.42 ' CA ' HD23 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -110.11 158.97 17.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.607 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -48.48 65.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.319 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.14 -34.32 77.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.922 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.54 -42.57 91.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.04 HD11 HD11 ' A' ' 17' ' ' LEU . 36.5 mm -56.23 -55.1 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.986 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.445 ' H1 ' ' HG3' ' A' ' 1' ' ' MET . 3.4 mtt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.674 0.273 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.631 ' SD ' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -77.23 113.56 15.11 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.891 0.377 . . . . 0.0 111.095 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.55 100.38 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.922 HD12 ' CE2' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -106.51 125.51 62.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.026 -179.085 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.816 ' O ' HD22 ' A' ' 54' ' ' LEU . 3.3 mm-40 -107.11 126.23 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.169 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.815 ' N ' HD11 ' A' ' 37' ' ' ILE . 2.9 mp -107.86 102.65 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.777 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 80.6 m-85 -88.94 124.26 34.07 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.924 0.392 . . . . 0.0 110.755 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.583 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 143.1 -85.36 0.19 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.299 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t 40.29 86.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.879 0.371 . . . . 0.0 111.778 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.42 -61.92 0.56 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.517 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.1 m -118.62 -2.57 10.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.526 0.203 . . . . 0.0 111.497 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.583 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -100.77 135.08 42.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.82 0.343 . . . . 0.0 111.154 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.69 ' O ' HG21 ' A' ' 66' ' ' VAL . 47.9 m-20 -76.55 20.1 0.24 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.023 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.564 ' HB2' HG23 ' A' ' 6' ' ' ILE . 3.8 p -57.15 -19.85 22.73 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.675 0.274 . . . . 0.0 111.509 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.08 -38.49 38.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.653 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.579 ' CB ' HG11 ' A' ' 66' ' ' VAL . 1.1 mpp? -64.65 -52.64 56.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.799 ' HB2' HG13 ' A' ' 66' ' ' VAL . 30.9 tp -66.78 -28.75 68.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.067 0.46 . . . . 0.0 110.143 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.01 -47.47 80.78 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.386 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -46.17 61.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.867 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -56.6 -53.02 62.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.044 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.416 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -54.43 -43.06 71.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.892 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.478 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 5.5 mtt180 -57.61 -43.71 84.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.665 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 61.6 tt0 -74.34 -50.75 17.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.368 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.28 -49.84 72.45 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.822 HG11 ' HB3' ' A' ' 32' ' ' ALA . 3.2 p -54.38 -53.9 26.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.613 0.244 . . . . 0.0 110.44 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.494 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 51.7 mttt -67.01 -50.09 63.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.784 0.326 . . . . 0.0 110.849 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 19.4 tt0 -57.82 -39.78 78.45 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.077 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.6 tp -52.14 -21.14 3.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.781 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.753 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.76 32.55 2.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.618 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.753 HG23 ' O ' ' A' ' 29' ' ' GLY . 2.2 pt -169.09 121.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.862 0.363 . . . . 0.0 111.222 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.434 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -61.36 164.0 6.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.167 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.822 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -150.62 140.07 21.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -100.72 111.17 23.35 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.386 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.922 ' CE2' HD12 ' A' ' 4' ' ' ILE . 68.9 m-85 -94.88 109.18 21.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.505 0.669 . . . . 0.0 111.966 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.31 128.36 54.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.374 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.708 ' C ' HD13 ' A' ' 37' ' ' ILE . 5.2 mttt -78.69 149.95 32.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.113 0.483 . . . . 0.0 110.806 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.855 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -115.7 76.62 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.687 -178.333 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.3 75.16 2.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.993 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.504 ' O ' HG13 ' A' ' 43' ' ' ILE . 2.6 mm-40 167.9 124.12 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.669 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.674 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -59.24 -20.31 53.05 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.213 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.46 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -51.46 -43.33 62.07 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.42 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -87.41 -34.8 18.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.475 178.296 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.957 HG22 HD21 ' A' ' 48' ' ' LEU . 16.9 mt -61.36 -54.94 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.345 0.593 . . . . 0.0 111.036 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -60.56 -35.84 77.04 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.612 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.442 ' H ' HD23 ' A' ' 44' ' ' LEU . 24.8 tt0 -56.35 -34.05 66.23 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.158 0.504 . . . . 0.0 109.818 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.716 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -75.55 -42.67 51.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.875 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.99 30.61 31.12 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.561 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.957 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -51.61 -41.75 61.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.443 0.621 . . . . 0.0 110.919 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 48' ' ' LEU . 5.6 p 90.64 7.23 0.08 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.241 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.751 ' HB3' ' HG2' ' A' ' 63' ' ' MET . . . -153.65 -157.27 0.76 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.948 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.594 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.4 mp -99.19 -61.15 0.11 Allowed Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 25.9 Cg_exo -62.94 52.85 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.843 2.362 . . . . 0.0 113.879 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.544 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -81.68 137.37 17.31 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.285 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.816 HD22 ' O ' ' A' ' 5' ' ' GLN . 2.5 tm? -136.41 101.51 4.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.673 0.273 . . . . 0.0 110.499 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -104.45 133.53 49.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.81 0.338 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.663 HG13 HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.59 141.45 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.183 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 50.83 23.18 1.33 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.595 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.43 31.02 23.15 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.257 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.7 106.59 5.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.118 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.816 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -83.18 130.08 35.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.016 179.23 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -138.23 1.23 2.2 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.527 HD11 HD23 ' A' ' 17' ' ' LEU . 1.6 pp -150.25 124.21 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.051 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.751 ' HG2' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.5 150.5 36.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.534 179.319 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.554 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 56.42 16.74 16.43 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.992 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -165.66 94.65 0.6 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.863 0.363 . . . . 0.0 110.531 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 17' ' ' LEU . 2.0 t -60.48 120.05 5.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.736 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.11 126.77 28.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.33 169.74 1.56 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.464 ' HA ' HD12 ' A' ' 72' ' ' ILE . 5.2 mtpt -60.52 -58.29 9.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.766 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -60.79 -33.16 72.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.24 -37.75 75.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 69' ' ' LYS . 8.5 mt -69.24 -52.68 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.919 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.972 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.659 ' H3 ' ' C ' ' A' ' 31' ' ' ASP . 2.1 mtt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.624 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 1.1 mpp? -86.67 119.29 26.75 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.334 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.94 111.46 18.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.621 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.972 HG13 HG12 ' A' ' 56' ' ' VAL . 3.7 mp -116.91 123.1 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.212 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -110.59 127.88 55.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.598 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.795 ' N ' HD11 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -110.37 113.01 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.869 0.366 . . . . 0.0 110.924 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.734 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 90.6 m-85 -91.91 111.91 23.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.22 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.648 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 136.66 -96.9 0.25 Allowed Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.195 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.96 -65.23 0.3 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.827 0.346 . . . . 0.0 111.463 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.68 -57.51 9.47 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.822 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.0 p -111.92 -35.46 5.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 110.982 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.648 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -65.63 124.73 23.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.071 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -76.5 16.67 0.46 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 p -59.24 -19.5 46.21 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.784 0.325 . . . . 0.0 111.337 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -24.98 5.25 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.872 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.5 mtp -63.26 -62.19 1.86 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.791 0.329 . . . . 0.0 110.475 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.757 HD22 HD13 ' A' ' 54' ' ' LEU . 5.6 tt -65.67 -20.37 66.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.512 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.598 ' HG3' HD13 ' A' ' 6' ' ' ILE . 5.8 tt0 -57.61 -51.45 69.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.129 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -69.15 -51.32 39.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.609 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -54.7 -40.34 69.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.594 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.54 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -59.72 -45.93 90.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.442 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.53 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -54.88 -38.48 67.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.718 0.294 . . . . 0.0 111.273 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 35.1 tp10 -73.4 -50.41 21.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.019 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.63 79.59 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.044 HG21 ' HB2' ' A' ' 32' ' ' ALA . 14.0 p -53.62 -56.05 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.626 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.59 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.16 -40.34 82.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.692 0.282 . . . . 0.0 110.741 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 6.0 tp10 -59.27 -47.44 85.38 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.958 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.415 HD21 ' HG3' ' A' ' 73' ' ' LYS . 1.7 mm? -54.06 -20.22 6.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.773 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.76 42.79 0.84 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.43 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.773 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -175.35 113.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.375 . . . . 0.0 111.054 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.659 ' C ' ' H3 ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -61.57 164.08 6.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.257 179.577 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 1.044 ' HB2' HG21 ' A' ' 25' ' ' VAL . . . -146.0 165.91 27.62 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -126.48 109.78 12.56 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.928 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 15.0 m-85 -98.71 108.67 21.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.38 0.609 . . . . 0.0 112.071 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -117.39 133.32 56.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.56 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.834 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -79.69 151.81 30.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.211 0.529 . . . . 0.0 111.396 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.921 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -127.77 78.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.616 -178.531 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 37.4 tptt -82.02 75.12 8.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.968 0.413 . . . . 0.0 111.191 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.524 ' O ' HG13 ' A' ' 43' ' ' ILE . 22.7 tp10 177.03 120.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.79 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.511 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 46.5 ttp -53.11 -32.21 46.14 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 121.268 -0.173 . . . . 0.0 110.942 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.449 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -51.55 -37.56 50.13 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.585 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.69 -34.22 19.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.113 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.851 HG22 HD21 ' A' ' 48' ' ' LEU . 29.0 mt -60.45 -55.21 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.055 0 CA-C-O 121.198 0.523 . . . . 0.0 111.29 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -63.46 -39.13 93.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.855 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.682 ' H ' HD23 ' A' ' 44' ' ' LEU . 6.0 tt0 -54.44 -25.26 23.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.056 0.455 . . . . 0.0 110.347 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.684 ' O ' HD21 ' A' ' 60' ' ' LEU . . . -71.6 -39.24 70.63 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.714 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.0 -8.22 25.33 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.644 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.851 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -80.31 167.1 20.68 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.693 0.282 . . . . 0.0 110.947 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.88 14.29 5.82 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HB1' ' N ' ' A' ' 64' ' ' GLY . . . -114.68 172.57 6.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.623 0.249 . . . . 0.0 110.75 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.524 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 2.9 mt -71.15 -72.32 0.23 Allowed Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 51' ' ' LEU . 74.2 Cg_endo -72.23 60.23 3.18 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.195 1.93 . . . . 0.0 112.425 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -79.54 147.46 29.75 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.963 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.757 HD13 HD22 ' A' ' 17' ' ' LEU . 7.4 tt -144.95 110.27 5.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.885 0.374 . . . . 0.0 111.075 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -98.6 126.29 44.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.563 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.972 HG12 HG13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -120.78 139.75 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.283 0.563 . . . . 0.0 111.936 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 47.24 26.83 0.75 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.183 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.03 27.32 53.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.524 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -148.26 98.05 2.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.967 0.413 . . . . 0.0 110.435 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.684 HD21 ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -77.29 141.76 39.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.203 0.525 . . . . 0.0 111.317 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.18 8.25 1.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.216 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.66 HG21 HG12 ' A' ' 66' ' ' VAL . 1.3 mp -119.36 123.1 70.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.443 ' CG ' ' HB2' ' A' ' 48' ' ' LEU . 32.3 mtp -146.49 115.31 6.87 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.493 ' N ' ' HB1' ' A' ' 50' ' ' ALA . . . 85.45 -5.87 81.96 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.64 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.479 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER 173.65 104.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.708 0.289 . . . . 0.0 110.591 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.66 HG12 HG21 ' A' ' 62' ' ' ILE . 6.3 m -50.62 158.62 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.875 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.668 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -80.47 174.26 11.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.052 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -93.73 167.27 11.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.824 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -53.82 -38.38 64.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.2 -36.99 74.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.725 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.422 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 13.3 mm-40 -68.86 -51.04 44.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 21' ' ' ALA . 15.3 tt -59.15 -41.5 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.423 ' N ' HG23 ' A' ' 72' ' ' ILE . 46.7 tttm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.736 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 31' ' ' ASP . 10.3 ttp . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.524 0.202 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.848 ' O ' HD12 ' A' ' 4' ' ' ILE . 12.2 mmt -87.82 116.15 25.77 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.407 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -71.19 104.95 3.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.174 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.957 HG13 HG12 ' A' ' 56' ' ' VAL . 2.8 mp -112.55 120.77 63.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.361 0.601 . . . . 0.0 111.833 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.685 ' CB ' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -111.72 131.22 55.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.835 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.858 HG22 HD12 ' A' ' 54' ' ' LEU . 12.0 pt -110.8 115.1 48.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-O 120.822 0.344 . . . . 0.0 111.097 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.746 ' CE1' HG13 ' A' ' 37' ' ' ILE . 85.2 m-85 -99.1 107.11 19.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.98 0.419 . . . . 0.0 111.095 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.79 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 175.74 -106.12 0.21 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.491 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 m 68.48 88.24 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 111.122 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.49 -74.73 0.43 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.529 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 55.5 m -106.56 -26.87 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.79 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -76.25 127.99 34.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.305 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.53 ' O ' HG21 ' A' ' 66' ' ' VAL . 47.4 m-80 -76.91 20.69 0.24 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.189 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.43 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.4 p -52.0 -25.44 8.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.958 0.409 . . . . 0.0 111.116 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -36.22 65.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.181 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.486 ' CB ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -63.64 -51.92 63.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.875 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.997 HD21 HD11 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -68.9 -22.01 64.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.994 0.426 . . . . 0.0 110.553 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.538 ' CD ' HD13 ' A' ' 6' ' ' ILE . 3.7 tp10 -60.62 -54.25 47.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.558 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -48.64 65.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.73 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -55.09 -49.88 70.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.834 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.565 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -58.72 -41.51 86.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.797 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.552 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 11.5 mtp180 -57.55 -46.18 84.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 111.373 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.7 pt-20 -72.6 -50.3 26.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.558 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.76 -49.37 75.28 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.733 HG11 ' HB3' ' A' ' 32' ' ' ALA . 3.8 p -53.56 -55.17 14.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.614 0.245 . . . . 0.0 110.883 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.511 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -69.56 -44.35 71.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.233 179.249 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 2.7 tt0 -56.68 -45.19 81.88 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.138 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.19 -22.1 3.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.907 0.384 . . . . 0.0 110.591 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.649 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.74 34.61 1.68 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.394 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 29' ' ' GLY . 6.4 pt -162.74 116.73 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 0.0 111.288 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -61.32 164.69 5.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.159 179.348 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.733 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -151.23 161.98 41.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -121.37 111.65 17.58 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.805 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 58.0 m-85 -98.01 108.86 21.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.481 0.657 . . . . 0.0 112.038 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.81 133.85 55.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.481 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.564 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -80.5 151.34 29.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.04 0.447 . . . . 0.0 111.027 -179.463 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.746 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -126.32 91.34 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.696 -179.071 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.18 75.76 6.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.979 0.419 . . . . 0.0 111.229 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.56 ' O ' HG13 ' A' ' 43' ' ' ILE . 2.8 tt0 173.69 121.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.903 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.556 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -54.65 -33.92 61.38 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.222 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.438 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -51.36 -36.34 42.66 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.417 ' HB3' HG21 ' A' ' 37' ' ' ILE . 4.9 mt-30 -86.55 -31.67 21.11 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.032 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.941 HG22 HD21 ' A' ' 48' ' ' LEU . 46.1 mt -63.05 -56.32 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.039 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.492 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -62.75 -34.73 77.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.182 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.517 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -59.01 -21.71 59.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.909 0.385 . . . . 0.0 110.488 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.526 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -76.93 -35.8 57.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.3 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.18 -8.94 22.85 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.619 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.941 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.33 152.27 39.64 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 117.326 0.563 . . . . 0.0 111.382 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.7 p -108.02 -19.91 13.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.647 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -87.39 -171.58 3.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.393 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.563 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 2.0 mp -86.16 -73.78 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.714 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 38.3 Cg_endo -66.12 63.78 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.361 2.04 . . . . 0.0 112.609 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.426 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -84.93 143.78 20.71 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.993 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.858 HD12 HG22 ' A' ' 6' ' ' ILE . 3.7 tt -134.86 109.57 8.6 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.766 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -98.16 123.15 42.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.021 0.439 . . . . 0.0 110.901 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.957 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -115.95 138.8 45.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.354 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 46.16 27.91 0.6 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.482 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.92 34.32 48.15 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.399 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.98 101.09 3.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.838 0.351 . . . . 0.0 111.099 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.881 HD21 HD13 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -45.81 130.2 9.38 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.159 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -118.33 -19.29 8.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.701 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.701 HD11 ' HB2' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -145.09 143.0 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 111.973 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.583 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -146.16 115.11 6.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.483 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.534 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 63.6 13.67 51.87 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.085 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.67 94.45 0.5 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.843 0.354 . . . . 0.0 110.77 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.577 HG13 ' HB2' ' A' ' 17' ' ' LEU . 2.0 t -60.54 126.08 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.242 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.577 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -63.77 142.58 58.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.836 0.351 . . . . 0.0 111.067 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.68 169.07 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.74 -49.83 76.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.975 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.99 -36.48 81.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -58.81 -49.7 76.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.997 HD11 HD21 ' A' ' 17' ' ' LEU . 37.2 mm -60.51 -54.28 37.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.008 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.421 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 33.5 ttm . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.566 0.222 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.928 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -83.65 114.03 21.27 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.045 0.45 . . . . 0.0 110.808 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -69.52 116.35 9.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.007 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 1.004 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 2.5 mp -124.25 128.29 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.47 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.593 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 0.8 OUTLIER -111.16 143.02 42.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.6 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.633 HD11 ' HB2' ' A' ' 36' ' ' LYS . 7.6 pt -127.31 110.25 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 110.395 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.979 ' CD2' HD11 ' A' ' 48' ' ' LEU . 8.1 m-30 -100.15 110.67 22.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.726 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.84 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 178.56 -66.34 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.525 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 m 74.63 79.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.793 0.33 . . . . 0.0 111.284 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.58 -62.76 1.9 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.846 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -50.47 -70.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.353 . . . . 0.0 111.235 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.84 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -57.36 147.78 24.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.021 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.4 17.06 0.4 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.544 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.4 p -55.43 -21.96 18.21 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.729 0.3 . . . . 0.0 111.228 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -37.45 74.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.326 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -62.43 1.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.886 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.712 HD13 ' HB2' ' A' ' 21' ' ' ALA . 1.6 tm? -59.31 -36.02 74.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.616 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG3' HD13 ' A' ' 6' ' ' ILE . 38.4 tt0 -56.87 -41.0 77.22 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.7 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -73.46 -51.94 15.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.969 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.664 ' OD1' HD22 ' A' ' 17' ' ' LEU . 30.7 p30 -64.61 -36.23 83.58 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.88 0.372 . . . . 0.0 111.025 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.712 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -62.49 -44.38 96.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.61 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.577 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 1.4 mtp180 -58.55 -45.12 89.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.748 0.308 . . . . 0.0 111.253 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.2 pt-20 -71.67 -47.57 53.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.076 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 23' ' ' GLU . . . -62.64 -49.99 73.0 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.822 HG21 ' HB2' ' A' ' 32' ' ' ALA . 9.1 p -53.3 -55.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 121.26 -0.176 . . . . 0.0 110.821 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.579 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.68 -40.77 79.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.5 0.191 . . . . 0.0 110.988 179.208 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 47.9 tt0 -60.27 -48.06 83.33 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.363 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.4 mt -53.84 -19.56 4.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.723 0.297 . . . . 0.0 110.966 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.778 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.74 42.93 0.84 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.433 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -175.65 106.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 111.21 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' O ' ' CA ' ' A' ' 1' ' ' MET . 28.5 t0 -61.26 164.35 5.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.105 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.928 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -148.0 179.28 7.85 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.58 110.95 9.66 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 1.004 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 17.7 m-85 -98.0 109.63 22.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.408 0.623 . . . . 0.0 111.982 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -109.97 124.61 51.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.35 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.633 ' HB2' HD11 ' A' ' 6' ' ' ILE . 2.9 tmmt? -92.38 144.2 25.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.579 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.903 HD12 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -118.49 172.28 5.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.374 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -155.7 75.35 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.277 0.56 . . . . 0.0 109.944 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER 157.5 136.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.418 -179.446 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.774 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -54.03 -20.6 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 -179.413 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.436 ' O ' HD23 ' A' ' 44' ' ' LEU . 4.4 m-20 -51.38 -45.12 62.35 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -86.44 -31.77 21.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.3 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.774 ' HB ' ' HA ' ' A' ' 40' ' ' MET . 62.7 mt -63.59 -56.07 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-O 121.549 0.69 . . . . 0.0 111.503 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -62.91 -36.52 83.64 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.086 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -55.76 -24.13 33.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.103 0.478 . . . . 0.0 110.362 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.77 ' O ' HD21 ' A' ' 60' ' ' LEU . . . -77.61 -41.86 37.11 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.525 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.89 -7.64 23.69 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.558 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.979 HD11 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -78.1 157.21 29.57 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.887 0.375 . . . . 0.0 110.933 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.89 -22.76 9.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.856 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.902 ' HB3' ' CB ' ' A' ' 63' ' ' MET . . . -79.7 170.49 16.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.049 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.5 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 2.7 mp -71.96 -70.08 0.31 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.793 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 47.8 Cg_endo -69.92 60.13 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.056 1.837 . . . . 0.0 112.234 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -83.68 128.82 8.77 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.615 HD12 ' CG2' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -121.97 107.93 12.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.759 0.314 . . . . 0.0 110.244 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.62 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -98.74 124.5 43.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.199 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.873 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.85 139.59 40.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.193 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.49 26.78 0.54 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.823 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.75 35.19 46.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.317 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -144.94 103.24 3.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.944 0.402 . . . . 0.0 111.132 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.77 HD21 ' O ' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -54.5 132.71 45.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.494 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.6 -5.21 1.57 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.557 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 0.7 OUTLIER -154.17 124.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.919 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.902 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -145.73 134.55 22.4 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.367 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.496 ' N ' ' HB1' ' A' ' 50' ' ' ALA . . . 80.2 -1.5 80.36 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.884 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.416 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -178.35 100.43 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.779 0.323 . . . . 0.0 110.582 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.615 ' CG2' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -65.09 137.28 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.065 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.628 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -63.73 164.38 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.33 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.8 p -92.16 -179.76 5.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.136 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.419 ' O ' HG22 ' A' ' 72' ' ' ILE . 16.5 pttm -64.14 -49.28 72.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.673 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -71.82 -30.23 65.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.722 0.296 . . . . 0.0 111.142 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.69 -51.33 23.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.373 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.657 ' HB ' HD21 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -55.65 -45.87 79.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.139 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.442 ' N ' HG23 ' A' ' 72' ' ' ILE . 13.4 tttt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.834 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.443 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 2.2 tpp . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.559 0.219 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.835 ' O ' HD12 ' A' ' 4' ' ' ILE . 8.2 tpp -80.65 112.01 17.61 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -70.12 118.3 12.78 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.028 0.442 . . . . 0.0 110.94 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.994 HG13 HG12 ' A' ' 56' ' ' VAL . 2.3 mp -126.14 124.95 66.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.941 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 3.7 mt-30 -110.36 139.1 45.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.945 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.5 mp -119.86 113.46 40.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.08 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.875 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 83.7 m-85 -104.71 115.94 31.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.249 0.547 . . . . 0.0 112.465 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 128.93 -66.91 0.56 Allowed Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.649 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 53.53 -84.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.608 0.242 . . . . 0.0 111.502 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 8' ' ' GLY . . . -58.96 -53.85 42.95 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.492 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.3 m -98.71 33.67 2.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.468 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -155.0 126.22 7.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -76.05 7.57 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.666 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.462 ' HB3' HG13 ' A' ' 66' ' ' VAL . 2.1 p -55.98 -20.38 16.17 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.735 0.303 . . . . 0.0 111.402 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.39 -25.46 6.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.511 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.7 mtt -63.49 -62.14 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.728 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.462 HD22 ' H ' ' A' ' 67' ' ' ALA . 9.3 tp -64.46 -24.03 67.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.782 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.75 -51.78 67.55 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.411 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -67.62 -47.39 69.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.818 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -56.51 -39.66 73.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.913 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -61.73 -46.97 87.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.605 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.476 ' CG ' ' CD1' ' A' ' 34' ' ' PHE . 41.8 mtp180 -54.63 -38.05 66.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.803 0.335 . . . . 0.0 111.14 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.8 tt0 -73.57 -49.92 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.8 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -60.55 -50.93 71.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.786 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.026 HG21 ' HB2' ' A' ' 32' ' ' ALA . 13.8 p -53.23 -56.05 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.631 0.253 . . . . 0.0 110.64 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.607 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -65.48 -47.64 75.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 0.0 110.923 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 17.8 tp10 -56.03 -48.07 76.67 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.283 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.499 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -53.32 -21.92 6.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.809 0.338 . . . . 0.0 110.765 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.62 47.41 0.63 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.597 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 25' ' ' VAL . 10.6 tt -179.23 128.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.305 0.574 . . . . 0.0 111.471 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' O ' ' CA ' ' A' ' 1' ' ' MET . 17.0 t0 -69.68 164.32 23.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.604 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 1.026 ' HB2' HG21 ' A' ' 25' ' ' VAL . . . -147.21 175.47 10.72 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.23 107.72 9.19 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.071 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.975 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 25.2 m-85 -101.38 108.58 20.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.346 0.594 . . . . 0.0 111.179 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -118.73 124.74 48.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.67 143.68 26.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.206 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.843 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -110.08 -178.02 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.333 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.489 ' N ' HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -158.92 75.37 0.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.106 0.479 . . . . 0.0 110.62 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.494 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER 158.14 130.05 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.96 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.508 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -52.63 -27.28 16.47 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 121.245 -0.182 . . . . 0.0 111.153 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -51.48 -39.0 56.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.737 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -86.75 -35.87 18.94 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.974 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.039 HG22 HD21 ' A' ' 48' ' ' LEU . 20.9 mt -60.76 -54.82 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.077 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.425 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.488 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -58.7 -37.33 75.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.768 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -55.18 -25.27 31.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 110.565 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.663 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -73.64 -34.75 65.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.996 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.12 -5.17 35.95 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.018 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.039 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.1 157.11 36.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.084 0.469 . . . . 0.0 111.512 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.6 p -112.41 -8.73 13.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.21 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.452 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -102.38 -175.41 2.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.41 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.62 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -86.1 -64.21 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.63 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 11.7 Cg_exo -69.53 59.87 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.254 1.969 . . . . 0.0 111.82 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.554 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -87.44 141.41 17.37 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.226 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.476 ' CB ' HD11 ' A' ' 62' ' ' ILE . 4.8 tt -135.27 111.45 9.64 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.729 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -98.32 124.42 42.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.934 0.397 . . . . 0.0 111.123 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.994 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -113.6 139.4 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.06 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 49.56 24.71 1.21 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.598 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.75 28.55 56.81 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.318 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -143.25 104.2 4.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.859 0.361 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.729 HD22 ' HB2' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -46.07 131.77 9.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.921 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.84 -13.84 7.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.985 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.552 HD13 ' HA ' ' A' ' 66' ' ' VAL . 2.7 pp -152.98 146.88 14.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.597 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 1.6 mtp -146.24 125.53 13.05 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.889 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.618 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 89.06 -17.17 53.07 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.034 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 178.22 109.77 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.552 ' HA ' HD13 ' A' ' 62' ' ' ILE . 9.4 m -49.51 174.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.88 0.371 . . . . 0.0 111.445 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.462 ' H ' HD22 ' A' ' 17' ' ' LEU . . . -92.61 -165.67 1.39 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.046 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.2 m -113.4 163.16 15.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.812 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HA ' HG22 ' A' ' 72' ' ' ILE . 4.0 pttp -55.75 -42.79 75.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -65.85 -32.63 74.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.804 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.47 -48.98 29.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.046 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.485 HG23 ' N ' ' A' ' 73' ' ' LYS . 16.9 tt -62.46 -46.74 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.204 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.485 ' N ' HG23 ' A' ' 72' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.896 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.434 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.825 0.345 . . . . 0.0 111.284 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.619 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -83.99 116.11 22.66 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.83 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -69.12 118.34 11.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.016 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.904 HG12 HG12 ' A' ' 56' ' ' VAL . 4.3 mt -128.8 123.03 58.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.094 0.473 . . . . 0.0 111.88 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -111.96 142.84 43.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.314 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.706 HG22 HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -120.55 106.23 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.767 0.318 . . . . 0.0 110.766 179.264 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.917 ' CD2' ' HA ' ' A' ' 43' ' ' ILE . 59.2 m-85 -91.77 109.68 21.01 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.069 0.461 . . . . 0.0 111.412 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.909 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 174.17 -100.1 0.14 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.269 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 51.86 100.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.874 0.369 . . . . 0.0 111.411 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.17 18.49 26.48 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.697 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.63 -41.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.346 . . . . 0.0 110.818 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.909 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -95.12 132.5 39.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.174 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -76.56 20.4 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.06 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.432 ' HA ' HG11 ' A' ' 66' ' ' VAL . 3.4 p -54.1 -24.06 16.2 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.953 0.406 . . . . 0.0 111.206 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.27 -32.79 64.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.111 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 23.0 ttt -63.61 -62.07 1.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.752 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.779 ' CD1' ' HB3' ' A' ' 67' ' ' ALA . 1.2 tt -64.69 -20.05 66.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 110.637 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -58.88 -54.35 48.06 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.303 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -50.09 43.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -54.83 -49.19 71.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.072 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.402 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -56.02 -40.88 74.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.517 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.518 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -57.32 -41.02 79.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.259 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -74.39 -50.4 18.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.106 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.501 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -61.95 -50.22 73.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.77 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.903 HG11 ' HB3' ' A' ' 32' ' ' ALA . 6.2 p -53.64 -55.53 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.154 -0.218 . . . . 0.0 110.614 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.548 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -64.65 -48.99 72.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 178.765 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -57.85 -42.85 85.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.51 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 24' ' ' ALA . 1.9 mm? -53.58 -20.01 4.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.811 0.339 . . . . 0.0 110.883 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.98 41.95 0.88 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.49 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.0 tt -179.22 120.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.24 0.543 . . . . 0.0 111.058 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.436 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 5.0 t70 -62.64 163.97 8.33 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.762 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.903 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -157.77 141.04 15.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.641 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -103.83 119.58 39.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.561 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.854 ' CE2' HD12 ' A' ' 4' ' ' ILE . 13.3 m-85 -103.17 109.59 21.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.349 0.595 . . . . 0.0 111.906 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -108.64 122.45 47.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.824 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.535 ' HG3' HD11 ' A' ' 6' ' ' ILE . 1.9 mtpt -90.21 141.37 28.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.059 0.457 . . . . 0.0 111.13 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.781 HG13 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -108.8 175.31 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.594 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -160.06 74.93 0.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.892 0.377 . . . . 0.0 110.896 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.562 ' O ' HG13 ' A' ' 43' ' ' ILE . 3.2 mt-10 157.0 127.29 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.311 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.546 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -53.96 -26.67 26.84 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.924 -0.126 . . . . 0.0 111.111 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.466 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -51.66 -39.84 58.92 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -86.62 -33.15 20.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.206 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.079 HG22 HD21 ' A' ' 48' ' ' LEU . 13.1 mt -63.18 -55.87 20.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.547 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -61.02 -35.89 78.06 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.681 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.86 -22.51 59.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.102 0.477 . . . . 0.0 110.234 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -73.42 -36.35 65.95 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.913 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 121.13 -15.08 9.45 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.583 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.079 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.85 158.79 32.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.361 0.58 . . . . 0.0 111.689 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 t -105.78 -28.07 10.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.458 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.42 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -81.93 -177.62 6.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.063 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.575 HD12 ' HD3' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -89.89 -55.57 0.29 Allowed Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.486 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.575 ' HD3' HD12 ' A' ' 51' ' ' LEU . 14.6 Cg_exo -69.65 56.89 1.38 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.511 2.141 . . . . 0.0 112.473 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -81.46 142.25 22.73 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.475 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.706 HD12 HG22 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -132.2 105.32 7.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.866 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -97.95 122.13 40.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.987 0.422 . . . . 0.0 111.507 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.904 HG12 HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -119.53 139.28 47.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.192 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.48 27.49 0.97 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.659 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.92 33.2 55.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.269 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.94 101.71 3.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.938 0.399 . . . . 0.0 111.171 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.872 HD11 HD12 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -52.44 127.42 22.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.608 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -125.72 -13.47 6.43 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.705 HG21 ' HA ' ' A' ' 66' ' ' VAL . 6.5 mt -139.63 130.55 32.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.523 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.75 ' SD ' HD12 ' A' ' 60' ' ' LEU . 4.0 mpp? -146.72 134.62 21.33 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.963 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 86.74 -10.61 67.04 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.575 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 3.8 ttp180 176.85 104.96 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.719 0.295 . . . . 0.0 110.436 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.705 ' HA ' HG21 ' A' ' 62' ' ' ILE . 2.1 p -59.28 142.84 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.839 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.779 ' HB3' ' CD1' ' A' ' 17' ' ' LEU . . . -67.43 170.79 6.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.806 0.336 . . . . 0.0 111.349 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.67 172.04 7.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.79 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.02 -38.02 69.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.281 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -73.29 -39.39 65.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 111.106 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.533 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 18.8 tt0 -69.23 -49.69 54.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.198 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.581 HD13 ' C ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -57.22 -46.72 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.253 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.488 ' N ' HG23 ' A' ' 72' ' ' ILE . 24.8 tttm . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.866 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.498 0.189 . . . . 0.0 111.266 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.599 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -76.54 112.56 13.21 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.762 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 100.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.042 0.449 . . . . 0.0 110.126 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.959 HD13 ' CE2' ' A' ' 34' ' ' PHE . 4.3 mt -110.61 130.26 64.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.51 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.804 ' C ' HD13 ' A' ' 6' ' ' ILE . 14.3 mt-30 -110.81 144.36 39.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.19 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.804 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -128.2 107.96 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-O 120.82 0.343 . . . . 0.0 110.975 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.953 ' CD2' HD11 ' A' ' 48' ' ' LEU . 6.1 m-30 -100.11 112.8 25.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.125 0.488 . . . . 0.0 111.469 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.836 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 161.57 -104.51 0.24 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.572 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.4 OUTLIER 62.37 136.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 0.0 111.063 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.52 25.67 42.97 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -175.99 -67.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 110.685 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.836 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -70.5 137.89 50.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -76.27 13.82 0.85 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.156 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.737 ' HB2' HG22 ' A' ' 6' ' ' ILE . 4.6 p -56.22 -29.22 60.67 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.915 0.388 . . . . 0.0 111.209 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.34 -35.26 60.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.45 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 tpt -64.78 -62.65 1.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.346 . . . . 0.0 111.127 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.821 HD13 ' O ' ' A' ' 17' ' ' LEU . 3.5 tm? -66.37 -24.18 66.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.767 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.431 ' HB2' HG21 ' A' ' 6' ' ' ILE . 3.6 tm-20 -57.17 -49.82 74.78 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.22 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.1 -46.09 82.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.43 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.506 ' HB2' HD22 ' A' ' 17' ' ' LEU . 1.7 m-20 -54.91 -45.53 74.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.551 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.74 -41.51 82.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.473 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.517 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 3.9 mtm180 -55.68 -41.68 74.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.038 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 13.9 tt0 -73.77 -49.85 23.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.186 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -62.28 -51.88 65.93 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.85 HG11 ' HB3' ' A' ' 32' ' ' ALA . 2.9 p -53.3 -53.98 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.418 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.487 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 3.4 mtpm? -65.46 -48.88 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.82 0.343 . . . . 0.0 110.841 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.411 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 4.4 tm-20 -58.13 -42.87 86.75 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.535 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -51.35 -21.36 2.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.878 0.37 . . . . 0.0 110.955 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.76 34.37 1.71 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.226 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.6 OUTLIER -169.37 113.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 2.2 t0 -61.07 164.13 5.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.213 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.85 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -150.87 167.56 27.14 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -125.86 115.14 19.51 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.26 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.959 ' CE2' HD13 ' A' ' 4' ' ' ILE . 12.4 m-85 -100.2 108.72 20.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.337 0.589 . . . . 0.0 111.093 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -110.57 112.24 24.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.696 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 mtmt -82.23 141.36 33.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.243 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.927 HD12 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -112.3 159.75 12.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.29 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -139.92 75.34 1.51 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.325 0.583 . . . . 0.0 110.123 179.197 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 0.3 OUTLIER 157.59 134.66 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.566 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.666 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 3.6 ttm -56.39 -16.91 6.47 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -51.17 -45.94 61.93 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.48 -31.62 21.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.299 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.746 HG22 HD21 ' A' ' 48' ' ' LEU . 30.4 mt -64.57 -54.73 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 121.504 0.668 . . . . 0.0 111.383 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.401 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -65.52 -36.26 83.3 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.007 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 28.6 tt0 -54.88 -26.19 33.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.209 0.528 . . . . 0.0 110.041 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.646 ' O ' HD21 ' A' ' 60' ' ' LEU . . . -74.59 -46.73 36.73 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.084 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.63 -7.76 13.51 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.528 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.953 HD11 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -76.26 155.22 34.55 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.774 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.82 -26.07 9.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.788 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.986 ' HB3' ' HB2' ' A' ' 63' ' ' MET . . . -75.73 179.66 5.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.59 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.476 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -81.69 -68.59 0.19 Allowed Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.117 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.732 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 45.0 Cg_endo -70.01 57.33 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.201 1.934 . . . . 0.0 113.809 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.482 ' HA2' ' HB3' ' A' ' 63' ' ' MET . . . -72.2 141.52 31.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.033 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.716 HD21 HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -130.76 104.07 6.96 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.934 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -98.39 123.48 42.53 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.102 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.687 HG12 ' CG1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -120.8 141.04 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.657 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 47.19 26.92 0.74 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.938 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.38 29.52 55.83 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.404 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -140.92 103.7 4.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.912 0.386 . . . . 0.0 110.84 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.934 HD12 ' HB2' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -72.87 126.53 30.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.161 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -147.16 10.18 0.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 54' ' ' LEU . 5.2 mt -147.1 103.9 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.989 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.986 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.37 149.92 35.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.132 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.421 ' N ' ' HG2' ' A' ' 52' ' ' PRO . . . 84.53 -5.94 79.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.978 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.456 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER 165.4 105.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.502 HG11 ' HA ' ' A' ' 14' ' ' CYS . 10.3 m -61.14 163.89 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 111.193 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.436 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -82.27 169.18 16.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.063 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 m -82.96 178.2 8.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.911 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.404 ' O ' HG22 ' A' ' 72' ' ' ILE . 18.0 tttt -65.35 -53.4 44.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.264 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -33.22 72.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.343 . . . . 0.0 110.931 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -72.62 -48.13 42.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.054 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -61.86 -42.21 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.996 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.635 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.444 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 2.7 ttp . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.448 0.166 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.791 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 2.3 mmt -81.11 113.03 19.01 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.947 0.403 . . . . 0.0 110.824 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 120.14 14.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.068 0.461 . . . . 0.0 110.767 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.914 HG13 HG12 ' A' ' 56' ' ' VAL . 2.1 mp -129.09 124.82 61.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.454 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.737 ' O ' HD22 ' A' ' 54' ' ' LEU . 6.5 mm-40 -111.1 141.98 43.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.257 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.668 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -130.28 113.44 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 0.0 110.608 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 1.359 ' CD2' ' CE2' ' A' ' 7' ' ' TYR . 27.5 m-85 -100.51 113.02 25.48 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.298 0.571 . . . . 0.0 112.042 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.895 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 171.24 -100.62 0.16 Allowed Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.412 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.91 103.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.786 0.326 . . . . 0.0 111.302 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.48 -28.62 11.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.711 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.8 p -138.57 -48.36 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 111.134 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.895 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -73.45 132.7 43.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -76.56 19.73 0.25 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.196 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.412 ' HA ' HG11 ' A' ' 66' ' ' VAL . 4.5 p -55.62 -23.06 25.53 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.808 0.337 . . . . 0.0 111.234 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -33.79 72.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.174 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 38.1 ttp -64.58 -62.09 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.372 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 67' ' ' ALA . 0.4 OUTLIER -60.97 -33.21 72.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.694 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -56.47 -39.84 73.88 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.666 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -73.52 -52.4 13.69 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.849 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.629 HD21 HD22 ' A' ' 17' ' ' LEU . 30.7 p30 -64.22 -34.02 77.14 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.849 0.357 . . . . 0.0 110.803 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.518 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -62.07 -49.28 76.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.026 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.495 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 2.2 mtm-85 -54.76 -39.04 67.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.716 0.293 . . . . 0.0 111.007 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -72.18 -50.26 29.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.079 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.405 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -62.43 -50.52 71.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.682 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.996 HG21 ' HB2' ' A' ' 32' ' ' ALA . 11.1 p -53.54 -55.8 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.607 0.241 . . . . 0.0 110.473 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.602 ' N ' HG13 ' A' ' 25' ' ' VAL . 11.8 mtpt -64.15 -49.36 72.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.755 0.312 . . . . 0.0 110.682 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -55.72 -47.15 77.38 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.349 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 24' ' ' ALA . 2.2 mm? -51.64 -22.3 3.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.856 0.36 . . . . 0.0 110.872 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.737 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.8 36.12 1.44 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.336 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 29' ' ' GLY . 1.1 pt -168.55 112.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.041 0.448 . . . . 0.0 111.103 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.465 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 30.5 t70 -61.44 164.61 5.52 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.49 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.996 ' HB2' HG21 ' A' ' 25' ' ' VAL . . . -148.65 171.72 15.72 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -128.51 110.23 12.1 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.957 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.871 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 15.1 m-85 -100.46 108.96 21.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.323 0.583 . . . . 0.0 111.374 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -113.17 121.05 43.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.789 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.434 ' HA ' HG12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -94.45 139.63 30.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.075 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.839 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -106.98 179.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.124 -179.639 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.437 ' N ' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -155.34 74.92 0.92 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.116 0.484 . . . . 0.0 110.884 179.114 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.53 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER 162.25 126.62 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.006 179.676 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.5 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 15.2 mtt -52.55 -29.24 24.42 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.569 0.223 . . . . 0.0 110.764 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.455 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -51.93 -38.13 55.2 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.407 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.884 ' O ' ' CE2' ' A' ' 7' ' ' TYR . 7.4 mt-30 -86.6 -34.94 19.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.083 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.985 HG22 HD21 ' A' ' 48' ' ' LEU . 10.7 mt -62.84 -54.67 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.512 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -63.58 -34.26 77.42 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.924 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -59.04 -23.58 62.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.919 0.39 . . . . 0.0 110.427 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.682 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -73.11 -36.52 66.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.707 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.76 -9.05 14.57 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.842 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.985 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -69.21 150.08 47.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.495 0.648 . . . . 0.0 111.243 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.31 -19.36 19.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.431 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.497 ' HB3' ' N ' ' A' ' 64' ' ' GLY . . . -100.92 -173.37 2.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.212 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.514 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.0 OUTLIER -86.87 -57.4 0.32 Allowed Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.643 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 17.0 Cg_exo -67.87 58.19 0.83 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.618 2.212 . . . . 0.0 112.38 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.432 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -74.88 148.32 37.94 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.559 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.737 HD22 ' O ' ' A' ' 5' ' ' GLN . 3.4 tm? -137.24 100.1 4.16 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.696 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -97.92 119.43 36.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.188 0.518 . . . . 0.0 111.217 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.914 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -115.03 138.74 44.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.888 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 47.25 27.25 0.82 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.497 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.53 35.43 47.01 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.284 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -148.47 100.66 3.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 0.0 111.268 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.696 ' CD1' ' HB2' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -47.75 129.45 14.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.974 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.85 ' O ' HD13 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -129.42 -13.16 4.39 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.397 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.85 HD13 ' O ' ' A' ' 61' ' ' LYS . 4.8 mm -139.59 135.84 39.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.754 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.487 ' CG ' ' HB2' ' A' ' 48' ' ' LEU . 1.4 mpp? -146.48 133.28 20.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.52 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.515 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 83.23 -6.34 72.46 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.273 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 173.44 103.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.624 ' HA ' HG21 ' A' ' 62' ' ' ILE . 9.0 p -48.47 155.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.337 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.697 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -63.77 178.74 0.57 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.894 0.378 . . . . 0.0 111.158 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 74.3 m -110.17 169.57 8.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.008 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -58.38 -45.86 87.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.239 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -73.1 -29.8 63.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 0.0 111.052 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -73.39 -46.69 47.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.376 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -61.71 -46.18 97.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.139 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.459 ' N ' HG23 ' A' ' 72' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 0.0 110.816 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.464 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 9.1 ptp . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.361 0.124 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.916 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -81.35 109.74 16.13 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.796 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -69.26 103.55 1.98 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.132 0.491 . . . . 0.0 110.664 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.667 HG23 HD21 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -101.64 116.65 45.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.107 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.759 ' O ' HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -110.11 115.04 29.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.017 179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.854 ' N ' HD11 ' A' ' 37' ' ' ILE . 15.8 pt -100.41 109.26 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-O 121.086 0.47 . . . . 0.0 111.847 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.746 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 90.3 m-85 -90.44 125.91 35.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.93 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.535 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 149.79 -82.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.514 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p 51.85 78.36 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 111.285 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.14 -84.01 0.18 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.542 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.9 m -93.99 -29.99 14.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.798 0.332 . . . . 0.0 110.926 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.535 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -63.42 133.28 53.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.384 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.791 ' O ' HG21 ' A' ' 66' ' ' VAL . 58.1 m-20 -76.63 20.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.083 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.421 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.2 p -53.03 -23.47 7.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.893 0.378 . . . . 0.0 111.287 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -39.45 71.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.562 ' HB3' HG11 ' A' ' 66' ' ' VAL . 16.9 ttt -68.08 -51.36 47.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.88 HD11 ' HG ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -69.04 -25.89 64.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.987 0.423 . . . . 0.0 110.389 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.593 ' N ' HD23 ' A' ' 17' ' ' LEU . 16.0 tt0 -58.78 -52.92 63.67 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.243 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -65.79 -44.71 84.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.829 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -58.12 -54.32 48.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.165 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.665 ' HB3' ' HE2' ' A' ' 34' ' ' PHE . . . -53.02 -36.3 60.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.32 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -60.4 -48.87 79.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.319 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.2 pt-20 -71.59 -47.83 52.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.298 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -63.03 -49.88 72.88 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.888 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.9 p -53.48 -54.99 15.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.919 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.541 ' N ' HG13 ' A' ' 25' ' ' VAL . 5.7 mtmm -70.04 -49.03 55.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.265 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 22.9 tt0 -51.81 -46.68 64.34 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.732 0.301 . . . . 0.0 111.172 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.655 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -51.47 -23.66 4.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.978 0.418 . . . . 0.0 110.487 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.737 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.53 37.57 1.3 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.572 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -167.97 117.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.987 0.422 . . . . 0.0 111.642 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -61.42 165.53 4.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.895 178.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.916 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -148.31 179.2 7.95 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -129.45 113.98 15.57 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.72 ' HE1' ' HB3' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -100.31 109.75 21.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.279 0.561 . . . . 0.0 111.659 -178.35 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -126.21 128.55 47.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.073 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.789 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -79.76 151.94 30.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.961 0.41 . . . . 0.0 110.762 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.952 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -123.27 78.35 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.938 -178.271 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.9 tttt -77.47 75.77 4.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.14 0.495 . . . . 0.0 110.825 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 43' ' ' ILE . 0.1 OUTLIER 172.07 127.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.414 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.586 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -63.92 -27.21 68.99 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.031 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.466 ' O ' HD23 ' A' ' 44' ' ' LEU . 2.1 t0 -51.48 -36.76 45.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.475 ' HG2' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -88.22 -33.41 18.13 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.893 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.746 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -68.51 -45.22 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.073 0.463 . . . . 0.0 111.432 -179.195 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.584 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -65.48 -37.96 88.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.178 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.584 ' H ' HD23 ' A' ' 44' ' ' LEU . 6.7 tt0 -60.59 -22.06 63.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.243 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.825 ' HB1' HD23 ' A' ' 60' ' ' LEU . . . -77.47 -35.4 53.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.0 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.87 -8.35 21.6 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.628 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.521 HD13 ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -81.46 158.8 24.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.431 0.616 . . . . 0.0 111.597 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 t -114.92 -31.87 5.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.587 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.822 ' HB3' ' HG2' ' A' ' 63' ' ' MET . . . -75.23 -159.73 0.1 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.23 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.495 HD12 ' HA2' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -101.87 -56.28 0.12 Allowed Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.483 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.559 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 21.1 Cg_exo -65.55 57.81 0.36 Allowed 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.477 2.118 . . . . 0.0 113.561 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -88.48 136.03 13.44 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.164 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.88 ' HG ' HD11 ' A' ' 17' ' ' LEU . 3.4 tm? -138.31 114.78 10.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.741 0.305 . . . . 0.0 110.77 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.933 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . . . -109.55 131.34 55.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.03 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.422 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -117.85 139.9 43.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.111 0.482 . . . . 0.0 111.013 179.571 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 46.58 27.9 0.7 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.6 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.87 42.05 17.46 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.378 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.14 100.58 3.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.933 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -69.01 128.17 35.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.916 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.769 ' O ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -146.29 7.75 1.03 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.769 HD13 ' O ' ' A' ' 61' ' ' LYS . 11.0 mm -143.72 110.57 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.791 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.822 ' HG2' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -145.52 141.45 28.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.926 0.393 . . . . 0.0 111.509 -179.478 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.559 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 67.39 11.45 59.42 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.858 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -178.09 103.63 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.821 0.343 . . . . 0.0 110.621 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.791 HG21 ' O ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -56.45 144.49 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.618 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.428 ' HB2' HD12 ' A' ' 62' ' ' ILE . . . -78.25 147.28 34.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.102 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.8 p -90.47 168.32 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -55.65 -41.78 74.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.13 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -69.37 -40.55 77.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.976 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -63.94 -45.91 87.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.013 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.8 mt -65.93 -50.44 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.964 179.941 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.447 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 6.9 mtp . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.731 0.3 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.555 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.05 114.54 17.03 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.828 0.347 . . . . 0.0 110.672 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.47 106.07 2.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.106 0.479 . . . . 0.0 110.105 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.916 HG12 HG12 ' A' ' 56' ' ' VAL . 7.3 mt -117.13 127.75 74.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.478 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.669 ' O ' HD22 ' A' ' 54' ' ' LEU . 2.9 mp0 -110.39 144.08 39.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.354 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.674 HD11 ' HB3' ' A' ' 34' ' ' PHE . 3.2 mp -124.72 108.24 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.793 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.873 ' CD2' ' HA ' ' A' ' 43' ' ' ILE . 56.9 m-85 -96.94 115.64 27.79 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.289 0.566 . . . . 0.0 111.586 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.853 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 159.88 -88.87 0.11 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.331 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.8 p 49.54 96.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.843 0.354 . . . . 0.0 111.43 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.9 -78.88 0.31 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.392 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 t -85.76 -39.57 17.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.781 0.324 . . . . 0.0 110.762 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.853 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -79.45 125.77 29.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.926 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -76.49 19.95 0.24 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.131 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.539 ' SG ' HG22 ' A' ' 6' ' ' ILE . 4.2 p -58.77 -19.92 45.11 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.696 0.284 . . . . 0.0 111.611 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.95 -31.62 60.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.405 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.09 -52.83 61.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.673 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.658 HD13 HG22 ' A' ' 66' ' ' VAL . 5.6 tt -69.09 -29.87 68.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.753 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -55.55 -40.6 72.12 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.899 0.381 . . . . 0.0 110.416 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -73.03 -52.33 14.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.918 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 31.9 p30 -64.49 -33.73 76.58 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.816 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.471 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . -60.74 -47.06 88.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.941 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.539 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 12.6 mtp180 -56.89 -42.32 79.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.651 0.262 . . . . 0.0 110.905 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -47.94 49.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.055 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.587 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -62.97 -51.73 65.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.691 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.891 HG11 ' HB3' ' A' ' 32' ' ' ALA . 9.8 p -53.55 -55.12 14.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.545 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -62.97 -49.15 75.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.651 178.454 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.11 -45.84 86.56 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.301 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 24' ' ' ALA . 3.1 mm? -52.12 -20.69 2.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.991 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.11 46.61 0.64 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.623 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 7.9 tt 177.14 124.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.11 0.481 . . . . 0.0 111.192 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.447 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -66.08 162.64 19.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.704 179.51 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.891 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -154.32 142.8 20.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -104.48 114.41 28.62 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.273 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.841 ' CZ ' HD12 ' A' ' 4' ' ' ILE . 17.8 m-85 -97.58 109.29 22.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.317 0.58 . . . . 0.0 111.471 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -110.06 114.71 28.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.62 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.51 138.54 31.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.245 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.866 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -107.29 177.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.442 ' N ' HG12 ' A' ' 37' ' ' ILE . 13.6 pttm -156.75 75.28 0.84 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.157 0.503 . . . . 0.0 110.889 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.515 ' O ' HG13 ' A' ' 43' ' ' ILE . 9.8 pt-20 157.31 130.77 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.839 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.49 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 2.2 ptt? -52.31 -25.35 9.32 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.804 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -51.5 -39.44 57.62 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.51 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -87.31 -38.8 15.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.166 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.056 HG22 HD21 ' A' ' 48' ' ' LEU . 8.5 mt -60.68 -55.59 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.561 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -34.83 77.42 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.879 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 1.4 tm-20 -57.21 -24.92 57.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.102 0.477 . . . . 0.0 110.248 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.58 ' O ' HD11 ' A' ' 60' ' ' LEU . . . -71.97 -37.24 69.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.726 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.05 -14.62 10.34 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.703 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.056 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.86 161.18 25.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.028 0.442 . . . . 0.0 111.289 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t -110.59 -24.58 10.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.997 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.578 ' HB3' ' HG2' ' A' ' 63' ' ' MET . . . -80.17 -179.74 7.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.417 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.557 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.6 mt -88.13 -60.08 0.25 Allowed Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.855 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.557 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 17.2 Cg_exo -66.52 49.6 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.637 2.224 . . . . 0.0 113.769 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.99 146.74 35.42 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.571 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.669 HD22 ' O ' ' A' ' 5' ' ' GLN . 2.8 tm? -136.55 102.4 4.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.738 ' CB ' HD12 ' A' ' 60' ' ' LEU . . . -97.9 123.68 41.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 111.335 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.916 HG12 HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -119.45 140.67 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.181 0.515 . . . . 0.0 111.487 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 t0 48.48 25.66 0.98 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.086 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.17 25.72 50.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.413 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -139.9 104.49 4.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.891 0.377 . . . . 0.0 110.601 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.738 HD12 ' CB ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -90.43 128.72 36.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.696 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -146.43 3.22 0.87 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.141 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 54' ' ' LEU . 19.5 mm -128.67 103.31 9.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.989 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.578 ' HG2' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -146.45 162.46 38.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.632 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . 80.9 -7.61 58.86 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.246 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER 170.37 103.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.658 HG22 HD13 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -67.68 151.93 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.821 0.343 . . . . 0.0 111.389 -179.14 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.836 ' HB1' ' HB3' ' A' ' 71' ' ' GLU . . . -79.9 179.58 7.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.341 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 m -104.26 -170.18 1.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.932 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.456 ' O ' HG22 ' A' ' 72' ' ' ILE . 25.7 tttt -65.55 -54.51 27.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.008 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.17 -29.8 70.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.906 0.384 . . . . 0.0 110.652 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.836 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 0.7 OUTLIER -73.45 -51.14 18.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.04 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.661 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -60.76 -42.85 93.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.858 0.361 . . . . 0.0 110.964 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.403 ' N ' HG23 ' A' ' 72' ' ' ILE . 16.6 tptm . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.706 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.426 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 8.6 ttp . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.554 0.216 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.503 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 1.4 mtt -77.73 113.61 15.76 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.951 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -69.35 100.8 1.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.012 0.434 . . . . 0.0 109.958 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.946 HD12 ' HB1' ' A' ' 32' ' ' ALA . 3.5 mt -109.95 135.66 48.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.998 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.916 ' O ' HD13 ' A' ' 54' ' ' LEU . 22.2 mm-40 -111.36 143.98 41.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.376 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.675 HG22 ' HB2' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -127.3 100.34 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 120.972 0.415 . . . . 0.0 110.349 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.994 ' CD2' HD11 ' A' ' 48' ' ' LEU . 8.3 m-30 -94.19 116.31 28.69 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.3 0.572 . . . . 0.0 112.155 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . -177.16 -90.52 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.213 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 m 48.57 29.71 2.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.76 0.314 . . . . 0.0 111.528 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.86 108.85 0.23 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.499 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t 59.78 27.17 16.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 110.994 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.492 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -124.73 132.47 53.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.896 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.731 ' O ' HG21 ' A' ' 66' ' ' VAL . 1.6 m120 -76.12 20.74 0.19 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.699 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.675 ' HB2' HG22 ' A' ' 6' ' ' ILE . 1.8 p -51.51 -28.96 15.0 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.953 0.406 . . . . 0.0 111.128 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -36.18 73.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.008 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.433 ' CB ' HG11 ' A' ' 66' ' ' VAL . 14.3 mtt -68.62 -50.67 49.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.354 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.766 HD11 HD12 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -71.09 -31.19 67.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.994 0.426 . . . . 0.0 110.628 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -58.48 -42.36 87.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.617 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.45 -42.4 62.01 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 36.1 p30 -74.96 -34.62 62.07 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.734 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.544 ' HB2' HD23 ' A' ' 17' ' ' LEU . . . -66.28 -50.44 63.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.558 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.57 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -59.91 -44.46 94.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.583 0.23 . . . . 0.0 111.457 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 41.7 tp10 -72.69 -50.17 26.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.622 0.248 . . . . 0.0 110.966 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -62.34 -51.8 66.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.692 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.798 HG11 ' HB3' ' A' ' 32' ' ' ALA . 4.0 p -53.3 -54.91 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.914 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.519 ' N ' HG13 ' A' ' 25' ' ' VAL . 11.1 mtmm -67.27 -46.6 73.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.636 0.255 . . . . 0.0 111.112 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.435 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -58.57 -46.24 87.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.359 -179.576 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.709 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -52.01 -21.83 3.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.924 0.393 . . . . 0.0 110.851 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.79 50.3 0.52 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.528 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 6.8 tt 178.03 122.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.238 0.542 . . . . 0.0 111.371 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.426 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -62.94 164.54 8.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.373 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.946 ' HB1' HD12 ' A' ' 4' ' ' ILE . . . -153.59 151.52 29.84 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -111.91 113.47 25.8 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.05 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.877 ' CE2' HD13 ' A' ' 4' ' ' ILE . 69.0 m-85 -99.85 108.81 21.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.281 0.563 . . . . 0.0 111.634 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -107.24 110.63 22.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.257 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -84.44 136.83 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.69 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.94 HD12 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -113.0 164.37 8.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.064 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -140.62 75.43 1.51 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.992 0.425 . . . . 0.0 110.73 179.553 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 1.4 mm-40 155.26 132.81 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.828 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.608 ' HA ' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -57.02 -28.43 62.49 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.709 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.518 ' HA ' HD22 ' A' ' 44' ' ' LEU . 1.7 m-20 -51.5 -33.58 32.17 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -86.93 -33.07 19.81 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.356 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.722 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 0.9 OUTLIER -71.19 -50.82 39.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 CA-C-O 121.083 0.468 . . . . 0.0 111.601 -179.387 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -57.22 -36.21 70.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.58 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.47 ' H ' HD23 ' A' ' 44' ' ' LEU . 2.1 mm-40 -53.73 -25.42 18.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.973 0.416 . . . . 0.0 110.173 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.893 ' HB1' HD11 ' A' ' 60' ' ' LEU . . . -78.67 -46.33 19.39 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.387 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.93 -20.6 4.52 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.518 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.994 HD11 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -69.0 155.67 39.95 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.895 0.379 . . . . 0.0 111.068 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.86 -16.22 12.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.394 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.51 ' HB1' ' HA2' ' A' ' 64' ' ' GLY . . . -89.19 -179.14 5.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.791 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.605 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.6 mp -83.72 -63.95 0.24 Allowed Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 16.4 Cg_exo -67.45 51.58 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.392 2.061 . . . . 0.0 112.927 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.74 116.75 4.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.22 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.916 HD13 ' O ' ' A' ' 5' ' ' GLN . 3.0 mm? -106.05 107.19 18.06 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.625 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -98.28 123.53 42.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.038 0.447 . . . . 0.0 111.632 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.726 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.37 139.01 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.919 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.8 t70 46.68 27.81 0.71 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.355 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.87 37.55 50.68 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.233 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -150.09 101.84 3.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 111.304 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.893 HD11 ' HB1' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -46.0 133.37 8.87 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.015 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.79 -16.8 2.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.994 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.766 HD12 HD11 ' A' ' 17' ' ' LEU . 15.6 mt -154.34 111.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.586 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -145.64 150.91 37.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.021 0.439 . . . . 0.0 111.627 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.51 ' HA2' ' HB1' ' A' ' 50' ' ' ALA . . . 83.4 -5.18 78.73 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.544 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 45.2 ttp85 174.25 106.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.743 0.306 . . . . 0.0 110.423 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.731 HG21 ' O ' ' A' ' 13' ' ' ASN . 2.6 t -54.34 141.06 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.651 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.476 ' HB3' HD13 ' A' ' 62' ' ' ILE . . . -87.83 142.27 27.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.043 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.4 t -63.66 156.95 25.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.1 -30.4 25.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.284 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -42.2 96.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.837 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.414 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 2.0 tp10 -67.18 -41.87 85.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.995 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.7 mm -58.88 -53.19 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 tptm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.842 179.952 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.437 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.452 0.168 . . . . 0.0 111.179 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.812 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -82.64 112.84 19.88 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.08 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.6 104.9 2.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.128 0.489 . . . . 0.0 110.253 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 1.028 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 2.2 mp -108.57 127.57 64.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.39 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -110.29 125.6 53.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.016 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.824 HG23 ' HB2' ' A' ' 14' ' ' CYS . 3.3 mp -103.93 98.3 6.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.324 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.871 ' CZ ' ' HB2' ' A' ' 46' ' ' ALA . 93.8 m-85 -93.5 116.92 29.46 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 120.926 0.393 . . . . 0.0 111.2 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 118.37 -1.99 16.21 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.088 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 9' ' ' THR . 7.6 t -40.05 120.1 1.12 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 111.668 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.3 -54.43 0.54 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.338 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.1 m -101.98 -33.01 9.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.917 0.389 . . . . 0.0 110.73 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.441 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -86.32 152.3 22.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.015 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -75.95 8.99 2.66 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.7 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.824 ' HB2' HG23 ' A' ' 6' ' ' ILE . 3.4 p -54.19 -30.99 51.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.998 0.427 . . . . 0.0 111.273 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -36.59 42.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.601 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 10.4 tpp -63.77 -62.44 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.092 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.88 HD11 HD11 ' A' ' 72' ' ' ILE . 6.5 tp -65.66 -24.7 67.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.697 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -55.7 -50.42 70.35 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.849 0.357 . . . . 0.0 110.136 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -47.07 76.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.693 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -56.11 -44.62 79.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.16 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.48 -40.84 83.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.805 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.574 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -59.11 -46.81 87.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.659 0.266 . . . . 0.0 111.245 -179.604 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 10.8 pt-20 -71.95 -47.33 53.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.226 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.5 -50.74 70.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.674 HG21 ' HB2' ' A' ' 32' ' ' ALA . 5.9 p -53.62 -55.74 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.591 0.234 . . . . 0.0 110.763 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.552 ' N ' HG13 ' A' ' 25' ' ' VAL . 21.3 mtpp -66.99 -49.9 63.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.38 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 2.0 tt0 -52.86 -48.19 67.26 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.59 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 28' ' ' LEU . 4.6 mt -52.46 -21.26 3.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.86 0.362 . . . . 0.0 110.719 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.55 30.68 2.56 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.311 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.518 HG21 ' CE ' ' A' ' 2' ' ' MET . 0.4 OUTLIER -156.75 107.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.963 0.411 . . . . 0.0 111.075 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.437 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.7 OUTLIER -61.56 164.16 6.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.042 179.331 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.812 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -152.53 175.66 12.52 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -129.6 114.14 15.69 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 1.028 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 40.8 m-85 -102.13 108.94 20.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.553 0.692 . . . . 0.0 112.278 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -118.38 129.45 55.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.008 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.817 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -78.98 153.09 30.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.103 0.478 . . . . 0.0 111.127 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.817 HD13 ' C ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -128.14 76.56 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.463 -178.829 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.53 75.65 4.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.061 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 43' ' ' ILE . 6.5 pt-20 171.47 125.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.609 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.675 ' HA ' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -59.92 -30.48 69.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.58 0.229 . . . . 0.0 110.973 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.473 ' O ' HD23 ' A' ' 44' ' ' LEU . 4.5 m-20 -51.23 -33.75 29.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.424 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 28.3 mm100 -87.91 -34.57 18.1 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.984 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.691 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 2.5 pt -61.86 -51.37 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.056 0.455 . . . . 0.0 111.029 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.65 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -62.84 -41.34 99.3 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.022 179.56 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.65 ' H ' HD23 ' A' ' 44' ' ' LEU . 5.5 tt0 -58.98 -22.41 60.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.945 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.871 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -75.27 -39.76 59.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.729 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.734 ' HA3' HD21 ' A' ' 60' ' ' LEU . . . 123.4 -20.43 7.44 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.084 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.513 HD11 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -77.28 163.75 26.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.1 m -115.58 -23.35 8.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.902 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.866 ' HB3' ' CB ' ' A' ' 63' ' ' MET . . . -78.84 173.26 12.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.47 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.631 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -78.72 -64.75 0.35 Allowed Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.292 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.631 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 15.4 Cg_exo -67.17 59.14 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.406 2.071 . . . . 0.0 112.426 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.478 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -80.9 136.83 17.01 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.602 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.595 HD22 ' CD2' ' A' ' 17' ' ' LEU . 3.1 tp -127.1 98.2 5.22 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.716 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -97.38 122.72 40.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.087 0.47 . . . . 0.0 111.079 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.911 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -112.94 139.98 35.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.989 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 45.5 27.05 0.36 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.726 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.2 39.44 31.81 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.31 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -149.03 100.9 3.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 111.314 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.734 HD21 ' HA3' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -51.31 131.4 28.34 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.798 179.456 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.05 -16.79 4.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.015 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.594 HD13 ' H ' ' A' ' 67' ' ' ALA . 2.1 mt -152.69 131.8 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.987 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.866 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.96 135.19 22.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.392 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.487 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 92.85 -10.56 73.74 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.474 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 165.69 106.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.623 ' HB ' HD22 ' A' ' 17' ' ' LEU . 5.8 m -53.05 166.09 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.793 0.33 . . . . 0.0 111.186 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.594 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -82.5 -173.98 4.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.151 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.0 t -97.77 168.85 10.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -58.1 -54.4 47.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -56.24 -39.49 72.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.982 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -56.94 -43.0 81.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 17' ' ' LEU . 47.4 mm -57.9 -55.22 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.972 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.906 179.928 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.408 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.567 0.222 . . . . 0.0 111.291 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.789 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 3.1 ttt -82.68 114.04 20.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.917 0.389 . . . . 0.0 110.97 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.39 118.87 17.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.938 0.399 . . . . 0.0 110.576 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 1.031 HG13 HG12 ' A' ' 56' ' ' VAL . 2.7 mp -125.61 118.1 51.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.092 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.642 ' CB ' HD11 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -111.14 122.57 48.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.799 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.691 HG22 HD22 ' A' ' 54' ' ' LEU . 13.8 pt -104.63 110.72 31.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 CA-C-O 120.848 0.356 . . . . 0.0 111.08 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.755 ' CE1' HG13 ' A' ' 37' ' ' ILE . 93.7 m-85 -90.74 122.88 33.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.038 0.447 . . . . 0.0 111.431 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.446 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 127.83 -65.85 0.57 Allowed Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.182 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.3 m 66.07 -73.1 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.734 0.302 . . . . 0.0 111.64 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.75 -96.37 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.853 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.8 -23.55 7.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.654 0.264 . . . . 0.0 111.508 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.446 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -82.8 121.89 27.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.913 0.387 . . . . 0.0 111.357 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -76.77 21.34 0.21 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.859 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.508 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.7 p -52.83 -24.43 8.99 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.89 0.376 . . . . 0.0 111.363 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.63 -28.02 3.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.506 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -62.51 1.51 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.836 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.659 HD13 ' HB3' ' A' ' 67' ' ' ALA . 4.0 tp -68.38 -20.05 64.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.806 0.336 . . . . 0.0 110.508 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -59.12 -49.91 76.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.251 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -50.05 24.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.812 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.41 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 3.3 m-20 -56.28 -50.82 70.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.114 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.638 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -56.6 -41.87 77.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.574 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.484 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 3.0 mtm180 -60.73 -44.43 96.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.578 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.488 ' HG3' ' N ' ' A' ' 24' ' ' ALA . 14.8 pt-20 -73.33 -45.95 52.27 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.925 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.488 ' N ' ' HG3' ' A' ' 23' ' ' GLU . . . -64.01 -49.23 73.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.98 HG21 ' HB2' ' A' ' 32' ' ' ALA . 14.0 p -53.44 -55.52 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.458 0.171 . . . . 0.0 110.842 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.589 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.09 -43.03 79.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.549 0.214 . . . . 0.0 110.926 179.208 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 13.4 tt0 -58.57 -47.0 85.72 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.731 0.3 . . . . 0.0 110.971 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.44 -20.43 7.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.9 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.765 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.57 41.72 0.93 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.554 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -173.89 110.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.42 . . . . 0.0 111.288 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.408 ' O ' ' CA ' ' A' ' 1' ' ' MET . 38.6 t70 -61.38 163.63 6.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.375 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.98 ' HB2' HG21 ' A' ' 25' ' ' VAL . . . -145.39 174.8 10.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -131.85 109.02 9.81 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.99 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 18.7 m-85 -100.85 108.84 20.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.503 0.668 . . . . 0.0 112.018 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.419 ' O ' HD13 ' A' ' 37' ' ' ILE . 68.1 tt0 -119.77 131.17 55.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.94 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.499 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -80.3 141.94 35.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.006 0.431 . . . . 0.0 110.646 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.755 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -116.76 70.62 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.481 -179.335 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 75.39 1.91 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.18 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.54 ' O ' HG13 ' A' ' 43' ' ' ILE . 1.3 mt-10 174.85 119.78 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.699 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.497 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 17.0 ptp -53.05 -27.76 21.39 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.467 0.175 . . . . 0.0 110.927 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.446 ' O ' HD23 ' A' ' 44' ' ' LEU . 4.5 m-20 -51.55 -39.87 58.6 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.49 ' HB3' HG21 ' A' ' 37' ' ' ILE . 1.9 mm-40 -87.74 -35.53 17.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.531 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.058 HG22 HD21 ' A' ' 48' ' ' LEU . 11.7 mt -62.06 -54.91 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.154 0.502 . . . . 0.0 111.216 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -58.88 -32.33 69.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.209 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' N ' HD23 ' A' ' 44' ' ' LEU . 1.6 tt0 -59.38 -38.65 81.06 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 1.034 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -68.71 -40.67 79.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.59 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.46 26.0 55.53 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.116 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.058 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -47.19 -87.43 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.25 0.525 . . . . 0.0 111.061 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.495 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 1.5 m 147.67 -25.52 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.563 0.745 . . . . 0.0 109.4 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.62 ' HB3' ' N ' ' A' ' 64' ' ' GLY . . . -122.15 -166.79 1.45 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.838 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.557 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -83.7 -59.52 0.36 Allowed Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.575 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.565 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 11.9 Cg_exo -70.06 57.76 1.64 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.5 2.133 . . . . 0.0 112.524 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -81.44 139.45 20.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.699 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.919 HD11 HG23 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -137.03 110.77 8.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.723 0.297 . . . . 0.0 110.944 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -99.55 123.27 43.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.035 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.031 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -115.48 137.21 49.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.307 0.575 . . . . 0.0 111.836 -179.116 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 46.62 27.45 0.65 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.738 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.8 33.41 37.6 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.315 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -148.27 97.88 2.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.863 0.363 . . . . 0.0 111.081 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.034 HD21 ' HB1' ' A' ' 46' ' ' ALA . 2.0 mp -60.74 134.64 57.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.03 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 2.52 1.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.775 HG21 ' HA ' ' A' ' 66' ' ' VAL . 3.9 mp -137.78 127.6 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.632 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.46 ' CG ' ' HB2' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -147.34 126.79 13.18 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.62 ' N ' ' HB3' ' A' ' 50' ' ' ALA . . . 77.06 4.57 83.63 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.506 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 178.36 108.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.741 0.271 . . . . 0.0 110.504 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.919 HG23 HD11 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -59.54 139.12 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.659 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.659 ' HB3' HD13 ' A' ' 17' ' ' LEU . . . -63.93 168.2 5.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.811 0.339 . . . . 0.0 111.346 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.4 t -103.28 -174.77 2.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.148 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.867 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -60.39 -57.26 13.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.137 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -53.46 -33.96 56.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.143 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.515 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 0.4 OUTLIER -63.87 -37.71 88.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 69' ' ' LYS . 8.2 mt -64.98 -55.07 22.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.977 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.433 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 2.6 mtm . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.616 0.246 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.529 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -76.45 113.32 13.93 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.987 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.29 118.59 12.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.411 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.713 HG21 ' CD2' ' A' ' 34' ' ' PHE . 7.4 mt -129.18 119.59 49.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.078 0.466 . . . . 0.0 112.117 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -112.0 123.89 51.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.333 178.87 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.517 ' C ' HD11 ' A' ' 37' ' ' ILE . 2.9 mp -101.74 111.82 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.661 0.267 . . . . 0.0 111.32 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.937 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 98.2 m-85 -95.17 108.59 20.72 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.073 0.463 . . . . 0.0 111.525 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.678 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 140.47 -82.3 0.24 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.468 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.504 HG23 ' HD3' ' A' ' 36' ' ' LYS . 10.8 m 69.68 -68.71 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 0.0 111.397 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.15 -92.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.635 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 m -54.47 -28.73 46.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 111.129 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.678 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -90.62 117.21 29.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.149 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -76.24 15.71 0.54 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.9 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.5 p -57.53 -19.92 28.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.742 0.306 . . . . 0.0 111.419 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -47.39 -28.79 2.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.572 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -60.29 3.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.73 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.688 HD22 ' OD1' ' A' ' 20' ' ' ASN . 0.5 OUTLIER -59.45 -37.84 79.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.383 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -54.37 -36.06 63.47 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.883 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -71.48 -52.45 18.3 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.531 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.688 ' OD1' HD22 ' A' ' 17' ' ' LEU . 28.4 p30 -62.68 -33.01 74.21 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.782 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.471 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . -58.89 -44.47 91.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.081 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.574 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 13.1 mtp180 -58.32 -52.64 64.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.292 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.41 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 2.7 pp20? -68.06 -50.12 57.15 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.378 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.634 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -60.87 -51.53 68.93 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.878 HG11 ' HB3' ' A' ' 32' ' ' ALA . 3.9 p -53.66 -55.64 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.883 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.525 ' N ' HG13 ' A' ' 25' ' ' VAL . 7.1 mttt -66.41 -50.25 64.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.689 0.28 . . . . 0.0 111.441 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -57.68 -41.48 81.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.384 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.67 HD21 ' HG2' ' A' ' 73' ' ' LYS . 1.7 mm? -53.57 -19.15 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.914 0.387 . . . . 0.0 110.899 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.76 26.23 3.96 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.409 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -156.5 112.25 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.785 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.433 ' O ' ' CA ' ' A' ' 1' ' ' MET . 2.3 m-20 -61.67 159.89 12.56 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.878 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -152.03 153.72 34.57 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -114.91 114.97 26.18 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.218 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.713 ' CD2' HG21 ' A' ' 4' ' ' ILE . 18.1 m-85 -98.75 108.94 21.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.361 0.601 . . . . 0.0 111.431 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -110.76 110.73 21.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.1 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.504 ' HD3' HG23 ' A' ' 9' ' ' THR . 0.1 OUTLIER -82.37 137.54 34.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.877 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.78 HG13 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -102.9 176.58 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.666 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 4.3 pttt -160.1 75.49 0.6 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.883 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.506 ' O ' HG13 ' A' ' 43' ' ' ILE . 1.4 mt-10 158.14 128.53 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.564 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.533 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -56.58 -29.81 62.47 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 121.366 -0.134 . . . . 0.0 110.867 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.422 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -51.46 -36.37 43.92 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.604 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -86.67 -36.94 18.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.95 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.937 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 40.4 mt -58.95 -55.49 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.731 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -61.35 -36.74 81.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.631 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.603 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -55.79 -25.39 40.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.019 0.438 . . . . 0.0 110.335 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.711 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -70.93 -34.84 71.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.792 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.39 -17.87 9.57 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.745 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.81 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -83.2 169.35 15.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.936 0.398 . . . . 0.0 111.324 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.4 p -124.07 -30.1 3.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.91 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.423 ' HB1' ' HA2' ' A' ' 64' ' ' GLY . . . -68.2 -178.62 1.08 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.216 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.595 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.5 mp -86.39 -63.59 0.22 Allowed Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.658 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.892 ' O ' HD12 ' A' ' 62' ' ' ILE . 17.0 Cg_exo -66.27 63.92 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.033 1.822 . . . . 0.0 111.709 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -104.04 145.52 16.11 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.098 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.853 ' HB3' HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -150.33 129.8 13.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.0 0.429 . . . . 0.0 110.165 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.741 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -103.55 125.03 49.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.021 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.852 HG13 HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -112.62 135.45 52.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.194 0.521 . . . . 0.0 111.45 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 48.12 27.35 1.23 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.257 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.75 38.64 31.12 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.344 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -154.98 99.52 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.827 0.346 . . . . 0.0 111.148 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.741 ' CD1' ' HB2' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -43.79 126.93 4.91 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.057 179.72 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.95 -17.68 9.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.91 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.946 HD13 HG12 ' A' ' 66' ' ' VAL . 1.3 pt -137.33 140.42 42.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.068 0.461 . . . . 0.0 112.103 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.461 ' HG3' ' HB2' ' A' ' 48' ' ' LEU . 1.6 ttm -145.98 114.63 6.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.606 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.573 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 88.75 -14.26 60.58 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 119.688 -1.244 . . . . 0.0 112.866 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -178.44 114.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.648 0.261 . . . . 0.0 110.355 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.946 HG12 HD13 ' A' ' 62' ' ' ILE . 28.8 m -54.21 -173.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.12 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.94 143.21 30.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.92 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.2 m -65.9 162.43 19.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -47.59 84.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -67.14 -29.91 69.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.508 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -74.03 -42.0 60.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.067 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.563 HD13 HD21 ' A' ' 17' ' ' LEU . 1.1 tt -73.74 -48.47 39.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.346 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.67 ' HG2' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.384 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.4 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 6.2 mtp . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.652 0.263 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.529 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -73.26 115.46 12.64 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.68 179.588 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.09 106.65 2.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.98 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.925 HG12 HG12 ' A' ' 56' ' ' VAL . 3.5 mt -122.45 124.88 71.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.743 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.438 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 2.5 mm-40 -110.75 138.9 46.57 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.856 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.512 ' C ' HD11 ' A' ' 37' ' ' ILE . 22.4 mt -114.24 104.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.944 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 94.5 m-85 -92.78 109.27 20.7 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.986 0.422 . . . . 0.0 111.369 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.529 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 134.55 -44.16 1.21 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.679 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 36' ' ' LYS . 82.4 p 52.73 -85.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 8' ' ' GLY . . . -94.71 -52.4 1.82 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.709 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 m -53.1 -26.38 16.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 111.098 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.529 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -111.55 147.23 35.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.143 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -76.29 15.32 0.6 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.953 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.451 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.3 p -57.3 -19.88 24.82 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.707 0.289 . . . . 0.0 111.493 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.62 -32.08 7.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.403 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 mtt -63.31 -62.08 1.92 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.559 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.756 HD22 HD13 ' A' ' 54' ' ' LEU . 4.0 tt -63.92 -19.81 65.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.644 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -59.35 -54.13 50.32 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.56 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -71.9 -40.23 69.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.262 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -64.54 -41.69 96.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.195 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HB2' HD23 ' A' ' 17' ' ' LEU . . . -62.49 -45.89 90.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.814 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.511 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -57.39 -42.52 82.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.617 0.246 . . . . 0.0 111.238 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 14.9 pt-20 -73.88 -49.22 25.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.321 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.8 -50.4 69.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.863 HG11 ' HB3' ' A' ' 32' ' ' ALA . 4.2 p -53.57 -52.84 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.357 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.486 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.23 -41.83 80.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.724 0.297 . . . . 0.0 110.742 178.688 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.421 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 1.1 tp10 -62.07 -43.79 98.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.418 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.856 HD23 ' HA ' ' A' ' 25' ' ' VAL . 0.7 OUTLIER -52.0 -19.49 1.87 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.791 0.329 . . . . 0.0 111.027 179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.52 44.58 0.7 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.8 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.2 tt 175.88 121.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.264 0.554 . . . . 0.0 111.158 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.43 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 3.6 t0 -62.53 163.81 8.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.849 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.863 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -151.09 152.51 33.52 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.549 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -112.72 118.39 34.87 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.317 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.888 ' CE2' HD12 ' A' ' 4' ' ' ILE . 22.2 m-85 -101.78 109.39 21.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.339 0.59 . . . . 0.0 111.707 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -105.42 114.67 28.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.003 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.569 ' HB3' HG22 ' A' ' 9' ' ' THR . 11.7 mttt -82.11 139.17 34.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.089 0.471 . . . . 0.0 110.813 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.799 HG13 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -104.49 175.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.682 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 7.0 ptmt -160.36 75.32 0.57 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.017 0.437 . . . . 0.0 110.916 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.514 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER 157.63 127.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.405 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.559 ' HA ' HD12 ' A' ' 43' ' ' ILE . 17.7 mtp -54.77 -28.51 49.3 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.987 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.462 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -51.34 -37.82 49.9 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.778 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -86.95 -36.52 18.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.952 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.944 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 25.9 mt -60.01 -55.26 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.767 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -61.79 -34.5 76.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.719 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -60.64 -21.91 63.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 0.0 110.084 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.792 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -71.9 -34.76 69.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.615 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.22 -20.42 7.07 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.874 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.901 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -83.32 176.69 8.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 111.026 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.3 m -126.59 -34.94 2.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.223 0.535 . . . . 0.0 110.486 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.11 -173.11 0.35 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.707 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.582 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.4 mp -92.48 -63.55 0.16 Allowed Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.456 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.628 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 28.6 Cg_exo -60.78 63.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.218 1.945 . . . . 0.0 112.645 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -103.84 147.17 16.56 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.973 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.756 HD13 HD22 ' A' ' 17' ' ' LEU . 5.6 tt -144.58 118.26 9.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.827 0.346 . . . . 0.0 110.862 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.658 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -99.57 122.65 42.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.037 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.925 HG12 HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -116.49 136.35 53.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.511 -179.836 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 46.75 28.17 0.78 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.898 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.47 30.39 58.46 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.433 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -142.97 103.95 4.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.892 0.377 . . . . 0.0 110.949 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.776 HD21 ' O ' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -54.98 127.32 28.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.06 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.752 ' O ' HD12 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -129.68 -9.15 4.52 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.787 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.752 HD12 ' O ' ' A' ' 61' ' ' LYS . 1.6 mp -134.4 127.73 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.573 0.225 . . . . 0.0 110.408 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 19.2 tmm? -146.81 116.51 7.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.83 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.628 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 70.19 3.27 44.82 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.121 -1.038 . . . . 0.0 113.651 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.97 96.6 0.21 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.919 0.359 . . . . 0.0 110.504 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.632 HG22 ' CB ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -68.27 129.62 32.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.813 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.522 ' HB3' ' CD1' ' A' ' 17' ' ' LEU . . . -63.79 166.04 7.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 111.345 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.9 m -98.29 173.02 7.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -57.06 -47.34 81.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.79 -36.12 76.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.966 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.42 -38.18 90.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.038 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.634 HD11 HD11 ' A' ' 17' ' ' LEU . 45.0 mm -61.63 -55.17 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.185 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.255 -179.793 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 2.4 mpp? . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.432 0.158 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.868 ' O ' HD12 ' A' ' 4' ' ' ILE . 2.1 ttt -80.05 112.5 17.41 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.861 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -69.78 114.69 8.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.638 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 1.027 HG13 HG12 ' A' ' 56' ' ' VAL . 2.3 mp -123.24 120.7 61.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.674 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -110.83 128.28 55.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.321 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.476 HD13 ' HG3' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -113.39 109.0 26.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.683 0.277 . . . . 0.0 111.474 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.919 ' CD2' ' HA ' ' A' ' 43' ' ' ILE . 40.2 m-85 -93.69 119.2 32.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.952 0.406 . . . . 0.0 110.636 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.629 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . -173.71 -85.77 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.498 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.7 m 56.61 77.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 0.0 110.794 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.02 117.66 3.54 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.068 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 78.89 -56.97 0.44 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.69 0.281 . . . . 0.0 110.934 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.629 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -54.73 122.08 9.92 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.916 0.389 . . . . 0.0 111.053 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -76.38 20.87 0.2 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.171 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.458 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.3 p -52.15 -25.98 10.26 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.004 0.43 . . . . 0.0 111.181 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -31.93 72.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.643 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.5 mtp -63.52 -62.67 1.52 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.307 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.799 HD23 ' O ' ' A' ' 67' ' ' ALA . 1.1 tm? -67.79 -21.48 65.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.8 0.333 . . . . 0.0 110.629 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.476 ' HG3' HD13 ' A' ' 6' ' ' ILE . 7.4 tt0 -57.81 -48.3 80.14 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.229 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -71.54 -46.41 59.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.768 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -59.28 -36.27 75.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.149 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.512 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -66.86 -50.4 62.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.108 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.51 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 20.8 ttt180 -55.66 -37.83 68.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.519 0.199 . . . . 0.0 111.406 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 23.7 pt-20 -74.24 -48.31 29.57 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.111 -0.236 . . . . 0.0 111.229 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.77 -50.95 67.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.842 HG21 ' HB2' ' A' ' 32' ' ' ALA . 8.9 p -53.8 -55.42 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.717 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.572 ' N ' HG13 ' A' ' 25' ' ' VAL . 5.6 mtpm? -66.94 -49.49 65.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.108 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.454 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 45.6 tp10 -56.29 -43.77 79.19 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 110.762 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.7 tp -53.11 -22.12 5.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.557 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.65 44.73 0.75 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.442 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.0 tt 179.76 124.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.308 0.575 . . . . 0.0 111.505 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -67.66 165.22 17.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.472 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.86 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -146.12 178.26 8.35 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.78 106.39 8.66 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.861 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.935 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 66.0 m-85 -99.4 109.0 21.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.424 0.63 . . . . 0.0 111.947 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.36 136.48 54.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.556 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.813 ' C ' HD13 ' A' ' 37' ' ' ILE . 4.9 ttpm? -89.37 153.64 20.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.12 0.486 . . . . 0.0 111.112 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.813 HG13 ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -126.47 83.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.307 -179.073 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.55 75.35 9.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.138 0.494 . . . . 0.0 111.636 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.6 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER 173.07 118.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.789 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.506 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 6.2 ptt? -53.53 -35.31 60.56 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.945 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.445 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -51.42 -35.78 40.77 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.562 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -86.63 -35.2 19.52 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.98 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.935 HG22 HD21 ' A' ' 48' ' ' LEU . 23.3 mt -60.32 -55.9 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.553 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -64.02 -34.35 77.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.2 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -60.21 -21.26 61.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.406 . . . . 0.0 110.155 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.801 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -72.61 -38.38 67.81 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.704 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.35 -14.62 7.76 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.473 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.935 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.02 158.0 35.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.364 0.582 . . . . 0.0 111.119 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.5 t -107.42 -10.33 15.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.04 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.471 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -102.51 -175.28 2.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.304 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.588 ' N ' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -89.64 -54.49 0.31 Allowed Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.616 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.649 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 11.1 Cg_exo -70.29 52.16 1.14 Allowed 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 122.626 2.218 . . . . 0.0 112.414 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -71.95 156.9 52.78 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.253 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.552 HD12 HG23 ' A' ' 66' ' ' VAL . 0.7 OUTLIER -154.36 101.49 2.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.844 0.354 . . . . 0.0 110.779 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.523 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -100.3 126.09 46.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.809 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.027 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -118.05 140.62 40.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.141 0.496 . . . . 0.0 111.572 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 44.91 27.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.252 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.75 34.68 30.47 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.443 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.32 99.84 3.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.639 HD21 ' O ' ' A' ' 46' ' ' ALA . 0.6 OUTLIER -69.9 131.31 44.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.019 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -146.09 11.45 1.2 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.719 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' A' ' 66' ' ' VAL . 3.2 mp -133.31 123.92 48.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.557 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 2.4 mtm -146.62 123.51 11.32 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.649 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 70.81 7.33 61.59 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.825 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.55 100.43 0.06 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.868 0.366 . . . . 0.0 110.588 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.712 HG22 ' CB ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -56.34 141.84 12.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.96 -179.623 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.799 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -63.66 172.35 2.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.902 0.382 . . . . 0.0 111.152 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -109.43 157.81 18.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.7 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.09 -41.18 71.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.206 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -60.14 -40.77 90.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -64.6 -37.45 87.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.649 HD11 HD11 ' A' ' 17' ' ' LEU . 39.2 mm -59.72 -54.86 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.984 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.5 tttm . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.033 179.949 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.442 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 15.2 mmt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.463 0.173 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.955 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -81.31 112.36 18.54 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.836 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.42 ' CG ' ' HA ' ' A' ' 57' ' ' ASP . 17.3 ptpt -68.72 115.05 7.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.992 0.425 . . . . 0.0 110.583 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.931 HG13 HG12 ' A' ' 56' ' ' VAL . 1.5 mt -121.23 121.97 66.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.45 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.693 ' O ' HD22 ' A' ' 54' ' ' LEU . 2.5 mt-30 -110.54 134.87 51.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.604 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.538 HG22 ' SG ' ' A' ' 14' ' ' CYS . 1.6 mp -119.93 113.71 41.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.398 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.891 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 48.9 m-85 -104.27 116.59 32.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.578 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 138.42 -78.36 0.31 Allowed Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.493 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m 69.27 -66.41 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 111.209 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.58 -96.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.708 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.6 m -63.73 -46.14 86.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 0.0 111.187 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.578 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -54.44 118.99 4.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.285 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -76.34 14.91 0.66 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.989 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' HG22 ' A' ' 6' ' ' ILE . 2.3 p -57.36 -19.83 25.33 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.755 0.312 . . . . 0.0 111.511 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -35.5 34.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.194 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.4 mmt -63.84 -62.07 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.793 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.792 HD13 ' O ' ' A' ' 17' ' ' LEU . 3.3 tm? -60.25 -30.03 69.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.66 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -54.7 -47.75 73.31 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.149 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -65.04 -39.78 93.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.481 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.467 ' HB2' HD22 ' A' ' 17' ' ' LEU . 1.2 m-20 -60.14 -51.04 71.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.753 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.708 ' HB3' ' HE2' ' A' ' 34' ' ' PHE . . . -54.01 -37.54 64.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.201 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.63 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 2.6 mtm-85 -59.92 -50.4 73.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 111.207 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.472 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 10.8 pt-20 -71.67 -47.75 52.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.075 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.13 -51.93 67.01 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.703 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.5 p -53.24 -55.54 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.684 0.278 . . . . 0.0 110.737 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.541 ' N ' HG13 ' A' ' 25' ' ' VAL . 7.5 mttm -67.51 -49.59 62.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.305 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 4.9 tt0 -53.99 -48.03 70.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.355 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -51.0 -22.47 2.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 110.671 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.63 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.57 34.64 1.7 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.648 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 29' ' ' GLY . 7.8 pt -161.98 112.85 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.872 0.368 . . . . 0.0 111.574 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.442 ' O ' ' CA ' ' A' ' 1' ' ' MET . 4.2 t70 -61.51 164.24 6.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.955 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -150.44 178.14 9.33 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -128.75 114.67 16.88 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.127 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.715 ' HE1' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -102.06 109.34 21.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.209 0.528 . . . . 0.0 111.218 -178.738 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -116.09 115.72 26.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.035 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.454 ' HG2' HD13 ' A' ' 6' ' ' ILE . 20.6 mtpt -90.19 140.32 29.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.975 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.891 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -111.98 179.14 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.477 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' N ' HG12 ' A' ' 37' ' ' ILE . 2.7 tmtt? -157.25 75.56 0.81 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.138 0.494 . . . . 0.0 110.452 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.7 OUTLIER 160.43 128.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.064 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.5 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -52.49 -27.41 16.2 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 121.25 -0.18 . . . . 0.0 110.831 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.488 ' O ' HD23 ' A' ' 44' ' ' LEU . 2.6 m-20 -51.7 -39.27 58.04 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -86.54 -37.7 17.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.024 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.975 HG22 HD21 ' A' ' 48' ' ' LEU . 16.4 mt -58.98 -55.36 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.094 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.63 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -61.24 -40.97 96.02 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.702 179.699 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.63 ' H ' HD23 ' A' ' 44' ' ' LEU . 36.8 tt0 -53.02 -26.13 14.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.972 0.415 . . . . 0.0 110.372 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.737 ' O ' HD11 ' A' ' 60' ' ' LEU . . . -70.36 -36.57 74.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.753 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.3 -13.37 16.15 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.907 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.975 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.3 162.96 26.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.904 0.352 . . . . 0.0 111.124 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.63 -17.83 11.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 111.67 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -87.48 175.61 7.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.654 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.611 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.7 mt -79.64 -63.88 0.35 Allowed Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.962 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 11.0 Cg_exo -70.04 58.91 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.278 1.985 . . . . 0.0 111.919 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -79.01 147.75 30.83 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.475 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.693 HD22 ' O ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -139.85 104.01 4.78 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.99 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -98.47 124.72 43.35 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.975 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.931 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -120.68 139.51 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.182 0.515 . . . . 0.0 112.218 -179.267 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.42 ' HA ' ' CG ' ' A' ' 3' ' ' LYS . 1.8 m-20 43.03 28.3 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.687 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.29 32.95 37.05 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.714 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.48 98.56 2.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.921 0.391 . . . . 0.0 110.468 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.99 HD23 ' HB2' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -70.2 133.75 47.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.827 -179.6 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.729 ' O ' HD12 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -141.29 6.68 1.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.72 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.729 HD12 ' O ' ' A' ' 61' ' ' LYS . 1.2 mp -127.88 125.78 65.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.662 0.268 . . . . 0.0 110.94 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.466 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 7.8 mtt -146.51 116.16 7.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.652 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.563 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 88.98 -13.24 63.65 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.134 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 179.46 114.42 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' ' 14' ' ' CYS . 3.6 m -52.11 179.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.392 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.722 ' HB2' HD11 ' A' ' 62' ' ' ILE . . . -91.71 177.31 6.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.1 p -99.67 158.49 15.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.806 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -52.64 -39.32 61.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.118 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -67.37 -38.78 85.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.01 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.47 -32.29 72.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.048 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.2 mm -71.08 -52.63 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.078 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.833 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 32' ' ' ALA . 10.8 mtt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.316 0.103 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.816 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 33.2 mmm -83.5 111.12 18.78 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.163 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.05 100.8 2.58 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.154 0.502 . . . . 0.0 110.44 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.662 HG21 ' CD2' ' A' ' 34' ' ' PHE . 1.7 mp -99.86 114.64 38.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.998 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.415 ' CA ' HD11 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -101.64 119.67 39.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.466 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.587 ' N ' HD11 ' A' ' 37' ' ' ILE . 26.3 mm -104.59 101.63 12.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 120.697 0.284 . . . . 0.0 111.574 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.737 ' CE1' HG13 ' A' ' 37' ' ' ILE . 79.4 m-85 -90.6 103.23 15.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.046 0.451 . . . . 0.0 110.739 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.879 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 160.39 -84.55 0.12 Allowed Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.986 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 t 40.44 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 112.001 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.07 -62.3 0.29 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.138 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 t -87.79 -30.79 19.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.98 0.419 . . . . 0.0 110.545 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.879 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -111.17 134.89 52.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.811 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.22 15.09 0.61 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.502 ' SG ' HG22 ' A' ' 6' ' ' ILE . 3.7 p -57.85 -20.13 34.06 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.67 0.271 . . . . 0.0 111.524 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -20.99 36.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.534 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.2 mtt -63.31 -62.43 1.7 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.771 0.319 . . . . 0.0 110.858 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.709 HD13 ' C ' ' A' ' 67' ' ' ALA . 4.0 tp -64.08 -22.45 66.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.34 . . . . 0.0 110.581 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.407 ' CG ' HG13 ' A' ' 6' ' ' ILE . 47.1 tt0 -56.18 -54.17 48.36 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.354 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.55 -46.73 78.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.95 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -54.78 -51.32 66.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.401 ' CB ' ' HE2' ' A' ' 34' ' ' PHE . . . -56.62 -36.73 69.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.806 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.533 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 44.2 mtp180 -57.26 -48.0 79.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 111.117 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 8.0 tt0 -72.39 -50.26 27.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.183 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.546 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -60.05 -51.08 71.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.609 HG11 ' HB3' ' A' ' 32' ' ' ALA . 2.4 p -53.64 -55.41 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.59 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.5 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 6.0 mttm -67.22 -50.36 61.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.681 0.277 . . . . 0.0 111.113 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 8.8 tt0 -52.01 -45.63 64.64 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.381 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 24' ' ' ALA . 2.6 mm? -52.99 -19.33 2.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.882 0.372 . . . . 0.0 110.608 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.872 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 113.37 21.31 5.89 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.599 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.872 HD13 ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -147.76 110.88 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.861 0.363 . . . . 0.0 110.899 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -64.92 162.81 15.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.345 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.816 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -149.27 -169.33 3.35 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -142.42 113.96 7.88 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.048 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.662 ' CD2' HG21 ' A' ' 4' ' ' ILE . 11.8 m-85 -105.75 109.13 20.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.569 0.699 . . . . 0.0 112.249 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -127.65 134.87 49.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.456 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.837 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -79.24 155.71 28.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.022 0.439 . . . . 0.0 110.905 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.837 HD13 ' C ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -126.21 80.34 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.663 -178.739 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -82.21 75.56 9.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.087 0.47 . . . . 0.0 111.143 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.545 ' O ' HG13 ' A' ' 43' ' ' ILE . 3.0 mm-40 173.52 121.7 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.67 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.543 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 1.6 tpt -53.88 -31.58 50.32 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.843 -0.162 . . . . 0.0 111.059 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.435 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -51.57 -37.96 52.19 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.814 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.443 ' CB ' HG22 ' A' ' 37' ' ' ILE . 47.9 mm-40 -86.9 -34.21 19.48 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.192 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.844 HG22 HD21 ' A' ' 48' ' ' LEU . 47.5 mt -59.76 -55.21 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.348 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -63.16 -38.37 90.9 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.048 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.664 ' H ' HD23 ' A' ' 44' ' ' LEU . 2.7 tt0 -56.11 -24.3 39.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.535 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.735 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -74.22 -34.78 63.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.974 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.43 -6.43 31.86 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.198 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.852 HD13 HD21 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -79.53 160.44 26.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.161 0.48 . . . . 0.0 111.643 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.51 HG22 ' HE2' ' A' ' 63' ' ' MET . 10.0 t -112.06 -30.09 7.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.743 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.447 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -77.58 -177.78 4.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.229 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.582 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.3 mp -87.98 -62.47 0.22 Allowed Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.912 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 16.9 Cg_exo -67.38 59.66 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.264 1.976 . . . . 0.0 112.255 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.8 139.52 17.92 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.574 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.647 ' CD1' HG23 ' A' ' 4' ' ' ILE . 16.3 tp -129.58 103.13 6.69 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.61 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -100.79 125.33 47.27 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.321 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.515 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.92 139.38 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.078 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 47.06 26.94 0.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.587 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.61 34.79 48.47 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.325 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -144.7 103.31 3.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.386 . . . . 0.0 111.197 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.852 HD21 HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -46.31 133.32 9.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.234 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -118.63 -23.7 6.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.532 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.618 HD13 ' HA ' ' A' ' 66' ' ' VAL . 2.8 pp -154.62 154.91 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.638 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 2.0 mtp -146.78 129.13 15.81 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.432 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.472 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 94.41 -20.51 47.77 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.369 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -179.79 112.18 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.785 0.326 . . . . 0.0 110.364 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.618 ' HA ' HD13 ' A' ' 62' ' ' ILE . 15.8 m -51.29 161.54 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.278 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.709 ' C ' HD13 ' A' ' 17' ' ' LEU . . . -64.1 -166.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.954 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.9 t -118.94 171.17 8.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.962 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -55.57 -56.64 17.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.066 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -59.77 -30.54 68.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.822 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -61.89 -46.38 89.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.634 HD11 HD11 ' A' ' 17' ' ' LEU . 43.5 mm -59.71 -54.25 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.882 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 179.858 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.437 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 4.8 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.523 0.201 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.83 ' O ' HD12 ' A' ' 4' ' ' ILE . 5.2 mmt -77.56 113.51 15.46 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.986 0.422 . . . . 0.0 110.808 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.81 100.51 1.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.084 0.468 . . . . 0.0 110.52 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.93 HG13 HG12 ' A' ' 56' ' ' VAL . 2.8 mp -109.24 128.79 64.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.933 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.735 ' O ' HD13 ' A' ' 54' ' ' LEU . 13.3 mm-40 -110.89 142.45 42.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.878 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.513 HG12 HD11 ' A' ' 54' ' ' LEU . 19.9 mt -122.09 115.0 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.196 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.863 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 86.6 m-85 -106.1 110.82 23.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.302 0.572 . . . . 0.0 112.134 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 155.78 -78.61 0.19 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.235 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 p 49.22 33.3 4.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.791 0.329 . . . . 0.0 111.584 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.38 -71.81 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.39 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.08 27.96 8.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 110.737 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.416 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -124.57 130.05 51.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.083 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -76.36 20.46 0.21 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.756 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.62 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.6 p -55.45 -19.86 10.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.796 0.332 . . . . 0.0 111.557 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.03 -41.47 47.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.787 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.0 mtp -63.74 -62.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.764 0.316 . . . . 0.0 111.218 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.059 HD21 HD11 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -59.47 -31.85 69.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.825 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.414 ' HG3' ' CD1' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -58.42 -40.05 81.45 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -73.28 -46.93 46.95 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.653 HD21 HD22 ' A' ' 17' ' ' LEU . 34.4 p30 -69.17 -34.3 74.74 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.151 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.495 ' HB1' ' HE2' ' A' ' 34' ' ' PHE . . . -63.06 -47.33 83.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.467 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.491 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -57.69 -47.5 82.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.712 0.291 . . . . 0.0 111.294 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.442 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 22.2 tp10 -72.75 -50.45 24.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.42 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.58 -49.1 76.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.783 HG11 ' HB3' ' A' ' 32' ' ' ALA . 3.8 p -53.36 -54.66 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.451 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.495 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.52 -43.43 76.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.619 0.247 . . . . 0.0 110.702 178.724 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 35.3 tt0 -57.28 -43.92 83.56 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.154 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.551 ' HB3' HD11 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -52.7 -19.12 2.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.8 0.333 . . . . 0.0 110.769 179.599 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.91 25.91 4.03 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.671 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.552 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -159.64 117.0 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.943 0.401 . . . . 0.0 111.443 179.698 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.452 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -61.46 164.79 5.35 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.242 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.783 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -148.78 165.74 30.53 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -125.13 110.05 13.64 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.042 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.842 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 30.3 m-85 -97.08 108.94 21.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.253 0.549 . . . . 0.0 111.418 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -112.97 115.58 28.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.809 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 136.62 33.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.032 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.863 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -101.66 -178.24 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.291 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.486 ' N ' HG12 ' A' ' 37' ' ' ILE . 3.3 ptmt -158.5 75.37 0.72 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.168 0.509 . . . . 0.0 110.651 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 0.2 OUTLIER 155.37 131.68 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.886 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' MET . . . . . 0.523 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 3.1 mpp? -52.61 -25.11 9.72 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.2 -0.2 . . . . 0.0 111.136 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.483 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.6 t0 -51.51 -39.82 58.39 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -86.54 -36.4 18.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.037 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.843 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 17.4 mt -59.67 -54.96 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.324 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -62.88 -38.58 91.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.835 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.556 ' H ' HD23 ' A' ' 44' ' ' LEU . 1.6 tp10 -55.63 -24.61 34.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.99 0.424 . . . . 0.0 110.294 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.793 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -72.62 -35.31 67.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.771 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.639 ' HA3' HD21 ' A' ' 60' ' ' LEU . . . 113.0 -11.76 24.67 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.973 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.79 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -81.48 161.72 23.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.076 0.438 . . . . 0.0 111.36 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.6 p -114.32 -25.48 8.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.16 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.84 ' HB3' ' CB ' ' A' ' 63' ' ' MET . . . -77.88 171.92 14.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.579 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.617 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.5 mp -77.99 -64.12 0.42 Allowed Pre-proline 0 C--N 1.332 -0.188 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.486 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.617 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 14.8 Cg_exo -67.9 58.13 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.239 1.959 . . . . 0.0 112.365 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.626 ' O ' HD22 ' A' ' 54' ' ' LEU . . . -84.26 137.69 16.23 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.926 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.735 HD13 ' O ' ' A' ' 5' ' ' GLN . 2.6 mm? -129.06 103.83 7.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.744 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -97.82 121.7 40.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.026 0.441 . . . . 0.0 111.422 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.93 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -112.95 139.16 39.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.826 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 47.96 26.41 0.96 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.553 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.13 33.16 50.51 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.502 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.09 102.27 3.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.827 0.346 . . . . 0.0 111.158 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.744 HD12 ' HB2' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -48.78 126.56 12.25 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.856 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -115.6 -21.9 9.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.7 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.496 HD13 ' H ' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -154.95 133.65 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.284 -179.392 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.84 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.88 138.02 25.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.355 178.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.509 ' N ' ' HB1' ' A' ' 50' ' ' ALA . . . 81.54 -3.54 77.94 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.816 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 179.61 100.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.34 . . . . 0.0 110.482 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' A' ' 14' ' ' CYS . 0.3 OUTLIER -65.5 141.3 18.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.961 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.496 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -63.93 -173.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.23 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.02 179.96 4.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.825 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.7 -46.19 87.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.212 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.61 -41.76 95.43 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.018 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.406 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 67.5 mm-40 -56.85 -44.05 81.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.075 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.059 HD11 HD21 ' A' ' 17' ' ' LEU . 40.3 mm -64.86 -55.1 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.935 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . 1.441 ' CE ' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 1 N--CA 1.362 -4.861 0 N-CA-C 113.763 1.023 . . . . 2.66 113.763 . . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 2' ' ' MET . . . . . 1.381 ' CE ' ' CG ' ' A' ' 2' ' ' MET . 1.7 mtt -80.54 113.76 18.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.594 -0.442 . . . . 1.73 110.938 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -70.72 107.89 4.17 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.142 0.496 . . . . 2.22 110.406 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.72 HG13 HG12 ' A' ' 56' ' ' VAL . 3.6 mt -114.65 122.68 69.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.124 0.487 . . . . 0.66 111.535 -179.274 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.1 133.67 52.7 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 115.867 -0.606 . . . . 1.82 110.632 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.445 ' CD1' ' CB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -115.03 108.91 26.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.832 0.349 . . . . 1.44 111.188 -179.915 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 1.419 ' CZ ' ' CD1' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -96.09 113.91 25.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.281 0.562 . . . . 1.25 111.591 -179.383 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.734 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 154.79 -83.8 0.15 Allowed Glycine 1 C--O 1.114 -7.378 0 CA-C-N 115.833 -0.621 . . . . 0.71 113.678 -179.865 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . 1.284 ' O ' ' CA ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER 61.18 69.21 0.68 Allowed 'General case' 2 C--O 0.484 -39.237 1 CA-C-O 149.367 13.937 . . . . 1.97 111.866 179.918 . . . . . . . . 5 4 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 1.284 ' CA ' ' O ' ' A' ' 9' ' ' THR . . . 142.4 -71.18 0.41 Allowed Glycine 3 C--N 0.807 -28.808 3 O-C-N 50.769 -44.957 . . . . 1.42 115.301 179.83 . . . . . . . . 4 3 . 1 . 021 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.234 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 1.1 m -90.58 -20.82 22.17 Favored 'General case' 2 C--N 1.078 -11.201 2 O-C-N 108.323 -8.751 . . . . 1.88 111.781 -179.946 . . . . . . . . 4 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.734 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -89.86 129.9 36.17 Favored 'General case' 1 C--N 1.184 -6.624 1 O-C-N 115.274 -4.641 . . . . 0.49 111.247 179.969 . . . . . . . . 4 3 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 1.388 ' OD1' ' CB ' ' A' ' 13' ' ' ASN . 68.6 m-20 -76.36 17.9 0.34 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.36 0.504 . . . . 1.66 112.36 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.56 ' HB2' HG22 ' A' ' 6' ' ' ILE . 2.0 p -54.7 -23.21 16.56 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.286 0.565 . . . . 0.7 111.936 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.478 ' HG2' ' N ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -52.85 -33.89 51.69 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.811 -0.631 . . . . 1.56 111.799 -179.85 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 16' ' ' MET . . . . . 1.586 ' CG ' ' CE ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -64.38 -59.14 4.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.161 0.505 . . . . 2.28 110.889 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.493 ' CD2' ' CB ' ' A' ' 17' ' ' LEU . 2.7 tm? -64.57 -25.8 68.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.187 0.517 . . . . 1.75 110.907 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.515 ' HG3' HD13 ' A' ' 6' ' ' ILE . 3.5 tt0 -57.56 -48.95 77.94 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.981 -0.554 . . . . 1.78 110.623 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 1.471 ' CD ' ' NZ ' ' A' ' 19' ' ' LYS . 25.6 tttt -69.05 -47.81 64.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.113 0.482 . . . . 2.32 111.316 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -43.81 92.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.086 -0.506 . . . . 1.92 111.176 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.407 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -58.94 -42.71 90.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.123 -0.489 . . . . 0.36 111.714 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 1.126 ' NE ' ' CG ' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -57.68 -45.62 85.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.816 0.341 . . . . 2.7 111.467 -179.638 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 0.6 OUTLIER -71.9 -49.33 38.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.407 -0.36 . . . . 2.18 111.296 -179.636 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.563 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -62.4 -50.43 71.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.877 0.325 . . . . 0.48 111.877 -179.515 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 32' ' ' ALA . 5.4 p -53.72 -54.86 16.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.643 0.258 . . . . 0.52 110.743 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 1.359 ' CE ' ' CG ' ' A' ' 26' ' ' LYS . 21.7 mttm -67.55 -47.23 70.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.734 0.302 . . . . 2.35 110.995 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 86.1 tt0 -57.12 -43.88 82.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 1.95 111.35 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -52.39 -20.94 3.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.997 0.427 . . . . 2.0 110.903 179.551 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.92 36.22 1.41 Allowed Glycine 0 C--O 1.22 -0.738 0 C-N-CA 120.798 -0.715 . . . . 0.65 112.474 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 1.549 ' CB ' ' CD1' ' A' ' 30' ' ' ILE . 17.7 pt -170.37 117.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.117 0.484 . . . . 1.76 111.434 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 1.423 ' OD1' ' CB ' ' A' ' 31' ' ' ASP . 0.4 OUTLIER -62.4 163.61 8.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.937 -0.574 . . . . 1.62 110.228 179.379 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.747 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -149.43 164.7 34.26 Favored 'General case' 0 C--O 1.188 -2.167 0 N-CA-C 109.584 -0.525 . . . . 0.6 109.584 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -122.0 113.15 19.17 Favored 'General case' 0 C--N 1.281 -2.398 0 O-C-N 121.008 -1.057 . . . . 2.18 110.17 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 1.431 ' CZ ' ' CD1' ' A' ' 34' ' ' PHE . 22.3 m-85 -98.93 109.4 22.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.398 0.618 . . . . 1.28 111.824 -178.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 1.473 ' CD ' ' CB ' ' A' ' 35' ' ' GLU . 1.8 mt-10 -115.64 122.9 46.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.169 -0.923 . . . . 2.3 110.278 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 1.412 ' CD ' ' NZ ' ' A' ' 36' ' ' LYS . 14.7 mttt -84.42 144.95 28.44 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.437 -0.347 . . . . 2.26 110.507 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 1.036 HD13 ' N ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -115.01 136.57 51.27 Favored 'Isoleucine or valine' 1 C--O 0.985 -12.837 0 CA-C-O 123.872 1.796 . . . . 1.81 110.205 -179.568 . . . . . . . . 4 4 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.714 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 53.1 pttt -124.71 75.3 1.41 Allowed 'General case' 1 C--N 1.132 -8.889 2 O-C-N 109.725 -8.11 . . . . 3.21 110.94 -179.98 . . . . . . . . 4 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER 163.4 128.29 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.339 -0.846 . . . . 2.44 110.7 179.839 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' MET . . . . . 1.347 ' CE ' ' CG ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -56.21 -26.52 51.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.573 0.225 . . . . 2.59 111.065 -179.871 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 1.165 ' OD2' ' CB ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -51.5 -38.7 55.28 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.899 -0.778 . . . . 1.7 108.899 178.645 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 1.079 ' CD ' ' CB ' ' A' ' 42' ' ' GLN . 6.3 mm-40 -87.02 -34.95 19.04 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.093 -0.958 . . . . 1.98 110.302 178.316 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.729 HG13 ' HA ' ' A' ' 40' ' ' MET . 5.2 mt -62.61 -52.76 55.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-O 121.108 0.48 . . . . 1.11 111.375 -179.567 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.523 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -63.38 -36.85 85.08 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.97 -0.559 . . . . 0.7 110.866 179.877 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 1.088 ' CD ' ' CB ' ' A' ' 45' ' ' GLU . 24.5 tt0 -57.14 -25.61 59.16 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.348 -0.387 . . . . 2.01 110.17 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.553 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -74.72 -38.07 62.39 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 115.951 -0.568 . . . . 0.89 109.75 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.43 -3.48 28.0 Favored Glycine 0 C--O 1.195 -2.293 0 C-N-CA 120.773 -0.727 . . . . 0.78 114.867 179.65 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.728 ' H ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -74.03 160.19 31.63 Favored 'General case' 1 C--O 0.896 -17.525 0 CA-C-O 121.69 0.757 . . . . 1.17 112.073 179.96 . . . . . . . . 4 4 . 1 . 021 nuclear build core ' A' A ' 49' ' ' THR . . . . . 1.305 ' CG2' ' CA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -115.55 -17.56 11.14 Favored 'General case' 2 C--N 1.111 -9.768 3 O-C-N 109.08 -8.513 . . . . 1.82 112.481 179.761 . . . . . . . . 5 4 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -97.01 -172.71 2.51 Favored 'General case' 1 C--N 1.208 -5.549 0 O-C-N 117.698 -3.126 . . . . 0.56 110.348 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 1.33 ' CD1' ' CB ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -89.01 -63.65 0.2 Allowed Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 112.13 0.419 . . . . 1.47 112.13 -179.572 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 6.3 Cg_exo -67.78 59.68 0.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.239 1.959 . . . . 0.59 112.829 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -86.9 144.44 19.47 Favored Glycine 0 C--O 1.21 -1.355 0 C-N-CA 120.642 -0.79 . . . . 0.46 112.862 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.483 ' CD1' ' CB ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -136.73 109.22 7.4 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 122.52 -0.4 . . . . 1.72 110.708 179.889 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -101.02 125.15 47.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.909 0.385 . . . . 0.42 111.269 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.72 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -116.82 139.12 45.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.073 -0.512 . . . . 0.51 111.306 -179.91 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 1.3 ' OD1' ' CB ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER 47.11 27.06 0.73 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.605 -0.725 . . . . 1.59 110.715 -179.575 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.58 32.89 44.86 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.864 -0.684 . . . . 0.62 112.527 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.267 ' CD ' ' CB ' ' A' ' 59' ' ' GLU . 3.9 mt-10 -145.75 102.27 3.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.856 0.36 . . . . 2.21 111.041 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.481 HD21 ' O ' ' A' ' 46' ' ' ALA . 2.1 mm? -58.92 131.95 52.53 Favored 'General case' 0 CA--C 1.482 -1.668 0 CA-C-N 116.094 -0.503 . . . . 1.82 111.32 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.47 -8.71 3.69 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 114.678 1.362 . . . . 2.47 114.678 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.518 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -142.08 130.78 22.18 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.908 0 C-N-CA 120.253 -0.579 . . . . 2.17 111.795 -179.881 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 63' ' ' MET . . . . . 1.251 ' CG ' ' SD ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -146.62 131.04 17.63 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 112.742 0.645 . . . . 2.28 112.742 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.601 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 77.46 -2.93 60.93 Favored Glycine 0 C--O 1.192 -2.512 0 C-N-CA 120.297 -0.954 . . . . 0.65 113.676 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 1.538 ' CD ' ' CB ' ' A' ' 65' ' ' ARG . 1.7 ttp180 -177.21 101.9 0.05 Allowed 'General case' 0 C--O 1.2 -1.549 0 CA-C-N 117.48 0.64 . . . . 3.53 112.7 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 1.18 ' CG2' ' CA ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -57.95 148.58 5.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 116.579 -0.282 . . . . 1.28 111.476 -179.666 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.54 167.44 21.89 Favored 'General case' 0 C--O 1.19 -2.047 0 CA-C-O 120.816 0.341 . . . . 0.73 111.511 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' SER . . . . . 1.132 ' OG ' ' HB3' ' A' ' 68' ' ' SER . 0.5 OUTLIER -97.21 170.72 8.91 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 122.085 -0.384 . . . . 1.61 111.297 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 1.468 ' CB ' ' CD ' ' A' ' 69' ' ' LYS . 2.7 pttt -57.54 -46.5 83.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.405 -0.361 . . . . 2.8 111.125 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -64.7 -34.95 79.52 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.88 0.371 . . . . 2.42 111.135 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -45.05 81.31 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.2 -0.454 . . . . 1.95 110.921 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -50.54 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 116.098 -0.501 . . . . 1.64 111.086 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 1.462 ' CE ' ' CG ' ' A' ' 73' ' ' LYS . 17.6 tttt . . . . . 0 N--CA 1.438 -1.046 0 CA-C-N 116.295 -0.411 . . . . 2.32 110.836 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.452 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 111.395 0.146 . . . . 0.0 111.395 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.712 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -80.55 116.23 20.48 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.865 0.364 . . . . 0.0 111.317 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -79.85 101.08 8.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.981 0.419 . . . . 0.0 109.95 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.884 HD12 ' CZ ' ' A' ' 34' ' ' PHE . 2.0 mt -109.95 124.92 67.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.579 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.407 ' O ' HD22 ' A' ' 54' ' ' LEU . 3.2 mp0 -110.47 133.74 53.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.146 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.433 ' CG2' ' CB ' ' A' ' 14' ' ' CYS . 42.0 mt -114.45 109.64 29.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.109 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.914 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 66.5 m-85 -95.78 125.3 40.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.072 0.463 . . . . 0.0 111.556 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.46 -70.42 0.42 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.287 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.47 -70.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.821 0.343 . . . . 0.0 111.469 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.36 -97.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.643 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.44 -29.44 61.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.76 0.314 . . . . 0.0 111.134 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.468 ' HB1' ' SG ' ' A' ' 14' ' ' CYS . . . -68.65 120.49 14.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.996 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -76.24 21.25 0.18 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.486 ' HA ' HG21 ' A' ' 66' ' ' VAL . 6.1 m -55.21 -21.61 14.51 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.694 0.283 . . . . 0.0 111.374 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.62 -39.48 11.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 mtp -63.68 -62.69 1.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.642 0.258 . . . . 0.0 111.257 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.04 HD11 HD11 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -67.22 -19.54 65.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.781 0.324 . . . . 0.0 110.724 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -60.29 -50.36 73.95 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.345 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -70.28 -45.87 65.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.713 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -60.76 -38.6 85.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.008 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -63.47 -45.91 88.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.296 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 5.6 mtt-85 -57.71 -53.15 61.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -65.58 -50.19 66.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.523 -179.336 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' O ' HD12 ' A' ' 28' ' ' LEU . . . -63.12 -51.91 64.66 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.924 HG11 ' HB3' ' A' ' 32' ' ' ALA . 4.4 p -53.77 -55.09 15.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.446 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.516 ' N ' HG13 ' A' ' 25' ' ' VAL . 36.6 mtpt -65.34 -49.56 68.93 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.676 0.274 . . . . 0.0 111.2 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 46.8 tp10 -60.01 -39.28 85.27 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.721 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.712 HD13 HD23 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -54.02 -15.93 1.68 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.751 0.31 . . . . 0.0 111.175 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.646 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 114.05 26.16 3.9 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.546 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.718 ' N ' HD13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -163.26 109.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 0.0 110.628 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.489 ' HA ' ' HG2' ' A' ' 26' ' ' LYS . 2.8 m-20 -60.71 156.49 16.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.924 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -145.29 140.06 27.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -103.94 117.12 33.56 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.044 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.884 ' CZ ' HD12 ' A' ' 4' ' ' ILE . 15.7 m-85 -98.48 109.3 22.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.331 0.586 . . . . 0.0 112.068 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.51 126.51 55.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.287 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.838 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -79.85 150.65 30.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.148 0.499 . . . . 0.0 111.068 -179.163 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.847 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -124.2 80.73 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.408 -179.002 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.04 75.03 6.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.132 0.491 . . . . 0.0 111.378 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.589 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.4 OUTLIER 173.95 119.02 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.704 179.385 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.516 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 1.2 ptp -54.02 -33.11 56.32 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.45 0.167 . . . . 0.0 111.089 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.26 -37.38 46.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 34.9 mm-40 -86.74 -33.86 19.84 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.185 178.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.027 HG22 HD21 ' A' ' 48' ' ' LEU . 26.8 mt -61.41 -55.95 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.061 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.412 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -63.06 -36.65 84.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.826 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' H ' HD23 ' A' ' 44' ' ' LEU . 3.6 tt0 -56.85 -24.56 52.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.993 0.425 . . . . 0.0 110.319 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.776 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -72.14 -40.08 68.31 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.574 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.512 ' HA3' HD11 ' A' ' 60' ' ' LEU . . . 119.53 -10.75 11.4 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.506 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.027 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -71.87 152.07 42.89 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 117.444 0.622 . . . . 0.0 111.017 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 t -104.35 -9.41 18.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.931 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' A' ' 63' ' ' MET . . . -104.06 -177.93 3.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.422 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -81.67 -64.09 0.28 Allowed Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.418 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.445 ' HG2' ' CA ' ' A' ' 64' ' ' GLY . 56.2 Cg_endo -70.29 56.48 1.62 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.371 2.047 . . . . 0.0 113.41 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -73.06 143.48 33.35 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.903 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.703 HD11 ' CG2' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -134.27 102.7 5.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.565 0.221 . . . . 0.0 110.432 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -104.95 124.47 49.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 111.581 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.873 HG12 HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.27 138.4 44.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.39 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 46.99 25.39 0.47 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.296 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.98 22.64 44.67 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.128 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 59' ' ' GLU . 4.6 pt-20 -137.28 108.19 6.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.216 0.531 . . . . 0.0 110.852 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.647 HD21 ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -85.4 131.32 34.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.887 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.84 2.49 2.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.546 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.597 HG21 ' HA ' ' A' ' 66' ' ' VAL . 9.7 mt -128.24 122.39 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.664 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.565 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 2.4 mpp? -145.74 130.81 18.33 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.474 ' N ' ' CB ' ' A' ' 50' ' ' ALA . . . 73.6 6.79 72.34 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.176 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.414 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 1.9 ttp85 178.81 101.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.761 0.315 . . . . 0.0 110.616 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.597 ' HA ' HG21 ' A' ' 62' ' ' ILE . 3.3 p -57.83 148.35 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.644 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.675 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -65.37 173.74 2.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.935 0.398 . . . . 0.0 111.434 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.42 ' CA ' HD23 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -110.11 158.97 17.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.607 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -48.48 65.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.319 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.14 -34.32 77.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.922 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.54 -42.57 91.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.04 HD11 HD11 ' A' ' 17' ' ' LEU . 36.5 mm -56.23 -55.1 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.986 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -58.63 -37.23 75.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -31.76 62.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.22 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -76.05 -29.78 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.989 0.423 . . . . 0.0 110.697 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.712 HD23 HD13 ' A' ' 28' ' ' LEU . 1.4 tp -108.01 -74.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.014 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.906 -179.934 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.445 ' H1 ' ' HG3' ' A' ' 1' ' ' MET . 3.4 mtt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.674 0.273 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.631 ' SD ' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -77.23 113.56 15.11 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.891 0.377 . . . . 0.0 111.095 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.55 100.38 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.922 HD12 ' CE2' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -106.51 125.51 62.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.026 -179.085 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.816 ' O ' HD22 ' A' ' 54' ' ' LEU . 3.3 mm-40 -107.11 126.23 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.169 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.815 ' N ' HD11 ' A' ' 37' ' ' ILE . 2.9 mp -107.86 102.65 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.777 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 80.6 m-85 -88.94 124.26 34.07 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.924 0.392 . . . . 0.0 110.755 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.583 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 143.1 -85.36 0.19 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.299 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t 40.29 86.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.879 0.371 . . . . 0.0 111.778 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.42 -61.92 0.56 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.517 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.1 m -118.62 -2.57 10.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.526 0.203 . . . . 0.0 111.497 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.583 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -100.77 135.08 42.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.82 0.343 . . . . 0.0 111.154 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.69 ' O ' HG21 ' A' ' 66' ' ' VAL . 47.9 m-20 -76.55 20.1 0.24 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.023 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.564 ' HB2' HG23 ' A' ' 6' ' ' ILE . 3.8 p -57.15 -19.85 22.73 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.675 0.274 . . . . 0.0 111.509 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.08 -38.49 38.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.653 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.579 ' CB ' HG11 ' A' ' 66' ' ' VAL . 1.1 mpp? -64.65 -52.64 56.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.799 ' HB2' HG13 ' A' ' 66' ' ' VAL . 30.9 tp -66.78 -28.75 68.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.067 0.46 . . . . 0.0 110.143 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.01 -47.47 80.78 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.386 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -46.17 61.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.867 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -56.6 -53.02 62.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.044 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.416 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -54.43 -43.06 71.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.892 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 5.5 mtt180 -57.61 -43.71 84.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.665 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 61.6 tt0 -74.34 -50.75 17.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.368 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.28 -49.84 72.45 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.822 HG11 ' HB3' ' A' ' 32' ' ' ALA . 3.2 p -54.38 -53.9 26.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.613 0.244 . . . . 0.0 110.44 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.494 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 51.7 mttt -67.01 -50.09 63.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.784 0.326 . . . . 0.0 110.849 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 19.4 tt0 -57.82 -39.78 78.45 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.077 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.6 tp -52.14 -21.14 3.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.781 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.753 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.76 32.55 2.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.618 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.753 HG23 ' O ' ' A' ' 29' ' ' GLY . 2.2 pt -169.09 121.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.862 0.363 . . . . 0.0 111.222 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.434 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -61.36 164.0 6.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.167 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.822 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -150.62 140.07 21.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -100.72 111.17 23.35 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.386 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.922 ' CE2' HD12 ' A' ' 4' ' ' ILE . 68.9 m-85 -94.88 109.18 21.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.505 0.669 . . . . 0.0 111.966 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.31 128.36 54.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.374 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.708 ' C ' HD13 ' A' ' 37' ' ' ILE . 5.2 mttt -78.69 149.95 32.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.113 0.483 . . . . 0.0 110.806 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.855 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -115.7 76.62 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.687 -178.333 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.3 75.16 2.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.993 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.504 ' O ' HG13 ' A' ' 43' ' ' ILE . 2.6 mm-40 167.9 124.12 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.669 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.674 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -59.24 -20.31 53.05 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.213 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.46 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -51.46 -43.33 62.07 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.42 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -87.41 -34.8 18.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.475 178.296 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.957 HG22 HD21 ' A' ' 48' ' ' LEU . 16.9 mt -61.36 -54.94 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.345 0.593 . . . . 0.0 111.036 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -60.56 -35.84 77.04 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.612 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.442 ' H ' HD23 ' A' ' 44' ' ' LEU . 24.8 tt0 -56.35 -34.05 66.23 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.158 0.504 . . . . 0.0 109.818 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.716 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -75.55 -42.67 51.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.875 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.99 30.61 31.12 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.561 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.957 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -51.61 -41.75 61.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.443 0.621 . . . . 0.0 110.919 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 48' ' ' LEU . 5.6 p 90.64 7.23 0.08 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.241 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.751 ' HB3' ' HG2' ' A' ' 63' ' ' MET . . . -153.65 -157.27 0.76 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.948 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.594 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.4 mp -99.19 -61.15 0.11 Allowed Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 25.9 Cg_exo -62.94 52.85 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.843 2.362 . . . . 0.0 113.879 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.544 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -81.68 137.37 17.31 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.285 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.816 HD22 ' O ' ' A' ' 5' ' ' GLN . 2.5 tm? -136.41 101.51 4.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.673 0.273 . . . . 0.0 110.499 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -104.45 133.53 49.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.81 0.338 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.663 HG13 HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.59 141.45 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.183 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 50.83 23.18 1.33 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.595 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.43 31.02 23.15 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.257 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.7 106.59 5.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.118 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.816 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -83.18 130.08 35.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.016 179.23 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -138.23 1.23 2.2 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.527 HD11 HD23 ' A' ' 17' ' ' LEU . 1.6 pp -150.25 124.21 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.051 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.751 ' HG2' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.5 150.5 36.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.534 179.319 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.554 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 56.42 16.74 16.43 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.992 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -165.66 94.65 0.6 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.863 0.363 . . . . 0.0 110.531 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 17' ' ' LEU . 2.0 t -60.48 120.05 5.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.736 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.11 126.77 28.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.33 169.74 1.56 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.464 ' HA ' HD12 ' A' ' 72' ' ' ILE . 5.2 mtpt -60.52 -58.29 9.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.766 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -60.79 -33.16 72.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.24 -37.75 75.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 69' ' ' LYS . 8.5 mt -69.24 -52.68 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.919 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -31.95 73.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.972 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.91 -30.13 62.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.822 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.0 mt -75.79 -37.84 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.143 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.14 8.52 43.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.309 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.989 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.659 ' H3 ' ' C ' ' A' ' 31' ' ' ASP . 2.1 mtt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.624 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 1.1 mpp? -86.67 119.29 26.75 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.334 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.94 111.46 18.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.621 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.972 HG13 HG12 ' A' ' 56' ' ' VAL . 3.7 mp -116.91 123.1 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.212 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -110.59 127.88 55.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.598 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.795 ' N ' HD11 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -110.37 113.01 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.869 0.366 . . . . 0.0 110.924 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.734 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 90.6 m-85 -91.91 111.91 23.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.22 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.648 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 136.66 -96.9 0.25 Allowed Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.195 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.96 -65.23 0.3 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.827 0.346 . . . . 0.0 111.463 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.68 -57.51 9.47 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.822 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.0 p -111.92 -35.46 5.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 110.982 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.648 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -65.63 124.73 23.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.071 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -76.5 16.67 0.46 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 p -59.24 -19.5 46.21 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.784 0.325 . . . . 0.0 111.337 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -24.98 5.25 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.872 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.5 mtp -63.26 -62.19 1.86 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.791 0.329 . . . . 0.0 110.475 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.757 HD22 HD13 ' A' ' 54' ' ' LEU . 5.6 tt -65.67 -20.37 66.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.512 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.598 ' HG3' HD13 ' A' ' 6' ' ' ILE . 5.8 tt0 -57.61 -51.45 69.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.129 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -69.15 -51.32 39.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.609 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -54.7 -40.34 69.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.594 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.54 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -59.72 -45.93 90.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.442 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.53 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -54.88 -38.48 67.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.718 0.294 . . . . 0.0 111.273 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 35.1 tp10 -73.4 -50.41 21.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.019 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.63 79.59 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.044 HG21 ' HB2' ' A' ' 32' ' ' ALA . 14.0 p -53.62 -56.05 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.626 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.59 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.16 -40.34 82.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.692 0.282 . . . . 0.0 110.741 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 6.0 tp10 -59.27 -47.44 85.38 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.958 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.415 HD21 ' HG3' ' A' ' 73' ' ' LYS . 1.7 mm? -54.06 -20.22 6.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.773 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.76 42.79 0.84 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.43 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.773 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -175.35 113.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.375 . . . . 0.0 111.054 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.659 ' C ' ' H3 ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -61.57 164.08 6.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.257 179.577 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.044 ' HB2' HG21 ' A' ' 25' ' ' VAL . . . -146.0 165.91 27.62 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -126.48 109.78 12.56 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.928 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 15.0 m-85 -98.71 108.67 21.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.38 0.609 . . . . 0.0 112.071 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -117.39 133.32 56.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.56 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.834 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -79.69 151.81 30.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.211 0.529 . . . . 0.0 111.396 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.921 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -127.77 78.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.616 -178.531 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 37.4 tptt -82.02 75.12 8.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.968 0.413 . . . . 0.0 111.191 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.524 ' O ' HG13 ' A' ' 43' ' ' ILE . 22.7 tp10 177.03 120.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.79 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.511 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 46.5 ttp -53.11 -32.21 46.14 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 121.268 -0.173 . . . . 0.0 110.942 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.449 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -51.55 -37.56 50.13 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.585 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.69 -34.22 19.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.113 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.851 HG22 HD21 ' A' ' 48' ' ' LEU . 29.0 mt -60.45 -55.21 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.055 0 CA-C-O 121.198 0.523 . . . . 0.0 111.29 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -63.46 -39.13 93.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.855 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.682 ' H ' HD23 ' A' ' 44' ' ' LEU . 6.0 tt0 -54.44 -25.26 23.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.056 0.455 . . . . 0.0 110.347 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.684 ' O ' HD21 ' A' ' 60' ' ' LEU . . . -71.6 -39.24 70.63 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.714 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.0 -8.22 25.33 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.644 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.851 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -80.31 167.1 20.68 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.693 0.282 . . . . 0.0 110.947 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.88 14.29 5.82 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HB1' ' N ' ' A' ' 64' ' ' GLY . . . -114.68 172.57 6.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.623 0.249 . . . . 0.0 110.75 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.524 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 2.9 mt -71.15 -72.32 0.23 Allowed Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 51' ' ' LEU . 74.2 Cg_endo -72.23 60.23 3.18 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.195 1.93 . . . . 0.0 112.425 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -79.54 147.46 29.75 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.963 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.757 HD13 HD22 ' A' ' 17' ' ' LEU . 7.4 tt -144.95 110.27 5.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.885 0.374 . . . . 0.0 111.075 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -98.6 126.29 44.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.563 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.972 HG12 HG13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -120.78 139.75 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.283 0.563 . . . . 0.0 111.936 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 47.24 26.83 0.75 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.183 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.03 27.32 53.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.524 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -148.26 98.05 2.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.967 0.413 . . . . 0.0 110.435 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.684 HD21 ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -77.29 141.76 39.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.203 0.525 . . . . 0.0 111.317 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.18 8.25 1.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.216 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.66 HG21 HG12 ' A' ' 66' ' ' VAL . 1.3 mp -119.36 123.1 70.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.443 ' CG ' ' HB2' ' A' ' 48' ' ' LEU . 32.3 mtp -146.49 115.31 6.87 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.493 ' N ' ' HB1' ' A' ' 50' ' ' ALA . . . 85.45 -5.87 81.96 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.64 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.479 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER 173.65 104.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.708 0.289 . . . . 0.0 110.591 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.66 HG12 HG21 ' A' ' 62' ' ' ILE . 6.3 m -50.62 158.62 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.875 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.668 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -80.47 174.26 11.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.052 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -93.73 167.27 11.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.824 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -53.82 -38.38 64.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.2 -36.99 74.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.725 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.422 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 13.3 mm-40 -68.86 -51.04 44.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 21' ' ' ALA . 15.3 tt -59.15 -41.5 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' N ' HG23 ' A' ' 72' ' ' ILE . 46.7 tttm -62.21 -31.91 72.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.736 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -73.84 -31.79 63.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.811 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 54.5 mt -75.71 -38.1 37.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.35 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.5 mt -62.42 -44.28 96.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.942 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.968 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 31' ' ' ASP . 10.3 ttp . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.524 0.202 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.848 ' O ' HD12 ' A' ' 4' ' ' ILE . 12.2 mmt -87.82 116.15 25.77 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.407 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -71.19 104.95 3.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.174 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.957 HG13 HG12 ' A' ' 56' ' ' VAL . 2.8 mp -112.55 120.77 63.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.361 0.601 . . . . 0.0 111.833 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.685 ' CB ' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -111.72 131.22 55.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.835 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.858 HG22 HD12 ' A' ' 54' ' ' LEU . 12.0 pt -110.8 115.1 48.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-O 120.822 0.344 . . . . 0.0 111.097 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.746 ' CE1' HG13 ' A' ' 37' ' ' ILE . 85.2 m-85 -99.1 107.11 19.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.98 0.419 . . . . 0.0 111.095 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.79 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 175.74 -106.12 0.21 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.491 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 m 68.48 88.24 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 111.122 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.49 -74.73 0.43 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.529 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 55.5 m -106.56 -26.87 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.79 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -76.25 127.99 34.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.305 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.53 ' O ' HG21 ' A' ' 66' ' ' VAL . 47.4 m-80 -76.91 20.69 0.24 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.189 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.43 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.4 p -52.0 -25.44 8.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.958 0.409 . . . . 0.0 111.116 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -36.22 65.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.181 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.486 ' CB ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -63.64 -51.92 63.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.875 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.997 HD21 HD11 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -68.9 -22.01 64.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.994 0.426 . . . . 0.0 110.553 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.538 ' CD ' HD13 ' A' ' 6' ' ' ILE . 3.7 tp10 -60.62 -54.25 47.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.558 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -48.64 65.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.73 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -55.09 -49.88 70.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.834 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.565 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -58.72 -41.51 86.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.797 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.552 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 11.5 mtp180 -57.55 -46.18 84.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 111.373 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.7 pt-20 -72.6 -50.3 26.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.558 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.76 -49.37 75.28 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.733 HG11 ' HB3' ' A' ' 32' ' ' ALA . 3.8 p -53.56 -55.17 14.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.614 0.245 . . . . 0.0 110.883 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.511 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -69.56 -44.35 71.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.233 179.249 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 2.7 tt0 -56.68 -45.19 81.88 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.138 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.19 -22.1 3.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.907 0.384 . . . . 0.0 110.591 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.649 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.74 34.61 1.68 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.394 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 29' ' ' GLY . 6.4 pt -162.74 116.73 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 0.0 111.288 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -61.32 164.69 5.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.159 179.348 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.733 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -151.23 161.98 41.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -121.37 111.65 17.58 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.805 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 58.0 m-85 -98.01 108.86 21.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.481 0.657 . . . . 0.0 112.038 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.81 133.85 55.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.481 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.564 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -80.5 151.34 29.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.04 0.447 . . . . 0.0 111.027 -179.463 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.746 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -126.32 91.34 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.696 -179.071 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.18 75.76 6.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.979 0.419 . . . . 0.0 111.229 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.56 ' O ' HG13 ' A' ' 43' ' ' ILE . 2.8 tt0 173.69 121.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.903 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.556 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -54.65 -33.92 61.38 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.222 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.438 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -51.36 -36.34 42.66 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.417 ' HB3' HG21 ' A' ' 37' ' ' ILE . 4.9 mt-30 -86.55 -31.67 21.11 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.032 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.941 HG22 HD21 ' A' ' 48' ' ' LEU . 46.1 mt -63.05 -56.32 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.039 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.492 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -62.75 -34.73 77.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.182 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.517 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -59.01 -21.71 59.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.909 0.385 . . . . 0.0 110.488 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.526 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -76.93 -35.8 57.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.3 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.18 -8.94 22.85 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.619 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.941 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.33 152.27 39.64 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 117.326 0.563 . . . . 0.0 111.382 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.7 p -108.02 -19.91 13.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.647 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -87.39 -171.58 3.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.393 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.563 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 2.0 mp -86.16 -73.78 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.714 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 38.3 Cg_endo -66.12 63.78 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.361 2.04 . . . . 0.0 112.609 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.426 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -84.93 143.78 20.71 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.993 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.858 HD12 HG22 ' A' ' 6' ' ' ILE . 3.7 tt -134.86 109.57 8.6 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.766 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -98.16 123.15 42.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.021 0.439 . . . . 0.0 110.901 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.957 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -115.95 138.8 45.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.354 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 46.16 27.91 0.6 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.482 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.92 34.32 48.15 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.399 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.98 101.09 3.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.838 0.351 . . . . 0.0 111.099 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.881 HD21 HD13 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -45.81 130.2 9.38 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.159 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -118.33 -19.29 8.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.701 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.701 HD11 ' HB2' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -145.09 143.0 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 111.973 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.583 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -146.16 115.11 6.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.483 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.534 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 63.6 13.67 51.87 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.085 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.67 94.45 0.5 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.843 0.354 . . . . 0.0 110.77 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.577 HG13 ' HB2' ' A' ' 17' ' ' LEU . 2.0 t -60.54 126.08 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.242 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.577 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -63.77 142.58 58.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.836 0.351 . . . . 0.0 111.067 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.68 169.07 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.74 -49.83 76.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.975 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.99 -36.48 81.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -58.81 -49.7 76.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.997 HD11 HD21 ' A' ' 17' ' ' LEU . 37.2 mm -60.51 -54.28 37.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.008 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -39.34 75.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -74.09 -31.73 62.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.061 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 75' ' ' ILE . 7.4 mm -76.04 -36.79 32.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.009 0.433 . . . . 0.0 110.389 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mt -73.76 -35.69 65.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.055 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.7 p . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.895 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.421 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 33.5 ttm . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.566 0.222 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.928 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -83.65 114.03 21.27 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.045 0.45 . . . . 0.0 110.808 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -69.52 116.35 9.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.007 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.004 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 2.5 mp -124.25 128.29 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.47 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.593 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 0.8 OUTLIER -111.16 143.02 42.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.6 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.633 HD11 ' HB2' ' A' ' 36' ' ' LYS . 7.6 pt -127.31 110.25 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 110.395 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.979 ' CD2' HD11 ' A' ' 48' ' ' LEU . 8.1 m-30 -100.15 110.67 22.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.726 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.84 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 178.56 -66.34 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.525 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 m 74.63 79.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.793 0.33 . . . . 0.0 111.284 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.58 -62.76 1.9 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.846 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -50.47 -70.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.353 . . . . 0.0 111.235 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.84 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -57.36 147.78 24.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.021 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.4 17.06 0.4 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.544 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.4 p -55.43 -21.96 18.21 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.729 0.3 . . . . 0.0 111.228 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -37.45 74.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.326 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -62.43 1.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.886 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.712 HD13 ' HB2' ' A' ' 21' ' ' ALA . 1.6 tm? -59.31 -36.02 74.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.616 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG3' HD13 ' A' ' 6' ' ' ILE . 38.4 tt0 -56.87 -41.0 77.22 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.7 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -73.46 -51.94 15.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.969 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.664 ' OD1' HD22 ' A' ' 17' ' ' LEU . 30.7 p30 -64.61 -36.23 83.58 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.88 0.372 . . . . 0.0 111.025 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.712 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -62.49 -44.38 96.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.61 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.577 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 1.4 mtp180 -58.55 -45.12 89.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.748 0.308 . . . . 0.0 111.253 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.2 pt-20 -71.67 -47.57 53.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.076 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 23' ' ' GLU . . . -62.64 -49.99 73.0 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.822 HG21 ' HB2' ' A' ' 32' ' ' ALA . 9.1 p -53.3 -55.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 121.26 -0.176 . . . . 0.0 110.821 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.579 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.68 -40.77 79.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.5 0.191 . . . . 0.0 110.988 179.208 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 47.9 tt0 -60.27 -48.06 83.33 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.363 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.4 mt -53.84 -19.56 4.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.723 0.297 . . . . 0.0 110.966 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.778 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.74 42.93 0.84 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.433 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -175.65 106.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 111.21 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' O ' ' CA ' ' A' ' 1' ' ' MET . 28.5 t0 -61.26 164.35 5.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.105 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.928 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -148.0 179.28 7.85 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.58 110.95 9.66 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 1.004 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 17.7 m-85 -98.0 109.63 22.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.408 0.623 . . . . 0.0 111.982 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -109.97 124.61 51.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.35 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.633 ' HB2' HD11 ' A' ' 6' ' ' ILE . 2.9 tmmt? -92.38 144.2 25.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.579 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.903 HD12 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -118.49 172.28 5.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.374 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -155.7 75.35 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.277 0.56 . . . . 0.0 109.944 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER 157.5 136.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.418 -179.446 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.774 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -54.03 -20.6 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 -179.413 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.436 ' O ' HD23 ' A' ' 44' ' ' LEU . 4.4 m-20 -51.38 -45.12 62.35 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -86.44 -31.77 21.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.3 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.774 ' HB ' ' HA ' ' A' ' 40' ' ' MET . 62.7 mt -63.59 -56.07 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-O 121.549 0.69 . . . . 0.0 111.503 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -62.91 -36.52 83.64 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.086 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -55.76 -24.13 33.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.103 0.478 . . . . 0.0 110.362 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.77 ' O ' HD21 ' A' ' 60' ' ' LEU . . . -77.61 -41.86 37.11 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.525 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.89 -7.64 23.69 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.558 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.979 HD11 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -78.1 157.21 29.57 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.887 0.375 . . . . 0.0 110.933 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.89 -22.76 9.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.856 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.902 ' HB3' ' CB ' ' A' ' 63' ' ' MET . . . -79.7 170.49 16.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.049 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.5 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 2.7 mp -71.96 -70.08 0.31 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.793 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 47.8 Cg_endo -69.92 60.13 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.056 1.837 . . . . 0.0 112.234 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -83.68 128.82 8.77 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.615 HD12 ' CG2' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -121.97 107.93 12.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.759 0.314 . . . . 0.0 110.244 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.62 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -98.74 124.5 43.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.199 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.873 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.85 139.59 40.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.193 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.49 26.78 0.54 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.823 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.75 35.19 46.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.317 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -144.94 103.24 3.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.944 0.402 . . . . 0.0 111.132 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.77 HD21 ' O ' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -54.5 132.71 45.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.494 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.6 -5.21 1.57 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.557 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 0.7 OUTLIER -154.17 124.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.919 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.902 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -145.73 134.55 22.4 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.367 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.496 ' N ' ' HB1' ' A' ' 50' ' ' ALA . . . 80.2 -1.5 80.36 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.884 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.416 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -178.35 100.43 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.779 0.323 . . . . 0.0 110.582 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.615 ' CG2' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -65.09 137.28 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.065 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.628 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -63.73 164.38 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.33 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.8 p -92.16 -179.76 5.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.136 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.419 ' O ' HG22 ' A' ' 72' ' ' ILE . 16.5 pttm -64.14 -49.28 72.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.673 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -71.82 -30.23 65.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.722 0.296 . . . . 0.0 111.142 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.423 ' O ' HD13 ' A' ' 75' ' ' ILE . 2.4 mm-40 -71.69 -51.33 23.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.373 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.657 ' HB ' HD21 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -55.65 -45.87 79.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.139 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.442 ' N ' HG23 ' A' ' 72' ' ' ILE . 13.4 tttt -60.35 -37.09 79.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.834 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -74.06 -30.16 62.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.169 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.423 HD13 ' O ' ' A' ' 71' ' ' GLU . 1.4 mp -75.92 -29.69 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.375 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.81 -31.54 40.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.869 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.932 -179.937 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.443 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 2.2 tpp . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.559 0.219 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.835 ' O ' HD12 ' A' ' 4' ' ' ILE . 8.2 tpp -80.65 112.01 17.61 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -70.12 118.3 12.78 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.028 0.442 . . . . 0.0 110.94 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.994 HG13 HG12 ' A' ' 56' ' ' VAL . 2.3 mp -126.14 124.95 66.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.941 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 3.7 mt-30 -110.36 139.1 45.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.945 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.5 mp -119.86 113.46 40.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.08 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.875 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 83.7 m-85 -104.71 115.94 31.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.249 0.547 . . . . 0.0 112.465 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 128.93 -66.91 0.56 Allowed Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.649 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 53.53 -84.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.608 0.242 . . . . 0.0 111.502 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 8' ' ' GLY . . . -58.96 -53.85 42.95 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.492 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.3 m -98.71 33.67 2.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.468 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -155.0 126.22 7.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -76.05 7.57 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.666 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.462 ' HB3' HG13 ' A' ' 66' ' ' VAL . 2.1 p -55.98 -20.38 16.17 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.735 0.303 . . . . 0.0 111.402 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.39 -25.46 6.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.511 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.7 mtt -63.49 -62.14 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.728 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.462 HD22 ' H ' ' A' ' 67' ' ' ALA . 9.3 tp -64.46 -24.03 67.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.782 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.75 -51.78 67.55 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.411 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -67.62 -47.39 69.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.818 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -56.51 -39.66 73.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.913 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -61.73 -46.97 87.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.605 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.476 ' CG ' ' CD1' ' A' ' 34' ' ' PHE . 41.8 mtp180 -54.63 -38.05 66.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.803 0.335 . . . . 0.0 111.14 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.8 tt0 -73.57 -49.92 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.8 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -60.55 -50.93 71.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.786 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.026 HG21 ' HB2' ' A' ' 32' ' ' ALA . 13.8 p -53.23 -56.05 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.631 0.253 . . . . 0.0 110.64 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.607 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -65.48 -47.64 75.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 0.0 110.923 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 17.8 tp10 -56.03 -48.07 76.67 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.283 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.499 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -53.32 -21.92 6.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.809 0.338 . . . . 0.0 110.765 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.62 47.41 0.63 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.597 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 25' ' ' VAL . 10.6 tt -179.23 128.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.305 0.574 . . . . 0.0 111.471 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.443 ' O ' ' CA ' ' A' ' 1' ' ' MET . 17.0 t0 -69.68 164.32 23.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.604 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.026 ' HB2' HG21 ' A' ' 25' ' ' VAL . . . -147.21 175.47 10.72 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.23 107.72 9.19 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.071 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.975 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 25.2 m-85 -101.38 108.58 20.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.346 0.594 . . . . 0.0 111.179 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -118.73 124.74 48.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.67 143.68 26.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.206 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.843 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -110.08 -178.02 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.333 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.489 ' N ' HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -158.92 75.37 0.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.106 0.479 . . . . 0.0 110.62 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.494 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER 158.14 130.05 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.96 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.508 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -52.63 -27.28 16.47 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 121.245 -0.182 . . . . 0.0 111.153 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -51.48 -39.0 56.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.737 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -86.75 -35.87 18.94 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.974 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.039 HG22 HD21 ' A' ' 48' ' ' LEU . 20.9 mt -60.76 -54.82 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.077 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.425 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.488 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -58.7 -37.33 75.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.768 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -55.18 -25.27 31.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 110.565 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.663 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -73.64 -34.75 65.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.996 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.12 -5.17 35.95 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.018 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.039 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.1 157.11 36.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.084 0.469 . . . . 0.0 111.512 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.6 p -112.41 -8.73 13.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.21 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.452 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -102.38 -175.41 2.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.41 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.62 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -86.1 -64.21 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.63 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 11.7 Cg_exo -69.53 59.87 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.254 1.969 . . . . 0.0 111.82 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.554 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -87.44 141.41 17.37 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.226 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.476 ' CB ' HD11 ' A' ' 62' ' ' ILE . 4.8 tt -135.27 111.45 9.64 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.729 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -98.32 124.42 42.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.934 0.397 . . . . 0.0 111.123 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.994 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -113.6 139.4 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.06 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 49.56 24.71 1.21 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.598 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.75 28.55 56.81 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.318 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -143.25 104.2 4.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.859 0.361 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.729 HD22 ' HB2' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -46.07 131.77 9.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.921 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.84 -13.84 7.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.985 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.552 HD13 ' HA ' ' A' ' 66' ' ' VAL . 2.7 pp -152.98 146.88 14.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.597 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 1.6 mtp -146.24 125.53 13.05 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.889 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.618 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 89.06 -17.17 53.07 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.034 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 178.22 109.77 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.552 ' HA ' HD13 ' A' ' 62' ' ' ILE . 9.4 m -49.51 174.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.88 0.371 . . . . 0.0 111.445 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.462 ' H ' HD22 ' A' ' 17' ' ' LEU . . . -92.61 -165.67 1.39 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.046 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.2 m -113.4 163.16 15.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.812 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HA ' HG22 ' A' ' 72' ' ' ILE . 4.0 pttp -55.75 -42.79 75.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -65.85 -32.63 74.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.804 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.685 ' O ' HD12 ' A' ' 75' ' ' ILE . 6.4 tp10 -73.47 -48.98 29.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.046 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.485 HG23 ' N ' ' A' ' 73' ' ' LYS . 16.9 tt -62.46 -46.74 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.204 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.485 ' N ' HG23 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.27 -37.69 75.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.896 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -40.16 95.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.767 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.685 HD12 ' O ' ' A' ' 71' ' ' GLU . 1.8 mp -75.93 -37.7 34.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.467 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.425 HD12 ' HG ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -53.12 -45.17 68.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.111 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 91.1 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.901 -179.931 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.434 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.825 0.345 . . . . 0.0 111.284 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.619 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -83.99 116.11 22.66 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.83 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -69.12 118.34 11.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.016 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.904 HG12 HG12 ' A' ' 56' ' ' VAL . 4.3 mt -128.8 123.03 58.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.094 0.473 . . . . 0.0 111.88 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -111.96 142.84 43.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.314 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.706 HG22 HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -120.55 106.23 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.767 0.318 . . . . 0.0 110.766 179.264 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.917 ' CD2' ' HA ' ' A' ' 43' ' ' ILE . 59.2 m-85 -91.77 109.68 21.01 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.069 0.461 . . . . 0.0 111.412 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.909 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 174.17 -100.1 0.14 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.269 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 51.86 100.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.874 0.369 . . . . 0.0 111.411 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.17 18.49 26.48 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.697 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.63 -41.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.346 . . . . 0.0 110.818 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.909 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -95.12 132.5 39.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.174 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -76.56 20.4 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.06 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.432 ' HA ' HG11 ' A' ' 66' ' ' VAL . 3.4 p -54.1 -24.06 16.2 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.953 0.406 . . . . 0.0 111.206 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.27 -32.79 64.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.111 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 23.0 ttt -63.61 -62.07 1.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.752 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.779 ' CD1' ' HB3' ' A' ' 67' ' ' ALA . 1.2 tt -64.69 -20.05 66.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 110.637 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -58.88 -54.35 48.06 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.303 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -50.09 43.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -54.83 -49.19 71.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.072 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.402 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -56.02 -40.88 74.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.517 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.518 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -57.32 -41.02 79.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.259 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -74.39 -50.4 18.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.106 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.501 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -61.95 -50.22 73.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.77 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.903 HG11 ' HB3' ' A' ' 32' ' ' ALA . 6.2 p -53.64 -55.53 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.154 -0.218 . . . . 0.0 110.614 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.548 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -64.65 -48.99 72.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 178.765 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -57.85 -42.85 85.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.51 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 24' ' ' ALA . 1.9 mm? -53.58 -20.01 4.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.811 0.339 . . . . 0.0 110.883 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.98 41.95 0.88 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.49 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.0 tt -179.22 120.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.24 0.543 . . . . 0.0 111.058 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.436 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 5.0 t70 -62.64 163.97 8.33 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.762 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.903 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -157.77 141.04 15.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.641 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -103.83 119.58 39.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.561 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.854 ' CE2' HD12 ' A' ' 4' ' ' ILE . 13.3 m-85 -103.17 109.59 21.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.349 0.595 . . . . 0.0 111.906 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -108.64 122.45 47.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.824 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.535 ' HG3' HD11 ' A' ' 6' ' ' ILE . 1.9 mtpt -90.21 141.37 28.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.059 0.457 . . . . 0.0 111.13 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.781 HG13 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -108.8 175.31 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.594 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -160.06 74.93 0.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.892 0.377 . . . . 0.0 110.896 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.562 ' O ' HG13 ' A' ' 43' ' ' ILE . 3.2 mt-10 157.0 127.29 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.311 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.546 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -53.96 -26.67 26.84 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.924 -0.126 . . . . 0.0 111.111 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.466 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -51.66 -39.84 58.92 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -86.62 -33.15 20.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.206 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.079 HG22 HD21 ' A' ' 48' ' ' LEU . 13.1 mt -63.18 -55.87 20.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.547 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -61.02 -35.89 78.06 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.681 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.86 -22.51 59.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.102 0.477 . . . . 0.0 110.234 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -73.42 -36.35 65.95 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.913 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 121.13 -15.08 9.45 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.583 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.079 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.85 158.79 32.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.361 0.58 . . . . 0.0 111.689 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 t -105.78 -28.07 10.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.458 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.42 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -81.93 -177.62 6.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.063 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.575 HD12 ' HD3' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -89.89 -55.57 0.29 Allowed Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.486 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.575 ' HD3' HD12 ' A' ' 51' ' ' LEU . 14.6 Cg_exo -69.65 56.89 1.38 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.511 2.141 . . . . 0.0 112.473 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -81.46 142.25 22.73 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.475 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.706 HD12 HG22 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -132.2 105.32 7.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.866 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -97.95 122.13 40.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.987 0.422 . . . . 0.0 111.507 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.904 HG12 HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -119.53 139.28 47.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.192 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.48 27.49 0.97 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.659 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.92 33.2 55.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.269 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.94 101.71 3.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.938 0.399 . . . . 0.0 111.171 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.872 HD11 HD12 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -52.44 127.42 22.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.608 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -125.72 -13.47 6.43 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.705 HG21 ' HA ' ' A' ' 66' ' ' VAL . 6.5 mt -139.63 130.55 32.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.523 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.75 ' SD ' HD12 ' A' ' 60' ' ' LEU . 4.0 mpp? -146.72 134.62 21.33 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.963 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 86.74 -10.61 67.04 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.575 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 3.8 ttp180 176.85 104.96 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.719 0.295 . . . . 0.0 110.436 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.705 ' HA ' HG21 ' A' ' 62' ' ' ILE . 2.1 p -59.28 142.84 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.839 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.779 ' HB3' ' CD1' ' A' ' 17' ' ' LEU . . . -67.43 170.79 6.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.806 0.336 . . . . 0.0 111.349 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.67 172.04 7.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.79 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.02 -38.02 69.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.281 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -73.29 -39.39 65.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 111.106 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.533 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 18.8 tt0 -69.23 -49.69 54.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.198 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.581 HD13 ' C ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -57.22 -46.72 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.253 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.488 ' N ' HG23 ' A' ' 72' ' ' ILE . 24.8 tttm -60.57 -37.42 81.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.866 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.15 -29.33 61.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.229 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -75.9 -28.91 19.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.945 0.402 . . . . 0.0 110.676 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.32 -32.66 20.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.983 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.2 p . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.943 179.917 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.498 0.189 . . . . 0.0 111.266 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.599 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -76.54 112.56 13.21 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.762 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 100.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.042 0.449 . . . . 0.0 110.126 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.959 HD13 ' CE2' ' A' ' 34' ' ' PHE . 4.3 mt -110.61 130.26 64.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.51 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.804 ' C ' HD13 ' A' ' 6' ' ' ILE . 14.3 mt-30 -110.81 144.36 39.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.19 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.804 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -128.2 107.96 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-O 120.82 0.343 . . . . 0.0 110.975 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.953 ' CD2' HD11 ' A' ' 48' ' ' LEU . 6.1 m-30 -100.11 112.8 25.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.125 0.488 . . . . 0.0 111.469 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.836 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 161.57 -104.51 0.24 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.572 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.4 OUTLIER 62.37 136.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 0.0 111.063 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.52 25.67 42.97 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -175.99 -67.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 110.685 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.836 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -70.5 137.89 50.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -76.27 13.82 0.85 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.156 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.737 ' HB2' HG22 ' A' ' 6' ' ' ILE . 4.6 p -56.22 -29.22 60.67 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.915 0.388 . . . . 0.0 111.209 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.34 -35.26 60.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.45 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 tpt -64.78 -62.65 1.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.346 . . . . 0.0 111.127 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.821 HD13 ' O ' ' A' ' 17' ' ' LEU . 3.5 tm? -66.37 -24.18 66.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.767 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.431 ' HB2' HG21 ' A' ' 6' ' ' ILE . 3.6 tm-20 -57.17 -49.82 74.78 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.22 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.1 -46.09 82.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.43 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.506 ' HB2' HD22 ' A' ' 17' ' ' LEU . 1.7 m-20 -54.91 -45.53 74.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.551 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.74 -41.51 82.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.473 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.517 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 3.9 mtm180 -55.68 -41.68 74.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.038 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 13.9 tt0 -73.77 -49.85 23.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.186 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -62.28 -51.88 65.93 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.85 HG11 ' HB3' ' A' ' 32' ' ' ALA . 2.9 p -53.3 -53.98 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.418 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.487 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 3.4 mtpm? -65.46 -48.88 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.82 0.343 . . . . 0.0 110.841 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.411 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 4.4 tm-20 -58.13 -42.87 86.75 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.535 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -51.35 -21.36 2.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.878 0.37 . . . . 0.0 110.955 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.76 34.37 1.71 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.226 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.6 OUTLIER -169.37 113.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.443 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 2.2 t0 -61.07 164.13 5.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.213 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.85 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -150.87 167.56 27.14 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -125.86 115.14 19.51 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.26 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.959 ' CE2' HD13 ' A' ' 4' ' ' ILE . 12.4 m-85 -100.2 108.72 20.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.337 0.589 . . . . 0.0 111.093 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -110.57 112.24 24.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.696 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 mtmt -82.23 141.36 33.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.243 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.927 HD12 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -112.3 159.75 12.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.29 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -139.92 75.34 1.51 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.325 0.583 . . . . 0.0 110.123 179.197 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 0.3 OUTLIER 157.59 134.66 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.566 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.666 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 3.6 ttm -56.39 -16.91 6.47 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -51.17 -45.94 61.93 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.48 -31.62 21.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.299 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.746 HG22 HD21 ' A' ' 48' ' ' LEU . 30.4 mt -64.57 -54.73 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 121.504 0.668 . . . . 0.0 111.383 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.401 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -65.52 -36.26 83.3 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.007 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 28.6 tt0 -54.88 -26.19 33.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.209 0.528 . . . . 0.0 110.041 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.646 ' O ' HD21 ' A' ' 60' ' ' LEU . . . -74.59 -46.73 36.73 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.084 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.63 -7.76 13.51 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.528 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.953 HD11 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -76.26 155.22 34.55 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.774 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.82 -26.07 9.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.788 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.986 ' HB3' ' HB2' ' A' ' 63' ' ' MET . . . -75.73 179.66 5.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.59 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.476 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -81.69 -68.59 0.19 Allowed Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.117 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.732 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 45.0 Cg_endo -70.01 57.33 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.201 1.934 . . . . 0.0 113.809 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.482 ' HA2' ' HB3' ' A' ' 63' ' ' MET . . . -72.2 141.52 31.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.033 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.716 HD21 HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -130.76 104.07 6.96 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.934 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -98.39 123.48 42.53 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.102 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.687 HG12 ' CG1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -120.8 141.04 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.657 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 47.19 26.92 0.74 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.938 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.38 29.52 55.83 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.404 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -140.92 103.7 4.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.912 0.386 . . . . 0.0 110.84 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.934 HD12 ' HB2' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -72.87 126.53 30.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.161 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -147.16 10.18 0.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 54' ' ' LEU . 5.2 mt -147.1 103.9 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.989 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.986 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.37 149.92 35.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.132 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.421 ' N ' ' HG2' ' A' ' 52' ' ' PRO . . . 84.53 -5.94 79.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.978 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.456 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER 165.4 105.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.502 HG11 ' HA ' ' A' ' 14' ' ' CYS . 10.3 m -61.14 163.89 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 111.193 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.436 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -82.27 169.18 16.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.063 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 m -82.96 178.2 8.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.911 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.404 ' O ' HG22 ' A' ' 72' ' ' ILE . 18.0 tttt -65.35 -53.4 44.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.264 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -33.22 72.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.343 . . . . 0.0 110.931 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -72.62 -48.13 42.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.054 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -61.86 -42.21 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.996 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.11 -31.88 73.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.635 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -69.74 -30.6 68.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.08 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 72' ' ' ILE . 1.1 tp -75.51 -28.3 19.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.678 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.405 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -67.94 -55.09 14.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.836 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.929 179.994 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.444 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 2.7 ttp . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.448 0.166 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.791 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 2.3 mmt -81.11 113.03 19.01 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.947 0.403 . . . . 0.0 110.824 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 120.14 14.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.068 0.461 . . . . 0.0 110.767 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.914 HG13 HG12 ' A' ' 56' ' ' VAL . 2.1 mp -129.09 124.82 61.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.454 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.737 ' O ' HD22 ' A' ' 54' ' ' LEU . 6.5 mm-40 -111.1 141.98 43.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.257 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.668 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -130.28 113.44 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 0.0 110.608 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 1.359 ' CD2' ' CE2' ' A' ' 7' ' ' TYR . 27.5 m-85 -100.51 113.02 25.48 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.298 0.571 . . . . 0.0 112.042 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.895 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 171.24 -100.62 0.16 Allowed Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.412 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.91 103.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.786 0.326 . . . . 0.0 111.302 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.48 -28.62 11.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.711 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.8 p -138.57 -48.36 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 111.134 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.895 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -73.45 132.7 43.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -76.56 19.73 0.25 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.196 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.412 ' HA ' HG11 ' A' ' 66' ' ' VAL . 4.5 p -55.62 -23.06 25.53 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.808 0.337 . . . . 0.0 111.234 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -33.79 72.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.174 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 38.1 ttp -64.58 -62.09 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.372 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 67' ' ' ALA . 0.4 OUTLIER -60.97 -33.21 72.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.694 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -56.47 -39.84 73.88 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.666 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -73.52 -52.4 13.69 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.849 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.629 HD21 HD22 ' A' ' 17' ' ' LEU . 30.7 p30 -64.22 -34.02 77.14 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.849 0.357 . . . . 0.0 110.803 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.518 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -62.07 -49.28 76.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.026 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.495 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 2.2 mtm-85 -54.76 -39.04 67.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.716 0.293 . . . . 0.0 111.007 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -72.18 -50.26 29.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.079 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.405 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -62.43 -50.52 71.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.682 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.996 HG21 ' HB2' ' A' ' 32' ' ' ALA . 11.1 p -53.54 -55.8 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.607 0.241 . . . . 0.0 110.473 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.602 ' N ' HG13 ' A' ' 25' ' ' VAL . 11.8 mtpt -64.15 -49.36 72.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.755 0.312 . . . . 0.0 110.682 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -55.72 -47.15 77.38 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.349 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 24' ' ' ALA . 2.2 mm? -51.64 -22.3 3.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.856 0.36 . . . . 0.0 110.872 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.737 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.8 36.12 1.44 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.336 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 29' ' ' GLY . 1.1 pt -168.55 112.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.041 0.448 . . . . 0.0 111.103 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.465 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 30.5 t70 -61.44 164.61 5.52 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.49 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.996 ' HB2' HG21 ' A' ' 25' ' ' VAL . . . -148.65 171.72 15.72 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -128.51 110.23 12.1 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.957 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.871 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 15.1 m-85 -100.46 108.96 21.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.323 0.583 . . . . 0.0 111.374 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -113.17 121.05 43.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.789 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.434 ' HA ' HG12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -94.45 139.63 30.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.075 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.839 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -106.98 179.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.124 -179.639 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.437 ' N ' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -155.34 74.92 0.92 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.116 0.484 . . . . 0.0 110.884 179.114 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.53 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER 162.25 126.62 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.006 179.676 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.5 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 15.2 mtt -52.55 -29.24 24.42 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.569 0.223 . . . . 0.0 110.764 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.455 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -51.93 -38.13 55.2 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.407 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.884 ' O ' ' CE2' ' A' ' 7' ' ' TYR . 7.4 mt-30 -86.6 -34.94 19.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.083 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.985 HG22 HD21 ' A' ' 48' ' ' LEU . 10.7 mt -62.84 -54.67 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.512 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -63.58 -34.26 77.42 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.924 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -59.04 -23.58 62.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.919 0.39 . . . . 0.0 110.427 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.682 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -73.11 -36.52 66.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.707 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.76 -9.05 14.57 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.842 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.985 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -69.21 150.08 47.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.495 0.648 . . . . 0.0 111.243 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.31 -19.36 19.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.431 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.497 ' HB3' ' N ' ' A' ' 64' ' ' GLY . . . -100.92 -173.37 2.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.212 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.514 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.0 OUTLIER -86.87 -57.4 0.32 Allowed Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.643 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 17.0 Cg_exo -67.87 58.19 0.83 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.618 2.212 . . . . 0.0 112.38 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.432 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -74.88 148.32 37.94 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.559 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.737 HD22 ' O ' ' A' ' 5' ' ' GLN . 3.4 tm? -137.24 100.1 4.16 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.696 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -97.92 119.43 36.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.188 0.518 . . . . 0.0 111.217 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.914 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -115.03 138.74 44.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.888 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 47.25 27.25 0.82 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.497 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.53 35.43 47.01 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.284 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -148.47 100.66 3.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 0.0 111.268 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.696 ' CD1' ' HB2' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -47.75 129.45 14.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.974 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.85 ' O ' HD13 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -129.42 -13.16 4.39 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.397 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.85 HD13 ' O ' ' A' ' 61' ' ' LYS . 4.8 mm -139.59 135.84 39.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.754 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.487 ' CG ' ' HB2' ' A' ' 48' ' ' LEU . 1.4 mpp? -146.48 133.28 20.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.52 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.515 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 83.23 -6.34 72.46 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.273 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 173.44 103.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.624 ' HA ' HG21 ' A' ' 62' ' ' ILE . 9.0 p -48.47 155.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.337 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.697 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -63.77 178.74 0.57 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.894 0.378 . . . . 0.0 111.158 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 74.3 m -110.17 169.57 8.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.008 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -58.38 -45.86 87.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.239 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -73.1 -29.8 63.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 0.0 111.052 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -73.39 -46.69 47.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.376 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -61.71 -46.18 97.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.139 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.459 ' N ' HG23 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -64.46 -32.76 74.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 0.0 110.816 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -27.99 61.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.9 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.6 mm -75.85 -35.54 30.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.019 0.438 . . . . 0.0 110.171 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -33.68 57.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.833 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.816 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.464 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 9.1 ptp . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.361 0.124 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.916 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -81.35 109.74 16.13 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.796 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -69.26 103.55 1.98 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.132 0.491 . . . . 0.0 110.664 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.667 HG23 HD21 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -101.64 116.65 45.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.107 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.759 ' O ' HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -110.11 115.04 29.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.017 179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.854 ' N ' HD11 ' A' ' 37' ' ' ILE . 15.8 pt -100.41 109.26 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-O 121.086 0.47 . . . . 0.0 111.847 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.746 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 90.3 m-85 -90.44 125.91 35.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.93 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.535 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 149.79 -82.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.514 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p 51.85 78.36 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 111.285 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.14 -84.01 0.18 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.542 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.9 m -93.99 -29.99 14.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.798 0.332 . . . . 0.0 110.926 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.535 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -63.42 133.28 53.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.384 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.791 ' O ' HG21 ' A' ' 66' ' ' VAL . 58.1 m-20 -76.63 20.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.083 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.421 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.2 p -53.03 -23.47 7.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.893 0.378 . . . . 0.0 111.287 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -39.45 71.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.562 ' HB3' HG11 ' A' ' 66' ' ' VAL . 16.9 ttt -68.08 -51.36 47.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.88 HD11 ' HG ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -69.04 -25.89 64.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.987 0.423 . . . . 0.0 110.389 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.593 ' N ' HD23 ' A' ' 17' ' ' LEU . 16.0 tt0 -58.78 -52.92 63.67 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.243 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -65.79 -44.71 84.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.829 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -58.12 -54.32 48.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.165 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.665 ' HB3' ' HE2' ' A' ' 34' ' ' PHE . . . -53.02 -36.3 60.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.32 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -60.4 -48.87 79.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.319 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.2 pt-20 -71.59 -47.83 52.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.298 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -63.03 -49.88 72.88 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.888 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.9 p -53.48 -54.99 15.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.919 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.541 ' N ' HG13 ' A' ' 25' ' ' VAL . 5.7 mtmm -70.04 -49.03 55.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.265 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 22.9 tt0 -51.81 -46.68 64.34 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.732 0.301 . . . . 0.0 111.172 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.655 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -51.47 -23.66 4.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.978 0.418 . . . . 0.0 110.487 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.737 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.53 37.57 1.3 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.572 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -167.97 117.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.987 0.422 . . . . 0.0 111.642 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -61.42 165.53 4.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.895 178.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.916 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -148.31 179.2 7.95 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -129.45 113.98 15.57 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.72 ' HE1' ' HB3' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -100.31 109.75 21.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.279 0.561 . . . . 0.0 111.659 -178.35 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -126.21 128.55 47.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.073 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.789 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -79.76 151.94 30.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.961 0.41 . . . . 0.0 110.762 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.952 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -123.27 78.35 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.938 -178.271 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.9 tttt -77.47 75.77 4.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.14 0.495 . . . . 0.0 110.825 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 43' ' ' ILE . 0.1 OUTLIER 172.07 127.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.414 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.586 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -63.92 -27.21 68.99 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.031 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.466 ' O ' HD23 ' A' ' 44' ' ' LEU . 2.1 t0 -51.48 -36.76 45.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.475 ' HG2' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -88.22 -33.41 18.13 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.893 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.746 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -68.51 -45.22 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.073 0.463 . . . . 0.0 111.432 -179.195 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.584 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -65.48 -37.96 88.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.178 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.584 ' H ' HD23 ' A' ' 44' ' ' LEU . 6.7 tt0 -60.59 -22.06 63.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.243 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.825 ' HB1' HD23 ' A' ' 60' ' ' LEU . . . -77.47 -35.4 53.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.0 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.87 -8.35 21.6 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.628 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.521 HD13 ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -81.46 158.8 24.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.431 0.616 . . . . 0.0 111.597 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 t -114.92 -31.87 5.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.587 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.822 ' HB3' ' HG2' ' A' ' 63' ' ' MET . . . -75.23 -159.73 0.1 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.23 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.495 HD12 ' HA2' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -101.87 -56.28 0.12 Allowed Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.483 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.559 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 21.1 Cg_exo -65.55 57.81 0.36 Allowed 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.477 2.118 . . . . 0.0 113.561 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -88.48 136.03 13.44 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.164 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.88 ' HG ' HD11 ' A' ' 17' ' ' LEU . 3.4 tm? -138.31 114.78 10.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.741 0.305 . . . . 0.0 110.77 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.933 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . . . -109.55 131.34 55.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.03 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.422 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -117.85 139.9 43.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.111 0.482 . . . . 0.0 111.013 179.571 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 46.58 27.9 0.7 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.6 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.87 42.05 17.46 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.378 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.14 100.58 3.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.933 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -69.01 128.17 35.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.916 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.769 ' O ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -146.29 7.75 1.03 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.769 HD13 ' O ' ' A' ' 61' ' ' LYS . 11.0 mm -143.72 110.57 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.791 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.822 ' HG2' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -145.52 141.45 28.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.926 0.393 . . . . 0.0 111.509 -179.478 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.559 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 67.39 11.45 59.42 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.858 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -178.09 103.63 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.821 0.343 . . . . 0.0 110.621 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.791 HG21 ' O ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -56.45 144.49 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.618 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.428 ' HB2' HD12 ' A' ' 62' ' ' ILE . . . -78.25 147.28 34.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.102 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.8 p -90.47 168.32 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -55.65 -41.78 74.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.13 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -69.37 -40.55 77.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.976 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -63.94 -45.91 87.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.013 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.8 mt -65.93 -50.44 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -57.78 -31.81 66.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.964 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -72.02 -38.81 69.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.0 mt -75.73 -38.41 37.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.509 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.69 HD21 ' HA ' ' A' ' 25' ' ' VAL . 1.5 mp -64.0 -53.31 52.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.001 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.617 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.903 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.447 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 6.9 mtp . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.731 0.3 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.555 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.05 114.54 17.03 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.828 0.347 . . . . 0.0 110.672 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.47 106.07 2.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.106 0.479 . . . . 0.0 110.105 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.916 HG12 HG12 ' A' ' 56' ' ' VAL . 7.3 mt -117.13 127.75 74.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.478 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.669 ' O ' HD22 ' A' ' 54' ' ' LEU . 2.9 mp0 -110.39 144.08 39.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.354 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.674 HD11 ' HB3' ' A' ' 34' ' ' PHE . 3.2 mp -124.72 108.24 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.793 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.873 ' CD2' ' HA ' ' A' ' 43' ' ' ILE . 56.9 m-85 -96.94 115.64 27.79 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.289 0.566 . . . . 0.0 111.586 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.853 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 159.88 -88.87 0.11 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.331 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.8 p 49.54 96.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.843 0.354 . . . . 0.0 111.43 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.9 -78.88 0.31 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.392 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 t -85.76 -39.57 17.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.781 0.324 . . . . 0.0 110.762 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.853 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -79.45 125.77 29.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.926 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -76.49 19.95 0.24 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.131 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.539 ' SG ' HG22 ' A' ' 6' ' ' ILE . 4.2 p -58.77 -19.92 45.11 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.696 0.284 . . . . 0.0 111.611 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.95 -31.62 60.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.405 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.09 -52.83 61.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.673 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.658 HD13 HG22 ' A' ' 66' ' ' VAL . 5.6 tt -69.09 -29.87 68.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.753 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -55.55 -40.6 72.12 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.899 0.381 . . . . 0.0 110.416 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -73.03 -52.33 14.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.918 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 31.9 p30 -64.49 -33.73 76.58 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.816 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . -60.74 -47.06 88.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.941 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.539 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 12.6 mtp180 -56.89 -42.32 79.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.651 0.262 . . . . 0.0 110.905 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -47.94 49.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.055 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.587 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -62.97 -51.73 65.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.691 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.891 HG11 ' HB3' ' A' ' 32' ' ' ALA . 9.8 p -53.55 -55.12 14.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.545 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -62.97 -49.15 75.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.651 178.454 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.11 -45.84 86.56 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.301 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 24' ' ' ALA . 3.1 mm? -52.12 -20.69 2.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.991 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.11 46.61 0.64 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.623 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 7.9 tt 177.14 124.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.11 0.481 . . . . 0.0 111.192 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.447 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -66.08 162.64 19.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.704 179.51 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.891 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -154.32 142.8 20.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -104.48 114.41 28.62 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.273 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.841 ' CZ ' HD12 ' A' ' 4' ' ' ILE . 17.8 m-85 -97.58 109.29 22.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.317 0.58 . . . . 0.0 111.471 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -110.06 114.71 28.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.62 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.51 138.54 31.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.245 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.866 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -107.29 177.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.442 ' N ' HG12 ' A' ' 37' ' ' ILE . 13.6 pttm -156.75 75.28 0.84 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.157 0.503 . . . . 0.0 110.889 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.515 ' O ' HG13 ' A' ' 43' ' ' ILE . 9.8 pt-20 157.31 130.77 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.839 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.49 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 2.2 ptt? -52.31 -25.35 9.32 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.804 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -51.5 -39.44 57.62 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.51 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -87.31 -38.8 15.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.166 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.056 HG22 HD21 ' A' ' 48' ' ' LEU . 8.5 mt -60.68 -55.59 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.561 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -34.83 77.42 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.879 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 1.4 tm-20 -57.21 -24.92 57.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.102 0.477 . . . . 0.0 110.248 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.58 ' O ' HD11 ' A' ' 60' ' ' LEU . . . -71.97 -37.24 69.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.726 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.05 -14.62 10.34 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.703 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.056 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.86 161.18 25.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.028 0.442 . . . . 0.0 111.289 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t -110.59 -24.58 10.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.997 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.578 ' HB3' ' HG2' ' A' ' 63' ' ' MET . . . -80.17 -179.74 7.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.417 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.557 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.6 mt -88.13 -60.08 0.25 Allowed Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.855 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.557 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 17.2 Cg_exo -66.52 49.6 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.637 2.224 . . . . 0.0 113.769 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.99 146.74 35.42 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.571 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.669 HD22 ' O ' ' A' ' 5' ' ' GLN . 2.8 tm? -136.55 102.4 4.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.738 ' CB ' HD12 ' A' ' 60' ' ' LEU . . . -97.9 123.68 41.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 111.335 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.916 HG12 HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -119.45 140.67 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.181 0.515 . . . . 0.0 111.487 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 t0 48.48 25.66 0.98 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.086 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.17 25.72 50.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.413 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -139.9 104.49 4.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.891 0.377 . . . . 0.0 110.601 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.738 HD12 ' CB ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -90.43 128.72 36.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.696 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -146.43 3.22 0.87 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.141 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 54' ' ' LEU . 19.5 mm -128.67 103.31 9.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.989 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.578 ' HG2' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -146.45 162.46 38.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.632 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . 80.9 -7.61 58.86 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.246 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER 170.37 103.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.658 HG22 HD13 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -67.68 151.93 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.821 0.343 . . . . 0.0 111.389 -179.14 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.836 ' HB1' ' HB3' ' A' ' 71' ' ' GLU . . . -79.9 179.58 7.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.341 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 m -104.26 -170.18 1.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.932 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.456 ' O ' HG22 ' A' ' 72' ' ' ILE . 25.7 tttt -65.55 -54.51 27.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.008 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.17 -29.8 70.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.906 0.384 . . . . 0.0 110.652 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.836 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 0.7 OUTLIER -73.45 -51.14 18.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.04 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.661 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -60.76 -42.85 93.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.858 0.361 . . . . 0.0 110.964 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.403 ' N ' HG23 ' A' ' 72' ' ' ILE . 16.6 tptm -65.52 -31.68 72.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.706 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -71.79 -29.15 64.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.75 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.4 mt -75.63 -37.21 36.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.144 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.11 -55.6 4.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.912 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.917 -179.99 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.426 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 8.6 ttp . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.554 0.216 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.503 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 1.4 mtt -77.73 113.61 15.76 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.951 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -69.35 100.8 1.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.012 0.434 . . . . 0.0 109.958 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.946 HD12 ' HB1' ' A' ' 32' ' ' ALA . 3.5 mt -109.95 135.66 48.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.998 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.916 ' O ' HD13 ' A' ' 54' ' ' LEU . 22.2 mm-40 -111.36 143.98 41.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.376 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.675 HG22 ' HB2' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -127.3 100.34 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 120.972 0.415 . . . . 0.0 110.349 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.994 ' CD2' HD11 ' A' ' 48' ' ' LEU . 8.3 m-30 -94.19 116.31 28.69 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.3 0.572 . . . . 0.0 112.155 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . -177.16 -90.52 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.213 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 m 48.57 29.71 2.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.76 0.314 . . . . 0.0 111.528 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.86 108.85 0.23 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.499 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t 59.78 27.17 16.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 110.994 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.492 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -124.73 132.47 53.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.896 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.731 ' O ' HG21 ' A' ' 66' ' ' VAL . 1.6 m120 -76.12 20.74 0.19 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.699 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.675 ' HB2' HG22 ' A' ' 6' ' ' ILE . 1.8 p -51.51 -28.96 15.0 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.953 0.406 . . . . 0.0 111.128 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -36.18 73.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.008 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.433 ' CB ' HG11 ' A' ' 66' ' ' VAL . 14.3 mtt -68.62 -50.67 49.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.354 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.766 HD11 HD12 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -71.09 -31.19 67.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.994 0.426 . . . . 0.0 110.628 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -58.48 -42.36 87.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.617 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.45 -42.4 62.01 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 36.1 p30 -74.96 -34.62 62.07 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.734 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.544 ' HB2' HD23 ' A' ' 17' ' ' LEU . . . -66.28 -50.44 63.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.558 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.57 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -59.91 -44.46 94.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.583 0.23 . . . . 0.0 111.457 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 41.7 tp10 -72.69 -50.17 26.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.622 0.248 . . . . 0.0 110.966 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -62.34 -51.8 66.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.692 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.798 HG11 ' HB3' ' A' ' 32' ' ' ALA . 4.0 p -53.3 -54.91 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.914 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.519 ' N ' HG13 ' A' ' 25' ' ' VAL . 11.1 mtmm -67.27 -46.6 73.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.636 0.255 . . . . 0.0 111.112 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.435 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -58.57 -46.24 87.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.359 -179.576 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.709 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -52.01 -21.83 3.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.924 0.393 . . . . 0.0 110.851 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.79 50.3 0.52 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.528 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 6.8 tt 178.03 122.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.238 0.542 . . . . 0.0 111.371 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.426 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -62.94 164.54 8.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.373 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.946 ' HB1' HD12 ' A' ' 4' ' ' ILE . . . -153.59 151.52 29.84 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -111.91 113.47 25.8 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.05 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.877 ' CE2' HD13 ' A' ' 4' ' ' ILE . 69.0 m-85 -99.85 108.81 21.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.281 0.563 . . . . 0.0 111.634 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -107.24 110.63 22.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.257 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -84.44 136.83 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.69 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.94 HD12 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -113.0 164.37 8.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.064 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -140.62 75.43 1.51 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.992 0.425 . . . . 0.0 110.73 179.553 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 1.4 mm-40 155.26 132.81 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.828 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.608 ' HA ' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -57.02 -28.43 62.49 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.709 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.518 ' HA ' HD22 ' A' ' 44' ' ' LEU . 1.7 m-20 -51.5 -33.58 32.17 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -86.93 -33.07 19.81 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.356 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.722 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 0.9 OUTLIER -71.19 -50.82 39.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 CA-C-O 121.083 0.468 . . . . 0.0 111.601 -179.387 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -57.22 -36.21 70.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.58 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.47 ' H ' HD23 ' A' ' 44' ' ' LEU . 2.1 mm-40 -53.73 -25.42 18.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.973 0.416 . . . . 0.0 110.173 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.893 ' HB1' HD11 ' A' ' 60' ' ' LEU . . . -78.67 -46.33 19.39 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.387 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.93 -20.6 4.52 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.518 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.994 HD11 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -69.0 155.67 39.95 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.895 0.379 . . . . 0.0 111.068 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.86 -16.22 12.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.394 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.51 ' HB1' ' HA2' ' A' ' 64' ' ' GLY . . . -89.19 -179.14 5.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.791 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.605 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.6 mp -83.72 -63.95 0.24 Allowed Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 16.4 Cg_exo -67.45 51.58 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.392 2.061 . . . . 0.0 112.927 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.74 116.75 4.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.22 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.916 HD13 ' O ' ' A' ' 5' ' ' GLN . 3.0 mm? -106.05 107.19 18.06 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.625 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -98.28 123.53 42.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.038 0.447 . . . . 0.0 111.632 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.726 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.37 139.01 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.919 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.8 t70 46.68 27.81 0.71 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.355 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.87 37.55 50.68 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.233 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -150.09 101.84 3.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 111.304 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.893 HD11 ' HB1' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -46.0 133.37 8.87 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.015 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.79 -16.8 2.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.994 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.766 HD12 HD11 ' A' ' 17' ' ' LEU . 15.6 mt -154.34 111.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.586 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -145.64 150.91 37.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.021 0.439 . . . . 0.0 111.627 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.51 ' HA2' ' HB1' ' A' ' 50' ' ' ALA . . . 83.4 -5.18 78.73 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.544 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 45.2 ttp85 174.25 106.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.743 0.306 . . . . 0.0 110.423 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.731 HG21 ' O ' ' A' ' 13' ' ' ASN . 2.6 t -54.34 141.06 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.651 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.476 ' HB3' HD13 ' A' ' 62' ' ' ILE . . . -87.83 142.27 27.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.043 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.4 t -63.66 156.95 25.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.1 -30.4 25.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.284 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -42.2 96.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.837 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.414 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 2.0 tp10 -67.18 -41.87 85.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.995 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.7 mm -58.88 -53.19 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -61.37 -34.23 74.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.842 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -73.73 -30.87 63.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 75' ' ' ILE . 9.0 mm -76.1 -36.78 31.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.978 0.418 . . . . 0.0 110.237 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.65 -33.23 35.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.489 ' O ' HD21 ' A' ' 28' ' ' LEU . 20.9 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.955 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.437 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.452 0.168 . . . . 0.0 111.179 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.812 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -82.64 112.84 19.88 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.08 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.6 104.9 2.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.128 0.489 . . . . 0.0 110.253 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.028 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 2.2 mp -108.57 127.57 64.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.39 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -110.29 125.6 53.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.016 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.824 HG23 ' HB2' ' A' ' 14' ' ' CYS . 3.3 mp -103.93 98.3 6.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.324 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.871 ' CZ ' ' HB2' ' A' ' 46' ' ' ALA . 93.8 m-85 -93.5 116.92 29.46 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 120.926 0.393 . . . . 0.0 111.2 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 118.37 -1.99 16.21 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.088 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 9' ' ' THR . 7.6 t -40.05 120.1 1.12 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 111.668 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.3 -54.43 0.54 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.338 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.1 m -101.98 -33.01 9.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.917 0.389 . . . . 0.0 110.73 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.441 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -86.32 152.3 22.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.015 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -75.95 8.99 2.66 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.7 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.824 ' HB2' HG23 ' A' ' 6' ' ' ILE . 3.4 p -54.19 -30.99 51.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.998 0.427 . . . . 0.0 111.273 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -36.59 42.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.601 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 10.4 tpp -63.77 -62.44 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.092 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.88 HD11 HD11 ' A' ' 72' ' ' ILE . 6.5 tp -65.66 -24.7 67.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.697 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -55.7 -50.42 70.35 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.849 0.357 . . . . 0.0 110.136 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -47.07 76.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.693 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -56.11 -44.62 79.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.16 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.48 -40.84 83.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.805 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.574 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -59.11 -46.81 87.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.659 0.266 . . . . 0.0 111.245 -179.604 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 10.8 pt-20 -71.95 -47.33 53.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.226 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.5 -50.74 70.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.674 HG21 ' HB2' ' A' ' 32' ' ' ALA . 5.9 p -53.62 -55.74 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.591 0.234 . . . . 0.0 110.763 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.552 ' N ' HG13 ' A' ' 25' ' ' VAL . 21.3 mtpp -66.99 -49.9 63.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.38 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 2.0 tt0 -52.86 -48.19 67.26 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.59 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.551 ' CD1' HD22 ' A' ' 76' ' ' LEU . 4.6 mt -52.46 -21.26 3.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.86 0.362 . . . . 0.0 110.719 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.55 30.68 2.56 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.311 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.518 HG21 ' CE ' ' A' ' 2' ' ' MET . 0.4 OUTLIER -156.75 107.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.963 0.411 . . . . 0.0 111.075 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.437 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.7 OUTLIER -61.56 164.16 6.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.042 179.331 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.812 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -152.53 175.66 12.52 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -129.6 114.14 15.69 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 1.028 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 40.8 m-85 -102.13 108.94 20.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.553 0.692 . . . . 0.0 112.278 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -118.38 129.45 55.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.008 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.817 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -78.98 153.09 30.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.103 0.478 . . . . 0.0 111.127 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.817 HD13 ' C ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -128.14 76.56 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.463 -178.829 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.53 75.65 4.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.061 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 43' ' ' ILE . 6.5 pt-20 171.47 125.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.609 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.675 ' HA ' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -59.92 -30.48 69.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.58 0.229 . . . . 0.0 110.973 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.473 ' O ' HD23 ' A' ' 44' ' ' LEU . 4.5 m-20 -51.23 -33.75 29.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.424 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 28.3 mm100 -87.91 -34.57 18.1 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.984 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.691 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 2.5 pt -61.86 -51.37 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.056 0.455 . . . . 0.0 111.029 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.65 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -62.84 -41.34 99.3 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.022 179.56 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.65 ' H ' HD23 ' A' ' 44' ' ' LEU . 5.5 tt0 -58.98 -22.41 60.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.945 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.871 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -75.27 -39.76 59.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.729 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.734 ' HA3' HD21 ' A' ' 60' ' ' LEU . . . 123.4 -20.43 7.44 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.084 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.513 HD11 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -77.28 163.75 26.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.1 m -115.58 -23.35 8.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.902 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.866 ' HB3' ' CB ' ' A' ' 63' ' ' MET . . . -78.84 173.26 12.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.47 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.631 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -78.72 -64.75 0.35 Allowed Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.292 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.631 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 15.4 Cg_exo -67.17 59.14 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.406 2.071 . . . . 0.0 112.426 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.478 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -80.9 136.83 17.01 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.602 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.595 HD22 ' CD2' ' A' ' 17' ' ' LEU . 3.1 tp -127.1 98.2 5.22 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.716 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -97.38 122.72 40.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.087 0.47 . . . . 0.0 111.079 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.911 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -112.94 139.98 35.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.989 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 45.5 27.05 0.36 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.726 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.2 39.44 31.81 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.31 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -149.03 100.9 3.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 111.314 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.734 HD21 ' HA3' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -51.31 131.4 28.34 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.798 179.456 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.05 -16.79 4.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.015 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.594 HD13 ' H ' ' A' ' 67' ' ' ALA . 2.1 mt -152.69 131.8 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.987 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.866 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.96 135.19 22.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.392 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.487 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 92.85 -10.56 73.74 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.474 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 165.69 106.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.623 ' HB ' HD22 ' A' ' 17' ' ' LEU . 5.8 m -53.05 166.09 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.793 0.33 . . . . 0.0 111.186 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.594 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -82.5 -173.98 4.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.151 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.0 t -97.77 168.85 10.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -58.1 -54.4 47.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -56.24 -39.49 72.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.982 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -56.94 -43.0 81.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 17' ' ' LEU . 47.4 mm -57.9 -55.22 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.972 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -61.48 -36.4 80.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.906 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.16 -28.98 61.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 75' ' ' ILE . 8.6 mm -76.01 -35.76 30.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.308 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.765 HD12 ' O ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -78.41 -31.98 48.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.047 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.2 p . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.953 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.408 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.567 0.222 . . . . 0.0 111.291 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.789 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 3.1 ttt -82.68 114.04 20.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.917 0.389 . . . . 0.0 110.97 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.39 118.87 17.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.938 0.399 . . . . 0.0 110.576 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.031 HG13 HG12 ' A' ' 56' ' ' VAL . 2.7 mp -125.61 118.1 51.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.092 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.642 ' CB ' HD11 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -111.14 122.57 48.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.799 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.691 HG22 HD22 ' A' ' 54' ' ' LEU . 13.8 pt -104.63 110.72 31.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 CA-C-O 120.848 0.356 . . . . 0.0 111.08 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.755 ' CE1' HG13 ' A' ' 37' ' ' ILE . 93.7 m-85 -90.74 122.88 33.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.038 0.447 . . . . 0.0 111.431 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.446 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 127.83 -65.85 0.57 Allowed Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.182 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.3 m 66.07 -73.1 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.734 0.302 . . . . 0.0 111.64 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.75 -96.37 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.853 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.8 -23.55 7.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.654 0.264 . . . . 0.0 111.508 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.446 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -82.8 121.89 27.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.913 0.387 . . . . 0.0 111.357 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -76.77 21.34 0.21 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.859 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.508 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.7 p -52.83 -24.43 8.99 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.89 0.376 . . . . 0.0 111.363 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.63 -28.02 3.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.506 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -62.51 1.51 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.836 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.659 HD13 ' HB3' ' A' ' 67' ' ' ALA . 4.0 tp -68.38 -20.05 64.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.806 0.336 . . . . 0.0 110.508 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -59.12 -49.91 76.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.251 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -50.05 24.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.812 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.41 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 3.3 m-20 -56.28 -50.82 70.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.114 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.638 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -56.6 -41.87 77.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.574 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.484 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 3.0 mtm180 -60.73 -44.43 96.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.578 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.488 ' HG3' ' N ' ' A' ' 24' ' ' ALA . 14.8 pt-20 -73.33 -45.95 52.27 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.925 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' N ' ' HG3' ' A' ' 23' ' ' GLU . . . -64.01 -49.23 73.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.98 HG21 ' HB2' ' A' ' 32' ' ' ALA . 14.0 p -53.44 -55.52 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.458 0.171 . . . . 0.0 110.842 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.589 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.09 -43.03 79.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.549 0.214 . . . . 0.0 110.926 179.208 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 13.4 tt0 -58.57 -47.0 85.72 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.731 0.3 . . . . 0.0 110.971 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.663 ' HG ' HD22 ' A' ' 76' ' ' LEU . 1.6 mm? -54.44 -20.43 7.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.9 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.765 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.57 41.72 0.93 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.554 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -173.89 110.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.42 . . . . 0.0 111.288 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.408 ' O ' ' CA ' ' A' ' 1' ' ' MET . 38.6 t70 -61.38 163.63 6.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.375 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.98 ' HB2' HG21 ' A' ' 25' ' ' VAL . . . -145.39 174.8 10.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -131.85 109.02 9.81 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.99 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 18.7 m-85 -100.85 108.84 20.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.503 0.668 . . . . 0.0 112.018 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.419 ' O ' HD13 ' A' ' 37' ' ' ILE . 68.1 tt0 -119.77 131.17 55.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.94 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.499 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -80.3 141.94 35.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.006 0.431 . . . . 0.0 110.646 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.755 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -116.76 70.62 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.481 -179.335 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 75.39 1.91 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.18 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.54 ' O ' HG13 ' A' ' 43' ' ' ILE . 1.3 mt-10 174.85 119.78 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.699 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.497 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 17.0 ptp -53.05 -27.76 21.39 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.467 0.175 . . . . 0.0 110.927 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.446 ' O ' HD23 ' A' ' 44' ' ' LEU . 4.5 m-20 -51.55 -39.87 58.6 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.49 ' HB3' HG21 ' A' ' 37' ' ' ILE . 1.9 mm-40 -87.74 -35.53 17.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.531 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.058 HG22 HD21 ' A' ' 48' ' ' LEU . 11.7 mt -62.06 -54.91 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.154 0.502 . . . . 0.0 111.216 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -58.88 -32.33 69.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.209 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' N ' HD23 ' A' ' 44' ' ' LEU . 1.6 tt0 -59.38 -38.65 81.06 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 1.034 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -68.71 -40.67 79.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.59 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.46 26.0 55.53 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.116 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.058 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -47.19 -87.43 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.25 0.525 . . . . 0.0 111.061 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.495 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 1.5 m 147.67 -25.52 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.563 0.745 . . . . 0.0 109.4 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.62 ' HB3' ' N ' ' A' ' 64' ' ' GLY . . . -122.15 -166.79 1.45 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.838 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.557 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -83.7 -59.52 0.36 Allowed Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.575 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.565 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 11.9 Cg_exo -70.06 57.76 1.64 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.5 2.133 . . . . 0.0 112.524 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -81.44 139.45 20.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.699 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.919 HD11 HG23 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -137.03 110.77 8.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.723 0.297 . . . . 0.0 110.944 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -99.55 123.27 43.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.035 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.031 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -115.48 137.21 49.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.307 0.575 . . . . 0.0 111.836 -179.116 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 46.62 27.45 0.65 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.738 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.8 33.41 37.6 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.315 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -148.27 97.88 2.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.863 0.363 . . . . 0.0 111.081 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.034 HD21 ' HB1' ' A' ' 46' ' ' ALA . 2.0 mp -60.74 134.64 57.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.03 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 2.52 1.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.775 HG21 ' HA ' ' A' ' 66' ' ' VAL . 3.9 mp -137.78 127.6 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.632 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.46 ' CG ' ' HB2' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -147.34 126.79 13.18 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.62 ' N ' ' HB3' ' A' ' 50' ' ' ALA . . . 77.06 4.57 83.63 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.506 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 178.36 108.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.741 0.271 . . . . 0.0 110.504 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.919 HG23 HD11 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -59.54 139.12 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.659 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.659 ' HB3' HD13 ' A' ' 17' ' ' LEU . . . -63.93 168.2 5.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.811 0.339 . . . . 0.0 111.346 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.4 t -103.28 -174.77 2.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.148 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.867 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -60.39 -57.26 13.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.137 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -53.46 -33.96 56.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.143 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.515 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 0.4 OUTLIER -63.87 -37.71 88.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 69' ' ' LYS . 8.2 mt -64.98 -55.07 22.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.977 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -34.41 72.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -74.1 -31.66 62.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.947 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 mm -76.14 -36.46 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.293 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.663 HD22 ' HG ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -74.69 -31.78 61.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.003 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.4 t . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.909 -179.899 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.433 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 2.6 mtm . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.616 0.246 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.529 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -76.45 113.32 13.93 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.987 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.29 118.59 12.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.411 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.713 HG21 ' CD2' ' A' ' 34' ' ' PHE . 7.4 mt -129.18 119.59 49.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.078 0.466 . . . . 0.0 112.117 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -112.0 123.89 51.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.333 178.87 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.517 ' C ' HD11 ' A' ' 37' ' ' ILE . 2.9 mp -101.74 111.82 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.661 0.267 . . . . 0.0 111.32 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.937 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 98.2 m-85 -95.17 108.59 20.72 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.073 0.463 . . . . 0.0 111.525 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.678 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 140.47 -82.3 0.24 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.468 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.504 HG23 ' HD3' ' A' ' 36' ' ' LYS . 10.8 m 69.68 -68.71 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 0.0 111.397 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.15 -92.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.635 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 m -54.47 -28.73 46.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 111.129 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.678 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -90.62 117.21 29.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.149 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -76.24 15.71 0.54 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.9 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.5 p -57.53 -19.92 28.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.742 0.306 . . . . 0.0 111.419 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -47.39 -28.79 2.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.572 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -60.29 3.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.73 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.688 HD22 ' OD1' ' A' ' 20' ' ' ASN . 0.5 OUTLIER -59.45 -37.84 79.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.383 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -54.37 -36.06 63.47 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.883 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -71.48 -52.45 18.3 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.531 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.688 ' OD1' HD22 ' A' ' 17' ' ' LEU . 28.4 p30 -62.68 -33.01 74.21 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.782 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . -58.89 -44.47 91.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.081 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.574 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 13.1 mtp180 -58.32 -52.64 64.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.292 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.41 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 2.7 pp20? -68.06 -50.12 57.15 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.378 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.634 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -60.87 -51.53 68.93 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.878 HG11 ' HB3' ' A' ' 32' ' ' ALA . 3.9 p -53.66 -55.64 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.883 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.525 ' N ' HG13 ' A' ' 25' ' ' VAL . 7.1 mttt -66.41 -50.25 64.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.689 0.28 . . . . 0.0 111.441 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -57.68 -41.48 81.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.384 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.67 HD21 ' HG2' ' A' ' 73' ' ' LYS . 1.7 mm? -53.57 -19.15 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.914 0.387 . . . . 0.0 110.899 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.76 26.23 3.96 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.409 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -156.5 112.25 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.785 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.433 ' O ' ' CA ' ' A' ' 1' ' ' MET . 2.3 m-20 -61.67 159.89 12.56 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.878 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -152.03 153.72 34.57 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -114.91 114.97 26.18 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.218 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.713 ' CD2' HG21 ' A' ' 4' ' ' ILE . 18.1 m-85 -98.75 108.94 21.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.361 0.601 . . . . 0.0 111.431 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -110.76 110.73 21.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.1 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.504 ' HD3' HG23 ' A' ' 9' ' ' THR . 0.1 OUTLIER -82.37 137.54 34.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.877 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.78 HG13 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -102.9 176.58 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.666 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 4.3 pttt -160.1 75.49 0.6 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.883 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.506 ' O ' HG13 ' A' ' 43' ' ' ILE . 1.4 mt-10 158.14 128.53 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.564 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.533 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -56.58 -29.81 62.47 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 121.366 -0.134 . . . . 0.0 110.867 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.422 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -51.46 -36.37 43.92 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.604 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -86.67 -36.94 18.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.95 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.937 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 40.4 mt -58.95 -55.49 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.731 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -61.35 -36.74 81.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.631 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.603 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -55.79 -25.39 40.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.019 0.438 . . . . 0.0 110.335 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.711 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -70.93 -34.84 71.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.792 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.39 -17.87 9.57 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.745 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.81 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -83.2 169.35 15.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.936 0.398 . . . . 0.0 111.324 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.4 p -124.07 -30.1 3.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.91 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.423 ' HB1' ' HA2' ' A' ' 64' ' ' GLY . . . -68.2 -178.62 1.08 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.216 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.595 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.5 mp -86.39 -63.59 0.22 Allowed Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.658 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.892 ' O ' HD12 ' A' ' 62' ' ' ILE . 17.0 Cg_exo -66.27 63.92 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.033 1.822 . . . . 0.0 111.709 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -104.04 145.52 16.11 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.098 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.853 ' HB3' HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -150.33 129.8 13.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.0 0.429 . . . . 0.0 110.165 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.741 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -103.55 125.03 49.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.021 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.852 HG13 HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -112.62 135.45 52.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.194 0.521 . . . . 0.0 111.45 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 48.12 27.35 1.23 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.257 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.75 38.64 31.12 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.344 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -154.98 99.52 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.827 0.346 . . . . 0.0 111.148 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.741 ' CD1' ' HB2' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -43.79 126.93 4.91 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.057 179.72 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.518 ' HE2' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -117.95 -17.68 9.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.91 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.946 HD13 HG12 ' A' ' 66' ' ' VAL . 1.3 pt -137.33 140.42 42.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.068 0.461 . . . . 0.0 112.103 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.461 ' HG3' ' HB2' ' A' ' 48' ' ' LEU . 1.6 ttm -145.98 114.63 6.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.606 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.573 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 88.75 -14.26 60.58 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 119.688 -1.244 . . . . 0.0 112.866 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -178.44 114.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.648 0.261 . . . . 0.0 110.355 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.946 HG12 HD13 ' A' ' 62' ' ' ILE . 28.8 m -54.21 -173.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.12 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.94 143.21 30.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.92 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.2 m -65.9 162.43 19.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -47.59 84.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -67.14 -29.91 69.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.508 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.507 ' O ' HD12 ' A' ' 75' ' ' ILE . 2.4 tp10 -74.03 -42.0 60.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.067 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.563 HD13 HD21 ' A' ' 17' ' ' LEU . 1.1 tt -73.74 -48.47 39.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.346 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.67 ' HG2' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -59.94 -39.7 86.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.384 -179.78 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -74.08 -27.83 61.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.978 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.518 HD13 ' HE2' ' A' ' 61' ' ' LYS . 32.2 mt -75.71 -36.79 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.12 0.486 . . . . 0.0 109.997 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.511 HD21 HG23 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -75.15 -30.77 60.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.943 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.967 -179.974 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 6.2 mtp . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.652 0.263 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.529 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -73.26 115.46 12.64 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.68 179.588 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.09 106.65 2.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.98 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.925 HG12 HG12 ' A' ' 56' ' ' VAL . 3.5 mt -122.45 124.88 71.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.743 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.438 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 2.5 mm-40 -110.75 138.9 46.57 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.856 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.512 ' C ' HD11 ' A' ' 37' ' ' ILE . 22.4 mt -114.24 104.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.944 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 94.5 m-85 -92.78 109.27 20.7 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.986 0.422 . . . . 0.0 111.369 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.529 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 134.55 -44.16 1.21 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.679 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 36' ' ' LYS . 82.4 p 52.73 -85.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 8' ' ' GLY . . . -94.71 -52.4 1.82 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.709 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 m -53.1 -26.38 16.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 111.098 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.529 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -111.55 147.23 35.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.143 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -76.29 15.32 0.6 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.953 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.451 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.3 p -57.3 -19.88 24.82 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.707 0.289 . . . . 0.0 111.493 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.62 -32.08 7.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.403 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 mtt -63.31 -62.08 1.92 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.559 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.756 HD22 HD13 ' A' ' 54' ' ' LEU . 4.0 tt -63.92 -19.81 65.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.644 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -59.35 -54.13 50.32 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.56 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -71.9 -40.23 69.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.262 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -64.54 -41.69 96.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.195 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HB2' HD23 ' A' ' 17' ' ' LEU . . . -62.49 -45.89 90.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.814 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.511 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -57.39 -42.52 82.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.617 0.246 . . . . 0.0 111.238 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 14.9 pt-20 -73.88 -49.22 25.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.321 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.8 -50.4 69.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.863 HG11 ' HB3' ' A' ' 32' ' ' ALA . 4.2 p -53.57 -52.84 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.357 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.486 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.23 -41.83 80.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.724 0.297 . . . . 0.0 110.742 178.688 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.421 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 1.1 tp10 -62.07 -43.79 98.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.418 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.968 HD22 HD21 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -52.0 -19.49 1.87 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.791 0.329 . . . . 0.0 111.027 179.898 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.52 44.58 0.7 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.8 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.2 tt 175.88 121.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.264 0.554 . . . . 0.0 111.158 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.43 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 3.6 t0 -62.53 163.81 8.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.849 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.863 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -151.09 152.51 33.52 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.549 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -112.72 118.39 34.87 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.317 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.888 ' CE2' HD12 ' A' ' 4' ' ' ILE . 22.2 m-85 -101.78 109.39 21.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.339 0.59 . . . . 0.0 111.707 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -105.42 114.67 28.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.003 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.569 ' HB3' HG22 ' A' ' 9' ' ' THR . 11.7 mttt -82.11 139.17 34.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.089 0.471 . . . . 0.0 110.813 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.799 HG13 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -104.49 175.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.682 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 7.0 ptmt -160.36 75.32 0.57 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.017 0.437 . . . . 0.0 110.916 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.514 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER 157.63 127.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.405 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.559 ' HA ' HD12 ' A' ' 43' ' ' ILE . 17.7 mtp -54.77 -28.51 49.3 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.987 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.462 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -51.34 -37.82 49.9 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.778 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -86.95 -36.52 18.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.952 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.944 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 25.9 mt -60.01 -55.26 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.767 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -61.79 -34.5 76.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.719 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -60.64 -21.91 63.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 0.0 110.084 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.792 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -71.9 -34.76 69.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.615 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.22 -20.42 7.07 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.874 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.901 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -83.32 176.69 8.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 111.026 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.3 m -126.59 -34.94 2.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.223 0.535 . . . . 0.0 110.486 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.11 -173.11 0.35 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.707 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.582 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.4 mp -92.48 -63.55 0.16 Allowed Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.456 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.628 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 28.6 Cg_exo -60.78 63.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.218 1.945 . . . . 0.0 112.645 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -103.84 147.17 16.56 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.973 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.756 HD13 HD22 ' A' ' 17' ' ' LEU . 5.6 tt -144.58 118.26 9.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.827 0.346 . . . . 0.0 110.862 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.658 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -99.57 122.65 42.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.037 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.925 HG12 HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -116.49 136.35 53.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.511 -179.836 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 46.75 28.17 0.78 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.898 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.47 30.39 58.46 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.433 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -142.97 103.95 4.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.892 0.377 . . . . 0.0 110.949 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.776 HD21 ' O ' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -54.98 127.32 28.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.06 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.752 ' O ' HD12 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -129.68 -9.15 4.52 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.787 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.752 HD12 ' O ' ' A' ' 61' ' ' LYS . 1.6 mp -134.4 127.73 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.573 0.225 . . . . 0.0 110.408 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 19.2 tmm? -146.81 116.51 7.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.83 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.628 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 70.19 3.27 44.82 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.121 -1.038 . . . . 0.0 113.651 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.97 96.6 0.21 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.919 0.359 . . . . 0.0 110.504 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.632 HG22 ' CB ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -68.27 129.62 32.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.813 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.522 ' HB3' ' CD1' ' A' ' 17' ' ' LEU . . . -63.79 166.04 7.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 111.345 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.9 m -98.29 173.02 7.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -57.06 -47.34 81.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.79 -36.12 76.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.966 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.42 -38.18 90.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.038 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.634 HD11 HD11 ' A' ' 17' ' ' LEU . 45.0 mm -61.63 -55.17 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.185 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -52.48 -34.82 50.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.255 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -74.2 -41.5 61.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.236 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -76.01 -24.46 16.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 110.872 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.968 HD21 HD22 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -95.73 -26.98 15.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.065 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.816 -179.955 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 2.4 mpp? . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.432 0.158 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.868 ' O ' HD12 ' A' ' 4' ' ' ILE . 2.1 ttt -80.05 112.5 17.41 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.861 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -69.78 114.69 8.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.638 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.027 HG13 HG12 ' A' ' 56' ' ' VAL . 2.3 mp -123.24 120.7 61.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.674 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -110.83 128.28 55.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.321 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.476 HD13 ' HG3' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -113.39 109.0 26.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.683 0.277 . . . . 0.0 111.474 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.919 ' CD2' ' HA ' ' A' ' 43' ' ' ILE . 40.2 m-85 -93.69 119.2 32.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.952 0.406 . . . . 0.0 110.636 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.629 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . -173.71 -85.77 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.498 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.7 m 56.61 77.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 0.0 110.794 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.02 117.66 3.54 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.068 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 78.89 -56.97 0.44 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.69 0.281 . . . . 0.0 110.934 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.629 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -54.73 122.08 9.92 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.916 0.389 . . . . 0.0 111.053 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -76.38 20.87 0.2 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.171 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.458 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.3 p -52.15 -25.98 10.26 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.004 0.43 . . . . 0.0 111.181 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -31.93 72.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.643 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.5 mtp -63.52 -62.67 1.52 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.307 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.799 HD23 ' O ' ' A' ' 67' ' ' ALA . 1.1 tm? -67.79 -21.48 65.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.8 0.333 . . . . 0.0 110.629 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.476 ' HG3' HD13 ' A' ' 6' ' ' ILE . 7.4 tt0 -57.81 -48.3 80.14 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.229 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -71.54 -46.41 59.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.768 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -59.28 -36.27 75.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.149 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.512 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -66.86 -50.4 62.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.108 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.51 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 20.8 ttt180 -55.66 -37.83 68.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.519 0.199 . . . . 0.0 111.406 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 23.7 pt-20 -74.24 -48.31 29.57 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.111 -0.236 . . . . 0.0 111.229 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.77 -50.95 67.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.842 HG21 ' HB2' ' A' ' 32' ' ' ALA . 8.9 p -53.8 -55.42 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.717 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.572 ' N ' HG13 ' A' ' 25' ' ' VAL . 5.6 mtpm? -66.94 -49.49 65.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.108 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.454 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 45.6 tp10 -56.29 -43.77 79.19 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 110.762 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.817 HD22 ' HB3' ' A' ' 76' ' ' LEU . 22.7 tp -53.11 -22.12 5.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.557 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.65 44.73 0.75 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.442 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.0 tt 179.76 124.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.308 0.575 . . . . 0.0 111.505 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -67.66 165.22 17.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.472 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.86 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -146.12 178.26 8.35 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.78 106.39 8.66 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.861 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.935 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 66.0 m-85 -99.4 109.0 21.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.424 0.63 . . . . 0.0 111.947 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.36 136.48 54.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.556 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.813 ' C ' HD13 ' A' ' 37' ' ' ILE . 4.9 ttpm? -89.37 153.64 20.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.12 0.486 . . . . 0.0 111.112 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.813 HG13 ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -126.47 83.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.307 -179.073 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.55 75.35 9.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.138 0.494 . . . . 0.0 111.636 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.6 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER 173.07 118.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.789 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.506 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 6.2 ptt? -53.53 -35.31 60.56 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.945 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.445 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -51.42 -35.78 40.77 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.562 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -86.63 -35.2 19.52 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.98 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.935 HG22 HD21 ' A' ' 48' ' ' LEU . 23.3 mt -60.32 -55.9 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.553 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -64.02 -34.35 77.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.2 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -60.21 -21.26 61.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.406 . . . . 0.0 110.155 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.801 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -72.61 -38.38 67.81 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.704 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.35 -14.62 7.76 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.473 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.935 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.02 158.0 35.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.364 0.582 . . . . 0.0 111.119 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.5 t -107.42 -10.33 15.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.04 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.471 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -102.51 -175.28 2.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.304 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.588 ' N ' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -89.64 -54.49 0.31 Allowed Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.616 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.649 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 11.1 Cg_exo -70.29 52.16 1.14 Allowed 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 122.626 2.218 . . . . 0.0 112.414 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -71.95 156.9 52.78 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.253 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.552 HD12 HG23 ' A' ' 66' ' ' VAL . 0.7 OUTLIER -154.36 101.49 2.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.844 0.354 . . . . 0.0 110.779 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.523 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -100.3 126.09 46.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.809 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.027 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -118.05 140.62 40.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.141 0.496 . . . . 0.0 111.572 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 44.91 27.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.252 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.75 34.68 30.47 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.443 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.32 99.84 3.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.639 HD21 ' O ' ' A' ' 46' ' ' ALA . 0.6 OUTLIER -69.9 131.31 44.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.019 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -146.09 11.45 1.2 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.719 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' A' ' 66' ' ' VAL . 3.2 mp -133.31 123.92 48.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.557 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 2.4 mtm -146.62 123.51 11.32 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.649 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 70.81 7.33 61.59 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.825 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.55 100.43 0.06 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.868 0.366 . . . . 0.0 110.588 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.712 HG22 ' CB ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -56.34 141.84 12.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.96 -179.623 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.799 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -63.66 172.35 2.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.902 0.382 . . . . 0.0 111.152 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -109.43 157.81 18.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.7 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.09 -41.18 71.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.206 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -60.14 -40.77 90.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.755 ' O ' HD12 ' A' ' 75' ' ' ILE . 1.1 mt-10 -64.6 -37.45 87.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.649 HD11 HD11 ' A' ' 17' ' ' LEU . 39.2 mm -59.72 -54.86 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.984 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -57.21 -33.31 67.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.033 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.52 -40.21 80.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.028 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 71' ' ' GLU . 2.2 mt -75.98 -38.2 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.362 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.817 ' HB3' HD22 ' A' ' 28' ' ' LEU . 43.6 mt -94.3 10.62 33.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.454 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.149 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.442 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 15.2 mmt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.463 0.173 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.955 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -81.31 112.36 18.54 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.836 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.42 ' CG ' ' HA ' ' A' ' 57' ' ' ASP . 17.3 ptpt -68.72 115.05 7.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.992 0.425 . . . . 0.0 110.583 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.931 HG13 HG12 ' A' ' 56' ' ' VAL . 1.5 mt -121.23 121.97 66.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.45 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.693 ' O ' HD22 ' A' ' 54' ' ' LEU . 2.5 mt-30 -110.54 134.87 51.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.604 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.538 HG22 ' SG ' ' A' ' 14' ' ' CYS . 1.6 mp -119.93 113.71 41.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.398 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.891 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 48.9 m-85 -104.27 116.59 32.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.578 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 138.42 -78.36 0.31 Allowed Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.493 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m 69.27 -66.41 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 111.209 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.58 -96.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.708 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.6 m -63.73 -46.14 86.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 0.0 111.187 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.578 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -54.44 118.99 4.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.285 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -76.34 14.91 0.66 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.989 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' HG22 ' A' ' 6' ' ' ILE . 2.3 p -57.36 -19.83 25.33 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.755 0.312 . . . . 0.0 111.511 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -35.5 34.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.194 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.4 mmt -63.84 -62.07 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.793 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.792 HD13 ' O ' ' A' ' 17' ' ' LEU . 3.3 tm? -60.25 -30.03 69.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.66 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -54.7 -47.75 73.31 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.149 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -65.04 -39.78 93.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.481 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.467 ' HB2' HD22 ' A' ' 17' ' ' LEU . 1.2 m-20 -60.14 -51.04 71.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.753 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.708 ' HB3' ' HE2' ' A' ' 34' ' ' PHE . . . -54.01 -37.54 64.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.201 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.63 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 2.6 mtm-85 -59.92 -50.4 73.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 111.207 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.472 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 10.8 pt-20 -71.67 -47.75 52.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.075 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.13 -51.93 67.01 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.703 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.5 p -53.24 -55.54 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.684 0.278 . . . . 0.0 110.737 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.541 ' N ' HG13 ' A' ' 25' ' ' VAL . 7.5 mttm -67.51 -49.59 62.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.305 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 4.9 tt0 -53.99 -48.03 70.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.355 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -51.0 -22.47 2.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 110.671 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.63 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.57 34.64 1.7 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.648 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 29' ' ' GLY . 7.8 pt -161.98 112.85 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.872 0.368 . . . . 0.0 111.574 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.442 ' O ' ' CA ' ' A' ' 1' ' ' MET . 4.2 t70 -61.51 164.24 6.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.955 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -150.44 178.14 9.33 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -128.75 114.67 16.88 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.127 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.715 ' HE1' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -102.06 109.34 21.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.209 0.528 . . . . 0.0 111.218 -178.738 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -116.09 115.72 26.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.035 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.454 ' HG2' HD13 ' A' ' 6' ' ' ILE . 20.6 mtpt -90.19 140.32 29.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.975 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.891 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -111.98 179.14 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.477 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' N ' HG12 ' A' ' 37' ' ' ILE . 2.7 tmtt? -157.25 75.56 0.81 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.138 0.494 . . . . 0.0 110.452 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.7 OUTLIER 160.43 128.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.064 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.5 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -52.49 -27.41 16.2 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 121.25 -0.18 . . . . 0.0 110.831 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.488 ' O ' HD23 ' A' ' 44' ' ' LEU . 2.6 m-20 -51.7 -39.27 58.04 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -86.54 -37.7 17.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.024 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.975 HG22 HD21 ' A' ' 48' ' ' LEU . 16.4 mt -58.98 -55.36 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.094 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.63 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -61.24 -40.97 96.02 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.702 179.699 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.63 ' H ' HD23 ' A' ' 44' ' ' LEU . 36.8 tt0 -53.02 -26.13 14.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.972 0.415 . . . . 0.0 110.372 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.737 ' O ' HD11 ' A' ' 60' ' ' LEU . . . -70.36 -36.57 74.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.753 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.3 -13.37 16.15 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.907 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.975 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.3 162.96 26.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.904 0.352 . . . . 0.0 111.124 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.63 -17.83 11.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 111.67 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -87.48 175.61 7.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.654 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.611 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.7 mt -79.64 -63.88 0.35 Allowed Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.962 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 11.0 Cg_exo -70.04 58.91 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.278 1.985 . . . . 0.0 111.919 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -79.01 147.75 30.83 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.475 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.693 HD22 ' O ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -139.85 104.01 4.78 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.99 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -98.47 124.72 43.35 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.975 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.931 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -120.68 139.51 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.182 0.515 . . . . 0.0 112.218 -179.267 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.42 ' HA ' ' CG ' ' A' ' 3' ' ' LYS . 1.8 m-20 43.03 28.3 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.687 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.29 32.95 37.05 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.714 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.48 98.56 2.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.921 0.391 . . . . 0.0 110.468 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.99 HD23 ' HB2' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -70.2 133.75 47.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.827 -179.6 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.729 ' O ' HD12 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -141.29 6.68 1.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.72 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.729 HD12 ' O ' ' A' ' 61' ' ' LYS . 1.2 mp -127.88 125.78 65.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.662 0.268 . . . . 0.0 110.94 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.466 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 7.8 mtt -146.51 116.16 7.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.652 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.563 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 88.98 -13.24 63.65 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.134 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 179.46 114.42 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' ' 14' ' ' CYS . 3.6 m -52.11 179.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.392 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.722 ' HB2' HD11 ' A' ' 62' ' ' ILE . . . -91.71 177.31 6.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.1 p -99.67 158.49 15.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.806 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -52.64 -39.32 61.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.118 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -67.37 -38.78 85.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.01 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.47 -32.29 72.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.048 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.2 mm -71.08 -52.63 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.078 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -34.25 73.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.833 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -33.34 66.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.76 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 75' ' ' ILE . 9.0 mm -76.05 -36.8 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.227 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.56 -30.9 64.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.9 p . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.815 179.938 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 32' ' ' ALA . 10.8 mtt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.316 0.103 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.816 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 33.2 mmm -83.5 111.12 18.78 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.163 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.05 100.8 2.58 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.154 0.502 . . . . 0.0 110.44 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.662 HG21 ' CD2' ' A' ' 34' ' ' PHE . 1.7 mp -99.86 114.64 38.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.998 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.415 ' CA ' HD11 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -101.64 119.67 39.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.466 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.587 ' N ' HD11 ' A' ' 37' ' ' ILE . 26.3 mm -104.59 101.63 12.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 120.697 0.284 . . . . 0.0 111.574 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.737 ' CE1' HG13 ' A' ' 37' ' ' ILE . 79.4 m-85 -90.6 103.23 15.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.046 0.451 . . . . 0.0 110.739 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.879 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 160.39 -84.55 0.12 Allowed Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.986 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 t 40.44 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 112.001 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.07 -62.3 0.29 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.138 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 t -87.79 -30.79 19.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.98 0.419 . . . . 0.0 110.545 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.879 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -111.17 134.89 52.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.811 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.22 15.09 0.61 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.502 ' SG ' HG22 ' A' ' 6' ' ' ILE . 3.7 p -57.85 -20.13 34.06 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.67 0.271 . . . . 0.0 111.524 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -20.99 36.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.534 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.2 mtt -63.31 -62.43 1.7 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.771 0.319 . . . . 0.0 110.858 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.709 HD13 ' C ' ' A' ' 67' ' ' ALA . 4.0 tp -64.08 -22.45 66.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.34 . . . . 0.0 110.581 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.407 ' CG ' HG13 ' A' ' 6' ' ' ILE . 47.1 tt0 -56.18 -54.17 48.36 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.354 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.55 -46.73 78.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.95 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -54.78 -51.32 66.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.401 ' CB ' ' HE2' ' A' ' 34' ' ' PHE . . . -56.62 -36.73 69.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.806 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.533 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 44.2 mtp180 -57.26 -48.0 79.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 111.117 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 8.0 tt0 -72.39 -50.26 27.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.183 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.546 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -60.05 -51.08 71.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.609 HG11 ' HB3' ' A' ' 32' ' ' ALA . 2.4 p -53.64 -55.41 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.59 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.5 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 6.0 mttm -67.22 -50.36 61.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.681 0.277 . . . . 0.0 111.113 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 8.8 tt0 -52.01 -45.63 64.64 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.381 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 24' ' ' ALA . 2.6 mm? -52.99 -19.33 2.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.882 0.372 . . . . 0.0 110.608 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.872 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 113.37 21.31 5.89 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.599 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.872 HD13 ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -147.76 110.88 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.861 0.363 . . . . 0.0 110.899 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -64.92 162.81 15.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.345 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.816 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -149.27 -169.33 3.35 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -142.42 113.96 7.88 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.048 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.662 ' CD2' HG21 ' A' ' 4' ' ' ILE . 11.8 m-85 -105.75 109.13 20.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.569 0.699 . . . . 0.0 112.249 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -127.65 134.87 49.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.456 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.837 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -79.24 155.71 28.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.022 0.439 . . . . 0.0 110.905 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.837 HD13 ' C ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -126.21 80.34 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.663 -178.739 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -82.21 75.56 9.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.087 0.47 . . . . 0.0 111.143 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.545 ' O ' HG13 ' A' ' 43' ' ' ILE . 3.0 mm-40 173.52 121.7 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.67 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.543 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 1.6 tpt -53.88 -31.58 50.32 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.843 -0.162 . . . . 0.0 111.059 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.435 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -51.57 -37.96 52.19 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.814 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.443 ' CB ' HG22 ' A' ' 37' ' ' ILE . 47.9 mm-40 -86.9 -34.21 19.48 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.192 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.844 HG22 HD21 ' A' ' 48' ' ' LEU . 47.5 mt -59.76 -55.21 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.348 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -63.16 -38.37 90.9 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.048 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.664 ' H ' HD23 ' A' ' 44' ' ' LEU . 2.7 tt0 -56.11 -24.3 39.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.535 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.735 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -74.22 -34.78 63.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.974 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.43 -6.43 31.86 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.198 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.852 HD13 HD21 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -79.53 160.44 26.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.161 0.48 . . . . 0.0 111.643 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.51 HG22 ' HE2' ' A' ' 63' ' ' MET . 10.0 t -112.06 -30.09 7.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.743 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.447 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -77.58 -177.78 4.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.229 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.582 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.3 mp -87.98 -62.47 0.22 Allowed Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.912 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 16.9 Cg_exo -67.38 59.66 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.264 1.976 . . . . 0.0 112.255 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.8 139.52 17.92 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.574 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.647 ' CD1' HG23 ' A' ' 4' ' ' ILE . 16.3 tp -129.58 103.13 6.69 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.61 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -100.79 125.33 47.27 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.321 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.515 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.92 139.38 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.078 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 47.06 26.94 0.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.587 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.61 34.79 48.47 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.325 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -144.7 103.31 3.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.386 . . . . 0.0 111.197 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.852 HD21 HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -46.31 133.32 9.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.234 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -118.63 -23.7 6.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.532 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.618 HD13 ' HA ' ' A' ' 66' ' ' VAL . 2.8 pp -154.62 154.91 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.638 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 2.0 mtp -146.78 129.13 15.81 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.432 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.472 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 94.41 -20.51 47.77 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.369 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -179.79 112.18 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.785 0.326 . . . . 0.0 110.364 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.618 ' HA ' HD13 ' A' ' 62' ' ' ILE . 15.8 m -51.29 161.54 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.278 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.709 ' C ' HD13 ' A' ' 17' ' ' LEU . . . -64.1 -166.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.954 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.9 t -118.94 171.17 8.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.962 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -55.57 -56.64 17.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.066 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -59.77 -30.54 68.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.822 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -61.89 -46.38 89.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.654 HG22 HD12 ' A' ' 76' ' ' LEU . 43.5 mm -59.71 -54.25 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.882 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -58.76 -33.27 70.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -71.84 -36.78 70.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.3 mt -75.83 -38.36 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.34 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.654 HD12 HG22 ' A' ' 72' ' ' ILE . 35.4 mt -88.07 0.05 56.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.452 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.6 t . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.975 -179.967 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.437 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 4.8 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.523 0.201 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.83 ' O ' HD12 ' A' ' 4' ' ' ILE . 5.2 mmt -77.56 113.51 15.46 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.986 0.422 . . . . 0.0 110.808 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.81 100.51 1.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.084 0.468 . . . . 0.0 110.52 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.93 HG13 HG12 ' A' ' 56' ' ' VAL . 2.8 mp -109.24 128.79 64.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.933 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.735 ' O ' HD13 ' A' ' 54' ' ' LEU . 13.3 mm-40 -110.89 142.45 42.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.878 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.513 HG12 HD11 ' A' ' 54' ' ' LEU . 19.9 mt -122.09 115.0 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.196 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.863 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 86.6 m-85 -106.1 110.82 23.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.302 0.572 . . . . 0.0 112.134 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 155.78 -78.61 0.19 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.235 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 p 49.22 33.3 4.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.791 0.329 . . . . 0.0 111.584 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.38 -71.81 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.39 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.08 27.96 8.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 110.737 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.416 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -124.57 130.05 51.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.083 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -76.36 20.46 0.21 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.756 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.62 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.6 p -55.45 -19.86 10.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.796 0.332 . . . . 0.0 111.557 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.03 -41.47 47.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.787 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.0 mtp -63.74 -62.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.764 0.316 . . . . 0.0 111.218 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.059 HD21 HD11 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -59.47 -31.85 69.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.825 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.414 ' HG3' ' CD1' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -58.42 -40.05 81.45 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -73.28 -46.93 46.95 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.653 HD21 HD22 ' A' ' 17' ' ' LEU . 34.4 p30 -69.17 -34.3 74.74 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.151 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.495 ' HB1' ' HE2' ' A' ' 34' ' ' PHE . . . -63.06 -47.33 83.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.467 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.491 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -57.69 -47.5 82.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.712 0.291 . . . . 0.0 111.294 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.442 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 22.2 tp10 -72.75 -50.45 24.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.42 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.58 -49.1 76.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.783 HG11 ' HB3' ' A' ' 32' ' ' ALA . 3.8 p -53.36 -54.66 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.451 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.495 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.52 -43.43 76.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.619 0.247 . . . . 0.0 110.702 178.724 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 35.3 tt0 -57.28 -43.92 83.56 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.154 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.551 ' HB3' HD11 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -52.7 -19.12 2.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.8 0.333 . . . . 0.0 110.769 179.599 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.91 25.91 4.03 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.671 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.552 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -159.64 117.0 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.943 0.401 . . . . 0.0 111.443 179.698 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.452 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -61.46 164.79 5.35 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.242 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.783 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -148.78 165.74 30.53 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -125.13 110.05 13.64 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.042 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.842 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 30.3 m-85 -97.08 108.94 21.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.253 0.549 . . . . 0.0 111.418 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -112.97 115.58 28.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.809 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 136.62 33.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.032 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.863 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -101.66 -178.24 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.291 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.486 ' N ' HG12 ' A' ' 37' ' ' ILE . 3.3 ptmt -158.5 75.37 0.72 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.168 0.509 . . . . 0.0 110.651 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 0.2 OUTLIER 155.37 131.68 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.886 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' MET . . . . . 0.523 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 3.1 mpp? -52.61 -25.11 9.72 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.2 -0.2 . . . . 0.0 111.136 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.483 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.6 t0 -51.51 -39.82 58.39 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -86.54 -36.4 18.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.037 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.843 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 17.4 mt -59.67 -54.96 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.324 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -62.88 -38.58 91.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.835 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.556 ' H ' HD23 ' A' ' 44' ' ' LEU . 1.6 tp10 -55.63 -24.61 34.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.99 0.424 . . . . 0.0 110.294 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.793 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -72.62 -35.31 67.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.771 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.639 ' HA3' HD21 ' A' ' 60' ' ' LEU . . . 113.0 -11.76 24.67 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.973 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.79 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -81.48 161.72 23.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.076 0.438 . . . . 0.0 111.36 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.6 p -114.32 -25.48 8.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.16 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.84 ' HB3' ' CB ' ' A' ' 63' ' ' MET . . . -77.88 171.92 14.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.579 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.617 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.5 mp -77.99 -64.12 0.42 Allowed Pre-proline 0 C--N 1.332 -0.188 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.486 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.617 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 14.8 Cg_exo -67.9 58.13 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.239 1.959 . . . . 0.0 112.365 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.626 ' O ' HD22 ' A' ' 54' ' ' LEU . . . -84.26 137.69 16.23 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.926 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.735 HD13 ' O ' ' A' ' 5' ' ' GLN . 2.6 mm? -129.06 103.83 7.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.744 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -97.82 121.7 40.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.026 0.441 . . . . 0.0 111.422 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.93 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -112.95 139.16 39.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.826 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 47.96 26.41 0.96 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.553 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.13 33.16 50.51 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.502 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.09 102.27 3.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.827 0.346 . . . . 0.0 111.158 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.744 HD12 ' HB2' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -48.78 126.56 12.25 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.856 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -115.6 -21.9 9.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.7 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.496 HD13 ' H ' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -154.95 133.65 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.284 -179.392 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.84 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.88 138.02 25.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.355 178.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.509 ' N ' ' HB1' ' A' ' 50' ' ' ALA . . . 81.54 -3.54 77.94 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.816 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 179.61 100.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.34 . . . . 0.0 110.482 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' A' ' 14' ' ' CYS . 0.3 OUTLIER -65.5 141.3 18.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.961 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.496 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -63.93 -173.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.23 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.02 179.96 4.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.825 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.7 -46.19 87.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.212 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.61 -41.76 95.43 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.018 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.406 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 67.5 mm-40 -56.85 -44.05 81.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.075 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.059 HD11 HD21 ' A' ' 17' ' ' LEU . 40.3 mm -64.86 -55.1 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -36.21 73.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.935 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -74.4 -31.77 62.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.031 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.0 mt -75.51 -37.54 37.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.284 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.3 mt -87.42 -29.32 21.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.9 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . 1.441 ' CE ' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 1 N--CA 1.362 -4.861 0 N-CA-C 113.763 1.023 . . . . 2.66 113.763 . . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 2' ' ' MET . . . . . 1.381 ' CE ' ' CG ' ' A' ' 2' ' ' MET . 1.7 mtt -80.54 113.76 18.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.594 -0.442 . . . . 1.73 110.938 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -70.72 107.89 4.17 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.142 0.496 . . . . 2.22 110.406 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.72 HG13 HG12 ' A' ' 56' ' ' VAL . 3.6 mt -114.65 122.68 69.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.124 0.487 . . . . 0.66 111.535 -179.274 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.1 133.67 52.7 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 115.867 -0.606 . . . . 1.82 110.632 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.445 ' CD1' ' CB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -115.03 108.91 26.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.832 0.349 . . . . 1.44 111.188 -179.915 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 1.419 ' CZ ' ' CD1' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -96.09 113.91 25.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.281 0.562 . . . . 1.25 111.591 -179.383 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.734 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 154.79 -83.8 0.15 Allowed Glycine 1 C--O 1.114 -7.378 0 CA-C-N 115.833 -0.621 . . . . 0.71 113.678 -179.865 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . 1.284 ' O ' ' CA ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER 61.18 69.21 0.68 Allowed 'General case' 2 C--O 0.484 -39.237 1 CA-C-O 149.367 13.937 . . . . 1.97 111.866 179.918 . . . . . . . . 5 4 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 1.284 ' CA ' ' O ' ' A' ' 9' ' ' THR . . . 142.4 -71.18 0.41 Allowed Glycine 3 C--N 0.807 -28.808 3 O-C-N 50.769 -44.957 . . . . 1.42 115.301 179.83 . . . . . . . . 4 3 . 1 . 021 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.234 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 1.1 m -90.58 -20.82 22.17 Favored 'General case' 2 C--N 1.078 -11.201 2 O-C-N 108.323 -8.751 . . . . 1.88 111.781 -179.946 . . . . . . . . 4 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.734 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -89.86 129.9 36.17 Favored 'General case' 1 C--N 1.184 -6.624 1 O-C-N 115.274 -4.641 . . . . 0.49 111.247 179.969 . . . . . . . . 4 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 1.388 ' OD1' ' CB ' ' A' ' 13' ' ' ASN . 68.6 m-20 -76.36 17.9 0.34 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.36 0.504 . . . . 1.66 112.36 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.56 ' HB2' HG22 ' A' ' 6' ' ' ILE . 2.0 p -54.7 -23.21 16.56 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.286 0.565 . . . . 0.7 111.936 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.478 ' HG2' ' N ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -52.85 -33.89 51.69 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.811 -0.631 . . . . 1.56 111.799 -179.85 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' MET . . . . . 1.586 ' CG ' ' CE ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -64.38 -59.14 4.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.161 0.505 . . . . 2.28 110.889 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.493 ' CD2' ' CB ' ' A' ' 17' ' ' LEU . 2.7 tm? -64.57 -25.8 68.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.187 0.517 . . . . 1.75 110.907 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.515 ' HG3' HD13 ' A' ' 6' ' ' ILE . 3.5 tt0 -57.56 -48.95 77.94 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.981 -0.554 . . . . 1.78 110.623 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 1.471 ' CD ' ' NZ ' ' A' ' 19' ' ' LYS . 25.6 tttt -69.05 -47.81 64.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.113 0.482 . . . . 2.32 111.316 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -43.81 92.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.086 -0.506 . . . . 1.92 111.176 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.407 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -58.94 -42.71 90.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.123 -0.489 . . . . 0.36 111.714 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 1.126 ' NE ' ' CG ' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -57.68 -45.62 85.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.816 0.341 . . . . 2.7 111.467 -179.638 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 0.6 OUTLIER -71.9 -49.33 38.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.407 -0.36 . . . . 2.18 111.296 -179.636 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.563 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -62.4 -50.43 71.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.877 0.325 . . . . 0.48 111.877 -179.515 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 32' ' ' ALA . 5.4 p -53.72 -54.86 16.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.643 0.258 . . . . 0.52 110.743 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 1.359 ' CE ' ' CG ' ' A' ' 26' ' ' LYS . 21.7 mttm -67.55 -47.23 70.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.734 0.302 . . . . 2.35 110.995 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 86.1 tt0 -57.12 -43.88 82.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 1.95 111.35 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -52.39 -20.94 3.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.997 0.427 . . . . 2.0 110.903 179.551 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.92 36.22 1.41 Allowed Glycine 0 C--O 1.22 -0.738 0 C-N-CA 120.798 -0.715 . . . . 0.65 112.474 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 1.549 ' CB ' ' CD1' ' A' ' 30' ' ' ILE . 17.7 pt -170.37 117.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.117 0.484 . . . . 1.76 111.434 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 1.423 ' OD1' ' CB ' ' A' ' 31' ' ' ASP . 0.4 OUTLIER -62.4 163.61 8.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.937 -0.574 . . . . 1.62 110.228 179.379 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.747 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -149.43 164.7 34.26 Favored 'General case' 0 C--O 1.188 -2.167 0 N-CA-C 109.584 -0.525 . . . . 0.6 109.584 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -122.0 113.15 19.17 Favored 'General case' 0 C--N 1.281 -2.398 0 O-C-N 121.008 -1.057 . . . . 2.18 110.17 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 1.431 ' CZ ' ' CD1' ' A' ' 34' ' ' PHE . 22.3 m-85 -98.93 109.4 22.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.398 0.618 . . . . 1.28 111.824 -178.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 1.473 ' CD ' ' CB ' ' A' ' 35' ' ' GLU . 1.8 mt-10 -115.64 122.9 46.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.169 -0.923 . . . . 2.3 110.278 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 1.412 ' CD ' ' NZ ' ' A' ' 36' ' ' LYS . 14.7 mttt -84.42 144.95 28.44 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.437 -0.347 . . . . 2.26 110.507 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 1.036 HD13 ' N ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -115.01 136.57 51.27 Favored 'Isoleucine or valine' 1 C--O 0.985 -12.837 0 CA-C-O 123.872 1.796 . . . . 1.81 110.205 -179.568 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.714 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 53.1 pttt -124.71 75.3 1.41 Allowed 'General case' 1 C--N 1.132 -8.889 2 O-C-N 109.725 -8.11 . . . . 3.21 110.94 -179.98 . . . . . . . . 4 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER 163.4 128.29 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.339 -0.846 . . . . 2.44 110.7 179.839 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' MET . . . . . 1.347 ' CE ' ' CG ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -56.21 -26.52 51.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.573 0.225 . . . . 2.59 111.065 -179.871 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 1.165 ' OD2' ' CB ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -51.5 -38.7 55.28 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.899 -0.778 . . . . 1.7 108.899 178.645 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 1.079 ' CD ' ' CB ' ' A' ' 42' ' ' GLN . 6.3 mm-40 -87.02 -34.95 19.04 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.093 -0.958 . . . . 1.98 110.302 178.316 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.729 HG13 ' HA ' ' A' ' 40' ' ' MET . 5.2 mt -62.61 -52.76 55.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-O 121.108 0.48 . . . . 1.11 111.375 -179.567 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.523 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -63.38 -36.85 85.08 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.97 -0.559 . . . . 0.7 110.866 179.877 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 1.088 ' CD ' ' CB ' ' A' ' 45' ' ' GLU . 24.5 tt0 -57.14 -25.61 59.16 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.348 -0.387 . . . . 2.01 110.17 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.553 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -74.72 -38.07 62.39 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 115.951 -0.568 . . . . 0.89 109.75 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.43 -3.48 28.0 Favored Glycine 0 C--O 1.195 -2.293 0 C-N-CA 120.773 -0.727 . . . . 0.78 114.867 179.65 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.728 ' H ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -74.03 160.19 31.63 Favored 'General case' 1 C--O 0.896 -17.525 0 CA-C-O 121.69 0.757 . . . . 1.17 112.073 179.96 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 49' ' ' THR . . . . . 1.305 ' CG2' ' CA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -115.55 -17.56 11.14 Favored 'General case' 2 C--N 1.111 -9.768 3 O-C-N 109.08 -8.513 . . . . 1.82 112.481 179.761 . . . . . . . . 5 4 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -97.01 -172.71 2.51 Favored 'General case' 1 C--N 1.208 -5.549 0 O-C-N 117.698 -3.126 . . . . 0.56 110.348 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 1.33 ' CD1' ' CB ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -89.01 -63.65 0.2 Allowed Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 112.13 0.419 . . . . 1.47 112.13 -179.572 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 6.3 Cg_exo -67.78 59.68 0.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.239 1.959 . . . . 0.59 112.829 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -86.9 144.44 19.47 Favored Glycine 0 C--O 1.21 -1.355 0 C-N-CA 120.642 -0.79 . . . . 0.46 112.862 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.483 ' CD1' ' CB ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -136.73 109.22 7.4 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 122.52 -0.4 . . . . 1.72 110.708 179.889 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -101.02 125.15 47.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.909 0.385 . . . . 0.42 111.269 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.72 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -116.82 139.12 45.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.073 -0.512 . . . . 0.51 111.306 -179.91 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 1.3 ' OD1' ' CB ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER 47.11 27.06 0.73 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.605 -0.725 . . . . 1.59 110.715 -179.575 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.58 32.89 44.86 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.864 -0.684 . . . . 0.62 112.527 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.267 ' CD ' ' CB ' ' A' ' 59' ' ' GLU . 3.9 mt-10 -145.75 102.27 3.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.856 0.36 . . . . 2.21 111.041 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.481 HD21 ' O ' ' A' ' 46' ' ' ALA . 2.1 mm? -58.92 131.95 52.53 Favored 'General case' 0 CA--C 1.482 -1.668 0 CA-C-N 116.094 -0.503 . . . . 1.82 111.32 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.47 -8.71 3.69 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 114.678 1.362 . . . . 2.47 114.678 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.518 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -142.08 130.78 22.18 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.908 0 C-N-CA 120.253 -0.579 . . . . 2.17 111.795 -179.881 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 63' ' ' MET . . . . . 1.251 ' CG ' ' SD ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -146.62 131.04 17.63 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 112.742 0.645 . . . . 2.28 112.742 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.601 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 77.46 -2.93 60.93 Favored Glycine 0 C--O 1.192 -2.512 0 C-N-CA 120.297 -0.954 . . . . 0.65 113.676 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 1.538 ' CD ' ' CB ' ' A' ' 65' ' ' ARG . 1.7 ttp180 -177.21 101.9 0.05 Allowed 'General case' 0 C--O 1.2 -1.549 0 CA-C-N 117.48 0.64 . . . . 3.53 112.7 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 1.18 ' CG2' ' CA ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -57.95 148.58 5.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 116.579 -0.282 . . . . 1.28 111.476 -179.666 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.54 167.44 21.89 Favored 'General case' 0 C--O 1.19 -2.047 0 CA-C-O 120.816 0.341 . . . . 0.73 111.511 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' SER . . . . . 1.132 ' OG ' ' HB3' ' A' ' 68' ' ' SER . 0.5 OUTLIER -97.21 170.72 8.91 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 122.085 -0.384 . . . . 1.61 111.297 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 1.468 ' CB ' ' CD ' ' A' ' 69' ' ' LYS . 2.7 pttt -57.54 -46.5 83.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.405 -0.361 . . . . 2.8 111.125 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 1.4 tt0 -64.7 -34.95 79.52 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.88 0.371 . . . . 2.42 111.135 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -45.05 81.31 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.2 -0.454 . . . . 1.95 110.921 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -50.54 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 116.098 -0.501 . . . . 1.64 111.086 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 1.462 ' CE ' ' CG ' ' A' ' 73' ' ' LYS . 17.6 tttt -59.26 -35.03 72.98 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 116.295 -0.411 . . . . 2.32 110.836 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 1.493 ' NZ ' ' CD ' ' A' ' 74' ' ' LYS . 4.8 tttt -71.8 -33.12 68.3 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.42 -0.354 . . . . 2.62 111.136 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 1.251 ' CD1' ' CB ' ' A' ' 75' ' ' ILE . 0.7 OUTLIER -76.3 -34.28 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 116.177 -0.465 . . . . 1.54 110.414 179.686 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.526 ' CD2' ' CB ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -79.16 -35.53 41.85 Favored 'General case' 0 C--O 1.162 -3.517 0 CA-C-N 116.167 -0.47 . . . . 2.61 111.678 -179.926 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 77' ' ' SER . . . . . 1.22 ' CB ' ' N ' ' A' ' 77' ' ' SER 1.471 0.0 OUTLIER . . . . . 2 C--O 0.09 -59.94 2 N-CA-C 166.842 20.682 . . . . 2.77 166.842 179.996 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.452 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 111.395 0.146 . . . . 0.0 111.395 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.712 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -80.55 116.23 20.48 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.865 0.364 . . . . 0.0 111.317 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -79.85 101.08 8.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.981 0.419 . . . . 0.0 109.95 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.884 HD12 ' CZ ' ' A' ' 34' ' ' PHE . 2.0 mt -109.95 124.92 67.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.579 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.407 ' O ' HD22 ' A' ' 54' ' ' LEU . 3.2 mp0 -110.47 133.74 53.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.146 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.433 ' CG2' ' CB ' ' A' ' 14' ' ' CYS . 42.0 mt -114.45 109.64 29.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.109 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.914 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 66.5 m-85 -95.78 125.3 40.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.072 0.463 . . . . 0.0 111.556 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.46 -70.42 0.42 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.287 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.47 -70.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.821 0.343 . . . . 0.0 111.469 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.36 -97.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.643 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.44 -29.44 61.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.76 0.314 . . . . 0.0 111.134 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.468 ' HB1' ' SG ' ' A' ' 14' ' ' CYS . . . -68.65 120.49 14.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.996 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -76.24 21.25 0.18 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.486 ' HA ' HG21 ' A' ' 66' ' ' VAL . 6.1 m -55.21 -21.61 14.51 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.694 0.283 . . . . 0.0 111.374 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.62 -39.48 11.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 mtp -63.68 -62.69 1.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.642 0.258 . . . . 0.0 111.257 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.04 HD11 HD11 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -67.22 -19.54 65.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.781 0.324 . . . . 0.0 110.724 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -60.29 -50.36 73.95 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.345 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -70.28 -45.87 65.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.713 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -60.76 -38.6 85.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.008 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -63.47 -45.91 88.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.296 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 5.6 mtt-85 -57.71 -53.15 61.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -65.58 -50.19 66.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.523 -179.336 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' O ' HD12 ' A' ' 28' ' ' LEU . . . -63.12 -51.91 64.66 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.924 HG11 ' HB3' ' A' ' 32' ' ' ALA . 4.4 p -53.77 -55.09 15.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.446 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.516 ' N ' HG13 ' A' ' 25' ' ' VAL . 36.6 mtpt -65.34 -49.56 68.93 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.676 0.274 . . . . 0.0 111.2 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 46.8 tp10 -60.01 -39.28 85.27 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.721 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 24' ' ' ALA . 0.4 OUTLIER -54.02 -15.93 1.68 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.751 0.31 . . . . 0.0 111.175 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.646 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 114.05 26.16 3.9 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.546 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.718 ' N ' HD13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -163.26 109.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 0.0 110.628 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.489 ' HA ' ' HG2' ' A' ' 26' ' ' LYS . 2.8 m-20 -60.71 156.49 16.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.924 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -145.29 140.06 27.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -103.94 117.12 33.56 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.044 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.884 ' CZ ' HD12 ' A' ' 4' ' ' ILE . 15.7 m-85 -98.48 109.3 22.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.331 0.586 . . . . 0.0 112.068 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.51 126.51 55.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.287 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.838 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -79.85 150.65 30.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.148 0.499 . . . . 0.0 111.068 -179.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.847 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -124.2 80.73 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.408 -179.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.04 75.03 6.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.132 0.491 . . . . 0.0 111.378 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.589 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.4 OUTLIER 173.95 119.02 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.704 179.385 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.516 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 1.2 ptp -54.02 -33.11 56.32 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.45 0.167 . . . . 0.0 111.089 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.26 -37.38 46.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 34.9 mm-40 -86.74 -33.86 19.84 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.185 178.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.027 HG22 HD21 ' A' ' 48' ' ' LEU . 26.8 mt -61.41 -55.95 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.061 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.412 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -63.06 -36.65 84.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.826 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.478 ' H ' HD23 ' A' ' 44' ' ' LEU . 3.6 tt0 -56.85 -24.56 52.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.993 0.425 . . . . 0.0 110.319 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.776 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -72.14 -40.08 68.31 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.574 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.512 ' HA3' HD11 ' A' ' 60' ' ' LEU . . . 119.53 -10.75 11.4 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.506 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.027 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -71.87 152.07 42.89 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 117.444 0.622 . . . . 0.0 111.017 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 t -104.35 -9.41 18.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.931 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' A' ' 63' ' ' MET . . . -104.06 -177.93 3.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.422 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -81.67 -64.09 0.28 Allowed Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.445 ' HG2' ' CA ' ' A' ' 64' ' ' GLY . 56.2 Cg_endo -70.29 56.48 1.62 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.371 2.047 . . . . 0.0 113.41 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -73.06 143.48 33.35 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.903 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.703 HD11 ' CG2' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -134.27 102.7 5.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.565 0.221 . . . . 0.0 110.432 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -104.95 124.47 49.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 111.581 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.873 HG12 HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.27 138.4 44.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.39 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 46.99 25.39 0.47 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.296 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.98 22.64 44.67 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.128 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 59' ' ' GLU . 4.6 pt-20 -137.28 108.19 6.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.216 0.531 . . . . 0.0 110.852 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.647 HD21 ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -85.4 131.32 34.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.887 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.84 2.49 2.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.546 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.597 HG21 ' HA ' ' A' ' 66' ' ' VAL . 9.7 mt -128.24 122.39 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.664 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.565 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 2.4 mpp? -145.74 130.81 18.33 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.474 ' N ' ' CB ' ' A' ' 50' ' ' ALA . . . 73.6 6.79 72.34 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.176 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.414 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 1.9 ttp85 178.81 101.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.761 0.315 . . . . 0.0 110.616 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.597 ' HA ' HG21 ' A' ' 62' ' ' ILE . 3.3 p -57.83 148.35 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.644 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.675 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -65.37 173.74 2.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.935 0.398 . . . . 0.0 111.434 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.42 ' CA ' HD23 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -110.11 158.97 17.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.607 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -48.48 65.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.319 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.14 -34.32 77.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.922 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.54 -42.57 91.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.04 HD11 HD11 ' A' ' 17' ' ' LEU . 36.5 mm -56.23 -55.1 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.986 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.445 ' H1 ' ' HG3' ' A' ' 1' ' ' MET . 3.4 mtt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.674 0.273 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.631 ' SD ' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -77.23 113.56 15.11 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.891 0.377 . . . . 0.0 111.095 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.55 100.38 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.922 HD12 ' CE2' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -106.51 125.51 62.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.026 -179.085 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.816 ' O ' HD22 ' A' ' 54' ' ' LEU . 3.3 mm-40 -107.11 126.23 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.169 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.815 ' N ' HD11 ' A' ' 37' ' ' ILE . 2.9 mp -107.86 102.65 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.777 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 80.6 m-85 -88.94 124.26 34.07 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.924 0.392 . . . . 0.0 110.755 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.583 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 143.1 -85.36 0.19 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.299 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t 40.29 86.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.879 0.371 . . . . 0.0 111.778 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.42 -61.92 0.56 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.517 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.1 m -118.62 -2.57 10.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.526 0.203 . . . . 0.0 111.497 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.583 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -100.77 135.08 42.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.82 0.343 . . . . 0.0 111.154 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.69 ' O ' HG21 ' A' ' 66' ' ' VAL . 47.9 m-20 -76.55 20.1 0.24 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.023 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.564 ' HB2' HG23 ' A' ' 6' ' ' ILE . 3.8 p -57.15 -19.85 22.73 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.675 0.274 . . . . 0.0 111.509 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.08 -38.49 38.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.653 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.579 ' CB ' HG11 ' A' ' 66' ' ' VAL . 1.1 mpp? -64.65 -52.64 56.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.799 ' HB2' HG13 ' A' ' 66' ' ' VAL . 30.9 tp -66.78 -28.75 68.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.067 0.46 . . . . 0.0 110.143 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.01 -47.47 80.78 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.386 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -46.17 61.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.867 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -56.6 -53.02 62.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.044 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.416 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -54.43 -43.06 71.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.892 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.478 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 5.5 mtt180 -57.61 -43.71 84.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.665 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 61.6 tt0 -74.34 -50.75 17.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.368 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.28 -49.84 72.45 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.822 HG11 ' HB3' ' A' ' 32' ' ' ALA . 3.2 p -54.38 -53.9 26.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.613 0.244 . . . . 0.0 110.44 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.494 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 51.7 mttt -67.01 -50.09 63.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.784 0.326 . . . . 0.0 110.849 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 19.4 tt0 -57.82 -39.78 78.45 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.077 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.6 tp -52.14 -21.14 3.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.781 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.753 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.76 32.55 2.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.618 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.753 HG23 ' O ' ' A' ' 29' ' ' GLY . 2.2 pt -169.09 121.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.862 0.363 . . . . 0.0 111.222 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.434 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -61.36 164.0 6.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.167 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.822 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -150.62 140.07 21.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -100.72 111.17 23.35 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.386 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.922 ' CE2' HD12 ' A' ' 4' ' ' ILE . 68.9 m-85 -94.88 109.18 21.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.505 0.669 . . . . 0.0 111.966 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.31 128.36 54.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.374 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.708 ' C ' HD13 ' A' ' 37' ' ' ILE . 5.2 mttt -78.69 149.95 32.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.113 0.483 . . . . 0.0 110.806 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.855 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -115.7 76.62 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.687 -178.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.3 75.16 2.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.993 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.504 ' O ' HG13 ' A' ' 43' ' ' ILE . 2.6 mm-40 167.9 124.12 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.669 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.674 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -59.24 -20.31 53.05 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.213 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.46 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -51.46 -43.33 62.07 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.42 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -87.41 -34.8 18.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.475 178.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.957 HG22 HD21 ' A' ' 48' ' ' LEU . 16.9 mt -61.36 -54.94 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.345 0.593 . . . . 0.0 111.036 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -60.56 -35.84 77.04 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.612 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.442 ' H ' HD23 ' A' ' 44' ' ' LEU . 24.8 tt0 -56.35 -34.05 66.23 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.158 0.504 . . . . 0.0 109.818 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.716 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -75.55 -42.67 51.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.875 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.99 30.61 31.12 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.561 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.957 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -51.61 -41.75 61.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.443 0.621 . . . . 0.0 110.919 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 48' ' ' LEU . 5.6 p 90.64 7.23 0.08 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.241 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.751 ' HB3' ' HG2' ' A' ' 63' ' ' MET . . . -153.65 -157.27 0.76 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.948 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.594 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.4 mp -99.19 -61.15 0.11 Allowed Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 25.9 Cg_exo -62.94 52.85 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.843 2.362 . . . . 0.0 113.879 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.544 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -81.68 137.37 17.31 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.285 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.816 HD22 ' O ' ' A' ' 5' ' ' GLN . 2.5 tm? -136.41 101.51 4.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.673 0.273 . . . . 0.0 110.499 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -104.45 133.53 49.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.81 0.338 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.663 HG13 HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.59 141.45 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.183 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 50.83 23.18 1.33 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.595 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.43 31.02 23.15 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.257 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.7 106.59 5.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.118 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.816 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -83.18 130.08 35.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.016 179.23 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -138.23 1.23 2.2 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.527 HD11 HD23 ' A' ' 17' ' ' LEU . 1.6 pp -150.25 124.21 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.051 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.751 ' HG2' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.5 150.5 36.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.534 179.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.554 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 56.42 16.74 16.43 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.992 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -165.66 94.65 0.6 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.863 0.363 . . . . 0.0 110.531 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 17' ' ' LEU . 2.0 t -60.48 120.05 5.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.736 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.11 126.77 28.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.33 169.74 1.56 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.464 ' HA ' HD12 ' A' ' 72' ' ' ILE . 5.2 mtpt -60.52 -58.29 9.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.766 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -60.79 -33.16 72.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.24 -37.75 75.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 69' ' ' LYS . 8.5 mt -69.24 -52.68 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.919 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.972 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.659 ' H3 ' ' C ' ' A' ' 31' ' ' ASP . 2.1 mtt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.624 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 1.1 mpp? -86.67 119.29 26.75 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.334 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.94 111.46 18.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.621 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.972 HG13 HG12 ' A' ' 56' ' ' VAL . 3.7 mp -116.91 123.1 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.212 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -110.59 127.88 55.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.598 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.795 ' N ' HD11 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -110.37 113.01 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.869 0.366 . . . . 0.0 110.924 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.734 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 90.6 m-85 -91.91 111.91 23.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.22 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.648 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 136.66 -96.9 0.25 Allowed Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.195 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.96 -65.23 0.3 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.827 0.346 . . . . 0.0 111.463 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.68 -57.51 9.47 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.822 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.0 p -111.92 -35.46 5.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 110.982 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.648 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -65.63 124.73 23.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.071 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -76.5 16.67 0.46 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 p -59.24 -19.5 46.21 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.784 0.325 . . . . 0.0 111.337 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -24.98 5.25 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.872 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.5 mtp -63.26 -62.19 1.86 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.791 0.329 . . . . 0.0 110.475 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.757 HD22 HD13 ' A' ' 54' ' ' LEU . 5.6 tt -65.67 -20.37 66.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.512 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.598 ' HG3' HD13 ' A' ' 6' ' ' ILE . 5.8 tt0 -57.61 -51.45 69.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.129 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -69.15 -51.32 39.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.609 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -54.7 -40.34 69.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.594 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.54 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -59.72 -45.93 90.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.442 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.53 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -54.88 -38.48 67.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.718 0.294 . . . . 0.0 111.273 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 35.1 tp10 -73.4 -50.41 21.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.019 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.63 79.59 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.044 HG21 ' HB2' ' A' ' 32' ' ' ALA . 14.0 p -53.62 -56.05 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.626 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.59 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.16 -40.34 82.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.692 0.282 . . . . 0.0 110.741 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 6.0 tp10 -59.27 -47.44 85.38 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.958 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.415 HD21 ' HG3' ' A' ' 73' ' ' LYS . 1.7 mm? -54.06 -20.22 6.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.773 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.76 42.79 0.84 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.43 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.773 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -175.35 113.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.375 . . . . 0.0 111.054 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.659 ' C ' ' H3 ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -61.57 164.08 6.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.257 179.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 1.044 ' HB2' HG21 ' A' ' 25' ' ' VAL . . . -146.0 165.91 27.62 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -126.48 109.78 12.56 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.928 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 15.0 m-85 -98.71 108.67 21.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.38 0.609 . . . . 0.0 112.071 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -117.39 133.32 56.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.56 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.834 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -79.69 151.81 30.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.211 0.529 . . . . 0.0 111.396 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.921 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -127.77 78.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.616 -178.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 37.4 tptt -82.02 75.12 8.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.968 0.413 . . . . 0.0 111.191 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.524 ' O ' HG13 ' A' ' 43' ' ' ILE . 22.7 tp10 177.03 120.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.79 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.511 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 46.5 ttp -53.11 -32.21 46.14 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 121.268 -0.173 . . . . 0.0 110.942 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.449 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -51.55 -37.56 50.13 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.69 -34.22 19.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.113 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.851 HG22 HD21 ' A' ' 48' ' ' LEU . 29.0 mt -60.45 -55.21 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.055 0 CA-C-O 121.198 0.523 . . . . 0.0 111.29 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -63.46 -39.13 93.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.855 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.682 ' H ' HD23 ' A' ' 44' ' ' LEU . 6.0 tt0 -54.44 -25.26 23.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.056 0.455 . . . . 0.0 110.347 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.684 ' O ' HD21 ' A' ' 60' ' ' LEU . . . -71.6 -39.24 70.63 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.714 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.0 -8.22 25.33 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.644 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.851 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -80.31 167.1 20.68 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.693 0.282 . . . . 0.0 110.947 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.88 14.29 5.82 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HB1' ' N ' ' A' ' 64' ' ' GLY . . . -114.68 172.57 6.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.623 0.249 . . . . 0.0 110.75 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.524 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 2.9 mt -71.15 -72.32 0.23 Allowed Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 51' ' ' LEU . 74.2 Cg_endo -72.23 60.23 3.18 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.195 1.93 . . . . 0.0 112.425 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -79.54 147.46 29.75 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.963 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.757 HD13 HD22 ' A' ' 17' ' ' LEU . 7.4 tt -144.95 110.27 5.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.885 0.374 . . . . 0.0 111.075 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -98.6 126.29 44.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.563 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.972 HG12 HG13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -120.78 139.75 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.283 0.563 . . . . 0.0 111.936 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 47.24 26.83 0.75 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.183 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.03 27.32 53.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.524 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -148.26 98.05 2.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.967 0.413 . . . . 0.0 110.435 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.684 HD21 ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -77.29 141.76 39.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.203 0.525 . . . . 0.0 111.317 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.18 8.25 1.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.216 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.66 HG21 HG12 ' A' ' 66' ' ' VAL . 1.3 mp -119.36 123.1 70.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.443 ' CG ' ' HB2' ' A' ' 48' ' ' LEU . 32.3 mtp -146.49 115.31 6.87 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.493 ' N ' ' HB1' ' A' ' 50' ' ' ALA . . . 85.45 -5.87 81.96 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.64 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.479 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER 173.65 104.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.708 0.289 . . . . 0.0 110.591 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.66 HG12 HG21 ' A' ' 62' ' ' ILE . 6.3 m -50.62 158.62 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.875 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.668 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -80.47 174.26 11.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.052 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -93.73 167.27 11.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.824 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -53.82 -38.38 64.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.2 -36.99 74.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.725 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.422 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 13.3 mm-40 -68.86 -51.04 44.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 21' ' ' ALA . 15.3 tt -59.15 -41.5 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.423 ' N ' HG23 ' A' ' 72' ' ' ILE . 46.7 tttm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.736 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 31' ' ' ASP . 10.3 ttp . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.524 0.202 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.848 ' O ' HD12 ' A' ' 4' ' ' ILE . 12.2 mmt -87.82 116.15 25.77 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.407 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -71.19 104.95 3.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.174 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.957 HG13 HG12 ' A' ' 56' ' ' VAL . 2.8 mp -112.55 120.77 63.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.361 0.601 . . . . 0.0 111.833 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.685 ' CB ' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -111.72 131.22 55.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.835 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.858 HG22 HD12 ' A' ' 54' ' ' LEU . 12.0 pt -110.8 115.1 48.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-O 120.822 0.344 . . . . 0.0 111.097 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.746 ' CE1' HG13 ' A' ' 37' ' ' ILE . 85.2 m-85 -99.1 107.11 19.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.98 0.419 . . . . 0.0 111.095 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.79 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 175.74 -106.12 0.21 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.491 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 m 68.48 88.24 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 111.122 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.49 -74.73 0.43 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.529 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 55.5 m -106.56 -26.87 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.79 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -76.25 127.99 34.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.305 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.53 ' O ' HG21 ' A' ' 66' ' ' VAL . 47.4 m-80 -76.91 20.69 0.24 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.189 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.43 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.4 p -52.0 -25.44 8.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.958 0.409 . . . . 0.0 111.116 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -36.22 65.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.181 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.486 ' CB ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -63.64 -51.92 63.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.875 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.997 HD21 HD11 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -68.9 -22.01 64.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.994 0.426 . . . . 0.0 110.553 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.538 ' CD ' HD13 ' A' ' 6' ' ' ILE . 3.7 tp10 -60.62 -54.25 47.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.558 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -48.64 65.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.73 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -55.09 -49.88 70.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.834 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.565 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -58.72 -41.51 86.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.797 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.552 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 11.5 mtp180 -57.55 -46.18 84.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 111.373 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.7 pt-20 -72.6 -50.3 26.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.558 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.76 -49.37 75.28 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.733 HG11 ' HB3' ' A' ' 32' ' ' ALA . 3.8 p -53.56 -55.17 14.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.614 0.245 . . . . 0.0 110.883 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.511 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -69.56 -44.35 71.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.233 179.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 2.7 tt0 -56.68 -45.19 81.88 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.138 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.19 -22.1 3.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.907 0.384 . . . . 0.0 110.591 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.649 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.74 34.61 1.68 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.394 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 29' ' ' GLY . 6.4 pt -162.74 116.73 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 0.0 111.288 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -61.32 164.69 5.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.159 179.348 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.733 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -151.23 161.98 41.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -121.37 111.65 17.58 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.805 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 58.0 m-85 -98.01 108.86 21.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.481 0.657 . . . . 0.0 112.038 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.81 133.85 55.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.481 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.564 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -80.5 151.34 29.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.04 0.447 . . . . 0.0 111.027 -179.463 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.746 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -126.32 91.34 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.696 -179.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.18 75.76 6.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.979 0.419 . . . . 0.0 111.229 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.56 ' O ' HG13 ' A' ' 43' ' ' ILE . 2.8 tt0 173.69 121.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.903 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.556 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -54.65 -33.92 61.38 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.222 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.438 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -51.36 -36.34 42.66 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.417 ' HB3' HG21 ' A' ' 37' ' ' ILE . 4.9 mt-30 -86.55 -31.67 21.11 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.032 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.941 HG22 HD21 ' A' ' 48' ' ' LEU . 46.1 mt -63.05 -56.32 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.039 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.492 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -62.75 -34.73 77.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.182 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.517 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -59.01 -21.71 59.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.909 0.385 . . . . 0.0 110.488 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.526 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -76.93 -35.8 57.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.3 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.18 -8.94 22.85 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.619 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.941 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.33 152.27 39.64 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 117.326 0.563 . . . . 0.0 111.382 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.7 p -108.02 -19.91 13.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.647 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -87.39 -171.58 3.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.393 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.563 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 2.0 mp -86.16 -73.78 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.714 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 38.3 Cg_endo -66.12 63.78 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.361 2.04 . . . . 0.0 112.609 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.426 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -84.93 143.78 20.71 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.993 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.858 HD12 HG22 ' A' ' 6' ' ' ILE . 3.7 tt -134.86 109.57 8.6 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.766 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -98.16 123.15 42.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.021 0.439 . . . . 0.0 110.901 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.957 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -115.95 138.8 45.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.354 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 46.16 27.91 0.6 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.482 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.92 34.32 48.15 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.399 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.98 101.09 3.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.838 0.351 . . . . 0.0 111.099 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.881 HD21 HD13 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -45.81 130.2 9.38 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.159 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -118.33 -19.29 8.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.701 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.701 HD11 ' HB2' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -145.09 143.0 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 111.973 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.583 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -146.16 115.11 6.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.483 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.534 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 63.6 13.67 51.87 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.085 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.67 94.45 0.5 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.843 0.354 . . . . 0.0 110.77 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.577 HG13 ' HB2' ' A' ' 17' ' ' LEU . 2.0 t -60.54 126.08 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.242 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.577 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -63.77 142.58 58.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.836 0.351 . . . . 0.0 111.067 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.68 169.07 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.74 -49.83 76.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.975 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.99 -36.48 81.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -58.81 -49.7 76.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.997 HD11 HD21 ' A' ' 17' ' ' LEU . 37.2 mm -60.51 -54.28 37.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.008 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.421 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 33.5 ttm . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.566 0.222 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.928 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -83.65 114.03 21.27 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.045 0.45 . . . . 0.0 110.808 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -69.52 116.35 9.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.007 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 1.004 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 2.5 mp -124.25 128.29 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.47 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.593 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 0.8 OUTLIER -111.16 143.02 42.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.6 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.633 HD11 ' HB2' ' A' ' 36' ' ' LYS . 7.6 pt -127.31 110.25 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 110.395 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.979 ' CD2' HD11 ' A' ' 48' ' ' LEU . 8.1 m-30 -100.15 110.67 22.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.726 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.84 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 178.56 -66.34 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.525 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 m 74.63 79.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.793 0.33 . . . . 0.0 111.284 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.58 -62.76 1.9 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.846 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -50.47 -70.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.353 . . . . 0.0 111.235 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.84 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -57.36 147.78 24.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.021 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.4 17.06 0.4 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.544 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.4 p -55.43 -21.96 18.21 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.729 0.3 . . . . 0.0 111.228 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -37.45 74.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.326 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -62.43 1.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.886 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.712 HD13 ' HB2' ' A' ' 21' ' ' ALA . 1.6 tm? -59.31 -36.02 74.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.616 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG3' HD13 ' A' ' 6' ' ' ILE . 38.4 tt0 -56.87 -41.0 77.22 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.7 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -73.46 -51.94 15.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.969 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.664 ' OD1' HD22 ' A' ' 17' ' ' LEU . 30.7 p30 -64.61 -36.23 83.58 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.88 0.372 . . . . 0.0 111.025 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.712 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -62.49 -44.38 96.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.61 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.577 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 1.4 mtp180 -58.55 -45.12 89.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.748 0.308 . . . . 0.0 111.253 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.2 pt-20 -71.67 -47.57 53.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.076 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 23' ' ' GLU . . . -62.64 -49.99 73.0 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.822 HG21 ' HB2' ' A' ' 32' ' ' ALA . 9.1 p -53.3 -55.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 121.26 -0.176 . . . . 0.0 110.821 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.579 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.68 -40.77 79.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.5 0.191 . . . . 0.0 110.988 179.208 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 47.9 tt0 -60.27 -48.06 83.33 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.363 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.4 mt -53.84 -19.56 4.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.723 0.297 . . . . 0.0 110.966 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.778 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.74 42.93 0.84 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.433 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -175.65 106.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 111.21 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' O ' ' CA ' ' A' ' 1' ' ' MET . 28.5 t0 -61.26 164.35 5.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.105 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.928 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -148.0 179.28 7.85 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.58 110.95 9.66 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 1.004 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 17.7 m-85 -98.0 109.63 22.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.408 0.623 . . . . 0.0 111.982 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -109.97 124.61 51.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.35 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.633 ' HB2' HD11 ' A' ' 6' ' ' ILE . 2.9 tmmt? -92.38 144.2 25.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.579 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.903 HD12 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -118.49 172.28 5.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.374 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -155.7 75.35 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.277 0.56 . . . . 0.0 109.944 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER 157.5 136.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.418 -179.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.774 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -54.03 -20.6 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 -179.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.436 ' O ' HD23 ' A' ' 44' ' ' LEU . 4.4 m-20 -51.38 -45.12 62.35 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -86.44 -31.77 21.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.3 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.774 ' HB ' ' HA ' ' A' ' 40' ' ' MET . 62.7 mt -63.59 -56.07 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-O 121.549 0.69 . . . . 0.0 111.503 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -62.91 -36.52 83.64 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.086 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -55.76 -24.13 33.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.103 0.478 . . . . 0.0 110.362 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.77 ' O ' HD21 ' A' ' 60' ' ' LEU . . . -77.61 -41.86 37.11 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.525 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.89 -7.64 23.69 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.558 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.979 HD11 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -78.1 157.21 29.57 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.887 0.375 . . . . 0.0 110.933 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.89 -22.76 9.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.856 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.902 ' HB3' ' CB ' ' A' ' 63' ' ' MET . . . -79.7 170.49 16.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.049 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.5 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 2.7 mp -71.96 -70.08 0.31 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.793 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 47.8 Cg_endo -69.92 60.13 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.056 1.837 . . . . 0.0 112.234 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -83.68 128.82 8.77 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.615 HD12 ' CG2' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -121.97 107.93 12.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.759 0.314 . . . . 0.0 110.244 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.62 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -98.74 124.5 43.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.199 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.873 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.85 139.59 40.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.193 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.49 26.78 0.54 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.823 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.75 35.19 46.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.317 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -144.94 103.24 3.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.944 0.402 . . . . 0.0 111.132 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.77 HD21 ' O ' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -54.5 132.71 45.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.494 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.6 -5.21 1.57 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.557 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 0.7 OUTLIER -154.17 124.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.919 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.902 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -145.73 134.55 22.4 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.367 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.496 ' N ' ' HB1' ' A' ' 50' ' ' ALA . . . 80.2 -1.5 80.36 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.884 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.416 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -178.35 100.43 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.779 0.323 . . . . 0.0 110.582 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.615 ' CG2' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -65.09 137.28 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.065 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.628 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -63.73 164.38 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.33 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.8 p -92.16 -179.76 5.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.136 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.419 ' O ' HG22 ' A' ' 72' ' ' ILE . 16.5 pttm -64.14 -49.28 72.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.673 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -71.82 -30.23 65.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.722 0.296 . . . . 0.0 111.142 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.69 -51.33 23.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.373 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.657 ' HB ' HD21 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -55.65 -45.87 79.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.139 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.442 ' N ' HG23 ' A' ' 72' ' ' ILE . 13.4 tttt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.834 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.443 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 2.2 tpp . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.559 0.219 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.835 ' O ' HD12 ' A' ' 4' ' ' ILE . 8.2 tpp -80.65 112.01 17.61 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -70.12 118.3 12.78 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.028 0.442 . . . . 0.0 110.94 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.994 HG13 HG12 ' A' ' 56' ' ' VAL . 2.3 mp -126.14 124.95 66.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.941 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 3.7 mt-30 -110.36 139.1 45.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.945 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.5 mp -119.86 113.46 40.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.08 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.875 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 83.7 m-85 -104.71 115.94 31.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.249 0.547 . . . . 0.0 112.465 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 128.93 -66.91 0.56 Allowed Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.649 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 53.53 -84.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.608 0.242 . . . . 0.0 111.502 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 8' ' ' GLY . . . -58.96 -53.85 42.95 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.492 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.3 m -98.71 33.67 2.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.468 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -155.0 126.22 7.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -76.05 7.57 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.666 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.462 ' HB3' HG13 ' A' ' 66' ' ' VAL . 2.1 p -55.98 -20.38 16.17 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.735 0.303 . . . . 0.0 111.402 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.39 -25.46 6.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.511 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.7 mtt -63.49 -62.14 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.728 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.462 HD22 ' H ' ' A' ' 67' ' ' ALA . 9.3 tp -64.46 -24.03 67.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.782 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.75 -51.78 67.55 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.411 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -67.62 -47.39 69.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.818 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -56.51 -39.66 73.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.913 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -61.73 -46.97 87.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.605 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.476 ' CG ' ' CD1' ' A' ' 34' ' ' PHE . 41.8 mtp180 -54.63 -38.05 66.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.803 0.335 . . . . 0.0 111.14 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.8 tt0 -73.57 -49.92 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.8 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -60.55 -50.93 71.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.786 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.026 HG21 ' HB2' ' A' ' 32' ' ' ALA . 13.8 p -53.23 -56.05 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.631 0.253 . . . . 0.0 110.64 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.607 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -65.48 -47.64 75.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 0.0 110.923 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 17.8 tp10 -56.03 -48.07 76.67 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.283 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.499 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -53.32 -21.92 6.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.809 0.338 . . . . 0.0 110.765 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.62 47.41 0.63 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.597 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 25' ' ' VAL . 10.6 tt -179.23 128.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.305 0.574 . . . . 0.0 111.471 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' O ' ' CA ' ' A' ' 1' ' ' MET . 17.0 t0 -69.68 164.32 23.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.604 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 1.026 ' HB2' HG21 ' A' ' 25' ' ' VAL . . . -147.21 175.47 10.72 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.23 107.72 9.19 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.071 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.975 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 25.2 m-85 -101.38 108.58 20.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.346 0.594 . . . . 0.0 111.179 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -118.73 124.74 48.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.67 143.68 26.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.206 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.843 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -110.08 -178.02 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.333 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.489 ' N ' HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -158.92 75.37 0.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.106 0.479 . . . . 0.0 110.62 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.494 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER 158.14 130.05 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.96 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.508 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -52.63 -27.28 16.47 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 121.245 -0.182 . . . . 0.0 111.153 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -51.48 -39.0 56.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -86.75 -35.87 18.94 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.974 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.039 HG22 HD21 ' A' ' 48' ' ' LEU . 20.9 mt -60.76 -54.82 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.077 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.425 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.488 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -58.7 -37.33 75.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.768 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.488 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -55.18 -25.27 31.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 110.565 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.663 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -73.64 -34.75 65.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.996 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.12 -5.17 35.95 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.018 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.039 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.1 157.11 36.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.084 0.469 . . . . 0.0 111.512 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.6 p -112.41 -8.73 13.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.21 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.452 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -102.38 -175.41 2.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.41 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.62 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -86.1 -64.21 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.63 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 11.7 Cg_exo -69.53 59.87 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.254 1.969 . . . . 0.0 111.82 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.554 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -87.44 141.41 17.37 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.226 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.476 ' CB ' HD11 ' A' ' 62' ' ' ILE . 4.8 tt -135.27 111.45 9.64 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.729 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -98.32 124.42 42.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.934 0.397 . . . . 0.0 111.123 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.994 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -113.6 139.4 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.06 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 49.56 24.71 1.21 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.598 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.75 28.55 56.81 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.318 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -143.25 104.2 4.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.859 0.361 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.729 HD22 ' HB2' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -46.07 131.77 9.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.921 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.84 -13.84 7.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.985 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.552 HD13 ' HA ' ' A' ' 66' ' ' VAL . 2.7 pp -152.98 146.88 14.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.597 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 1.6 mtp -146.24 125.53 13.05 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.889 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.618 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 89.06 -17.17 53.07 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.034 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 178.22 109.77 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.552 ' HA ' HD13 ' A' ' 62' ' ' ILE . 9.4 m -49.51 174.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.88 0.371 . . . . 0.0 111.445 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.462 ' H ' HD22 ' A' ' 17' ' ' LEU . . . -92.61 -165.67 1.39 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.046 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.2 m -113.4 163.16 15.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.812 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HA ' HG22 ' A' ' 72' ' ' ILE . 4.0 pttp -55.75 -42.79 75.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -65.85 -32.63 74.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.804 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -73.47 -48.98 29.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.046 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.485 HG23 ' N ' ' A' ' 73' ' ' LYS . 16.9 tt -62.46 -46.74 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.204 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.485 ' N ' HG23 ' A' ' 72' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.896 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.434 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.825 0.345 . . . . 0.0 111.284 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.619 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -83.99 116.11 22.66 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.83 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -69.12 118.34 11.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.016 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.904 HG12 HG12 ' A' ' 56' ' ' VAL . 4.3 mt -128.8 123.03 58.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.094 0.473 . . . . 0.0 111.88 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -111.96 142.84 43.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.314 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.706 HG22 HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -120.55 106.23 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.767 0.318 . . . . 0.0 110.766 179.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.917 ' CD2' ' HA ' ' A' ' 43' ' ' ILE . 59.2 m-85 -91.77 109.68 21.01 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.069 0.461 . . . . 0.0 111.412 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.909 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 174.17 -100.1 0.14 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.269 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 51.86 100.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.874 0.369 . . . . 0.0 111.411 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.17 18.49 26.48 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.697 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.63 -41.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.346 . . . . 0.0 110.818 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.909 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -95.12 132.5 39.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.174 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -76.56 20.4 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.06 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.432 ' HA ' HG11 ' A' ' 66' ' ' VAL . 3.4 p -54.1 -24.06 16.2 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.953 0.406 . . . . 0.0 111.206 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.27 -32.79 64.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.111 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 23.0 ttt -63.61 -62.07 1.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.752 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.779 ' CD1' ' HB3' ' A' ' 67' ' ' ALA . 1.2 tt -64.69 -20.05 66.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 110.637 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -58.88 -54.35 48.06 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.303 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -50.09 43.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -54.83 -49.19 71.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.072 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.402 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -56.02 -40.88 74.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.517 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.518 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -57.32 -41.02 79.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.259 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -74.39 -50.4 18.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.106 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.501 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -61.95 -50.22 73.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.77 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.903 HG11 ' HB3' ' A' ' 32' ' ' ALA . 6.2 p -53.64 -55.53 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.154 -0.218 . . . . 0.0 110.614 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.548 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -64.65 -48.99 72.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 178.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -57.85 -42.85 85.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.51 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 24' ' ' ALA . 1.9 mm? -53.58 -20.01 4.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.811 0.339 . . . . 0.0 110.883 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.98 41.95 0.88 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.49 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.0 tt -179.22 120.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.24 0.543 . . . . 0.0 111.058 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.436 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 5.0 t70 -62.64 163.97 8.33 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.762 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.903 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -157.77 141.04 15.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.641 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -103.83 119.58 39.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.561 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.854 ' CE2' HD12 ' A' ' 4' ' ' ILE . 13.3 m-85 -103.17 109.59 21.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.349 0.595 . . . . 0.0 111.906 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -108.64 122.45 47.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.824 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.535 ' HG3' HD11 ' A' ' 6' ' ' ILE . 1.9 mtpt -90.21 141.37 28.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.059 0.457 . . . . 0.0 111.13 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.781 HG13 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -108.8 175.31 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.594 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -160.06 74.93 0.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.892 0.377 . . . . 0.0 110.896 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.562 ' O ' HG13 ' A' ' 43' ' ' ILE . 3.2 mt-10 157.0 127.29 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.311 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.546 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -53.96 -26.67 26.84 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.924 -0.126 . . . . 0.0 111.111 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.466 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -51.66 -39.84 58.92 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -86.62 -33.15 20.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.206 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.079 HG22 HD21 ' A' ' 48' ' ' LEU . 13.1 mt -63.18 -55.87 20.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.547 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -61.02 -35.89 78.06 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.681 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.86 -22.51 59.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.102 0.477 . . . . 0.0 110.234 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -73.42 -36.35 65.95 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.913 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 121.13 -15.08 9.45 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.583 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.079 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.85 158.79 32.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.361 0.58 . . . . 0.0 111.689 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 t -105.78 -28.07 10.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.458 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.42 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -81.93 -177.62 6.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.063 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.575 HD12 ' HD3' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -89.89 -55.57 0.29 Allowed Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.486 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.575 ' HD3' HD12 ' A' ' 51' ' ' LEU . 14.6 Cg_exo -69.65 56.89 1.38 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.511 2.141 . . . . 0.0 112.473 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -81.46 142.25 22.73 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.475 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.706 HD12 HG22 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -132.2 105.32 7.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.866 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -97.95 122.13 40.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.987 0.422 . . . . 0.0 111.507 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.904 HG12 HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -119.53 139.28 47.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.192 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.48 27.49 0.97 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.659 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.92 33.2 55.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.269 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.94 101.71 3.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.938 0.399 . . . . 0.0 111.171 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.872 HD11 HD12 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -52.44 127.42 22.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.608 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -125.72 -13.47 6.43 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.705 HG21 ' HA ' ' A' ' 66' ' ' VAL . 6.5 mt -139.63 130.55 32.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.523 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.75 ' SD ' HD12 ' A' ' 60' ' ' LEU . 4.0 mpp? -146.72 134.62 21.33 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.963 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 86.74 -10.61 67.04 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.575 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 3.8 ttp180 176.85 104.96 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.719 0.295 . . . . 0.0 110.436 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.705 ' HA ' HG21 ' A' ' 62' ' ' ILE . 2.1 p -59.28 142.84 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.839 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.779 ' HB3' ' CD1' ' A' ' 17' ' ' LEU . . . -67.43 170.79 6.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.806 0.336 . . . . 0.0 111.349 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.67 172.04 7.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.79 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.02 -38.02 69.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.281 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -73.29 -39.39 65.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 111.106 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.533 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 18.8 tt0 -69.23 -49.69 54.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.198 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.581 HD13 ' C ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -57.22 -46.72 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.253 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.488 ' N ' HG23 ' A' ' 72' ' ' ILE . 24.8 tttm . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.866 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.498 0.189 . . . . 0.0 111.266 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.599 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -76.54 112.56 13.21 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.762 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 100.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.042 0.449 . . . . 0.0 110.126 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.959 HD13 ' CE2' ' A' ' 34' ' ' PHE . 4.3 mt -110.61 130.26 64.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.51 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.804 ' C ' HD13 ' A' ' 6' ' ' ILE . 14.3 mt-30 -110.81 144.36 39.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.19 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.804 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -128.2 107.96 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-O 120.82 0.343 . . . . 0.0 110.975 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.953 ' CD2' HD11 ' A' ' 48' ' ' LEU . 6.1 m-30 -100.11 112.8 25.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.125 0.488 . . . . 0.0 111.469 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.836 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 161.57 -104.51 0.24 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.572 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.4 OUTLIER 62.37 136.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 0.0 111.063 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.52 25.67 42.97 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -175.99 -67.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 110.685 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.836 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -70.5 137.89 50.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -76.27 13.82 0.85 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.156 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.737 ' HB2' HG22 ' A' ' 6' ' ' ILE . 4.6 p -56.22 -29.22 60.67 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.915 0.388 . . . . 0.0 111.209 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.34 -35.26 60.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.45 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 tpt -64.78 -62.65 1.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.346 . . . . 0.0 111.127 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.821 HD13 ' O ' ' A' ' 17' ' ' LEU . 3.5 tm? -66.37 -24.18 66.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.767 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.431 ' HB2' HG21 ' A' ' 6' ' ' ILE . 3.6 tm-20 -57.17 -49.82 74.78 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.22 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.1 -46.09 82.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.43 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.506 ' HB2' HD22 ' A' ' 17' ' ' LEU . 1.7 m-20 -54.91 -45.53 74.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.551 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.74 -41.51 82.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.473 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.517 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 3.9 mtm180 -55.68 -41.68 74.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.038 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 13.9 tt0 -73.77 -49.85 23.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.186 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -62.28 -51.88 65.93 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.85 HG11 ' HB3' ' A' ' 32' ' ' ALA . 2.9 p -53.3 -53.98 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.418 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.487 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 3.4 mtpm? -65.46 -48.88 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.82 0.343 . . . . 0.0 110.841 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.411 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 4.4 tm-20 -58.13 -42.87 86.75 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.535 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -51.35 -21.36 2.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.878 0.37 . . . . 0.0 110.955 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.76 34.37 1.71 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.226 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.6 OUTLIER -169.37 113.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 2.2 t0 -61.07 164.13 5.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.213 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.85 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -150.87 167.56 27.14 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -125.86 115.14 19.51 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.26 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.959 ' CE2' HD13 ' A' ' 4' ' ' ILE . 12.4 m-85 -100.2 108.72 20.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.337 0.589 . . . . 0.0 111.093 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -110.57 112.24 24.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.696 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 mtmt -82.23 141.36 33.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.243 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.927 HD12 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -112.3 159.75 12.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.29 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -139.92 75.34 1.51 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.325 0.583 . . . . 0.0 110.123 179.197 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 0.3 OUTLIER 157.59 134.66 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.566 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.666 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 3.6 ttm -56.39 -16.91 6.47 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -51.17 -45.94 61.93 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.48 -31.62 21.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.299 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.746 HG22 HD21 ' A' ' 48' ' ' LEU . 30.4 mt -64.57 -54.73 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 121.504 0.668 . . . . 0.0 111.383 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.401 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -65.52 -36.26 83.3 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.007 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 28.6 tt0 -54.88 -26.19 33.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.209 0.528 . . . . 0.0 110.041 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.646 ' O ' HD21 ' A' ' 60' ' ' LEU . . . -74.59 -46.73 36.73 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.084 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.63 -7.76 13.51 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.528 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.953 HD11 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -76.26 155.22 34.55 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.774 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.82 -26.07 9.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.788 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.986 ' HB3' ' HB2' ' A' ' 63' ' ' MET . . . -75.73 179.66 5.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.59 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.476 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -81.69 -68.59 0.19 Allowed Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.117 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.732 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 45.0 Cg_endo -70.01 57.33 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.201 1.934 . . . . 0.0 113.809 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.482 ' HA2' ' HB3' ' A' ' 63' ' ' MET . . . -72.2 141.52 31.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.033 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.716 HD21 HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -130.76 104.07 6.96 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.934 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -98.39 123.48 42.53 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.102 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.687 HG12 ' CG1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -120.8 141.04 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.657 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 47.19 26.92 0.74 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.938 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.38 29.52 55.83 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.404 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -140.92 103.7 4.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.912 0.386 . . . . 0.0 110.84 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.934 HD12 ' HB2' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -72.87 126.53 30.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.161 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -147.16 10.18 0.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 54' ' ' LEU . 5.2 mt -147.1 103.9 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.989 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.986 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.37 149.92 35.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.132 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.421 ' N ' ' HG2' ' A' ' 52' ' ' PRO . . . 84.53 -5.94 79.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.978 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.456 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER 165.4 105.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.502 HG11 ' HA ' ' A' ' 14' ' ' CYS . 10.3 m -61.14 163.89 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 111.193 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.436 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -82.27 169.18 16.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.063 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 m -82.96 178.2 8.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.911 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.404 ' O ' HG22 ' A' ' 72' ' ' ILE . 18.0 tttt -65.35 -53.4 44.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.264 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -33.22 72.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.343 . . . . 0.0 110.931 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -72.62 -48.13 42.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.054 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -61.86 -42.21 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.996 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.635 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.444 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 2.7 ttp . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.448 0.166 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.791 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 2.3 mmt -81.11 113.03 19.01 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.947 0.403 . . . . 0.0 110.824 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 120.14 14.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.068 0.461 . . . . 0.0 110.767 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.914 HG13 HG12 ' A' ' 56' ' ' VAL . 2.1 mp -129.09 124.82 61.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.454 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.737 ' O ' HD22 ' A' ' 54' ' ' LEU . 6.5 mm-40 -111.1 141.98 43.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.257 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.668 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -130.28 113.44 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 0.0 110.608 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 1.359 ' CD2' ' CE2' ' A' ' 7' ' ' TYR . 27.5 m-85 -100.51 113.02 25.48 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.298 0.571 . . . . 0.0 112.042 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.895 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 171.24 -100.62 0.16 Allowed Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.412 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.91 103.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.786 0.326 . . . . 0.0 111.302 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.48 -28.62 11.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.711 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.8 p -138.57 -48.36 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 111.134 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.895 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -73.45 132.7 43.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -76.56 19.73 0.25 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.196 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.412 ' HA ' HG11 ' A' ' 66' ' ' VAL . 4.5 p -55.62 -23.06 25.53 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.808 0.337 . . . . 0.0 111.234 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -33.79 72.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.174 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 38.1 ttp -64.58 -62.09 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.372 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 67' ' ' ALA . 0.4 OUTLIER -60.97 -33.21 72.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.694 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -56.47 -39.84 73.88 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.666 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -73.52 -52.4 13.69 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.849 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.629 HD21 HD22 ' A' ' 17' ' ' LEU . 30.7 p30 -64.22 -34.02 77.14 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.849 0.357 . . . . 0.0 110.803 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.518 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -62.07 -49.28 76.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.026 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.495 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 2.2 mtm-85 -54.76 -39.04 67.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.716 0.293 . . . . 0.0 111.007 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -72.18 -50.26 29.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.079 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.405 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -62.43 -50.52 71.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.682 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.996 HG21 ' HB2' ' A' ' 32' ' ' ALA . 11.1 p -53.54 -55.8 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.607 0.241 . . . . 0.0 110.473 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.602 ' N ' HG13 ' A' ' 25' ' ' VAL . 11.8 mtpt -64.15 -49.36 72.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.755 0.312 . . . . 0.0 110.682 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -55.72 -47.15 77.38 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.349 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 24' ' ' ALA . 2.2 mm? -51.64 -22.3 3.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.856 0.36 . . . . 0.0 110.872 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.737 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.8 36.12 1.44 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.336 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 29' ' ' GLY . 1.1 pt -168.55 112.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.041 0.448 . . . . 0.0 111.103 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.465 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 30.5 t70 -61.44 164.61 5.52 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.49 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.996 ' HB2' HG21 ' A' ' 25' ' ' VAL . . . -148.65 171.72 15.72 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -128.51 110.23 12.1 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.957 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.871 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 15.1 m-85 -100.46 108.96 21.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.323 0.583 . . . . 0.0 111.374 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -113.17 121.05 43.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.789 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.434 ' HA ' HG12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -94.45 139.63 30.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.075 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.839 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -106.98 179.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.124 -179.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.437 ' N ' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -155.34 74.92 0.92 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.116 0.484 . . . . 0.0 110.884 179.114 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.53 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER 162.25 126.62 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.006 179.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.5 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 15.2 mtt -52.55 -29.24 24.42 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.569 0.223 . . . . 0.0 110.764 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.455 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -51.93 -38.13 55.2 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.884 ' O ' ' CE2' ' A' ' 7' ' ' TYR . 7.4 mt-30 -86.6 -34.94 19.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.083 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.985 HG22 HD21 ' A' ' 48' ' ' LEU . 10.7 mt -62.84 -54.67 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.512 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -63.58 -34.26 77.42 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.924 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -59.04 -23.58 62.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.919 0.39 . . . . 0.0 110.427 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.682 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -73.11 -36.52 66.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.707 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.76 -9.05 14.57 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.842 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.985 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -69.21 150.08 47.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.495 0.648 . . . . 0.0 111.243 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.31 -19.36 19.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.431 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.497 ' HB3' ' N ' ' A' ' 64' ' ' GLY . . . -100.92 -173.37 2.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.212 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.514 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.0 OUTLIER -86.87 -57.4 0.32 Allowed Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.643 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 17.0 Cg_exo -67.87 58.19 0.83 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.618 2.212 . . . . 0.0 112.38 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.432 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -74.88 148.32 37.94 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.559 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.737 HD22 ' O ' ' A' ' 5' ' ' GLN . 3.4 tm? -137.24 100.1 4.16 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.696 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -97.92 119.43 36.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.188 0.518 . . . . 0.0 111.217 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.914 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -115.03 138.74 44.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.888 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 47.25 27.25 0.82 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.497 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.53 35.43 47.01 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.284 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -148.47 100.66 3.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 0.0 111.268 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.696 ' CD1' ' HB2' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -47.75 129.45 14.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.974 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.85 ' O ' HD13 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -129.42 -13.16 4.39 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.85 HD13 ' O ' ' A' ' 61' ' ' LYS . 4.8 mm -139.59 135.84 39.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.754 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.487 ' CG ' ' HB2' ' A' ' 48' ' ' LEU . 1.4 mpp? -146.48 133.28 20.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.52 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.515 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 83.23 -6.34 72.46 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.273 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 173.44 103.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.624 ' HA ' HG21 ' A' ' 62' ' ' ILE . 9.0 p -48.47 155.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.337 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.697 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -63.77 178.74 0.57 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.894 0.378 . . . . 0.0 111.158 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 74.3 m -110.17 169.57 8.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.008 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -58.38 -45.86 87.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.239 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -73.1 -29.8 63.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 0.0 111.052 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -73.39 -46.69 47.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.376 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -61.71 -46.18 97.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.139 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.459 ' N ' HG23 ' A' ' 72' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 0.0 110.816 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.464 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 9.1 ptp . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.361 0.124 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.916 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -81.35 109.74 16.13 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.796 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -69.26 103.55 1.98 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.132 0.491 . . . . 0.0 110.664 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.667 HG23 HD21 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -101.64 116.65 45.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.107 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.759 ' O ' HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -110.11 115.04 29.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.017 179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.854 ' N ' HD11 ' A' ' 37' ' ' ILE . 15.8 pt -100.41 109.26 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-O 121.086 0.47 . . . . 0.0 111.847 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.746 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 90.3 m-85 -90.44 125.91 35.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.93 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.535 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 149.79 -82.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.514 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p 51.85 78.36 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 111.285 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.14 -84.01 0.18 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.542 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.9 m -93.99 -29.99 14.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.798 0.332 . . . . 0.0 110.926 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.535 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -63.42 133.28 53.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.384 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.791 ' O ' HG21 ' A' ' 66' ' ' VAL . 58.1 m-20 -76.63 20.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.083 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.421 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.2 p -53.03 -23.47 7.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.893 0.378 . . . . 0.0 111.287 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -39.45 71.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.562 ' HB3' HG11 ' A' ' 66' ' ' VAL . 16.9 ttt -68.08 -51.36 47.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.88 HD11 ' HG ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -69.04 -25.89 64.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.987 0.423 . . . . 0.0 110.389 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.593 ' N ' HD23 ' A' ' 17' ' ' LEU . 16.0 tt0 -58.78 -52.92 63.67 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.243 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -65.79 -44.71 84.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.829 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -58.12 -54.32 48.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.165 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.665 ' HB3' ' HE2' ' A' ' 34' ' ' PHE . . . -53.02 -36.3 60.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.32 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -60.4 -48.87 79.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.319 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.2 pt-20 -71.59 -47.83 52.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.298 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -63.03 -49.88 72.88 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.888 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.9 p -53.48 -54.99 15.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.919 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.541 ' N ' HG13 ' A' ' 25' ' ' VAL . 5.7 mtmm -70.04 -49.03 55.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.265 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 22.9 tt0 -51.81 -46.68 64.34 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.732 0.301 . . . . 0.0 111.172 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.655 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -51.47 -23.66 4.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.978 0.418 . . . . 0.0 110.487 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.737 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.53 37.57 1.3 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.572 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -167.97 117.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.987 0.422 . . . . 0.0 111.642 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -61.42 165.53 4.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.895 178.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.916 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -148.31 179.2 7.95 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -129.45 113.98 15.57 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.72 ' HE1' ' HB3' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -100.31 109.75 21.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.279 0.561 . . . . 0.0 111.659 -178.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -126.21 128.55 47.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.073 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.789 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -79.76 151.94 30.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.961 0.41 . . . . 0.0 110.762 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.952 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -123.27 78.35 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.938 -178.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.9 tttt -77.47 75.77 4.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.14 0.495 . . . . 0.0 110.825 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 43' ' ' ILE . 0.1 OUTLIER 172.07 127.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.414 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.586 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -63.92 -27.21 68.99 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.031 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.466 ' O ' HD23 ' A' ' 44' ' ' LEU . 2.1 t0 -51.48 -36.76 45.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.475 ' HG2' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -88.22 -33.41 18.13 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.893 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.746 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -68.51 -45.22 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.073 0.463 . . . . 0.0 111.432 -179.195 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.584 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -65.48 -37.96 88.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.178 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.584 ' H ' HD23 ' A' ' 44' ' ' LEU . 6.7 tt0 -60.59 -22.06 63.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.243 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.825 ' HB1' HD23 ' A' ' 60' ' ' LEU . . . -77.47 -35.4 53.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.0 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.87 -8.35 21.6 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.628 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.521 HD13 ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -81.46 158.8 24.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.431 0.616 . . . . 0.0 111.597 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 t -114.92 -31.87 5.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.587 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.822 ' HB3' ' HG2' ' A' ' 63' ' ' MET . . . -75.23 -159.73 0.1 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.23 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.495 HD12 ' HA2' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -101.87 -56.28 0.12 Allowed Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.483 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.559 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 21.1 Cg_exo -65.55 57.81 0.36 Allowed 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.477 2.118 . . . . 0.0 113.561 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -88.48 136.03 13.44 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.164 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.88 ' HG ' HD11 ' A' ' 17' ' ' LEU . 3.4 tm? -138.31 114.78 10.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.741 0.305 . . . . 0.0 110.77 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.933 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . . . -109.55 131.34 55.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.03 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.422 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -117.85 139.9 43.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.111 0.482 . . . . 0.0 111.013 179.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 46.58 27.9 0.7 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.6 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.87 42.05 17.46 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.378 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.14 100.58 3.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.933 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -69.01 128.17 35.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.916 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.769 ' O ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -146.29 7.75 1.03 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.769 HD13 ' O ' ' A' ' 61' ' ' LYS . 11.0 mm -143.72 110.57 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.791 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.822 ' HG2' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -145.52 141.45 28.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.926 0.393 . . . . 0.0 111.509 -179.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.559 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 67.39 11.45 59.42 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.858 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -178.09 103.63 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.821 0.343 . . . . 0.0 110.621 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.791 HG21 ' O ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -56.45 144.49 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.618 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.428 ' HB2' HD12 ' A' ' 62' ' ' ILE . . . -78.25 147.28 34.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.102 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.8 p -90.47 168.32 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -55.65 -41.78 74.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.13 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -69.37 -40.55 77.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.976 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -63.94 -45.91 87.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.013 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.8 mt -65.93 -50.44 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.964 179.941 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.447 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 6.9 mtp . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.731 0.3 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.555 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.05 114.54 17.03 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.828 0.347 . . . . 0.0 110.672 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.47 106.07 2.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.106 0.479 . . . . 0.0 110.105 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.916 HG12 HG12 ' A' ' 56' ' ' VAL . 7.3 mt -117.13 127.75 74.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.478 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.669 ' O ' HD22 ' A' ' 54' ' ' LEU . 2.9 mp0 -110.39 144.08 39.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.354 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.674 HD11 ' HB3' ' A' ' 34' ' ' PHE . 3.2 mp -124.72 108.24 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.793 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.873 ' CD2' ' HA ' ' A' ' 43' ' ' ILE . 56.9 m-85 -96.94 115.64 27.79 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.289 0.566 . . . . 0.0 111.586 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.853 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 159.88 -88.87 0.11 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.331 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.8 p 49.54 96.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.843 0.354 . . . . 0.0 111.43 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.9 -78.88 0.31 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.392 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 t -85.76 -39.57 17.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.781 0.324 . . . . 0.0 110.762 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.853 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -79.45 125.77 29.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.926 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -76.49 19.95 0.24 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.131 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.539 ' SG ' HG22 ' A' ' 6' ' ' ILE . 4.2 p -58.77 -19.92 45.11 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.696 0.284 . . . . 0.0 111.611 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.95 -31.62 60.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.405 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.09 -52.83 61.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.673 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.658 HD13 HG22 ' A' ' 66' ' ' VAL . 5.6 tt -69.09 -29.87 68.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.753 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -55.55 -40.6 72.12 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.899 0.381 . . . . 0.0 110.416 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -73.03 -52.33 14.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.918 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 31.9 p30 -64.49 -33.73 76.58 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.816 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.471 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . -60.74 -47.06 88.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.941 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.539 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 12.6 mtp180 -56.89 -42.32 79.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.651 0.262 . . . . 0.0 110.905 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -47.94 49.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.055 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.587 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -62.97 -51.73 65.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.691 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.891 HG11 ' HB3' ' A' ' 32' ' ' ALA . 9.8 p -53.55 -55.12 14.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.545 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -62.97 -49.15 75.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.651 178.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.11 -45.84 86.56 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.301 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 24' ' ' ALA . 3.1 mm? -52.12 -20.69 2.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.991 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.11 46.61 0.64 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.623 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 7.9 tt 177.14 124.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.11 0.481 . . . . 0.0 111.192 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.447 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -66.08 162.64 19.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.704 179.51 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.891 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -154.32 142.8 20.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -104.48 114.41 28.62 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.273 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.841 ' CZ ' HD12 ' A' ' 4' ' ' ILE . 17.8 m-85 -97.58 109.29 22.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.317 0.58 . . . . 0.0 111.471 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -110.06 114.71 28.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.62 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.51 138.54 31.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.245 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.866 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -107.29 177.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.442 ' N ' HG12 ' A' ' 37' ' ' ILE . 13.6 pttm -156.75 75.28 0.84 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.157 0.503 . . . . 0.0 110.889 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.515 ' O ' HG13 ' A' ' 43' ' ' ILE . 9.8 pt-20 157.31 130.77 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.839 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.49 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 2.2 ptt? -52.31 -25.35 9.32 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.804 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -51.5 -39.44 57.62 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.51 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -87.31 -38.8 15.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.166 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.056 HG22 HD21 ' A' ' 48' ' ' LEU . 8.5 mt -60.68 -55.59 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.561 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -34.83 77.42 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.879 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 1.4 tm-20 -57.21 -24.92 57.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.102 0.477 . . . . 0.0 110.248 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.58 ' O ' HD11 ' A' ' 60' ' ' LEU . . . -71.97 -37.24 69.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.726 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.05 -14.62 10.34 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.703 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.056 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.86 161.18 25.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.028 0.442 . . . . 0.0 111.289 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t -110.59 -24.58 10.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.997 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.578 ' HB3' ' HG2' ' A' ' 63' ' ' MET . . . -80.17 -179.74 7.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.417 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.557 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.6 mt -88.13 -60.08 0.25 Allowed Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.855 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.557 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 17.2 Cg_exo -66.52 49.6 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.637 2.224 . . . . 0.0 113.769 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.99 146.74 35.42 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.571 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.669 HD22 ' O ' ' A' ' 5' ' ' GLN . 2.8 tm? -136.55 102.4 4.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.738 ' CB ' HD12 ' A' ' 60' ' ' LEU . . . -97.9 123.68 41.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 111.335 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.916 HG12 HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -119.45 140.67 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.181 0.515 . . . . 0.0 111.487 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 t0 48.48 25.66 0.98 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.086 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.17 25.72 50.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.413 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -139.9 104.49 4.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.891 0.377 . . . . 0.0 110.601 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.738 HD12 ' CB ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -90.43 128.72 36.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.696 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -146.43 3.22 0.87 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.141 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 54' ' ' LEU . 19.5 mm -128.67 103.31 9.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.989 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.578 ' HG2' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -146.45 162.46 38.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.632 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . 80.9 -7.61 58.86 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.246 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER 170.37 103.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.658 HG22 HD13 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -67.68 151.93 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.821 0.343 . . . . 0.0 111.389 -179.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.836 ' HB1' ' HB3' ' A' ' 71' ' ' GLU . . . -79.9 179.58 7.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.341 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 m -104.26 -170.18 1.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.932 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.456 ' O ' HG22 ' A' ' 72' ' ' ILE . 25.7 tttt -65.55 -54.51 27.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.008 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.17 -29.8 70.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.906 0.384 . . . . 0.0 110.652 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.836 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 0.7 OUTLIER -73.45 -51.14 18.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.04 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.661 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -60.76 -42.85 93.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.858 0.361 . . . . 0.0 110.964 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.403 ' N ' HG23 ' A' ' 72' ' ' ILE . 16.6 tptm . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.706 179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.426 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 8.6 ttp . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.554 0.216 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.503 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 1.4 mtt -77.73 113.61 15.76 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.951 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -69.35 100.8 1.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.012 0.434 . . . . 0.0 109.958 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.946 HD12 ' HB1' ' A' ' 32' ' ' ALA . 3.5 mt -109.95 135.66 48.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.998 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.916 ' O ' HD13 ' A' ' 54' ' ' LEU . 22.2 mm-40 -111.36 143.98 41.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.376 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.675 HG22 ' HB2' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -127.3 100.34 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 120.972 0.415 . . . . 0.0 110.349 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.994 ' CD2' HD11 ' A' ' 48' ' ' LEU . 8.3 m-30 -94.19 116.31 28.69 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.3 0.572 . . . . 0.0 112.155 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . -177.16 -90.52 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.213 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 m 48.57 29.71 2.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.76 0.314 . . . . 0.0 111.528 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.86 108.85 0.23 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.499 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t 59.78 27.17 16.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 110.994 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.492 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -124.73 132.47 53.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.896 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.731 ' O ' HG21 ' A' ' 66' ' ' VAL . 1.6 m120 -76.12 20.74 0.19 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.699 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.675 ' HB2' HG22 ' A' ' 6' ' ' ILE . 1.8 p -51.51 -28.96 15.0 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.953 0.406 . . . . 0.0 111.128 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -36.18 73.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.008 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.433 ' CB ' HG11 ' A' ' 66' ' ' VAL . 14.3 mtt -68.62 -50.67 49.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.354 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.766 HD11 HD12 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -71.09 -31.19 67.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.994 0.426 . . . . 0.0 110.628 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -58.48 -42.36 87.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.617 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.45 -42.4 62.01 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 36.1 p30 -74.96 -34.62 62.07 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.734 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.544 ' HB2' HD23 ' A' ' 17' ' ' LEU . . . -66.28 -50.44 63.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.558 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.57 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -59.91 -44.46 94.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.583 0.23 . . . . 0.0 111.457 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 41.7 tp10 -72.69 -50.17 26.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.622 0.248 . . . . 0.0 110.966 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -62.34 -51.8 66.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.692 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.798 HG11 ' HB3' ' A' ' 32' ' ' ALA . 4.0 p -53.3 -54.91 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.914 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.519 ' N ' HG13 ' A' ' 25' ' ' VAL . 11.1 mtmm -67.27 -46.6 73.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.636 0.255 . . . . 0.0 111.112 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.435 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -58.57 -46.24 87.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.359 -179.576 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.709 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -52.01 -21.83 3.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.924 0.393 . . . . 0.0 110.851 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.79 50.3 0.52 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.528 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 6.8 tt 178.03 122.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.238 0.542 . . . . 0.0 111.371 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.426 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -62.94 164.54 8.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.373 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.946 ' HB1' HD12 ' A' ' 4' ' ' ILE . . . -153.59 151.52 29.84 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -111.91 113.47 25.8 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.05 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.877 ' CE2' HD13 ' A' ' 4' ' ' ILE . 69.0 m-85 -99.85 108.81 21.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.281 0.563 . . . . 0.0 111.634 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -107.24 110.63 22.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.257 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -84.44 136.83 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.69 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.94 HD12 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -113.0 164.37 8.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.064 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -140.62 75.43 1.51 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.992 0.425 . . . . 0.0 110.73 179.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 1.4 mm-40 155.26 132.81 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.828 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.608 ' HA ' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -57.02 -28.43 62.49 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.709 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.518 ' HA ' HD22 ' A' ' 44' ' ' LEU . 1.7 m-20 -51.5 -33.58 32.17 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -86.93 -33.07 19.81 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.356 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.722 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 0.9 OUTLIER -71.19 -50.82 39.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 CA-C-O 121.083 0.468 . . . . 0.0 111.601 -179.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -57.22 -36.21 70.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.58 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.47 ' H ' HD23 ' A' ' 44' ' ' LEU . 2.1 mm-40 -53.73 -25.42 18.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.973 0.416 . . . . 0.0 110.173 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.893 ' HB1' HD11 ' A' ' 60' ' ' LEU . . . -78.67 -46.33 19.39 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.387 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.93 -20.6 4.52 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.518 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.994 HD11 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -69.0 155.67 39.95 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.895 0.379 . . . . 0.0 111.068 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.86 -16.22 12.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.394 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.51 ' HB1' ' HA2' ' A' ' 64' ' ' GLY . . . -89.19 -179.14 5.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.791 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.605 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.6 mp -83.72 -63.95 0.24 Allowed Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 16.4 Cg_exo -67.45 51.58 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.392 2.061 . . . . 0.0 112.927 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.74 116.75 4.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.22 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.916 HD13 ' O ' ' A' ' 5' ' ' GLN . 3.0 mm? -106.05 107.19 18.06 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.625 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -98.28 123.53 42.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.038 0.447 . . . . 0.0 111.632 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.726 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.37 139.01 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.919 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.8 t70 46.68 27.81 0.71 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.355 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.87 37.55 50.68 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.233 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -150.09 101.84 3.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 111.304 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.893 HD11 ' HB1' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -46.0 133.37 8.87 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.015 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.79 -16.8 2.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.994 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.766 HD12 HD11 ' A' ' 17' ' ' LEU . 15.6 mt -154.34 111.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.586 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -145.64 150.91 37.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.021 0.439 . . . . 0.0 111.627 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.51 ' HA2' ' HB1' ' A' ' 50' ' ' ALA . . . 83.4 -5.18 78.73 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.544 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 45.2 ttp85 174.25 106.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.743 0.306 . . . . 0.0 110.423 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.731 HG21 ' O ' ' A' ' 13' ' ' ASN . 2.6 t -54.34 141.06 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.651 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.476 ' HB3' HD13 ' A' ' 62' ' ' ILE . . . -87.83 142.27 27.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.043 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.4 t -63.66 156.95 25.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.1 -30.4 25.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.284 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -42.2 96.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.837 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.414 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 2.0 tp10 -67.18 -41.87 85.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.995 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.7 mm -58.88 -53.19 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 tptm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.842 179.952 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.437 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.452 0.168 . . . . 0.0 111.179 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.812 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -82.64 112.84 19.88 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.08 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.6 104.9 2.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.128 0.489 . . . . 0.0 110.253 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 1.028 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 2.2 mp -108.57 127.57 64.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.39 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -110.29 125.6 53.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.016 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.824 HG23 ' HB2' ' A' ' 14' ' ' CYS . 3.3 mp -103.93 98.3 6.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.324 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.871 ' CZ ' ' HB2' ' A' ' 46' ' ' ALA . 93.8 m-85 -93.5 116.92 29.46 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 120.926 0.393 . . . . 0.0 111.2 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 118.37 -1.99 16.21 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.088 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 9' ' ' THR . 7.6 t -40.05 120.1 1.12 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 111.668 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.3 -54.43 0.54 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.338 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.1 m -101.98 -33.01 9.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.917 0.389 . . . . 0.0 110.73 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.441 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -86.32 152.3 22.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.015 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -75.95 8.99 2.66 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.7 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.824 ' HB2' HG23 ' A' ' 6' ' ' ILE . 3.4 p -54.19 -30.99 51.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.998 0.427 . . . . 0.0 111.273 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -36.59 42.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.601 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 10.4 tpp -63.77 -62.44 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.092 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.88 HD11 HD11 ' A' ' 72' ' ' ILE . 6.5 tp -65.66 -24.7 67.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.697 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -55.7 -50.42 70.35 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.849 0.357 . . . . 0.0 110.136 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -47.07 76.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.693 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -56.11 -44.62 79.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.16 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.48 -40.84 83.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.805 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.574 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -59.11 -46.81 87.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.659 0.266 . . . . 0.0 111.245 -179.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 10.8 pt-20 -71.95 -47.33 53.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.226 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.5 -50.74 70.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.674 HG21 ' HB2' ' A' ' 32' ' ' ALA . 5.9 p -53.62 -55.74 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.591 0.234 . . . . 0.0 110.763 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.552 ' N ' HG13 ' A' ' 25' ' ' VAL . 21.3 mtpp -66.99 -49.9 63.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.38 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 2.0 tt0 -52.86 -48.19 67.26 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.59 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 28' ' ' LEU . 4.6 mt -52.46 -21.26 3.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.86 0.362 . . . . 0.0 110.719 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.55 30.68 2.56 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.311 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.518 HG21 ' CE ' ' A' ' 2' ' ' MET . 0.4 OUTLIER -156.75 107.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.963 0.411 . . . . 0.0 111.075 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.437 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.7 OUTLIER -61.56 164.16 6.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.042 179.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.812 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -152.53 175.66 12.52 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -129.6 114.14 15.69 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 1.028 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 40.8 m-85 -102.13 108.94 20.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.553 0.692 . . . . 0.0 112.278 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -118.38 129.45 55.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.008 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.817 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -78.98 153.09 30.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.103 0.478 . . . . 0.0 111.127 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.817 HD13 ' C ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -128.14 76.56 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.463 -178.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.53 75.65 4.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.061 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 43' ' ' ILE . 6.5 pt-20 171.47 125.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.609 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.675 ' HA ' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -59.92 -30.48 69.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.58 0.229 . . . . 0.0 110.973 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.473 ' O ' HD23 ' A' ' 44' ' ' LEU . 4.5 m-20 -51.23 -33.75 29.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.424 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 28.3 mm100 -87.91 -34.57 18.1 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.984 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.691 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 2.5 pt -61.86 -51.37 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.056 0.455 . . . . 0.0 111.029 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.65 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -62.84 -41.34 99.3 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.022 179.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.65 ' H ' HD23 ' A' ' 44' ' ' LEU . 5.5 tt0 -58.98 -22.41 60.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.945 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.871 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -75.27 -39.76 59.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.729 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.734 ' HA3' HD21 ' A' ' 60' ' ' LEU . . . 123.4 -20.43 7.44 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.084 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.513 HD11 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -77.28 163.75 26.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.1 m -115.58 -23.35 8.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.902 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.866 ' HB3' ' CB ' ' A' ' 63' ' ' MET . . . -78.84 173.26 12.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.47 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.631 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -78.72 -64.75 0.35 Allowed Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.292 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.631 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 15.4 Cg_exo -67.17 59.14 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.406 2.071 . . . . 0.0 112.426 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.478 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -80.9 136.83 17.01 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.602 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.595 HD22 ' CD2' ' A' ' 17' ' ' LEU . 3.1 tp -127.1 98.2 5.22 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.716 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -97.38 122.72 40.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.087 0.47 . . . . 0.0 111.079 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.911 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -112.94 139.98 35.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.989 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 45.5 27.05 0.36 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.726 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.2 39.44 31.81 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.31 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -149.03 100.9 3.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 111.314 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.734 HD21 ' HA3' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -51.31 131.4 28.34 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.798 179.456 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.05 -16.79 4.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.015 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.594 HD13 ' H ' ' A' ' 67' ' ' ALA . 2.1 mt -152.69 131.8 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.987 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.866 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.96 135.19 22.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.392 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.487 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 92.85 -10.56 73.74 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.474 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 165.69 106.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.623 ' HB ' HD22 ' A' ' 17' ' ' LEU . 5.8 m -53.05 166.09 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.793 0.33 . . . . 0.0 111.186 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.594 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -82.5 -173.98 4.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.151 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.0 t -97.77 168.85 10.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -58.1 -54.4 47.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -56.24 -39.49 72.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.982 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -56.94 -43.0 81.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 17' ' ' LEU . 47.4 mm -57.9 -55.22 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.972 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.906 179.928 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.408 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.567 0.222 . . . . 0.0 111.291 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.789 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 3.1 ttt -82.68 114.04 20.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.917 0.389 . . . . 0.0 110.97 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.39 118.87 17.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.938 0.399 . . . . 0.0 110.576 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 1.031 HG13 HG12 ' A' ' 56' ' ' VAL . 2.7 mp -125.61 118.1 51.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.092 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.642 ' CB ' HD11 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -111.14 122.57 48.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.799 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.691 HG22 HD22 ' A' ' 54' ' ' LEU . 13.8 pt -104.63 110.72 31.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 CA-C-O 120.848 0.356 . . . . 0.0 111.08 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.755 ' CE1' HG13 ' A' ' 37' ' ' ILE . 93.7 m-85 -90.74 122.88 33.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.038 0.447 . . . . 0.0 111.431 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.446 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 127.83 -65.85 0.57 Allowed Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.182 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.3 m 66.07 -73.1 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.734 0.302 . . . . 0.0 111.64 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.75 -96.37 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.853 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.8 -23.55 7.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.654 0.264 . . . . 0.0 111.508 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.446 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -82.8 121.89 27.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.913 0.387 . . . . 0.0 111.357 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -76.77 21.34 0.21 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.859 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.508 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.7 p -52.83 -24.43 8.99 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.89 0.376 . . . . 0.0 111.363 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.63 -28.02 3.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.506 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -62.51 1.51 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.836 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.659 HD13 ' HB3' ' A' ' 67' ' ' ALA . 4.0 tp -68.38 -20.05 64.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.806 0.336 . . . . 0.0 110.508 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -59.12 -49.91 76.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.251 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -50.05 24.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.812 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.41 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 3.3 m-20 -56.28 -50.82 70.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.114 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.638 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -56.6 -41.87 77.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.574 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.484 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 3.0 mtm180 -60.73 -44.43 96.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.578 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.488 ' HG3' ' N ' ' A' ' 24' ' ' ALA . 14.8 pt-20 -73.33 -45.95 52.27 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.925 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.488 ' N ' ' HG3' ' A' ' 23' ' ' GLU . . . -64.01 -49.23 73.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.98 HG21 ' HB2' ' A' ' 32' ' ' ALA . 14.0 p -53.44 -55.52 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.458 0.171 . . . . 0.0 110.842 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.589 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.09 -43.03 79.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.549 0.214 . . . . 0.0 110.926 179.208 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 13.4 tt0 -58.57 -47.0 85.72 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.731 0.3 . . . . 0.0 110.971 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -54.44 -20.43 7.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.9 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.765 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.57 41.72 0.93 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.554 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -173.89 110.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.42 . . . . 0.0 111.288 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.408 ' O ' ' CA ' ' A' ' 1' ' ' MET . 38.6 t70 -61.38 163.63 6.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.375 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.98 ' HB2' HG21 ' A' ' 25' ' ' VAL . . . -145.39 174.8 10.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -131.85 109.02 9.81 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.99 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 18.7 m-85 -100.85 108.84 20.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.503 0.668 . . . . 0.0 112.018 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.419 ' O ' HD13 ' A' ' 37' ' ' ILE . 68.1 tt0 -119.77 131.17 55.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.94 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.499 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -80.3 141.94 35.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.006 0.431 . . . . 0.0 110.646 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.755 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -116.76 70.62 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.481 -179.335 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 75.39 1.91 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.18 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.54 ' O ' HG13 ' A' ' 43' ' ' ILE . 1.3 mt-10 174.85 119.78 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.699 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.497 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 17.0 ptp -53.05 -27.76 21.39 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.467 0.175 . . . . 0.0 110.927 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.446 ' O ' HD23 ' A' ' 44' ' ' LEU . 4.5 m-20 -51.55 -39.87 58.6 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.49 ' HB3' HG21 ' A' ' 37' ' ' ILE . 1.9 mm-40 -87.74 -35.53 17.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.531 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.058 HG22 HD21 ' A' ' 48' ' ' LEU . 11.7 mt -62.06 -54.91 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.154 0.502 . . . . 0.0 111.216 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -58.88 -32.33 69.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.209 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' N ' HD23 ' A' ' 44' ' ' LEU . 1.6 tt0 -59.38 -38.65 81.06 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 1.034 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -68.71 -40.67 79.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.59 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.46 26.0 55.53 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.116 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.058 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -47.19 -87.43 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.25 0.525 . . . . 0.0 111.061 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.495 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 1.5 m 147.67 -25.52 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.563 0.745 . . . . 0.0 109.4 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.62 ' HB3' ' N ' ' A' ' 64' ' ' GLY . . . -122.15 -166.79 1.45 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.838 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.557 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -83.7 -59.52 0.36 Allowed Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.575 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.565 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 11.9 Cg_exo -70.06 57.76 1.64 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.5 2.133 . . . . 0.0 112.524 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -81.44 139.45 20.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.699 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.919 HD11 HG23 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -137.03 110.77 8.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.723 0.297 . . . . 0.0 110.944 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -99.55 123.27 43.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.035 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.031 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -115.48 137.21 49.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.307 0.575 . . . . 0.0 111.836 -179.116 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 46.62 27.45 0.65 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.738 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.8 33.41 37.6 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.315 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -148.27 97.88 2.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.863 0.363 . . . . 0.0 111.081 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.034 HD21 ' HB1' ' A' ' 46' ' ' ALA . 2.0 mp -60.74 134.64 57.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.03 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 2.52 1.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.775 HG21 ' HA ' ' A' ' 66' ' ' VAL . 3.9 mp -137.78 127.6 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.632 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.46 ' CG ' ' HB2' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -147.34 126.79 13.18 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.62 ' N ' ' HB3' ' A' ' 50' ' ' ALA . . . 77.06 4.57 83.63 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.506 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 178.36 108.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.741 0.271 . . . . 0.0 110.504 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.919 HG23 HD11 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -59.54 139.12 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.659 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.659 ' HB3' HD13 ' A' ' 17' ' ' LEU . . . -63.93 168.2 5.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.811 0.339 . . . . 0.0 111.346 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.4 t -103.28 -174.77 2.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.148 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.867 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -60.39 -57.26 13.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.137 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -53.46 -33.96 56.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.143 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.515 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 0.4 OUTLIER -63.87 -37.71 88.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 69' ' ' LYS . 8.2 mt -64.98 -55.07 22.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.977 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.433 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 2.6 mtm . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.616 0.246 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.529 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -76.45 113.32 13.93 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.987 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.29 118.59 12.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.411 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.713 HG21 ' CD2' ' A' ' 34' ' ' PHE . 7.4 mt -129.18 119.59 49.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.078 0.466 . . . . 0.0 112.117 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -112.0 123.89 51.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.333 178.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.517 ' C ' HD11 ' A' ' 37' ' ' ILE . 2.9 mp -101.74 111.82 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.661 0.267 . . . . 0.0 111.32 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.937 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 98.2 m-85 -95.17 108.59 20.72 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.073 0.463 . . . . 0.0 111.525 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.678 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 140.47 -82.3 0.24 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.468 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.504 HG23 ' HD3' ' A' ' 36' ' ' LYS . 10.8 m 69.68 -68.71 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 0.0 111.397 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.15 -92.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.635 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 m -54.47 -28.73 46.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 111.129 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.678 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -90.62 117.21 29.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.149 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -76.24 15.71 0.54 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.9 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.5 p -57.53 -19.92 28.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.742 0.306 . . . . 0.0 111.419 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -47.39 -28.79 2.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.572 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -60.29 3.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.73 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.688 HD22 ' OD1' ' A' ' 20' ' ' ASN . 0.5 OUTLIER -59.45 -37.84 79.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.383 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -54.37 -36.06 63.47 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.883 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -71.48 -52.45 18.3 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.531 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.688 ' OD1' HD22 ' A' ' 17' ' ' LEU . 28.4 p30 -62.68 -33.01 74.21 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.782 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.471 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . -58.89 -44.47 91.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.081 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.574 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 13.1 mtp180 -58.32 -52.64 64.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.292 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.41 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 2.7 pp20? -68.06 -50.12 57.15 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.378 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.634 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -60.87 -51.53 68.93 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.878 HG11 ' HB3' ' A' ' 32' ' ' ALA . 3.9 p -53.66 -55.64 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.883 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.525 ' N ' HG13 ' A' ' 25' ' ' VAL . 7.1 mttt -66.41 -50.25 64.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.689 0.28 . . . . 0.0 111.441 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -57.68 -41.48 81.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.384 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.67 HD21 ' HG2' ' A' ' 73' ' ' LYS . 1.7 mm? -53.57 -19.15 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.914 0.387 . . . . 0.0 110.899 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.76 26.23 3.96 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.409 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -156.5 112.25 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.785 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.433 ' O ' ' CA ' ' A' ' 1' ' ' MET . 2.3 m-20 -61.67 159.89 12.56 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.878 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -152.03 153.72 34.57 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -114.91 114.97 26.18 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.218 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.713 ' CD2' HG21 ' A' ' 4' ' ' ILE . 18.1 m-85 -98.75 108.94 21.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.361 0.601 . . . . 0.0 111.431 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -110.76 110.73 21.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.1 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.504 ' HD3' HG23 ' A' ' 9' ' ' THR . 0.1 OUTLIER -82.37 137.54 34.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.877 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.78 HG13 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -102.9 176.58 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.666 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 4.3 pttt -160.1 75.49 0.6 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.883 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.506 ' O ' HG13 ' A' ' 43' ' ' ILE . 1.4 mt-10 158.14 128.53 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.564 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.533 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -56.58 -29.81 62.47 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 121.366 -0.134 . . . . 0.0 110.867 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.422 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -51.46 -36.37 43.92 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -86.67 -36.94 18.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.95 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.937 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 40.4 mt -58.95 -55.49 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.731 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -61.35 -36.74 81.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.631 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.603 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -55.79 -25.39 40.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.019 0.438 . . . . 0.0 110.335 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.711 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -70.93 -34.84 71.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.792 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.39 -17.87 9.57 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.745 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.81 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -83.2 169.35 15.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.936 0.398 . . . . 0.0 111.324 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.4 p -124.07 -30.1 3.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.91 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.423 ' HB1' ' HA2' ' A' ' 64' ' ' GLY . . . -68.2 -178.62 1.08 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.216 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.595 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.5 mp -86.39 -63.59 0.22 Allowed Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.658 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.892 ' O ' HD12 ' A' ' 62' ' ' ILE . 17.0 Cg_exo -66.27 63.92 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.033 1.822 . . . . 0.0 111.709 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -104.04 145.52 16.11 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.098 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.853 ' HB3' HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -150.33 129.8 13.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.0 0.429 . . . . 0.0 110.165 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.741 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -103.55 125.03 49.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.021 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.852 HG13 HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -112.62 135.45 52.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.194 0.521 . . . . 0.0 111.45 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 48.12 27.35 1.23 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.257 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.75 38.64 31.12 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.344 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -154.98 99.52 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.827 0.346 . . . . 0.0 111.148 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.741 ' CD1' ' HB2' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -43.79 126.93 4.91 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.057 179.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.95 -17.68 9.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.91 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.946 HD13 HG12 ' A' ' 66' ' ' VAL . 1.3 pt -137.33 140.42 42.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.068 0.461 . . . . 0.0 112.103 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.461 ' HG3' ' HB2' ' A' ' 48' ' ' LEU . 1.6 ttm -145.98 114.63 6.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.606 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.573 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 88.75 -14.26 60.58 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 119.688 -1.244 . . . . 0.0 112.866 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -178.44 114.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.648 0.261 . . . . 0.0 110.355 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.946 HG12 HD13 ' A' ' 62' ' ' ILE . 28.8 m -54.21 -173.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.12 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.94 143.21 30.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.92 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.2 m -65.9 162.43 19.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -47.59 84.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -67.14 -29.91 69.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.508 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -74.03 -42.0 60.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.067 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.563 HD13 HD21 ' A' ' 17' ' ' LEU . 1.1 tt -73.74 -48.47 39.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.346 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.67 ' HG2' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.384 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.4 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 6.2 mtp . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.652 0.263 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.529 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -73.26 115.46 12.64 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.68 179.588 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.09 106.65 2.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.98 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.925 HG12 HG12 ' A' ' 56' ' ' VAL . 3.5 mt -122.45 124.88 71.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.743 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.438 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 2.5 mm-40 -110.75 138.9 46.57 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.856 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.512 ' C ' HD11 ' A' ' 37' ' ' ILE . 22.4 mt -114.24 104.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.944 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 94.5 m-85 -92.78 109.27 20.7 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.986 0.422 . . . . 0.0 111.369 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.529 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 134.55 -44.16 1.21 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.679 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 36' ' ' LYS . 82.4 p 52.73 -85.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 8' ' ' GLY . . . -94.71 -52.4 1.82 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.709 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 m -53.1 -26.38 16.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 111.098 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.529 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -111.55 147.23 35.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.143 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -76.29 15.32 0.6 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.953 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.451 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.3 p -57.3 -19.88 24.82 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.707 0.289 . . . . 0.0 111.493 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.62 -32.08 7.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.403 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 mtt -63.31 -62.08 1.92 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.559 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.756 HD22 HD13 ' A' ' 54' ' ' LEU . 4.0 tt -63.92 -19.81 65.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.644 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -59.35 -54.13 50.32 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.56 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -71.9 -40.23 69.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.262 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -64.54 -41.69 96.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.195 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HB2' HD23 ' A' ' 17' ' ' LEU . . . -62.49 -45.89 90.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.814 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.511 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -57.39 -42.52 82.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.617 0.246 . . . . 0.0 111.238 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 14.9 pt-20 -73.88 -49.22 25.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.321 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.8 -50.4 69.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.863 HG11 ' HB3' ' A' ' 32' ' ' ALA . 4.2 p -53.57 -52.84 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.357 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.486 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.23 -41.83 80.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.724 0.297 . . . . 0.0 110.742 178.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.421 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 1.1 tp10 -62.07 -43.79 98.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.418 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.856 HD23 ' HA ' ' A' ' 25' ' ' VAL . 0.7 OUTLIER -52.0 -19.49 1.87 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.791 0.329 . . . . 0.0 111.027 179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.52 44.58 0.7 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.8 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.2 tt 175.88 121.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.264 0.554 . . . . 0.0 111.158 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.43 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 3.6 t0 -62.53 163.81 8.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.849 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.863 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -151.09 152.51 33.52 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.549 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -112.72 118.39 34.87 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.317 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.888 ' CE2' HD12 ' A' ' 4' ' ' ILE . 22.2 m-85 -101.78 109.39 21.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.339 0.59 . . . . 0.0 111.707 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -105.42 114.67 28.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.003 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.569 ' HB3' HG22 ' A' ' 9' ' ' THR . 11.7 mttt -82.11 139.17 34.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.089 0.471 . . . . 0.0 110.813 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.799 HG13 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -104.49 175.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.682 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 7.0 ptmt -160.36 75.32 0.57 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.017 0.437 . . . . 0.0 110.916 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.514 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER 157.63 127.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.405 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.559 ' HA ' HD12 ' A' ' 43' ' ' ILE . 17.7 mtp -54.77 -28.51 49.3 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.987 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.462 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -51.34 -37.82 49.9 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -86.95 -36.52 18.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.952 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.944 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 25.9 mt -60.01 -55.26 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.767 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -61.79 -34.5 76.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.719 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -60.64 -21.91 63.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 0.0 110.084 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.792 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -71.9 -34.76 69.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.615 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.22 -20.42 7.07 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.874 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.901 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -83.32 176.69 8.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 111.026 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.3 m -126.59 -34.94 2.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.223 0.535 . . . . 0.0 110.486 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.11 -173.11 0.35 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.707 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.582 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.4 mp -92.48 -63.55 0.16 Allowed Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.456 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.628 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 28.6 Cg_exo -60.78 63.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.218 1.945 . . . . 0.0 112.645 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -103.84 147.17 16.56 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.973 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.756 HD13 HD22 ' A' ' 17' ' ' LEU . 5.6 tt -144.58 118.26 9.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.827 0.346 . . . . 0.0 110.862 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.658 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -99.57 122.65 42.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.037 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.925 HG12 HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -116.49 136.35 53.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.511 -179.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 46.75 28.17 0.78 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.898 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.47 30.39 58.46 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.433 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -142.97 103.95 4.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.892 0.377 . . . . 0.0 110.949 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.776 HD21 ' O ' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -54.98 127.32 28.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.06 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.752 ' O ' HD12 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -129.68 -9.15 4.52 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.787 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.752 HD12 ' O ' ' A' ' 61' ' ' LYS . 1.6 mp -134.4 127.73 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.573 0.225 . . . . 0.0 110.408 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 19.2 tmm? -146.81 116.51 7.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.83 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.628 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 70.19 3.27 44.82 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.121 -1.038 . . . . 0.0 113.651 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.97 96.6 0.21 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.919 0.359 . . . . 0.0 110.504 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.632 HG22 ' CB ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -68.27 129.62 32.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.813 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.522 ' HB3' ' CD1' ' A' ' 17' ' ' LEU . . . -63.79 166.04 7.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 111.345 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.9 m -98.29 173.02 7.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -57.06 -47.34 81.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.79 -36.12 76.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.966 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.42 -38.18 90.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.038 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.634 HD11 HD11 ' A' ' 17' ' ' LEU . 45.0 mm -61.63 -55.17 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.185 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.255 -179.793 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 2.4 mpp? . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.432 0.158 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.868 ' O ' HD12 ' A' ' 4' ' ' ILE . 2.1 ttt -80.05 112.5 17.41 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.861 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -69.78 114.69 8.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.638 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 1.027 HG13 HG12 ' A' ' 56' ' ' VAL . 2.3 mp -123.24 120.7 61.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.674 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -110.83 128.28 55.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.321 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.476 HD13 ' HG3' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -113.39 109.0 26.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.683 0.277 . . . . 0.0 111.474 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.919 ' CD2' ' HA ' ' A' ' 43' ' ' ILE . 40.2 m-85 -93.69 119.2 32.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.952 0.406 . . . . 0.0 110.636 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.629 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . -173.71 -85.77 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.498 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.7 m 56.61 77.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 0.0 110.794 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.02 117.66 3.54 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.068 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 78.89 -56.97 0.44 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.69 0.281 . . . . 0.0 110.934 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.629 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -54.73 122.08 9.92 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.916 0.389 . . . . 0.0 111.053 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -76.38 20.87 0.2 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.171 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.458 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.3 p -52.15 -25.98 10.26 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.004 0.43 . . . . 0.0 111.181 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -31.93 72.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.643 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.5 mtp -63.52 -62.67 1.52 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.307 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.799 HD23 ' O ' ' A' ' 67' ' ' ALA . 1.1 tm? -67.79 -21.48 65.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.8 0.333 . . . . 0.0 110.629 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.476 ' HG3' HD13 ' A' ' 6' ' ' ILE . 7.4 tt0 -57.81 -48.3 80.14 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.229 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -71.54 -46.41 59.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.768 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -59.28 -36.27 75.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.149 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.512 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -66.86 -50.4 62.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.108 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.51 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 20.8 ttt180 -55.66 -37.83 68.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.519 0.199 . . . . 0.0 111.406 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 23.7 pt-20 -74.24 -48.31 29.57 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.111 -0.236 . . . . 0.0 111.229 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.77 -50.95 67.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.842 HG21 ' HB2' ' A' ' 32' ' ' ALA . 8.9 p -53.8 -55.42 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.717 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.572 ' N ' HG13 ' A' ' 25' ' ' VAL . 5.6 mtpm? -66.94 -49.49 65.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.108 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.454 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 45.6 tp10 -56.29 -43.77 79.19 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 110.762 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.7 tp -53.11 -22.12 5.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.557 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.65 44.73 0.75 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.442 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.0 tt 179.76 124.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.308 0.575 . . . . 0.0 111.505 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -67.66 165.22 17.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.472 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.86 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -146.12 178.26 8.35 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.78 106.39 8.66 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.861 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.935 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 66.0 m-85 -99.4 109.0 21.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.424 0.63 . . . . 0.0 111.947 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.36 136.48 54.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.556 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.813 ' C ' HD13 ' A' ' 37' ' ' ILE . 4.9 ttpm? -89.37 153.64 20.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.12 0.486 . . . . 0.0 111.112 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.813 HG13 ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -126.47 83.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.307 -179.073 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.55 75.35 9.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.138 0.494 . . . . 0.0 111.636 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.6 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER 173.07 118.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.789 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.506 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 6.2 ptt? -53.53 -35.31 60.56 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.945 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.445 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -51.42 -35.78 40.77 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -86.63 -35.2 19.52 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.98 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.935 HG22 HD21 ' A' ' 48' ' ' LEU . 23.3 mt -60.32 -55.9 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.553 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -64.02 -34.35 77.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.2 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -60.21 -21.26 61.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.406 . . . . 0.0 110.155 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.801 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -72.61 -38.38 67.81 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.704 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.35 -14.62 7.76 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.473 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.935 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.02 158.0 35.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.364 0.582 . . . . 0.0 111.119 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.5 t -107.42 -10.33 15.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.04 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.471 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -102.51 -175.28 2.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.304 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.588 ' N ' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -89.64 -54.49 0.31 Allowed Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.616 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.649 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 11.1 Cg_exo -70.29 52.16 1.14 Allowed 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 122.626 2.218 . . . . 0.0 112.414 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -71.95 156.9 52.78 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.253 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.552 HD12 HG23 ' A' ' 66' ' ' VAL . 0.7 OUTLIER -154.36 101.49 2.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.844 0.354 . . . . 0.0 110.779 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.523 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -100.3 126.09 46.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.809 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.027 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -118.05 140.62 40.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.141 0.496 . . . . 0.0 111.572 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 44.91 27.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.252 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.75 34.68 30.47 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.443 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.32 99.84 3.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.639 HD21 ' O ' ' A' ' 46' ' ' ALA . 0.6 OUTLIER -69.9 131.31 44.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.019 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -146.09 11.45 1.2 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.719 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' A' ' 66' ' ' VAL . 3.2 mp -133.31 123.92 48.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.557 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 2.4 mtm -146.62 123.51 11.32 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.649 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 70.81 7.33 61.59 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.825 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.55 100.43 0.06 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.868 0.366 . . . . 0.0 110.588 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.712 HG22 ' CB ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -56.34 141.84 12.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.96 -179.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.799 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -63.66 172.35 2.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.902 0.382 . . . . 0.0 111.152 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -109.43 157.81 18.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.7 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.09 -41.18 71.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.206 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -60.14 -40.77 90.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -64.6 -37.45 87.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.649 HD11 HD11 ' A' ' 17' ' ' LEU . 39.2 mm -59.72 -54.86 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.984 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.5 tttm . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.033 179.949 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.442 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 15.2 mmt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.463 0.173 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.955 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -81.31 112.36 18.54 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.836 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.42 ' CG ' ' HA ' ' A' ' 57' ' ' ASP . 17.3 ptpt -68.72 115.05 7.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.992 0.425 . . . . 0.0 110.583 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.931 HG13 HG12 ' A' ' 56' ' ' VAL . 1.5 mt -121.23 121.97 66.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.45 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.693 ' O ' HD22 ' A' ' 54' ' ' LEU . 2.5 mt-30 -110.54 134.87 51.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.604 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.538 HG22 ' SG ' ' A' ' 14' ' ' CYS . 1.6 mp -119.93 113.71 41.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.398 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.891 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 48.9 m-85 -104.27 116.59 32.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.578 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 138.42 -78.36 0.31 Allowed Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.493 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m 69.27 -66.41 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 111.209 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.58 -96.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.708 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.6 m -63.73 -46.14 86.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 0.0 111.187 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.578 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -54.44 118.99 4.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.285 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -76.34 14.91 0.66 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.989 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' HG22 ' A' ' 6' ' ' ILE . 2.3 p -57.36 -19.83 25.33 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.755 0.312 . . . . 0.0 111.511 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -35.5 34.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.194 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.4 mmt -63.84 -62.07 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.793 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.792 HD13 ' O ' ' A' ' 17' ' ' LEU . 3.3 tm? -60.25 -30.03 69.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.66 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -54.7 -47.75 73.31 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.149 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -65.04 -39.78 93.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.481 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.467 ' HB2' HD22 ' A' ' 17' ' ' LEU . 1.2 m-20 -60.14 -51.04 71.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.753 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.708 ' HB3' ' HE2' ' A' ' 34' ' ' PHE . . . -54.01 -37.54 64.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.201 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.63 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 2.6 mtm-85 -59.92 -50.4 73.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 111.207 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.472 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 10.8 pt-20 -71.67 -47.75 52.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.075 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.13 -51.93 67.01 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.703 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.5 p -53.24 -55.54 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.684 0.278 . . . . 0.0 110.737 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.541 ' N ' HG13 ' A' ' 25' ' ' VAL . 7.5 mttm -67.51 -49.59 62.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.305 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 4.9 tt0 -53.99 -48.03 70.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.355 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -51.0 -22.47 2.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 110.671 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.63 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.57 34.64 1.7 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.648 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 29' ' ' GLY . 7.8 pt -161.98 112.85 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.872 0.368 . . . . 0.0 111.574 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.442 ' O ' ' CA ' ' A' ' 1' ' ' MET . 4.2 t70 -61.51 164.24 6.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.955 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -150.44 178.14 9.33 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -128.75 114.67 16.88 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.127 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.715 ' HE1' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -102.06 109.34 21.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.209 0.528 . . . . 0.0 111.218 -178.738 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -116.09 115.72 26.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.035 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.454 ' HG2' HD13 ' A' ' 6' ' ' ILE . 20.6 mtpt -90.19 140.32 29.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.975 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.891 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -111.98 179.14 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.477 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' N ' HG12 ' A' ' 37' ' ' ILE . 2.7 tmtt? -157.25 75.56 0.81 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.138 0.494 . . . . 0.0 110.452 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.7 OUTLIER 160.43 128.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.064 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.5 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -52.49 -27.41 16.2 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 121.25 -0.18 . . . . 0.0 110.831 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.488 ' O ' HD23 ' A' ' 44' ' ' LEU . 2.6 m-20 -51.7 -39.27 58.04 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -86.54 -37.7 17.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.024 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.975 HG22 HD21 ' A' ' 48' ' ' LEU . 16.4 mt -58.98 -55.36 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.094 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.63 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -61.24 -40.97 96.02 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.702 179.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.63 ' H ' HD23 ' A' ' 44' ' ' LEU . 36.8 tt0 -53.02 -26.13 14.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.972 0.415 . . . . 0.0 110.372 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.737 ' O ' HD11 ' A' ' 60' ' ' LEU . . . -70.36 -36.57 74.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.753 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.3 -13.37 16.15 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.907 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.975 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.3 162.96 26.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.904 0.352 . . . . 0.0 111.124 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.63 -17.83 11.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 111.67 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -87.48 175.61 7.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.654 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.611 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.7 mt -79.64 -63.88 0.35 Allowed Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.962 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 11.0 Cg_exo -70.04 58.91 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.278 1.985 . . . . 0.0 111.919 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -79.01 147.75 30.83 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.475 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.693 HD22 ' O ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -139.85 104.01 4.78 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.99 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -98.47 124.72 43.35 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.975 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.931 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -120.68 139.51 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.182 0.515 . . . . 0.0 112.218 -179.267 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.42 ' HA ' ' CG ' ' A' ' 3' ' ' LYS . 1.8 m-20 43.03 28.3 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.687 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.29 32.95 37.05 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.714 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.48 98.56 2.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.921 0.391 . . . . 0.0 110.468 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.99 HD23 ' HB2' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -70.2 133.75 47.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.827 -179.6 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.729 ' O ' HD12 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -141.29 6.68 1.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.72 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.729 HD12 ' O ' ' A' ' 61' ' ' LYS . 1.2 mp -127.88 125.78 65.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.662 0.268 . . . . 0.0 110.94 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.466 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 7.8 mtt -146.51 116.16 7.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.652 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.563 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 88.98 -13.24 63.65 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.134 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 179.46 114.42 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' ' 14' ' ' CYS . 3.6 m -52.11 179.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.392 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.722 ' HB2' HD11 ' A' ' 62' ' ' ILE . . . -91.71 177.31 6.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.1 p -99.67 158.49 15.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.806 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -52.64 -39.32 61.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.118 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -67.37 -38.78 85.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.01 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.47 -32.29 72.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.048 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.2 mm -71.08 -52.63 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.078 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.833 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 32' ' ' ALA . 10.8 mtt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.316 0.103 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.816 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 33.2 mmm -83.5 111.12 18.78 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.163 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.05 100.8 2.58 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.154 0.502 . . . . 0.0 110.44 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.662 HG21 ' CD2' ' A' ' 34' ' ' PHE . 1.7 mp -99.86 114.64 38.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.998 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.415 ' CA ' HD11 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -101.64 119.67 39.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.466 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.587 ' N ' HD11 ' A' ' 37' ' ' ILE . 26.3 mm -104.59 101.63 12.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 120.697 0.284 . . . . 0.0 111.574 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.737 ' CE1' HG13 ' A' ' 37' ' ' ILE . 79.4 m-85 -90.6 103.23 15.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.046 0.451 . . . . 0.0 110.739 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.879 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 160.39 -84.55 0.12 Allowed Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.986 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 t 40.44 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 112.001 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.07 -62.3 0.29 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.138 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 t -87.79 -30.79 19.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.98 0.419 . . . . 0.0 110.545 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.879 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -111.17 134.89 52.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.811 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.22 15.09 0.61 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.502 ' SG ' HG22 ' A' ' 6' ' ' ILE . 3.7 p -57.85 -20.13 34.06 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.67 0.271 . . . . 0.0 111.524 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -20.99 36.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.534 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.2 mtt -63.31 -62.43 1.7 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.771 0.319 . . . . 0.0 110.858 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.709 HD13 ' C ' ' A' ' 67' ' ' ALA . 4.0 tp -64.08 -22.45 66.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.34 . . . . 0.0 110.581 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.407 ' CG ' HG13 ' A' ' 6' ' ' ILE . 47.1 tt0 -56.18 -54.17 48.36 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.354 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.55 -46.73 78.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.95 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -54.78 -51.32 66.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.401 ' CB ' ' HE2' ' A' ' 34' ' ' PHE . . . -56.62 -36.73 69.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.806 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.533 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 44.2 mtp180 -57.26 -48.0 79.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 111.117 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 8.0 tt0 -72.39 -50.26 27.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.183 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.546 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -60.05 -51.08 71.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.609 HG11 ' HB3' ' A' ' 32' ' ' ALA . 2.4 p -53.64 -55.41 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.59 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.5 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 6.0 mttm -67.22 -50.36 61.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.681 0.277 . . . . 0.0 111.113 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 8.8 tt0 -52.01 -45.63 64.64 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.381 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 24' ' ' ALA . 2.6 mm? -52.99 -19.33 2.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.882 0.372 . . . . 0.0 110.608 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.872 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 113.37 21.31 5.89 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.599 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.872 HD13 ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -147.76 110.88 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.861 0.363 . . . . 0.0 110.899 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -64.92 162.81 15.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.345 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.816 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -149.27 -169.33 3.35 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -142.42 113.96 7.88 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.048 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.662 ' CD2' HG21 ' A' ' 4' ' ' ILE . 11.8 m-85 -105.75 109.13 20.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.569 0.699 . . . . 0.0 112.249 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -127.65 134.87 49.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.456 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.837 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -79.24 155.71 28.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.022 0.439 . . . . 0.0 110.905 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.837 HD13 ' C ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -126.21 80.34 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.663 -178.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -82.21 75.56 9.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.087 0.47 . . . . 0.0 111.143 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.545 ' O ' HG13 ' A' ' 43' ' ' ILE . 3.0 mm-40 173.52 121.7 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.67 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.543 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 1.6 tpt -53.88 -31.58 50.32 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.843 -0.162 . . . . 0.0 111.059 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.435 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -51.57 -37.96 52.19 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.443 ' CB ' HG22 ' A' ' 37' ' ' ILE . 47.9 mm-40 -86.9 -34.21 19.48 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.192 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.844 HG22 HD21 ' A' ' 48' ' ' LEU . 47.5 mt -59.76 -55.21 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.348 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -63.16 -38.37 90.9 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.048 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.664 ' H ' HD23 ' A' ' 44' ' ' LEU . 2.7 tt0 -56.11 -24.3 39.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.535 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.735 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -74.22 -34.78 63.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.974 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.43 -6.43 31.86 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.198 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.852 HD13 HD21 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -79.53 160.44 26.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.161 0.48 . . . . 0.0 111.643 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.51 HG22 ' HE2' ' A' ' 63' ' ' MET . 10.0 t -112.06 -30.09 7.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.743 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.447 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -77.58 -177.78 4.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.229 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.582 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.3 mp -87.98 -62.47 0.22 Allowed Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.912 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 16.9 Cg_exo -67.38 59.66 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.264 1.976 . . . . 0.0 112.255 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.8 139.52 17.92 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.574 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.647 ' CD1' HG23 ' A' ' 4' ' ' ILE . 16.3 tp -129.58 103.13 6.69 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.61 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -100.79 125.33 47.27 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.321 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.515 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.92 139.38 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.078 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 47.06 26.94 0.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.587 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.61 34.79 48.47 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.325 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -144.7 103.31 3.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.386 . . . . 0.0 111.197 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.852 HD21 HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -46.31 133.32 9.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.234 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -118.63 -23.7 6.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.532 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.618 HD13 ' HA ' ' A' ' 66' ' ' VAL . 2.8 pp -154.62 154.91 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.638 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 2.0 mtp -146.78 129.13 15.81 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.432 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.472 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 94.41 -20.51 47.77 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.369 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -179.79 112.18 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.785 0.326 . . . . 0.0 110.364 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.618 ' HA ' HD13 ' A' ' 62' ' ' ILE . 15.8 m -51.29 161.54 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.278 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.709 ' C ' HD13 ' A' ' 17' ' ' LEU . . . -64.1 -166.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.954 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.9 t -118.94 171.17 8.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.962 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -55.57 -56.64 17.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.066 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -59.77 -30.54 68.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.822 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -61.89 -46.38 89.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.634 HD11 HD11 ' A' ' 17' ' ' LEU . 43.5 mm -59.71 -54.25 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.882 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 179.858 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.437 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 4.8 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.523 0.201 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.83 ' O ' HD12 ' A' ' 4' ' ' ILE . 5.2 mmt -77.56 113.51 15.46 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.986 0.422 . . . . 0.0 110.808 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.81 100.51 1.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.084 0.468 . . . . 0.0 110.52 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.93 HG13 HG12 ' A' ' 56' ' ' VAL . 2.8 mp -109.24 128.79 64.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.933 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.735 ' O ' HD13 ' A' ' 54' ' ' LEU . 13.3 mm-40 -110.89 142.45 42.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.878 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.513 HG12 HD11 ' A' ' 54' ' ' LEU . 19.9 mt -122.09 115.0 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.196 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.863 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 86.6 m-85 -106.1 110.82 23.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.302 0.572 . . . . 0.0 112.134 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 155.78 -78.61 0.19 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.235 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 p 49.22 33.3 4.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.791 0.329 . . . . 0.0 111.584 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.38 -71.81 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.39 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.08 27.96 8.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 110.737 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.416 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -124.57 130.05 51.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.083 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -76.36 20.46 0.21 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.756 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.62 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.6 p -55.45 -19.86 10.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.796 0.332 . . . . 0.0 111.557 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.03 -41.47 47.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.787 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.0 mtp -63.74 -62.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.764 0.316 . . . . 0.0 111.218 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.059 HD21 HD11 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -59.47 -31.85 69.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.825 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.414 ' HG3' ' CD1' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -58.42 -40.05 81.45 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -73.28 -46.93 46.95 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.653 HD21 HD22 ' A' ' 17' ' ' LEU . 34.4 p30 -69.17 -34.3 74.74 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.151 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.495 ' HB1' ' HE2' ' A' ' 34' ' ' PHE . . . -63.06 -47.33 83.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.467 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.491 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -57.69 -47.5 82.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.712 0.291 . . . . 0.0 111.294 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.442 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 22.2 tp10 -72.75 -50.45 24.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.42 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.58 -49.1 76.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.783 HG11 ' HB3' ' A' ' 32' ' ' ALA . 3.8 p -53.36 -54.66 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.451 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.495 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.52 -43.43 76.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.619 0.247 . . . . 0.0 110.702 178.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 35.3 tt0 -57.28 -43.92 83.56 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.154 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.551 ' HB3' HD11 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -52.7 -19.12 2.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.8 0.333 . . . . 0.0 110.769 179.599 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.91 25.91 4.03 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.671 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.552 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -159.64 117.0 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.943 0.401 . . . . 0.0 111.443 179.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.452 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -61.46 164.79 5.35 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.242 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.783 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -148.78 165.74 30.53 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -125.13 110.05 13.64 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.042 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.842 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 30.3 m-85 -97.08 108.94 21.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.253 0.549 . . . . 0.0 111.418 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -112.97 115.58 28.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.809 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 136.62 33.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.032 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.863 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -101.66 -178.24 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.291 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.486 ' N ' HG12 ' A' ' 37' ' ' ILE . 3.3 ptmt -158.5 75.37 0.72 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.168 0.509 . . . . 0.0 110.651 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 0.2 OUTLIER 155.37 131.68 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.886 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 0.523 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 3.1 mpp? -52.61 -25.11 9.72 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.2 -0.2 . . . . 0.0 111.136 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.483 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.6 t0 -51.51 -39.82 58.39 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -86.54 -36.4 18.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.037 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.843 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 17.4 mt -59.67 -54.96 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.324 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -62.88 -38.58 91.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.835 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.556 ' H ' HD23 ' A' ' 44' ' ' LEU . 1.6 tp10 -55.63 -24.61 34.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.99 0.424 . . . . 0.0 110.294 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.793 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -72.62 -35.31 67.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.771 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.639 ' HA3' HD21 ' A' ' 60' ' ' LEU . . . 113.0 -11.76 24.67 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.973 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.79 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -81.48 161.72 23.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.076 0.438 . . . . 0.0 111.36 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.6 p -114.32 -25.48 8.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.16 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.84 ' HB3' ' CB ' ' A' ' 63' ' ' MET . . . -77.88 171.92 14.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.579 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.617 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.5 mp -77.99 -64.12 0.42 Allowed Pre-proline 0 C--N 1.332 -0.188 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.486 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.617 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 14.8 Cg_exo -67.9 58.13 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.239 1.959 . . . . 0.0 112.365 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.626 ' O ' HD22 ' A' ' 54' ' ' LEU . . . -84.26 137.69 16.23 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.926 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.735 HD13 ' O ' ' A' ' 5' ' ' GLN . 2.6 mm? -129.06 103.83 7.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.744 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -97.82 121.7 40.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.026 0.441 . . . . 0.0 111.422 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.93 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -112.95 139.16 39.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.826 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 47.96 26.41 0.96 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.553 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.13 33.16 50.51 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.502 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.09 102.27 3.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.827 0.346 . . . . 0.0 111.158 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.744 HD12 ' HB2' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -48.78 126.56 12.25 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.856 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -115.6 -21.9 9.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.7 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.496 HD13 ' H ' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -154.95 133.65 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.284 -179.392 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.84 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.88 138.02 25.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.355 178.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.509 ' N ' ' HB1' ' A' ' 50' ' ' ALA . . . 81.54 -3.54 77.94 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.816 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 179.61 100.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.34 . . . . 0.0 110.482 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' A' ' 14' ' ' CYS . 0.3 OUTLIER -65.5 141.3 18.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.961 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.496 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -63.93 -173.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.23 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.02 179.96 4.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.825 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.7 -46.19 87.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.212 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.61 -41.76 95.43 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.018 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.406 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 67.5 mm-40 -56.85 -44.05 81.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.075 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.059 HD11 HD21 ' A' ' 17' ' ' LEU . 40.3 mm -64.86 -55.1 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.935 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 1.441 ' CE ' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 1 N--CA 1.362 -4.861 0 N-CA-C 113.763 1.023 . . . . 2.66 113.763 . . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 1.381 ' CE ' ' CG ' ' A' ' 2' ' ' MET . 1.7 mtt -80.54 113.76 18.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.594 -0.442 . . . . 1.73 110.938 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -70.72 107.89 4.17 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.142 0.496 . . . . 2.22 110.406 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.72 HG13 HG12 ' A' ' 56' ' ' VAL . 3.6 mt -114.65 122.68 69.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.124 0.487 . . . . 0.66 111.535 -179.274 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.1 133.67 52.7 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 115.867 -0.606 . . . . 1.82 110.632 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.445 ' CD1' ' CB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -115.03 108.91 26.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.832 0.349 . . . . 1.44 111.188 -179.915 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 1.419 ' CZ ' ' CD1' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -96.09 113.91 25.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.281 0.562 . . . . 1.25 111.591 -179.383 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.734 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 154.79 -83.8 0.15 Allowed Glycine 1 C--O 1.114 -7.378 0 CA-C-N 115.833 -0.621 . . . . 0.71 113.678 -179.865 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 1.284 ' O ' ' CA ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER 61.18 69.21 0.68 Allowed 'General case' 2 C--O 0.484 -39.237 1 CA-C-O 149.367 13.937 . . . . 1.97 111.866 179.918 . . . . . . . . 5 4 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 1.284 ' CA ' ' O ' ' A' ' 9' ' ' THR . . . 142.4 -71.18 0.41 Allowed Glycine 3 C--N 0.807 -28.808 3 O-C-N 50.769 -44.957 . . . . 1.42 115.301 179.83 . . . . . . . . 4 3 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.234 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 1.1 m -90.58 -20.82 22.17 Favored 'General case' 2 C--N 1.078 -11.201 2 O-C-N 108.323 -8.751 . . . . 1.88 111.781 -179.946 . . . . . . . . 4 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.734 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -89.86 129.9 36.17 Favored 'General case' 1 C--N 1.184 -6.624 1 O-C-N 115.274 -4.641 . . . . 0.49 111.247 179.969 . . . . . . . . 4 3 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 1.388 ' OD1' ' CB ' ' A' ' 13' ' ' ASN . 68.6 m-20 -76.36 17.9 0.34 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.36 0.504 . . . . 1.66 112.36 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.56 ' HB2' HG22 ' A' ' 6' ' ' ILE . 2.0 p -54.7 -23.21 16.56 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.286 0.565 . . . . 0.7 111.936 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.478 ' HG2' ' N ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -52.85 -33.89 51.69 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.811 -0.631 . . . . 1.56 111.799 -179.85 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 1.586 ' CG ' ' CE ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -64.38 -59.14 4.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.161 0.505 . . . . 2.28 110.889 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.493 ' CD2' ' CB ' ' A' ' 17' ' ' LEU . 2.7 tm? -64.57 -25.8 68.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.187 0.517 . . . . 1.75 110.907 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.515 ' HG3' HD13 ' A' ' 6' ' ' ILE . 3.5 tt0 -57.56 -48.95 77.94 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.981 -0.554 . . . . 1.78 110.623 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 1.471 ' CD ' ' NZ ' ' A' ' 19' ' ' LYS . 25.6 tttt -69.05 -47.81 64.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.113 0.482 . . . . 2.32 111.316 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -43.81 92.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.086 -0.506 . . . . 1.92 111.176 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.407 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -58.94 -42.71 90.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.123 -0.489 . . . . 0.36 111.714 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 1.126 ' NE ' ' CG ' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -57.68 -45.62 85.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.816 0.341 . . . . 2.7 111.467 -179.638 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 0.6 OUTLIER -71.9 -49.33 38.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.407 -0.36 . . . . 2.18 111.296 -179.636 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.563 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -62.4 -50.43 71.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.877 0.325 . . . . 0.48 111.877 -179.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 32' ' ' ALA . 5.4 p -53.72 -54.86 16.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.643 0.258 . . . . 0.52 110.743 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 1.359 ' CE ' ' CG ' ' A' ' 26' ' ' LYS . 21.7 mttm -67.55 -47.23 70.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.734 0.302 . . . . 2.35 110.995 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 86.1 tt0 -57.12 -43.88 82.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 1.95 111.35 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -52.39 -20.94 3.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.997 0.427 . . . . 2.0 110.903 179.551 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.92 36.22 1.41 Allowed Glycine 0 C--O 1.22 -0.738 0 C-N-CA 120.798 -0.715 . . . . 0.65 112.474 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 1.549 ' CB ' ' CD1' ' A' ' 30' ' ' ILE . 17.7 pt -170.37 117.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.117 0.484 . . . . 1.76 111.434 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 1.423 ' OD1' ' CB ' ' A' ' 31' ' ' ASP . 0.4 OUTLIER -62.4 163.61 8.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.937 -0.574 . . . . 1.62 110.228 179.379 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.747 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -149.43 164.7 34.26 Favored 'General case' 0 C--O 1.188 -2.167 0 N-CA-C 109.584 -0.525 . . . . 0.6 109.584 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -122.0 113.15 19.17 Favored 'General case' 0 C--N 1.281 -2.398 0 O-C-N 121.008 -1.057 . . . . 2.18 110.17 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 1.431 ' CZ ' ' CD1' ' A' ' 34' ' ' PHE . 22.3 m-85 -98.93 109.4 22.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.398 0.618 . . . . 1.28 111.824 -178.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 1.473 ' CD ' ' CB ' ' A' ' 35' ' ' GLU . 1.8 mt-10 -115.64 122.9 46.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.169 -0.923 . . . . 2.3 110.278 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 1.412 ' CD ' ' NZ ' ' A' ' 36' ' ' LYS . 14.7 mttt -84.42 144.95 28.44 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.437 -0.347 . . . . 2.26 110.507 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 1.036 HD13 ' N ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -115.01 136.57 51.27 Favored 'Isoleucine or valine' 1 C--O 0.985 -12.837 0 CA-C-O 123.872 1.796 . . . . 1.81 110.205 -179.568 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.714 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 53.1 pttt -124.71 75.3 1.41 Allowed 'General case' 1 C--N 1.132 -8.889 2 O-C-N 109.725 -8.11 . . . . 3.21 110.94 -179.98 . . . . . . . . 4 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER 163.4 128.29 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.339 -0.846 . . . . 2.44 110.7 179.839 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . 1.347 ' CE ' ' CG ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -56.21 -26.52 51.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.573 0.225 . . . . 2.59 111.065 -179.871 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 1.165 ' OD2' ' CB ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -51.5 -38.7 55.28 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.899 -0.778 . . . . 1.7 108.899 178.645 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 1.079 ' CD ' ' CB ' ' A' ' 42' ' ' GLN . 6.3 mm-40 -87.02 -34.95 19.04 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.093 -0.958 . . . . 1.98 110.302 178.316 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.729 HG13 ' HA ' ' A' ' 40' ' ' MET . 5.2 mt -62.61 -52.76 55.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-O 121.108 0.48 . . . . 1.11 111.375 -179.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.523 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -63.38 -36.85 85.08 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.97 -0.559 . . . . 0.7 110.866 179.877 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 1.088 ' CD ' ' CB ' ' A' ' 45' ' ' GLU . 24.5 tt0 -57.14 -25.61 59.16 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.348 -0.387 . . . . 2.01 110.17 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.553 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -74.72 -38.07 62.39 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 115.951 -0.568 . . . . 0.89 109.75 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.43 -3.48 28.0 Favored Glycine 0 C--O 1.195 -2.293 0 C-N-CA 120.773 -0.727 . . . . 0.78 114.867 179.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.728 ' H ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -74.03 160.19 31.63 Favored 'General case' 1 C--O 0.896 -17.525 0 CA-C-O 121.69 0.757 . . . . 1.17 112.073 179.96 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 1.305 ' CG2' ' CA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -115.55 -17.56 11.14 Favored 'General case' 2 C--N 1.111 -9.768 3 O-C-N 109.08 -8.513 . . . . 1.82 112.481 179.761 . . . . . . . . 5 4 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -97.01 -172.71 2.51 Favored 'General case' 1 C--N 1.208 -5.549 0 O-C-N 117.698 -3.126 . . . . 0.56 110.348 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 1.33 ' CD1' ' CB ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -89.01 -63.65 0.2 Allowed Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 112.13 0.419 . . . . 1.47 112.13 -179.572 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 6.3 Cg_exo -67.78 59.68 0.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.239 1.959 . . . . 0.59 112.829 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -86.9 144.44 19.47 Favored Glycine 0 C--O 1.21 -1.355 0 C-N-CA 120.642 -0.79 . . . . 0.46 112.862 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.483 ' CD1' ' CB ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -136.73 109.22 7.4 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 122.52 -0.4 . . . . 1.72 110.708 179.889 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -101.02 125.15 47.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.909 0.385 . . . . 0.42 111.269 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.72 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -116.82 139.12 45.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.073 -0.512 . . . . 0.51 111.306 -179.91 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 1.3 ' OD1' ' CB ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER 47.11 27.06 0.73 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.605 -0.725 . . . . 1.59 110.715 -179.575 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.58 32.89 44.86 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.864 -0.684 . . . . 0.62 112.527 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.267 ' CD ' ' CB ' ' A' ' 59' ' ' GLU . 3.9 mt-10 -145.75 102.27 3.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.856 0.36 . . . . 2.21 111.041 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.481 HD21 ' O ' ' A' ' 46' ' ' ALA . 2.1 mm? -58.92 131.95 52.53 Favored 'General case' 0 CA--C 1.482 -1.668 0 CA-C-N 116.094 -0.503 . . . . 1.82 111.32 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.47 -8.71 3.69 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 114.678 1.362 . . . . 2.47 114.678 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.518 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -142.08 130.78 22.18 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.908 0 C-N-CA 120.253 -0.579 . . . . 2.17 111.795 -179.881 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 1.251 ' CG ' ' SD ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -146.62 131.04 17.63 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 112.742 0.645 . . . . 2.28 112.742 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.601 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 77.46 -2.93 60.93 Favored Glycine 0 C--O 1.192 -2.512 0 C-N-CA 120.297 -0.954 . . . . 0.65 113.676 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 1.538 ' CD ' ' CB ' ' A' ' 65' ' ' ARG . 1.7 ttp180 -177.21 101.9 0.05 Allowed 'General case' 0 C--O 1.2 -1.549 0 CA-C-N 117.48 0.64 . . . . 3.53 112.7 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 1.18 ' CG2' ' CA ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -57.95 148.58 5.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 116.579 -0.282 . . . . 1.28 111.476 -179.666 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.54 167.44 21.89 Favored 'General case' 0 C--O 1.19 -2.047 0 CA-C-O 120.816 0.341 . . . . 0.73 111.511 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 1.132 ' OG ' ' HB3' ' A' ' 68' ' ' SER . 0.5 OUTLIER -97.21 170.72 8.91 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 122.085 -0.384 . . . . 1.61 111.297 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 1.468 ' CB ' ' CD ' ' A' ' 69' ' ' LYS . 2.7 pttt -57.54 -46.5 83.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.405 -0.361 . . . . 2.8 111.125 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -64.7 -34.95 79.52 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.88 0.371 . . . . 2.42 111.135 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -45.05 81.31 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.2 -0.454 . . . . 1.95 110.921 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -50.54 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 116.098 -0.501 . . . . 1.64 111.086 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 1.462 ' CE ' ' CG ' ' A' ' 73' ' ' LYS . 17.6 tttt . . . . . 0 N--CA 1.438 -1.046 0 CA-C-N 116.295 -0.411 . . . . 2.32 110.836 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.452 ' CB ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 111.395 0.146 . . . . 0.0 111.395 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.712 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -80.55 116.23 20.48 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.865 0.364 . . . . 0.0 111.317 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -79.85 101.08 8.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.981 0.419 . . . . 0.0 109.95 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.884 HD12 ' CZ ' ' A' ' 34' ' ' PHE . 2.0 mt -109.95 124.92 67.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.579 -178.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.407 ' O ' HD22 ' A' ' 54' ' ' LEU . 3.2 mp0 -110.47 133.74 53.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.146 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.433 ' CG2' ' CB ' ' A' ' 14' ' ' CYS . 42.0 mt -114.45 109.64 29.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.109 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.914 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 66.5 m-85 -95.78 125.3 40.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.072 0.463 . . . . 0.0 111.556 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 122.46 -70.42 0.42 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.287 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.47 -70.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.821 0.343 . . . . 0.0 111.469 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.36 -97.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.643 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.44 -29.44 61.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.76 0.314 . . . . 0.0 111.134 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.468 ' HB1' ' SG ' ' A' ' 14' ' ' CYS . . . -68.65 120.49 14.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.996 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -76.24 21.25 0.18 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.486 ' HA ' HG21 ' A' ' 66' ' ' VAL . 6.1 m -55.21 -21.61 14.51 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.694 0.283 . . . . 0.0 111.374 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.62 -39.48 11.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 mtp -63.68 -62.69 1.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.642 0.258 . . . . 0.0 111.257 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.04 HD11 HD11 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -67.22 -19.54 65.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.781 0.324 . . . . 0.0 110.724 179.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -60.29 -50.36 73.95 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.345 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -70.28 -45.87 65.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.713 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -60.76 -38.6 85.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.008 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -63.47 -45.91 88.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.296 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.507 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 5.6 mtt-85 -57.71 -53.15 61.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -65.58 -50.19 66.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.523 -179.336 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' O ' HD12 ' A' ' 28' ' ' LEU . . . -63.12 -51.91 64.66 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.924 HG11 ' HB3' ' A' ' 32' ' ' ALA . 4.4 p -53.77 -55.09 15.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.083 -0.247 . . . . 0.0 110.446 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.516 ' N ' HG13 ' A' ' 25' ' ' VAL . 36.6 mtpt -65.34 -49.56 68.93 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.676 0.274 . . . . 0.0 111.2 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 46.8 tp10 -60.01 -39.28 85.27 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.721 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.712 HD13 HD23 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -54.02 -15.93 1.68 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.751 0.31 . . . . 0.0 111.175 179.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.646 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 114.05 26.16 3.9 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.546 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.718 ' N ' HD13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -163.26 109.59 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.797 0.332 . . . . 0.0 110.628 179.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.489 ' HA ' ' HG2' ' A' ' 26' ' ' LYS . 2.8 m-20 -60.71 156.49 16.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.924 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -145.29 140.06 27.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -103.94 117.12 33.56 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.044 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.884 ' CZ ' HD12 ' A' ' 4' ' ' ILE . 15.7 m-85 -98.48 109.3 22.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.331 0.586 . . . . 0.0 112.068 -178.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.51 126.51 55.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.287 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.838 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -79.85 150.65 30.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.148 0.499 . . . . 0.0 111.068 -179.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.847 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -124.2 80.73 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.408 -179.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.04 75.03 6.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.132 0.491 . . . . 0.0 111.378 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.589 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.4 OUTLIER 173.95 119.02 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.704 179.385 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.516 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 1.2 ptp -54.02 -33.11 56.32 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.45 0.167 . . . . 0.0 111.089 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.26 -37.38 46.83 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 34.9 mm-40 -86.74 -33.86 19.84 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.185 178.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.027 HG22 HD21 ' A' ' 48' ' ' LEU . 26.8 mt -61.41 -55.95 21.09 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.061 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.412 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.478 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -63.06 -36.65 84.29 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.826 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.478 ' H ' HD23 ' A' ' 44' ' ' LEU . 3.6 tt0 -56.85 -24.56 52.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.993 0.425 . . . . 0.0 110.319 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.776 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -72.14 -40.08 68.31 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.574 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.512 ' HA3' HD11 ' A' ' 60' ' ' LEU . . . 119.53 -10.75 11.4 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.506 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.027 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -71.87 152.07 42.89 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 117.444 0.622 . . . . 0.0 111.017 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 t -104.35 -9.41 18.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.931 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' A' ' 63' ' ' MET . . . -104.06 -177.93 3.51 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.422 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -81.67 -64.09 0.28 Allowed Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -179.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.445 ' HG2' ' CA ' ' A' ' 64' ' ' GLY . 56.2 Cg_endo -70.29 56.48 1.62 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.371 2.047 . . . . 0.0 113.41 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -73.06 143.48 33.35 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.46 -0.876 . . . . 0.0 111.903 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.703 HD11 ' CG2' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -134.27 102.7 5.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.565 0.221 . . . . 0.0 110.432 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -104.95 124.47 49.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.961 0.41 . . . . 0.0 111.581 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.873 HG12 HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.27 138.4 44.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.39 179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 46.99 25.39 0.47 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.296 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.98 22.64 44.67 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.128 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.46 ' CG ' ' O ' ' A' ' 59' ' ' GLU . 4.6 pt-20 -137.28 108.19 6.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.216 0.531 . . . . 0.0 110.852 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.647 HD21 ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -85.4 131.32 34.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.887 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.84 2.49 2.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.546 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.597 HG21 ' HA ' ' A' ' 66' ' ' VAL . 9.7 mt -128.24 122.39 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.187 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.664 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.565 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 2.4 mpp? -145.74 130.81 18.33 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.474 ' N ' ' CB ' ' A' ' 50' ' ' ALA . . . 73.6 6.79 72.34 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.176 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.414 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 1.9 ttp85 178.81 101.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.761 0.315 . . . . 0.0 110.616 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.597 ' HA ' HG21 ' A' ' 62' ' ' ILE . 3.3 p -57.83 148.35 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.644 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.675 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -65.37 173.74 2.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.935 0.398 . . . . 0.0 111.434 -179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.42 ' CA ' HD23 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -110.11 158.97 17.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.607 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.48 -48.48 65.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.319 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -63.14 -34.32 77.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.922 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -65.54 -42.57 91.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.04 HD11 HD11 ' A' ' 17' ' ' LEU . 36.5 mm -56.23 -55.1 20.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.986 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -58.63 -37.23 75.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -31.76 62.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.22 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 72' ' ' ILE . 0.3 OUTLIER -76.05 -29.78 19.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.989 0.423 . . . . 0.0 110.697 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.712 HD23 HD13 ' A' ' 28' ' ' LEU . 1.4 tp -108.01 -74.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.014 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.906 -179.934 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.445 ' H1 ' ' HG3' ' A' ' 1' ' ' MET . 3.4 mtt . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.674 0.273 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.631 ' SD ' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -77.23 113.56 15.11 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.891 0.377 . . . . 0.0 111.095 179.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.55 100.38 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.922 HD12 ' CE2' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -106.51 125.51 62.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.026 -179.085 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.816 ' O ' HD22 ' A' ' 54' ' ' LEU . 3.3 mm-40 -107.11 126.23 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.169 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.815 ' N ' HD11 ' A' ' 37' ' ' ILE . 2.9 mp -107.86 102.65 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.777 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 80.6 m-85 -88.94 124.26 34.07 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.924 0.392 . . . . 0.0 110.755 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.583 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 143.1 -85.36 0.19 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.299 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t 40.29 86.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.879 0.371 . . . . 0.0 111.778 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.42 -61.92 0.56 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.517 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 85.1 m -118.62 -2.57 10.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.526 0.203 . . . . 0.0 111.497 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.583 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -100.77 135.08 42.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.82 0.343 . . . . 0.0 111.154 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.69 ' O ' HG21 ' A' ' 66' ' ' VAL . 47.9 m-20 -76.55 20.1 0.24 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.023 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.564 ' HB2' HG23 ' A' ' 6' ' ' ILE . 3.8 p -57.15 -19.85 22.73 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.675 0.274 . . . . 0.0 111.509 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -50.08 -38.49 38.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.653 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.579 ' CB ' HG11 ' A' ' 66' ' ' VAL . 1.1 mpp? -64.65 -52.64 56.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.799 ' HB2' HG13 ' A' ' 66' ' ' VAL . 30.9 tp -66.78 -28.75 68.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.067 0.46 . . . . 0.0 110.143 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.01 -47.47 80.78 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.386 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -46.17 61.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.867 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -56.6 -53.02 62.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.044 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.416 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -54.43 -43.06 71.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.892 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 5.5 mtt180 -57.61 -43.71 84.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.665 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 61.6 tt0 -74.34 -50.75 17.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.368 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.28 -49.84 72.45 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.822 HG11 ' HB3' ' A' ' 32' ' ' ALA . 3.2 p -54.38 -53.9 26.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.613 0.244 . . . . 0.0 110.44 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.494 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 51.7 mttt -67.01 -50.09 63.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.784 0.326 . . . . 0.0 110.849 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.436 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 19.4 tt0 -57.82 -39.78 78.45 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.077 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.6 tp -52.14 -21.14 3.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.781 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.753 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.76 32.55 2.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.618 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.753 HG23 ' O ' ' A' ' 29' ' ' GLY . 2.2 pt -169.09 121.52 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.862 0.363 . . . . 0.0 111.222 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.434 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -61.36 164.0 6.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.167 179.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.822 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -150.62 140.07 21.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -100.72 111.17 23.35 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.386 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.922 ' CE2' HD12 ' A' ' 4' ' ' ILE . 68.9 m-85 -94.88 109.18 21.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.505 0.669 . . . . 0.0 111.966 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.31 128.36 54.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.374 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.708 ' C ' HD13 ' A' ' 37' ' ' ILE . 5.2 mttt -78.69 149.95 32.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.113 0.483 . . . . 0.0 110.806 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.855 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -115.7 76.62 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.687 -178.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.3 75.16 2.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.993 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.504 ' O ' HG13 ' A' ' 43' ' ' ILE . 2.6 mm-40 167.9 124.12 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.669 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.674 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -59.24 -20.31 53.05 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 116.751 -0.204 . . . . 0.0 111.213 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.46 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -51.46 -43.33 62.07 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.42 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -87.41 -34.8 18.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.475 178.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.957 HG22 HD21 ' A' ' 48' ' ' LEU . 16.9 mt -61.36 -54.94 28.29 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 121.345 0.593 . . . . 0.0 111.036 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -60.56 -35.84 77.04 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.612 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.442 ' H ' HD23 ' A' ' 44' ' ' LEU . 24.8 tt0 -56.35 -34.05 66.23 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.158 0.504 . . . . 0.0 109.818 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.716 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -75.55 -42.67 51.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.875 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.99 30.61 31.12 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.561 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.957 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -51.61 -41.75 61.46 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.443 0.621 . . . . 0.0 110.919 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 48' ' ' LEU . 5.6 p 90.64 7.23 0.08 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.241 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.751 ' HB3' ' HG2' ' A' ' 63' ' ' MET . . . -153.65 -157.27 0.76 Allowed 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.948 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.594 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.4 mp -99.19 -61.15 0.11 Allowed Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 25.9 Cg_exo -62.94 52.85 0.13 Allowed 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 122.843 2.362 . . . . 0.0 113.879 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.544 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -81.68 137.37 17.31 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.285 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.816 HD22 ' O ' ' A' ' 5' ' ' GLN . 2.5 tm? -136.41 101.51 4.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.673 0.273 . . . . 0.0 110.499 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -104.45 133.53 49.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.81 0.338 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.663 HG13 HG23 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.59 141.45 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.183 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 50.83 23.18 1.33 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.595 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.43 31.02 23.15 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.257 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.7 106.59 5.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 111.118 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.816 ' H ' HD22 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -83.18 130.08 35.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.016 179.23 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -138.23 1.23 2.2 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.527 HD11 HD23 ' A' ' 17' ' ' LEU . 1.6 pp -150.25 124.21 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 C-N-CA 120.255 -0.578 . . . . 0.0 112.051 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.751 ' HG2' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.5 150.5 36.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.534 179.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.554 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 56.42 16.74 16.43 Favored Glycine 0 C--N 1.331 0.252 0 C-N-CA 119.873 -1.156 . . . . 0.0 111.992 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -165.66 94.65 0.6 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.863 0.363 . . . . 0.0 110.531 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 17' ' ' LEU . 2.0 t -60.48 120.05 5.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.736 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.11 126.77 28.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.33 169.74 1.56 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.464 ' HA ' HD12 ' A' ' 72' ' ' ILE . 5.2 mtpt -60.52 -58.29 9.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.766 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -60.79 -33.16 72.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.24 -37.75 75.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 69' ' ' LYS . 8.5 mt -69.24 -52.68 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.919 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -31.95 73.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.972 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.91 -30.13 62.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.822 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.0 mt -75.79 -37.84 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.143 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.14 8.52 43.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.309 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.989 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.659 ' H3 ' ' C ' ' A' ' 31' ' ' ASP . 2.1 mtt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.624 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 1.1 mpp? -86.67 119.29 26.75 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.334 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.94 111.46 18.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.621 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.972 HG13 HG12 ' A' ' 56' ' ' VAL . 3.7 mp -116.91 123.1 71.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.212 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -110.59 127.88 55.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.598 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.795 ' N ' HD11 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -110.37 113.01 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-O 120.869 0.366 . . . . 0.0 110.924 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.734 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 90.6 m-85 -91.91 111.91 23.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.22 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.648 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 136.66 -96.9 0.25 Allowed Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.195 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.96 -65.23 0.3 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.827 0.346 . . . . 0.0 111.463 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.68 -57.51 9.47 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.822 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.0 p -111.92 -35.46 5.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.885 0.374 . . . . 0.0 110.982 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.648 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -65.63 124.73 23.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.071 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -76.5 16.67 0.46 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 p -59.24 -19.5 46.21 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.784 0.325 . . . . 0.0 111.337 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.34 -24.98 5.25 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.872 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.5 mtp -63.26 -62.19 1.86 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.791 0.329 . . . . 0.0 110.475 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.757 HD22 HD13 ' A' ' 54' ' ' LEU . 5.6 tt -65.67 -20.37 66.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.512 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.598 ' HG3' HD13 ' A' ' 6' ' ' ILE . 5.8 tt0 -57.61 -51.45 69.43 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.129 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -69.15 -51.32 39.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.609 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -54.7 -40.34 69.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.594 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.54 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -59.72 -45.93 90.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.442 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.53 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -54.88 -38.48 67.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.718 0.294 . . . . 0.0 111.273 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 35.1 tp10 -73.4 -50.41 21.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.019 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.93 -48.63 79.59 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.044 HG21 ' HB2' ' A' ' 32' ' ' ALA . 14.0 p -53.62 -56.05 10.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.626 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.59 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.16 -40.34 82.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.692 0.282 . . . . 0.0 110.741 178.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 6.0 tp10 -59.27 -47.44 85.38 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.958 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.415 HD21 ' HG3' ' A' ' 73' ' ' LYS . 1.7 mm? -54.06 -20.22 6.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.773 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.76 42.79 0.84 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.43 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.773 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -175.35 113.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.375 . . . . 0.0 111.054 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.659 ' C ' ' H3 ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -61.57 164.08 6.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.257 179.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.044 ' HB2' HG21 ' A' ' 25' ' ' VAL . . . -146.0 165.91 27.62 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -126.48 109.78 12.56 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.928 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 15.0 m-85 -98.71 108.67 21.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.38 0.609 . . . . 0.0 112.071 -178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -117.39 133.32 56.1 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.56 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.834 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -79.69 151.81 30.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.211 0.529 . . . . 0.0 111.396 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.921 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -127.77 78.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.616 -178.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 39' ' ' GLU . 37.4 tptt -82.02 75.12 8.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.968 0.413 . . . . 0.0 111.191 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.524 ' O ' HG13 ' A' ' 43' ' ' ILE . 22.7 tp10 177.03 120.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.79 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.511 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 46.5 ttp -53.11 -32.21 46.14 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 121.268 -0.173 . . . . 0.0 110.942 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.449 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -51.55 -37.56 50.13 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.69 -34.22 19.8 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.113 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.851 HG22 HD21 ' A' ' 48' ' ' LEU . 29.0 mt -60.45 -55.21 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.055 0 CA-C-O 121.198 0.523 . . . . 0.0 111.29 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.682 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -63.46 -39.13 93.64 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.855 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.682 ' H ' HD23 ' A' ' 44' ' ' LEU . 6.0 tt0 -54.44 -25.26 23.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.056 0.455 . . . . 0.0 110.347 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.684 ' O ' HD21 ' A' ' 60' ' ' LEU . . . -71.6 -39.24 70.63 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.714 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.0 -8.22 25.33 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.644 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.851 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -80.31 167.1 20.68 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.693 0.282 . . . . 0.0 110.947 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.88 14.29 5.82 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HB1' ' N ' ' A' ' 64' ' ' GLY . . . -114.68 172.57 6.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.623 0.249 . . . . 0.0 110.75 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.524 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 2.9 mt -71.15 -72.32 0.23 Allowed Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.524 ' CD ' ' CB ' ' A' ' 51' ' ' LEU . 74.2 Cg_endo -72.23 60.23 3.18 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.195 1.93 . . . . 0.0 112.425 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -79.54 147.46 29.75 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.963 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.757 HD13 HD22 ' A' ' 17' ' ' LEU . 7.4 tt -144.95 110.27 5.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.885 0.374 . . . . 0.0 111.075 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -98.6 126.29 44.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.563 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.972 HG12 HG13 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -120.78 139.75 47.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.283 0.563 . . . . 0.0 111.936 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 47.24 26.83 0.75 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.183 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.03 27.32 53.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.524 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -148.26 98.05 2.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.967 0.413 . . . . 0.0 110.435 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.684 HD21 ' O ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -77.29 141.76 39.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.203 0.525 . . . . 0.0 111.317 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -146.18 8.25 1.06 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.216 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.66 HG21 HG12 ' A' ' 66' ' ' VAL . 1.3 mp -119.36 123.1 70.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.443 ' CG ' ' HB2' ' A' ' 48' ' ' LEU . 32.3 mtp -146.49 115.31 6.87 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.493 ' N ' ' HB1' ' A' ' 50' ' ' ALA . . . 85.45 -5.87 81.96 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.64 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.479 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER 173.65 104.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.708 0.289 . . . . 0.0 110.591 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.66 HG12 HG21 ' A' ' 62' ' ' ILE . 6.3 m -50.62 158.62 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.875 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.668 ' O ' HD12 ' A' ' 17' ' ' LEU . . . -80.47 174.26 11.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.052 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -93.73 167.27 11.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.824 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.5 tmtm? -53.82 -38.38 64.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.108 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.2 -36.99 74.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.725 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.422 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 13.3 mm-40 -68.86 -51.04 44.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.807 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 21' ' ' ALA . 15.3 tt -59.15 -41.5 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.926 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' N ' HG23 ' A' ' 72' ' ' ILE . 46.7 tttm -62.21 -31.91 72.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.736 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -73.84 -31.79 63.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.811 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 54.5 mt -75.71 -38.1 37.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.35 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 54.5 mt -62.42 -44.28 96.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.942 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.968 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.444 ' N ' ' O ' ' A' ' 31' ' ' ASP . 10.3 ttp . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.524 0.202 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.848 ' O ' HD12 ' A' ' 4' ' ' ILE . 12.2 mmt -87.82 116.15 25.77 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.407 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -71.19 104.95 3.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.174 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.957 HG13 HG12 ' A' ' 56' ' ' VAL . 2.8 mp -112.55 120.77 63.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.361 0.601 . . . . 0.0 111.833 -179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.685 ' CB ' HD11 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -111.72 131.22 55.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.835 179.661 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.858 HG22 HD12 ' A' ' 54' ' ' LEU . 12.0 pt -110.8 115.1 48.94 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-O 120.822 0.344 . . . . 0.0 111.097 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.746 ' CE1' HG13 ' A' ' 37' ' ' ILE . 85.2 m-85 -99.1 107.11 19.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.98 0.419 . . . . 0.0 111.095 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.79 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 175.74 -106.12 0.21 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.491 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 m 68.48 88.24 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 111.122 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.49 -74.73 0.43 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.529 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 55.5 m -106.56 -26.87 11.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 0.0 111.108 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.79 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -76.25 127.99 34.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.305 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.53 ' O ' HG21 ' A' ' 66' ' ' VAL . 47.4 m-80 -76.91 20.69 0.24 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.189 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.43 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.4 p -52.0 -25.44 8.42 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.958 0.409 . . . . 0.0 111.116 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.22 -36.22 65.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.181 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.486 ' CB ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -63.64 -51.92 63.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.875 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.997 HD21 HD11 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -68.9 -22.01 64.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.994 0.426 . . . . 0.0 110.553 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.538 ' CD ' HD13 ' A' ' 6' ' ' ILE . 3.7 tp10 -60.62 -54.25 47.67 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.558 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -48.64 65.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.73 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -55.09 -49.88 70.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.834 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.565 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -58.72 -41.51 86.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.797 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.552 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 11.5 mtp180 -57.55 -46.18 84.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.756 0.312 . . . . 0.0 111.373 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.7 pt-20 -72.6 -50.3 26.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.558 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.76 -49.37 75.28 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.733 HG11 ' HB3' ' A' ' 32' ' ' ALA . 3.8 p -53.56 -55.17 14.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.614 0.245 . . . . 0.0 110.883 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.511 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -69.56 -44.35 71.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.233 179.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 2.7 tt0 -56.68 -45.19 81.88 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.138 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.19 -22.1 3.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.907 0.384 . . . . 0.0 110.591 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.649 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.74 34.61 1.68 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.394 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 29' ' ' GLY . 6.4 pt -162.74 116.73 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.894 0.378 . . . . 0.0 111.288 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -61.32 164.69 5.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.159 179.348 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.733 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -151.23 161.98 41.73 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -121.37 111.65 17.58 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.805 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 58.0 m-85 -98.01 108.86 21.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.481 0.657 . . . . 0.0 112.038 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.81 133.85 55.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.907 -1.042 . . . . 0.0 109.481 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.564 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -80.5 151.34 29.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.04 0.447 . . . . 0.0 111.027 -179.463 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.746 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -126.32 91.34 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.696 -179.071 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.18 75.76 6.97 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.979 0.419 . . . . 0.0 111.229 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.56 ' O ' HG13 ' A' ' 43' ' ' ILE . 2.8 tt0 173.69 121.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.903 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.556 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -54.65 -33.92 61.38 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.222 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.438 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -51.36 -36.34 42.66 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.417 ' HB3' HG21 ' A' ' 37' ' ' ILE . 4.9 mt-30 -86.55 -31.67 21.11 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.032 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.941 HG22 HD21 ' A' ' 48' ' ' LEU . 46.1 mt -63.05 -56.32 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.039 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.492 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.8 OUTLIER -62.75 -34.73 77.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.182 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.517 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -59.01 -21.71 59.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.909 0.385 . . . . 0.0 110.488 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.526 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -76.93 -35.8 57.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.3 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.18 -8.94 22.85 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.384 -0.913 . . . . 0.0 113.619 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.941 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.33 152.27 39.64 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 117.326 0.563 . . . . 0.0 111.382 -179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.7 p -108.02 -19.91 13.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.647 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -87.39 -171.58 3.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.393 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.563 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 2.0 mp -86.16 -73.78 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.714 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 38.3 Cg_endo -66.12 63.78 0.47 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.361 2.04 . . . . 0.0 112.609 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.426 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -84.93 143.78 20.71 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.993 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.858 HD12 HG22 ' A' ' 6' ' ' ILE . 3.7 tt -134.86 109.57 8.6 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.766 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -98.16 123.15 42.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.021 0.439 . . . . 0.0 110.901 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.957 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -115.95 138.8 45.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.354 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 46.16 27.91 0.6 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.482 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.92 34.32 48.15 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.399 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.98 101.09 3.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.838 0.351 . . . . 0.0 111.099 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.881 HD21 HD13 ' A' ' 48' ' ' LEU . 0.3 OUTLIER -45.81 130.2 9.38 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.159 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -118.33 -19.29 8.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.701 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.701 HD11 ' HB2' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -145.09 143.0 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 111.973 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.583 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 0.6 OUTLIER -146.16 115.11 6.94 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.483 179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.534 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 63.6 13.67 51.87 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.252 -0.975 . . . . 0.0 113.085 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.67 94.45 0.5 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.843 0.354 . . . . 0.0 110.77 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.577 HG13 ' HB2' ' A' ' 17' ' ' LEU . 2.0 t -60.54 126.08 17.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.242 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.577 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -63.77 142.58 58.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.836 0.351 . . . . 0.0 111.067 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.68 169.07 10.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.74 -49.83 76.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.975 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -61.99 -36.48 81.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -58.81 -49.7 76.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.997 HD11 HD21 ' A' ' 17' ' ' LEU . 37.2 mm -60.51 -54.28 37.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.008 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -39.34 75.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.082 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -74.09 -31.73 62.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.061 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 75' ' ' ILE . 7.4 mm -76.04 -36.79 32.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.009 0.433 . . . . 0.0 110.389 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mt -73.76 -35.69 65.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.055 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 19.7 p . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.895 179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.421 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 33.5 ttm . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.566 0.222 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.928 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -83.65 114.03 21.27 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 121.045 0.45 . . . . 0.0 110.808 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -69.52 116.35 9.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.007 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.004 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 2.5 mp -124.25 128.29 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.47 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.593 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . 0.8 OUTLIER -111.16 143.02 42.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.6 179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.633 HD11 ' HB2' ' A' ' 36' ' ' LYS . 7.6 pt -127.31 110.25 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 120.923 0.392 . . . . 0.0 110.395 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.979 ' CD2' HD11 ' A' ' 48' ' ' LEU . 8.1 m-30 -100.15 110.67 22.95 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.726 -178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.84 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 178.56 -66.34 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.525 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 m 74.63 79.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.793 0.33 . . . . 0.0 111.284 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.58 -62.76 1.9 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.846 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -50.47 -70.91 0.07 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.353 . . . . 0.0 111.235 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.84 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -57.36 147.78 24.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.021 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -76.4 17.06 0.4 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.544 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.4 p -55.43 -21.96 18.21 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.729 0.3 . . . . 0.0 111.228 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.03 -37.45 74.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.326 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.15 -62.43 1.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.844 0.354 . . . . 0.0 110.886 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.712 HD13 ' HB2' ' A' ' 21' ' ' ALA . 1.6 tm? -59.31 -36.02 74.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.616 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.456 ' HG3' HD13 ' A' ' 6' ' ' ILE . 38.4 tt0 -56.87 -41.0 77.22 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.7 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.2 tttp -73.46 -51.94 15.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.969 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.664 ' OD1' HD22 ' A' ' 17' ' ' LEU . 30.7 p30 -64.61 -36.23 83.58 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.88 0.372 . . . . 0.0 111.025 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.712 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -62.49 -44.38 96.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.61 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.577 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 1.4 mtp180 -58.55 -45.12 89.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.748 0.308 . . . . 0.0 111.253 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.2 pt-20 -71.67 -47.57 53.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.076 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.404 ' N ' ' HG3' ' A' ' 23' ' ' GLU . . . -62.64 -49.99 73.0 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.822 HG21 ' HB2' ' A' ' 32' ' ' ALA . 9.1 p -53.3 -55.39 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 121.26 -0.176 . . . . 0.0 110.821 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.579 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.68 -40.77 79.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.5 0.191 . . . . 0.0 110.988 179.208 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 47.9 tt0 -60.27 -48.06 83.33 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.363 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.4 mt -53.84 -19.56 4.58 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.723 0.297 . . . . 0.0 110.966 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.778 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.74 42.93 0.84 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.433 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -175.65 106.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.915 0.388 . . . . 0.0 111.21 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' O ' ' CA ' ' A' ' 1' ' ' MET . 28.5 t0 -61.26 164.35 5.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.105 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.928 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -148.0 179.28 7.85 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.58 110.95 9.66 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 1.004 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 17.7 m-85 -98.0 109.63 22.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.408 0.623 . . . . 0.0 111.982 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -109.97 124.61 51.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.35 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.633 ' HB2' HD11 ' A' ' 6' ' ' ILE . 2.9 tmmt? -92.38 144.2 25.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.579 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.903 HD12 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -118.49 172.28 5.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.374 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.447 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -155.7 75.35 0.91 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.277 0.56 . . . . 0.0 109.944 178.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER 157.5 136.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.418 -179.446 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.774 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -54.03 -20.6 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 -179.413 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.436 ' O ' HD23 ' A' ' 44' ' ' LEU . 4.4 m-20 -51.38 -45.12 62.35 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -86.44 -31.77 21.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.3 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.774 ' HB ' ' HA ' ' A' ' 40' ' ' MET . 62.7 mt -63.59 -56.07 19.11 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 CA-C-O 121.549 0.69 . . . . 0.0 111.503 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -62.91 -36.52 83.64 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.086 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -55.76 -24.13 33.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.103 0.478 . . . . 0.0 110.362 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.77 ' O ' HD21 ' A' ' 60' ' ' LEU . . . -77.61 -41.86 37.11 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.525 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.89 -7.64 23.69 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.558 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.979 HD11 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -78.1 157.21 29.57 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.887 0.375 . . . . 0.0 110.933 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.89 -22.76 9.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.856 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.902 ' HB3' ' CB ' ' A' ' 63' ' ' MET . . . -79.7 170.49 16.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.049 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.5 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 2.7 mp -71.96 -70.08 0.31 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.793 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.594 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 47.8 Cg_endo -69.92 60.13 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.056 1.837 . . . . 0.0 112.234 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.557 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -83.68 128.82 8.77 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.516 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.615 HD12 ' CG2' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -121.97 107.93 12.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.759 0.314 . . . . 0.0 110.244 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.62 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -98.74 124.5 43.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.199 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.873 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.85 139.59 40.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.193 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 46.49 26.78 0.54 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.823 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.75 35.19 46.53 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.317 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -144.94 103.24 3.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.944 0.402 . . . . 0.0 111.132 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.77 HD21 ' O ' ' A' ' 46' ' ' ALA . 0.3 OUTLIER -54.5 132.71 45.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.494 179.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.6 -5.21 1.57 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.557 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 0.7 OUTLIER -154.17 124.45 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.619 -0.433 . . . . 0.0 111.919 -179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.902 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -145.73 134.55 22.4 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.367 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.496 ' N ' ' HB1' ' A' ' 50' ' ' ALA . . . 80.2 -1.5 80.36 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.884 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.416 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -178.35 100.43 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.779 0.323 . . . . 0.0 110.582 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.615 ' CG2' HD12 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -65.09 137.28 25.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.065 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.628 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -63.73 164.38 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.33 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 54.8 p -92.16 -179.76 5.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.136 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.419 ' O ' HG22 ' A' ' 72' ' ' ILE . 16.5 pttm -64.14 -49.28 72.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.673 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -71.82 -30.23 65.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.722 0.296 . . . . 0.0 111.142 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.423 ' O ' HD13 ' A' ' 75' ' ' ILE . 2.4 mm-40 -71.69 -51.33 23.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.373 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.657 ' HB ' HD21 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -55.65 -45.87 79.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.139 -179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.442 ' N ' HG23 ' A' ' 72' ' ' ILE . 13.4 tttt -60.35 -37.09 79.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.834 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.0 mmtt -74.06 -30.16 62.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.169 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.423 HD13 ' O ' ' A' ' 71' ' ' GLU . 1.4 mp -75.92 -29.69 20.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.375 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.81 -31.54 40.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.869 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.932 -179.937 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.443 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 2.2 tpp . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.559 0.219 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.835 ' O ' HD12 ' A' ' 4' ' ' ILE . 8.2 tpp -80.65 112.01 17.61 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.862 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -70.12 118.3 12.78 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.028 0.442 . . . . 0.0 110.94 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.994 HG13 HG12 ' A' ' 56' ' ' VAL . 2.3 mp -126.14 124.95 66.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.941 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.429 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 3.7 mt-30 -110.36 139.1 45.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.945 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.5 mp -119.86 113.46 40.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.08 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.875 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 83.7 m-85 -104.71 115.94 31.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.249 0.547 . . . . 0.0 112.465 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 128.93 -66.91 0.56 Allowed Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.649 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 53.53 -84.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.608 0.242 . . . . 0.0 111.502 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 8' ' ' GLY . . . -58.96 -53.85 42.95 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.492 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 12.3 m -98.71 33.67 2.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.347 . . . . 0.0 110.935 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.468 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -155.0 126.22 7.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -76.05 7.57 3.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.666 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.462 ' HB3' HG13 ' A' ' 66' ' ' VAL . 2.1 p -55.98 -20.38 16.17 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.735 0.303 . . . . 0.0 111.402 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.39 -25.46 6.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.511 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.7 mtt -63.49 -62.14 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.728 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.462 HD22 ' H ' ' A' ' 67' ' ' ALA . 9.3 tp -64.46 -24.03 67.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.782 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.75 -51.78 67.55 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.411 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -67.62 -47.39 69.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.818 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -56.51 -39.66 73.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.913 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -61.73 -46.97 87.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.605 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.476 ' CG ' ' CD1' ' A' ' 34' ' ' PHE . 41.8 mtp180 -54.63 -38.05 66.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.803 0.335 . . . . 0.0 111.14 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.401 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.8 tt0 -73.57 -49.92 23.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.8 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -60.55 -50.93 71.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.786 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.026 HG21 ' HB2' ' A' ' 32' ' ' ALA . 13.8 p -53.23 -56.05 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.631 0.253 . . . . 0.0 110.64 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.607 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.7 OUTLIER -65.48 -47.64 75.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.753 0.311 . . . . 0.0 110.923 178.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.401 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 17.8 tp10 -56.03 -48.07 76.67 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.283 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.499 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -53.32 -21.92 6.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.809 0.338 . . . . 0.0 110.765 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.62 47.41 0.63 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.597 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.41 ' O ' HG22 ' A' ' 25' ' ' VAL . 10.6 tt -179.23 128.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.305 0.574 . . . . 0.0 111.471 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.443 ' O ' ' CA ' ' A' ' 1' ' ' MET . 17.0 t0 -69.68 164.32 23.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.604 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.026 ' HB2' HG21 ' A' ' 25' ' ' VAL . . . -147.21 175.47 10.72 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.23 107.72 9.19 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.071 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.975 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 25.2 m-85 -101.38 108.58 20.24 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.346 0.594 . . . . 0.0 111.179 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -118.73 124.74 48.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.67 143.68 26.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.206 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.843 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -110.08 -178.02 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.333 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.489 ' N ' HG12 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -158.92 75.37 0.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.106 0.479 . . . . 0.0 110.62 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.494 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER 158.14 130.05 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.96 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.508 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -52.63 -27.28 16.47 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 121.245 -0.182 . . . . 0.0 111.153 -179.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -51.48 -39.0 56.67 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -86.75 -35.87 18.94 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.974 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.039 HG22 HD21 ' A' ' 48' ' ' LEU . 20.9 mt -60.76 -54.82 29.94 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.077 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.425 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.488 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -58.7 -37.33 75.87 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.768 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.488 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -55.18 -25.27 31.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.017 0.437 . . . . 0.0 110.565 179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.663 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -73.64 -34.75 65.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.996 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.12 -5.17 35.95 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.642 -0.79 . . . . 0.0 113.018 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.039 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.1 157.11 36.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.084 0.469 . . . . 0.0 111.512 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.6 p -112.41 -8.73 13.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.21 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.452 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -102.38 -175.41 2.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.41 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.62 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -86.1 -64.21 0.22 Allowed Pre-proline 0 C--N 1.328 -0.343 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.63 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.62 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 11.7 Cg_exo -69.53 59.87 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.254 1.969 . . . . 0.0 111.82 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.554 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -87.44 141.41 17.37 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.226 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.476 ' CB ' HD11 ' A' ' 62' ' ' ILE . 4.8 tt -135.27 111.45 9.64 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.729 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -98.32 124.42 42.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.934 0.397 . . . . 0.0 111.123 -179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.994 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -113.6 139.4 39.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.06 -179.977 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t70 49.56 24.71 1.21 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.598 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.75 28.55 56.81 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.318 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -143.25 104.2 4.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.859 0.361 . . . . 0.0 111.166 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.729 HD22 ' HB2' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -46.07 131.77 9.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.921 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.84 -13.84 7.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.985 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.552 HD13 ' HA ' ' A' ' 66' ' ' VAL . 2.7 pp -152.98 146.88 14.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.597 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 1.6 mtp -146.24 125.53 13.05 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.889 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.618 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 89.06 -17.17 53.07 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.053 -1.07 . . . . 0.0 113.034 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 178.22 109.77 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.552 ' HA ' HD13 ' A' ' 62' ' ' ILE . 9.4 m -49.51 174.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.88 0.371 . . . . 0.0 111.445 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.462 ' H ' HD22 ' A' ' 17' ' ' LEU . . . -92.61 -165.67 1.39 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.046 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.2 m -113.4 163.16 15.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.812 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.406 ' HA ' HG22 ' A' ' 72' ' ' ILE . 4.0 pttp -55.75 -42.79 75.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.124 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -65.85 -32.63 74.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.804 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.685 ' O ' HD12 ' A' ' 75' ' ' ILE . 6.4 tp10 -73.47 -48.98 29.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.046 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.485 HG23 ' N ' ' A' ' 73' ' ' LYS . 16.9 tt -62.46 -46.74 95.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.204 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.485 ' N ' HG23 ' A' ' 72' ' ' ILE . 0.0 OUTLIER -58.27 -37.69 75.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.896 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -40.16 95.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.767 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.685 HD12 ' O ' ' A' ' 71' ' ' GLU . 1.8 mp -75.93 -37.7 34.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.467 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.425 HD12 ' HG ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -53.12 -45.17 68.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.111 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 91.1 p . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.901 -179.931 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.434 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.825 0.345 . . . . 0.0 111.284 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.619 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -83.99 116.11 22.66 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.83 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -69.12 118.34 11.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.016 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.904 HG12 HG12 ' A' ' 56' ' ' VAL . 4.3 mt -128.8 123.03 58.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.094 0.473 . . . . 0.0 111.88 -178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -111.96 142.84 43.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.314 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.706 HG22 HD12 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -120.55 106.23 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.767 0.318 . . . . 0.0 110.766 179.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.917 ' CD2' ' HA ' ' A' ' 43' ' ' ILE . 59.2 m-85 -91.77 109.68 21.01 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.069 0.461 . . . . 0.0 111.412 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.909 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 174.17 -100.1 0.14 Allowed Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.269 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 51.86 100.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.874 0.369 . . . . 0.0 111.411 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.17 18.49 26.48 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.697 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 178.63 -41.1 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.346 . . . . 0.0 110.818 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.909 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -95.12 132.5 39.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.174 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -76.56 20.4 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.06 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.432 ' HA ' HG11 ' A' ' 66' ' ' VAL . 3.4 p -54.1 -24.06 16.2 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.953 0.406 . . . . 0.0 111.206 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.27 -32.79 64.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.111 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 23.0 ttt -63.61 -62.07 1.91 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.752 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.779 ' CD1' ' HB3' ' A' ' 67' ' ' ALA . 1.2 tt -64.69 -20.05 66.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.821 0.343 . . . . 0.0 110.637 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -58.88 -54.35 48.06 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.303 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -50.09 43.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -54.83 -49.19 71.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.072 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.402 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -56.02 -40.88 74.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.517 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.518 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -57.32 -41.02 79.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.259 -179.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -74.39 -50.4 18.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.106 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.501 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -61.95 -50.22 73.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.77 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.903 HG11 ' HB3' ' A' ' 32' ' ' ALA . 6.2 p -53.64 -55.53 13.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.154 -0.218 . . . . 0.0 110.614 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.548 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -64.65 -48.99 72.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.783 0.325 . . . . 0.0 110.754 178.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -57.85 -42.85 85.29 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.51 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 24' ' ' ALA . 1.9 mm? -53.58 -20.01 4.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.811 0.339 . . . . 0.0 110.883 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.98 41.95 0.88 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.49 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.0 tt -179.22 120.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.24 0.543 . . . . 0.0 111.058 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.436 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 5.0 t70 -62.64 163.97 8.33 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.762 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.903 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -157.77 141.04 15.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.641 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -103.83 119.58 39.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.561 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.854 ' CE2' HD12 ' A' ' 4' ' ' ILE . 13.3 m-85 -103.17 109.59 21.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.349 0.595 . . . . 0.0 111.906 -179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -108.64 122.45 47.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.824 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.535 ' HG3' HD11 ' A' ' 6' ' ' ILE . 1.9 mtpt -90.21 141.37 28.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.059 0.457 . . . . 0.0 111.13 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.781 HG13 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -108.8 175.31 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.594 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -160.06 74.93 0.59 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.892 0.377 . . . . 0.0 110.896 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.562 ' O ' HG13 ' A' ' 43' ' ' ILE . 3.2 mt-10 157.0 127.29 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.311 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.546 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -53.96 -26.67 26.84 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.924 -0.126 . . . . 0.0 111.111 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.466 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -51.66 -39.84 58.92 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -86.62 -33.15 20.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.206 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.079 HG22 HD21 ' A' ' 48' ' ' LEU . 13.1 mt -63.18 -55.87 20.7 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.547 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -61.02 -35.89 78.06 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.681 179.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -58.86 -22.51 59.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.102 0.477 . . . . 0.0 110.234 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -73.42 -36.35 65.95 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.913 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 121.13 -15.08 9.45 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.373 -0.918 . . . . 0.0 113.583 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.079 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.85 158.79 32.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.361 0.58 . . . . 0.0 111.689 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 t -105.78 -28.07 10.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.458 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.42 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -81.93 -177.62 6.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.063 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.575 HD12 ' HD3' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -89.89 -55.57 0.29 Allowed Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.486 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.575 ' HD3' HD12 ' A' ' 51' ' ' LEU . 14.6 Cg_exo -69.65 56.89 1.38 Allowed 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.511 2.141 . . . . 0.0 112.473 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -81.46 142.25 22.73 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.475 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.706 HD12 HG22 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -132.2 105.32 7.27 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.866 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -97.95 122.13 40.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.987 0.422 . . . . 0.0 111.507 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.904 HG12 HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -119.53 139.28 47.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.192 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.48 27.49 0.97 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.659 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.92 33.2 55.7 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.269 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.94 101.71 3.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.938 0.399 . . . . 0.0 111.171 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.872 HD11 HD12 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -52.44 127.42 22.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.608 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.9 mmtt -125.72 -13.47 6.43 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.705 HG21 ' HA ' ' A' ' 66' ' ' VAL . 6.5 mt -139.63 130.55 32.33 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.523 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.75 ' SD ' HD12 ' A' ' 60' ' ' LEU . 4.0 mpp? -146.72 134.62 21.33 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.963 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.453 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 86.74 -10.61 67.04 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.575 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 3.8 ttp180 176.85 104.96 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.719 0.295 . . . . 0.0 110.436 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.705 ' HA ' HG21 ' A' ' 62' ' ' ILE . 2.1 p -59.28 142.84 14.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.839 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.779 ' HB3' ' CD1' ' A' ' 17' ' ' LEU . . . -67.43 170.79 6.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.806 0.336 . . . . 0.0 111.349 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.67 172.04 7.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.79 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.02 -38.02 69.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.281 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -73.29 -39.39 65.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 111.106 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.533 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 18.8 tt0 -69.23 -49.69 54.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.198 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.581 HD13 ' C ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -57.22 -46.72 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.253 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.488 ' N ' HG23 ' A' ' 72' ' ' ILE . 24.8 tttm -60.57 -37.42 81.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.866 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.15 -29.33 61.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.229 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 72' ' ' ILE . 0.4 OUTLIER -75.9 -28.91 19.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.945 0.402 . . . . 0.0 110.676 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.32 -32.66 20.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.983 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.2 p . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.943 179.917 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.498 0.189 . . . . 0.0 111.266 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.599 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -76.54 112.56 13.21 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.762 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 100.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.042 0.449 . . . . 0.0 110.126 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.959 HD13 ' CE2' ' A' ' 34' ' ' PHE . 4.3 mt -110.61 130.26 64.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.51 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.804 ' C ' HD13 ' A' ' 6' ' ' ILE . 14.3 mt-30 -110.81 144.36 39.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.19 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.804 HD13 ' C ' ' A' ' 5' ' ' GLN . 0.0 OUTLIER -128.2 107.96 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-O 120.82 0.343 . . . . 0.0 110.975 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.953 ' CD2' HD11 ' A' ' 48' ' ' LEU . 6.1 m-30 -100.11 112.8 25.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.125 0.488 . . . . 0.0 111.469 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.836 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 161.57 -104.51 0.24 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.572 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 8' ' ' GLY . 0.4 OUTLIER 62.37 136.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 0.0 111.063 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.52 25.67 42.97 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.477 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -175.99 -67.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 0.0 110.685 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.836 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -70.5 137.89 50.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.927 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -76.27 13.82 0.85 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 112.156 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.737 ' HB2' HG22 ' A' ' 6' ' ' ILE . 4.6 p -56.22 -29.22 60.67 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.915 0.388 . . . . 0.0 111.209 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.34 -35.26 60.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.45 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 tpt -64.78 -62.65 1.44 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.828 0.346 . . . . 0.0 111.127 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.821 HD13 ' O ' ' A' ' 17' ' ' LEU . 3.5 tm? -66.37 -24.18 66.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.767 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.431 ' HB2' HG21 ' A' ' 6' ' ' ILE . 3.6 tm-20 -57.17 -49.82 74.78 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.22 179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.1 -46.09 82.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.43 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.506 ' HB2' HD22 ' A' ' 17' ' ' LEU . 1.7 m-20 -54.91 -45.53 74.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.551 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.74 -41.51 82.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.473 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.517 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 3.9 mtm180 -55.68 -41.68 74.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 111.038 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 13.9 tt0 -73.77 -49.85 23.4 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.186 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -62.28 -51.88 65.93 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.86 0.318 . . . . 0.0 111.86 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.85 HG11 ' HB3' ' A' ' 32' ' ' ALA . 2.9 p -53.3 -53.98 20.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.418 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.487 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 3.4 mtpm? -65.46 -48.88 71.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.82 0.343 . . . . 0.0 110.841 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.411 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 4.4 tm-20 -58.13 -42.87 86.75 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.535 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER -51.35 -21.36 2.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.878 0.37 . . . . 0.0 110.955 179.795 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.548 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.76 34.37 1.71 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.226 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.6 OUTLIER -169.37 113.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.443 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 2.2 t0 -61.07 164.13 5.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.213 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.85 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -150.87 167.56 27.14 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -125.86 115.14 19.51 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.26 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.959 ' CE2' HD13 ' A' ' 4' ' ' ILE . 12.4 m-85 -100.2 108.72 20.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.337 0.589 . . . . 0.0 111.093 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -110.57 112.24 24.02 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.696 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.6 mtmt -82.23 141.36 33.04 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.243 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.927 HD12 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -112.3 159.75 12.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.29 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.442 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -139.92 75.34 1.51 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.325 0.583 . . . . 0.0 110.123 179.197 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 0.3 OUTLIER 157.59 134.66 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.566 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.666 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 3.6 ttm -56.39 -16.91 6.47 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -51.17 -45.94 61.93 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -86.48 -31.62 21.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.299 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.746 HG22 HD21 ' A' ' 48' ' ' LEU . 30.4 mt -64.57 -54.73 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.151 0 CA-C-O 121.504 0.668 . . . . 0.0 111.383 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.401 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.1 OUTLIER -65.52 -36.26 83.3 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.007 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 28.6 tt0 -54.88 -26.19 33.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.209 0.528 . . . . 0.0 110.041 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.646 ' O ' HD21 ' A' ' 60' ' ' LEU . . . -74.59 -46.73 36.73 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.084 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.63 -7.76 13.51 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.528 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.953 HD11 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -76.26 155.22 34.55 Favored 'General case' 0 C--O 1.231 0.094 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.774 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.82 -26.07 9.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.788 -178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.986 ' HB3' ' HB2' ' A' ' 63' ' ' MET . . . -75.73 179.66 5.3 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.59 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.476 ' CB ' ' CD ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -81.69 -68.59 0.19 Allowed Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.117 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.732 ' HB3' ' HB1' ' A' ' 12' ' ' ALA . 45.0 Cg_endo -70.01 57.33 1.58 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.201 1.934 . . . . 0.0 113.809 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.482 ' HA2' ' HB3' ' A' ' 63' ' ' MET . . . -72.2 141.52 31.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.033 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.716 HD21 HG23 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -130.76 104.07 6.96 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 -179.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.934 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -98.39 123.48 42.53 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.102 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.687 HG12 ' CG1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -120.8 141.04 43.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.657 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 47.19 26.92 0.74 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.938 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.38 29.52 55.83 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.404 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -140.92 103.7 4.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.912 0.386 . . . . 0.0 110.84 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.934 HD12 ' HB2' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -72.87 126.53 30.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.161 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -147.16 10.18 0.99 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 54' ' ' LEU . 5.2 mt -147.1 103.9 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.989 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.986 ' HB2' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.37 149.92 35.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.095 0.474 . . . . 0.0 111.132 179.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.421 ' N ' ' HG2' ' A' ' 52' ' ' PRO . . . 84.53 -5.94 79.25 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.978 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.456 ' N ' ' HG2' ' A' ' 52' ' ' PRO . 0.0 OUTLIER 165.4 105.56 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.502 HG11 ' HA ' ' A' ' 14' ' ' CYS . 10.3 m -61.14 163.89 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 111.193 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.436 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -82.27 169.18 16.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.063 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 m -82.96 178.2 8.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.911 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.404 ' O ' HG22 ' A' ' 72' ' ' ILE . 18.0 tttt -65.35 -53.4 44.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.264 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -33.22 72.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.343 . . . . 0.0 110.931 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -72.62 -48.13 42.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.054 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -61.86 -42.21 93.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.996 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.11 -31.88 73.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.635 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 tptp -69.74 -30.6 68.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.08 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 72' ' ' ILE . 1.1 tp -75.51 -28.3 19.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.678 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.405 ' CD1' ' CD1' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -67.94 -55.09 14.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.836 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.929 179.994 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.444 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 2.7 ttp . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.448 0.166 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.791 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 2.3 mmt -81.11 113.03 19.01 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.947 0.403 . . . . 0.0 110.824 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.51 120.14 14.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.068 0.461 . . . . 0.0 110.767 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.914 HG13 HG12 ' A' ' 56' ' ' VAL . 2.1 mp -129.09 124.82 61.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.454 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.737 ' O ' HD22 ' A' ' 54' ' ' LEU . 6.5 mm-40 -111.1 141.98 43.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.257 179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.668 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -130.28 113.44 25.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 0.0 110.608 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 1.359 ' CD2' ' CE2' ' A' ' 7' ' ' TYR . 27.5 m-85 -100.51 113.02 25.48 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.298 0.571 . . . . 0.0 112.042 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.895 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 171.24 -100.62 0.16 Allowed Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.412 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.91 103.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.786 0.326 . . . . 0.0 111.302 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.48 -28.62 11.28 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.711 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.8 p -138.57 -48.36 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 111.134 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.895 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -73.45 132.7 43.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.085 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -76.56 19.73 0.25 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.196 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.412 ' HA ' HG11 ' A' ' 66' ' ' VAL . 4.5 p -55.62 -23.06 25.53 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.808 0.337 . . . . 0.0 111.234 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -33.79 72.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.174 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 38.1 ttp -64.58 -62.09 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.882 0.372 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 67' ' ' ALA . 0.4 OUTLIER -60.97 -33.21 72.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.694 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -56.47 -39.84 73.88 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.666 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.3 tttt -73.52 -52.4 13.69 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.849 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.629 HD21 HD22 ' A' ' 17' ' ' LEU . 30.7 p30 -64.22 -34.02 77.14 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.849 0.357 . . . . 0.0 110.803 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.518 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -62.07 -49.28 76.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.026 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.495 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 2.2 mtm-85 -54.76 -39.04 67.93 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.716 0.293 . . . . 0.0 111.007 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -72.18 -50.26 29.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.079 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.405 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -62.43 -50.52 71.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.682 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.996 HG21 ' HB2' ' A' ' 32' ' ' ALA . 11.1 p -53.54 -55.8 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.607 0.241 . . . . 0.0 110.473 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.602 ' N ' HG13 ' A' ' 25' ' ' VAL . 11.8 mtpt -64.15 -49.36 72.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.755 0.312 . . . . 0.0 110.682 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -55.72 -47.15 77.38 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.349 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 24' ' ' ALA . 2.2 mm? -51.64 -22.3 3.28 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.856 0.36 . . . . 0.0 110.872 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.737 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.8 36.12 1.44 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.336 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 29' ' ' GLY . 1.1 pt -168.55 112.63 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.041 0.448 . . . . 0.0 111.103 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.465 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 30.5 t70 -61.44 164.61 5.52 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.49 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.996 ' HB2' HG21 ' A' ' 25' ' ' VAL . . . -148.65 171.72 15.72 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -128.51 110.23 12.1 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.957 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.871 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 15.1 m-85 -100.46 108.96 21.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.323 0.583 . . . . 0.0 111.374 -179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -113.17 121.05 43.35 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.789 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.434 ' HA ' HG12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -94.45 139.63 30.89 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.075 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.839 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -106.98 179.13 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.124 -179.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.437 ' N ' HG12 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -155.34 74.92 0.92 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.116 0.484 . . . . 0.0 110.884 179.114 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.53 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER 162.25 126.62 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.006 179.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.5 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 15.2 mtt -52.55 -29.24 24.42 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 120.569 0.223 . . . . 0.0 110.764 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.455 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -51.93 -38.13 55.2 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.884 ' O ' ' CE2' ' A' ' 7' ' ' TYR . 7.4 mt-30 -86.6 -34.94 19.7 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.083 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.985 HG22 HD21 ' A' ' 48' ' ' LEU . 10.7 mt -62.84 -54.67 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.512 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -63.58 -34.26 77.42 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.924 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -59.04 -23.58 62.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.919 0.39 . . . . 0.0 110.427 179.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.682 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -73.11 -36.52 66.76 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.707 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.76 -9.05 14.57 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.842 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.985 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -69.21 150.08 47.86 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.495 0.648 . . . . 0.0 111.243 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.31 -19.36 19.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.431 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.497 ' HB3' ' N ' ' A' ' 64' ' ' GLY . . . -100.92 -173.37 2.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.212 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.514 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.0 OUTLIER -86.87 -57.4 0.32 Allowed Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.643 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.515 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 17.0 Cg_exo -67.87 58.19 0.83 Allowed 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.618 2.212 . . . . 0.0 112.38 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.432 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -74.88 148.32 37.94 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.559 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.737 HD22 ' O ' ' A' ' 5' ' ' GLN . 3.4 tm? -137.24 100.1 4.16 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.696 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -97.92 119.43 36.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.188 0.518 . . . . 0.0 111.217 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.914 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -115.03 138.74 44.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.888 179.897 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 47.25 27.25 0.82 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.497 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.53 35.43 47.01 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.284 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -148.47 100.66 3.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.873 0.368 . . . . 0.0 111.268 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.696 ' CD1' ' HB2' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -47.75 129.45 14.05 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.974 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.85 ' O ' HD13 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -129.42 -13.16 4.39 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -179.397 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.85 HD13 ' O ' ' A' ' 61' ' ' LYS . 4.8 mm -139.59 135.84 39.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.754 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.487 ' CG ' ' HB2' ' A' ' 48' ' ' LEU . 1.4 mpp? -146.48 133.28 20.05 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.52 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.515 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 83.23 -6.34 72.46 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.306 -0.95 . . . . 0.0 113.273 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 173.44 103.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.624 ' HA ' HG21 ' A' ' 62' ' ' ILE . 9.0 p -48.47 155.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.337 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.697 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -63.77 178.74 0.57 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.894 0.378 . . . . 0.0 111.158 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 74.3 m -110.17 169.57 8.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.008 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -58.38 -45.86 87.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.239 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -73.1 -29.8 63.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 0.0 111.052 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -73.39 -46.69 47.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.376 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -61.71 -46.18 97.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.139 -179.673 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.459 ' N ' HG23 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -64.46 -32.76 74.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.923 0.392 . . . . 0.0 110.816 179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -27.99 61.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.9 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.6 mm -75.85 -35.54 30.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.019 0.438 . . . . 0.0 110.171 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.81 -33.68 57.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.833 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.816 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.464 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 9.1 ptp . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.361 0.124 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.916 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -81.35 109.74 16.13 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.796 179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.8 mtpp -69.26 103.55 1.98 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.132 0.491 . . . . 0.0 110.664 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.667 HG23 HD21 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -101.64 116.65 45.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.107 -179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.759 ' O ' HD22 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -110.11 115.04 29.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.017 179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.854 ' N ' HD11 ' A' ' 37' ' ' ILE . 15.8 pt -100.41 109.26 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.115 0 CA-C-O 121.086 0.47 . . . . 0.0 111.847 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.746 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 90.3 m-85 -90.44 125.91 35.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.93 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.535 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 149.79 -82.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.514 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.7 p 51.85 78.36 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.833 0.349 . . . . 0.0 111.285 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 148.14 -84.01 0.18 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.542 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.9 m -93.99 -29.99 14.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.798 0.332 . . . . 0.0 110.926 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.535 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -63.42 133.28 53.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.384 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.791 ' O ' HG21 ' A' ' 66' ' ' VAL . 58.1 m-20 -76.63 20.96 0.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.083 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.421 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.2 p -53.03 -23.47 7.59 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.893 0.378 . . . . 0.0 111.287 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -39.45 71.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.114 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.562 ' HB3' HG11 ' A' ' 66' ' ' VAL . 16.9 ttt -68.08 -51.36 47.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.88 HD11 ' HG ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -69.04 -25.89 64.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.987 0.423 . . . . 0.0 110.389 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.593 ' N ' HD23 ' A' ' 17' ' ' LEU . 16.0 tt0 -58.78 -52.92 63.67 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.243 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -65.79 -44.71 84.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.829 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -58.12 -54.32 48.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.165 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.665 ' HB3' ' HE2' ' A' ' 34' ' ' PHE . . . -53.02 -36.3 60.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.32 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.599 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 0.4 OUTLIER -60.4 -48.87 79.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.319 -179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.489 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 12.2 pt-20 -71.59 -47.83 52.22 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.298 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -63.03 -49.88 72.88 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.888 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.9 p -53.48 -54.99 15.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.919 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.541 ' N ' HG13 ' A' ' 25' ' ' VAL . 5.7 mtmm -70.04 -49.03 55.3 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.265 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 22.9 tt0 -51.81 -46.68 64.34 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.732 0.301 . . . . 0.0 111.172 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.655 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -51.47 -23.66 4.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.978 0.418 . . . . 0.0 110.487 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.737 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.53 37.57 1.3 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.572 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.737 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -167.97 117.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.987 0.422 . . . . 0.0 111.642 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -61.42 165.53 4.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.895 178.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.916 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -148.31 179.2 7.95 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -129.45 113.98 15.57 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.72 ' HE1' ' HB3' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -100.31 109.75 21.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.279 0.561 . . . . 0.0 111.659 -178.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -126.21 128.55 47.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.073 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.789 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -79.76 151.94 30.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.961 0.41 . . . . 0.0 110.762 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.952 ' N ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -123.27 78.35 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.938 -178.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.9 tttt -77.47 75.77 4.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.14 0.495 . . . . 0.0 110.825 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.697 ' O ' HG23 ' A' ' 43' ' ' ILE . 0.1 OUTLIER 172.07 127.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.414 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.586 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -63.92 -27.21 68.99 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.031 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.466 ' O ' HD23 ' A' ' 44' ' ' LEU . 2.1 t0 -51.48 -36.76 45.81 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.475 ' HG2' HG21 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -88.22 -33.41 18.13 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.893 178.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.746 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 0.6 OUTLIER -68.51 -45.22 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 121.073 0.463 . . . . 0.0 111.432 -179.195 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.584 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -65.48 -37.96 88.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.178 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.584 ' H ' HD23 ' A' ' 44' ' ' LEU . 6.7 tt0 -60.59 -22.06 63.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.243 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.825 ' HB1' HD23 ' A' ' 60' ' ' LEU . . . -77.47 -35.4 53.83 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.0 179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.87 -8.35 21.6 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.628 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.521 HD13 ' HB3' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -81.46 158.8 24.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.431 0.616 . . . . 0.0 111.597 -179.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 t -114.92 -31.87 5.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.587 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.822 ' HB3' ' HG2' ' A' ' 63' ' ' MET . . . -75.23 -159.73 0.1 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.23 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.495 HD12 ' HA2' ' A' ' 8' ' ' GLY . 0.6 OUTLIER -101.87 -56.28 0.12 Allowed Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.483 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.559 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 21.1 Cg_exo -65.55 57.81 0.36 Allowed 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.477 2.118 . . . . 0.0 113.561 -179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -88.48 136.03 13.44 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.164 179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.88 ' HG ' HD11 ' A' ' 17' ' ' LEU . 3.4 tm? -138.31 114.78 10.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.741 0.305 . . . . 0.0 110.77 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.933 ' HB2' ' CD2' ' A' ' 60' ' ' LEU . . . -109.55 131.34 55.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.03 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.422 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -117.85 139.9 43.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.111 0.482 . . . . 0.0 111.013 179.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 46.58 27.9 0.7 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.6 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.87 42.05 17.46 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.378 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.14 100.58 3.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.885 0.374 . . . . 0.0 111.181 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.933 ' CD2' ' HB2' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -69.01 128.17 35.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.916 179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.769 ' O ' HD13 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -146.29 7.75 1.03 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.769 HD13 ' O ' ' A' ' 61' ' ' LYS . 11.0 mm -143.72 110.57 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.791 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.822 ' HG2' ' HB3' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -145.52 141.45 28.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.926 0.393 . . . . 0.0 111.509 -179.478 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.559 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 67.39 11.45 59.42 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.858 179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -178.09 103.63 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.821 0.343 . . . . 0.0 110.621 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.791 HG21 ' O ' ' A' ' 13' ' ' ASN . 0.9 OUTLIER -56.45 144.49 8.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.618 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.428 ' HB2' HD12 ' A' ' 62' ' ' ILE . . . -78.25 147.28 34.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.102 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 51.8 p -90.47 168.32 11.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.855 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -55.65 -41.78 74.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.13 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -69.37 -40.55 77.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.976 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -63.94 -45.91 87.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.013 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.8 mt -65.93 -50.44 69.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -57.78 -31.81 66.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.964 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -72.02 -38.81 69.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.0 mt -75.73 -38.41 37.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.509 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.69 HD21 ' HA ' ' A' ' 25' ' ' VAL . 1.5 mp -64.0 -53.31 52.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.001 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.617 ' CB ' HD21 ' A' ' 28' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.903 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.447 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 6.9 mtp . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.731 0.3 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.555 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.05 114.54 17.03 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.828 0.347 . . . . 0.0 110.672 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.47 106.07 2.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.106 0.479 . . . . 0.0 110.105 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.916 HG12 HG12 ' A' ' 56' ' ' VAL . 7.3 mt -117.13 127.75 74.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.478 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.669 ' O ' HD22 ' A' ' 54' ' ' LEU . 2.9 mp0 -110.39 144.08 39.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.354 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.674 HD11 ' HB3' ' A' ' 34' ' ' PHE . 3.2 mp -124.72 108.24 19.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.793 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.873 ' CD2' ' HA ' ' A' ' 43' ' ' ILE . 56.9 m-85 -96.94 115.64 27.79 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.289 0.566 . . . . 0.0 111.586 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.853 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 159.88 -88.87 0.11 Allowed Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.331 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.8 p 49.54 96.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.843 0.354 . . . . 0.0 111.43 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.9 -78.88 0.31 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.392 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.9 t -85.76 -39.57 17.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.781 0.324 . . . . 0.0 110.762 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.853 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -79.45 125.77 29.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.926 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -76.49 19.95 0.24 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.131 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.539 ' SG ' HG22 ' A' ' 6' ' ' ILE . 4.2 p -58.77 -19.92 45.11 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.696 0.284 . . . . 0.0 111.611 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.95 -31.62 60.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.405 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.09 -52.83 61.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.673 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.658 HD13 HG22 ' A' ' 66' ' ' VAL . 5.6 tt -69.09 -29.87 68.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.753 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -55.55 -40.6 72.12 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.899 0.381 . . . . 0.0 110.416 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 47.0 tttt -73.03 -52.33 14.77 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.918 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.471 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 31.9 p30 -64.49 -33.73 76.58 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.816 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . -60.74 -47.06 88.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.941 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.539 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 12.6 mtp180 -56.89 -42.32 79.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.651 0.262 . . . . 0.0 110.905 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -47.94 49.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.055 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.587 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -62.97 -51.73 65.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.691 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.891 HG11 ' HB3' ' A' ' 32' ' ' ALA . 9.8 p -53.55 -55.12 14.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.545 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.3 OUTLIER -62.97 -49.15 75.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.841 0.353 . . . . 0.0 110.651 178.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.11 -45.84 86.56 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.301 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 24' ' ' ALA . 3.1 mm? -52.12 -20.69 2.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.991 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.11 46.61 0.64 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.623 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 7.9 tt 177.14 124.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.11 0.481 . . . . 0.0 111.192 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.447 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -66.08 162.64 19.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.704 179.51 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.891 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -154.32 142.8 20.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -104.48 114.41 28.62 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.66 -0.416 . . . . 0.0 110.273 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.841 ' CZ ' HD12 ' A' ' 4' ' ' ILE . 17.8 m-85 -97.58 109.29 22.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.317 0.58 . . . . 0.0 111.471 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -110.06 114.71 28.45 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.62 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.51 138.54 31.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.245 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.866 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -107.29 177.79 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.442 ' N ' HG12 ' A' ' 37' ' ' ILE . 13.6 pttm -156.75 75.28 0.84 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.157 0.503 . . . . 0.0 110.889 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.515 ' O ' HG13 ' A' ' 43' ' ' ILE . 9.8 pt-20 157.31 130.77 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.839 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.49 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 2.2 ptt? -52.31 -25.35 9.32 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.804 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -51.5 -39.44 57.62 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.51 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -87.31 -38.8 15.93 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.166 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.056 HG22 HD21 ' A' ' 48' ' ' LEU . 8.5 mt -60.68 -55.59 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.561 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.34 -34.83 77.42 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.879 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 41' ' ' ASP . 1.4 tm-20 -57.21 -24.92 57.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.102 0.477 . . . . 0.0 110.248 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.58 ' O ' HD11 ' A' ' 60' ' ' LEU . . . -71.97 -37.24 69.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.726 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.05 -14.62 10.34 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.703 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.056 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -79.86 161.18 25.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.028 0.442 . . . . 0.0 111.289 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.0 t -110.59 -24.58 10.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.997 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.578 ' HB3' ' HG2' ' A' ' 63' ' ' MET . . . -80.17 -179.74 7.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.417 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.557 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.6 mt -88.13 -60.08 0.25 Allowed Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.855 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.557 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 17.2 Cg_exo -66.52 49.6 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.637 2.224 . . . . 0.0 113.769 -179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.99 146.74 35.42 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.571 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.669 HD22 ' O ' ' A' ' 5' ' ' GLN . 2.8 tm? -136.55 102.4 4.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.738 ' CB ' HD12 ' A' ' 60' ' ' LEU . . . -97.9 123.68 41.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 111.335 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.916 HG12 HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -119.45 140.67 42.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.181 0.515 . . . . 0.0 111.487 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.5 t0 48.48 25.66 0.98 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.086 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.17 25.72 50.82 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.413 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -139.9 104.49 4.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.891 0.377 . . . . 0.0 110.601 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.738 HD12 ' CB ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -90.43 128.72 36.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.696 179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.0 mtpt -146.43 3.22 0.87 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.141 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.422 ' HB ' ' HB3' ' A' ' 54' ' ' LEU . 19.5 mm -128.67 103.31 9.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.989 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.578 ' HG2' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -146.45 162.46 38.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.632 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . 80.9 -7.61 58.86 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.246 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER 170.37 103.7 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.658 HG22 HD13 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -67.68 151.93 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.821 0.343 . . . . 0.0 111.389 -179.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.836 ' HB1' ' HB3' ' A' ' 71' ' ' GLU . . . -79.9 179.58 7.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.341 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 m -104.26 -170.18 1.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.932 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.456 ' O ' HG22 ' A' ' 72' ' ' ILE . 25.7 tttt -65.55 -54.51 27.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.008 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.17 -29.8 70.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.906 0.384 . . . . 0.0 110.652 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.836 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 0.7 OUTLIER -73.45 -51.14 18.23 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.04 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.661 HD13 ' O ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -60.76 -42.85 93.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.858 0.361 . . . . 0.0 110.964 -179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.403 ' N ' HG23 ' A' ' 72' ' ' ILE . 16.6 tptm -65.52 -31.68 72.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.706 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 mttp -71.79 -29.15 64.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.75 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 50.4 mt -75.63 -37.21 36.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.144 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.11 -55.6 4.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.912 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.917 -179.99 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.426 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 8.6 ttp . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.554 0.216 . . . . 0.0 111.272 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.503 ' N ' ' HA ' ' A' ' 32' ' ' ALA . 1.4 mtt -77.73 113.61 15.76 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.951 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -69.35 100.8 1.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.012 0.434 . . . . 0.0 109.958 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.946 HD12 ' HB1' ' A' ' 32' ' ' ALA . 3.5 mt -109.95 135.66 48.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.998 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.916 ' O ' HD13 ' A' ' 54' ' ' LEU . 22.2 mm-40 -111.36 143.98 41.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.376 178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.675 HG22 ' HB2' ' A' ' 14' ' ' CYS . 0.2 OUTLIER -127.3 100.34 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 120.972 0.415 . . . . 0.0 110.349 -179.692 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.994 ' CD2' HD11 ' A' ' 48' ' ' LEU . 8.3 m-30 -94.19 116.31 28.69 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.3 0.572 . . . . 0.0 112.155 -178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . -177.16 -90.52 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.25 -0.886 . . . . 0.0 112.213 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 m 48.57 29.71 2.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.76 0.314 . . . . 0.0 111.528 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.86 108.85 0.23 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.499 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 6.2 t 59.78 27.17 16.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 110.994 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.492 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -124.73 132.47 53.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.896 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.731 ' O ' HG21 ' A' ' 66' ' ' VAL . 1.6 m120 -76.12 20.74 0.19 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.699 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.675 ' HB2' HG22 ' A' ' 6' ' ' ILE . 1.8 p -51.51 -28.96 15.0 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.953 0.406 . . . . 0.0 111.128 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -36.18 73.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.008 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.433 ' CB ' HG11 ' A' ' 66' ' ' VAL . 14.3 mtt -68.62 -50.67 49.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.354 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.766 HD11 HD12 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -71.09 -31.19 67.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.994 0.426 . . . . 0.0 110.628 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -58.48 -42.36 87.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.617 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.45 -42.4 62.01 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 21' ' ' ALA . 36.1 p30 -74.96 -34.62 62.07 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.734 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.544 ' HB2' HD23 ' A' ' 17' ' ' LEU . . . -66.28 -50.44 63.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.558 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.57 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -59.91 -44.46 94.28 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.583 0.23 . . . . 0.0 111.457 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.435 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 41.7 tp10 -72.69 -50.17 26.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.622 0.248 . . . . 0.0 110.966 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -62.34 -51.8 66.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.692 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.798 HG11 ' HB3' ' A' ' 32' ' ' ALA . 4.0 p -53.3 -54.91 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.914 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.519 ' N ' HG13 ' A' ' 25' ' ' VAL . 11.1 mtmm -67.27 -46.6 73.16 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.636 0.255 . . . . 0.0 111.112 179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.435 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -58.57 -46.24 87.33 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.359 -179.576 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.709 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.4 OUTLIER -52.01 -21.83 3.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.924 0.393 . . . . 0.0 110.851 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.79 50.3 0.52 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.528 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 6.8 tt 178.03 122.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.238 0.542 . . . . 0.0 111.371 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.426 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -62.94 164.54 8.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.373 179.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.946 ' HB1' HD12 ' A' ' 4' ' ' ILE . . . -153.59 151.52 29.84 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -111.91 113.47 25.8 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.05 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.877 ' CE2' HD13 ' A' ' 4' ' ' ILE . 69.0 m-85 -99.85 108.81 21.18 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.281 0.563 . . . . 0.0 111.634 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -107.24 110.63 22.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.257 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -84.44 136.83 33.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.69 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.94 HD12 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -113.0 164.37 8.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.064 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -140.62 75.43 1.51 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.992 0.425 . . . . 0.0 110.73 179.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 1.4 mm-40 155.26 132.81 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.828 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.608 ' HA ' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -57.02 -28.43 62.49 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.709 -179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.518 ' HA ' HD22 ' A' ' 44' ' ' LEU . 1.7 m-20 -51.5 -33.58 32.17 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -86.93 -33.07 19.81 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.356 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.722 ' HA ' ' CE2' ' A' ' 7' ' ' TYR . 0.9 OUTLIER -71.19 -50.82 39.03 Favored 'Isoleucine or valine' 0 C--N 1.339 0.134 0 CA-C-O 121.083 0.468 . . . . 0.0 111.601 -179.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -57.22 -36.21 70.62 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.58 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.47 ' H ' HD23 ' A' ' 44' ' ' LEU . 2.1 mm-40 -53.73 -25.42 18.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.973 0.416 . . . . 0.0 110.173 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.893 ' HB1' HD11 ' A' ' 60' ' ' LEU . . . -78.67 -46.33 19.39 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.387 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.93 -20.6 4.52 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.518 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.994 HD11 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -69.0 155.67 39.95 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.895 0.379 . . . . 0.0 111.068 179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.86 -16.22 12.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.394 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.51 ' HB1' ' HA2' ' A' ' 64' ' ' GLY . . . -89.19 -179.14 5.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.791 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.605 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.6 mp -83.72 -63.95 0.24 Allowed Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 16.4 Cg_exo -67.45 51.58 0.44 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.392 2.061 . . . . 0.0 112.927 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.74 116.75 4.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.22 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.916 HD13 ' O ' ' A' ' 5' ' ' GLN . 3.0 mm? -106.05 107.19 18.06 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.625 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -98.28 123.53 42.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.038 0.447 . . . . 0.0 111.632 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.726 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.37 139.01 42.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.919 179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 28.8 t70 46.68 27.81 0.71 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.355 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.87 37.55 50.68 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.233 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -150.09 101.84 3.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 111.304 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.893 HD11 ' HB1' ' A' ' 46' ' ' ALA . 0.5 OUTLIER -46.0 133.37 8.87 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.015 179.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.79 -16.8 2.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.994 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.766 HD12 HD11 ' A' ' 17' ' ' LEU . 15.6 mt -154.34 111.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.586 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -145.64 150.91 37.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.021 0.439 . . . . 0.0 111.627 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.51 ' HA2' ' HB1' ' A' ' 50' ' ' ALA . . . 83.4 -5.18 78.73 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.544 -179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 64' ' ' GLY . 45.2 ttp85 174.25 106.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.743 0.306 . . . . 0.0 110.423 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.731 HG21 ' O ' ' A' ' 13' ' ' ASN . 2.6 t -54.34 141.06 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.651 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.476 ' HB3' HD13 ' A' ' 62' ' ' ILE . . . -87.83 142.27 27.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.043 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.4 t -63.66 156.95 25.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.1 -30.4 25.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.284 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -42.2 96.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.837 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.414 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 2.0 tp10 -67.18 -41.87 85.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.995 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.7 mm -58.88 -53.19 51.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.109 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -61.37 -34.23 74.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.842 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -73.73 -30.87 63.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 75' ' ' ILE . 9.0 mm -76.1 -36.78 31.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.978 0.418 . . . . 0.0 110.237 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -80.65 -33.23 35.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.489 ' O ' HD21 ' A' ' 28' ' ' LEU . 20.9 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.955 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.437 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.452 0.168 . . . . 0.0 111.179 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.812 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -82.64 112.84 19.88 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.08 -179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.6 104.9 2.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.128 0.489 . . . . 0.0 110.253 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.028 HD13 ' CZ ' ' A' ' 34' ' ' PHE . 2.2 mp -108.57 127.57 64.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.39 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -110.29 125.6 53.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.016 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.824 HG23 ' HB2' ' A' ' 14' ' ' CYS . 3.3 mp -103.93 98.3 6.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.324 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.871 ' CZ ' ' HB2' ' A' ' 46' ' ' ALA . 93.8 m-85 -93.5 116.92 29.46 Favored 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 120.926 0.393 . . . . 0.0 111.2 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.441 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 118.37 -1.99 16.21 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.088 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 9' ' ' THR . 7.6 t -40.05 120.1 1.12 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.848 0.356 . . . . 0.0 111.668 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.3 -54.43 0.54 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.338 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 71.1 m -101.98 -33.01 9.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.917 0.389 . . . . 0.0 110.73 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.441 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -86.32 152.3 22.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.015 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -75.95 8.99 2.66 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.7 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.824 ' HB2' HG23 ' A' ' 6' ' ' ILE . 3.4 p -54.19 -30.99 51.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.998 0.427 . . . . 0.0 111.273 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.25 -36.59 42.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.601 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 10.4 tpp -63.77 -62.44 1.65 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.092 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.88 HD11 HD11 ' A' ' 72' ' ' ILE . 6.5 tp -65.66 -24.7 67.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.697 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -55.7 -50.42 70.35 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.849 0.357 . . . . 0.0 110.136 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -47.07 76.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.693 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -56.11 -44.62 79.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.16 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.48 -40.84 83.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.805 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.574 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.7 OUTLIER -59.11 -46.81 87.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.659 0.266 . . . . 0.0 111.245 -179.604 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 10.8 pt-20 -71.95 -47.33 53.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.226 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.5 -50.74 70.2 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.674 HG21 ' HB2' ' A' ' 32' ' ' ALA . 5.9 p -53.62 -55.74 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.591 0.234 . . . . 0.0 110.763 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.552 ' N ' HG13 ' A' ' 25' ' ' VAL . 21.3 mtpp -66.99 -49.9 63.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.38 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.447 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 2.0 tt0 -52.86 -48.19 67.26 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.59 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.551 ' CD1' HD22 ' A' ' 76' ' ' LEU . 4.6 mt -52.46 -21.26 3.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.86 0.362 . . . . 0.0 110.719 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.55 30.68 2.56 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.311 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.518 HG21 ' CE ' ' A' ' 2' ' ' MET . 0.4 OUTLIER -156.75 107.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.963 0.411 . . . . 0.0 111.075 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.437 ' O ' ' CA ' ' A' ' 1' ' ' MET . 0.7 OUTLIER -61.56 164.16 6.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.042 179.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.812 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -152.53 175.66 12.52 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -129.6 114.14 15.69 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 1.028 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 40.8 m-85 -102.13 108.94 20.51 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.553 0.692 . . . . 0.0 112.278 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -118.38 129.45 55.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.008 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.817 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -78.98 153.09 30.6 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.103 0.478 . . . . 0.0 111.127 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.817 HD13 ' C ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -128.14 76.56 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.463 -178.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.53 75.65 4.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.061 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 43' ' ' ILE . 6.5 pt-20 171.47 125.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.609 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.675 ' HA ' HG23 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -59.92 -30.48 69.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 120.58 0.229 . . . . 0.0 110.973 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.473 ' O ' HD23 ' A' ' 44' ' ' LEU . 4.5 m-20 -51.23 -33.75 29.35 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.424 ' HB3' ' CG2' ' A' ' 37' ' ' ILE . 28.3 mm100 -87.91 -34.57 18.1 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.882 -1.053 . . . . 0.0 110.984 178.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.691 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 2.5 pt -61.86 -51.37 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 121.056 0.455 . . . . 0.0 111.029 -179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.65 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -62.84 -41.34 99.3 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.022 179.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.65 ' H ' HD23 ' A' ' 44' ' ' LEU . 5.5 tt0 -58.98 -22.41 60.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.945 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.871 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -75.27 -39.76 59.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.729 178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.734 ' HA3' HD21 ' A' ' 60' ' ' LEU . . . 123.4 -20.43 7.44 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.084 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.513 HD11 ' CD2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -77.28 163.75 26.21 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 17.1 m -115.58 -23.35 8.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.902 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.866 ' HB3' ' CB ' ' A' ' 63' ' ' MET . . . -78.84 173.26 12.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.47 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.631 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -78.72 -64.75 0.35 Allowed Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.292 -179.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.631 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 15.4 Cg_exo -67.17 59.14 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.406 2.071 . . . . 0.0 112.426 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.478 ' HA3' ' HG ' ' A' ' 48' ' ' LEU . . . -80.9 136.83 17.01 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.602 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.595 HD22 ' CD2' ' A' ' 17' ' ' LEU . 3.1 tp -127.1 98.2 5.22 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.716 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -97.38 122.72 40.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.087 0.47 . . . . 0.0 111.079 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.911 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -112.94 139.98 35.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.989 -179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 45.5 27.05 0.36 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.726 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.2 39.44 31.81 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.31 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -149.03 100.9 3.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 111.314 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.734 HD21 ' HA3' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -51.31 131.4 28.34 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.798 179.456 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.05 -16.79 4.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.015 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.594 HD13 ' H ' ' A' ' 67' ' ' ALA . 2.1 mt -152.69 131.8 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.987 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.866 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.96 135.19 22.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.392 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.487 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 92.85 -10.56 73.74 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.474 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 165.69 106.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.623 ' HB ' HD22 ' A' ' 17' ' ' LEU . 5.8 m -53.05 166.09 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.793 0.33 . . . . 0.0 111.186 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.594 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -82.5 -173.98 4.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.151 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.0 t -97.77 168.85 10.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.95 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.2 tttt -58.1 -54.4 47.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -56.24 -39.49 72.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.982 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -56.94 -43.0 81.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.937 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.88 HD11 HD11 ' A' ' 17' ' ' LEU . 47.4 mm -57.9 -55.22 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.972 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -61.48 -36.4 80.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.906 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.16 -28.98 61.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 75' ' ' ILE . 8.6 mm -76.01 -35.76 30.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.308 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.765 HD12 ' O ' ' A' ' 72' ' ' ILE . 0.5 OUTLIER -78.41 -31.98 48.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.047 -179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.2 p . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.953 179.916 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.408 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.567 0.222 . . . . 0.0 111.291 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.789 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 3.1 ttt -82.68 114.04 20.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.917 0.389 . . . . 0.0 110.97 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.39 118.87 17.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.938 0.399 . . . . 0.0 110.576 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.031 HG13 HG12 ' A' ' 56' ' ' VAL . 2.7 mp -125.61 118.1 51.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.092 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.642 ' CB ' HD11 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -111.14 122.57 48.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.799 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.691 HG22 HD22 ' A' ' 54' ' ' LEU . 13.8 pt -104.63 110.72 31.56 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 CA-C-O 120.848 0.356 . . . . 0.0 111.08 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.755 ' CE1' HG13 ' A' ' 37' ' ' ILE . 93.7 m-85 -90.74 122.88 33.87 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.038 0.447 . . . . 0.0 111.431 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.446 ' HA3' ' CB ' ' A' ' 12' ' ' ALA . . . 127.83 -65.85 0.57 Allowed Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.182 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.3 m 66.07 -73.1 0.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.734 0.302 . . . . 0.0 111.64 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.75 -96.37 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.853 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -52.8 -23.55 7.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.654 0.264 . . . . 0.0 111.508 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.446 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . . . -82.8 121.89 27.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.913 0.387 . . . . 0.0 111.357 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -76.77 21.34 0.21 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.859 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.508 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.7 p -52.83 -24.43 8.99 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.89 0.376 . . . . 0.0 111.363 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.63 -28.02 3.22 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.506 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.99 -62.51 1.51 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.836 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.659 HD13 ' HB3' ' A' ' 67' ' ' ALA . 4.0 tp -68.38 -20.05 64.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.806 0.336 . . . . 0.0 110.508 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -59.12 -49.91 76.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.251 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -50.05 24.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.812 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.41 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 3.3 m-20 -56.28 -50.82 70.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.114 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.638 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -56.6 -41.87 77.77 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.574 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.484 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 3.0 mtm180 -60.73 -44.43 96.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.578 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.488 ' HG3' ' N ' ' A' ' 24' ' ' ALA . 14.8 pt-20 -73.33 -45.95 52.27 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.925 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' N ' ' HG3' ' A' ' 23' ' ' GLU . . . -64.01 -49.23 73.26 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.98 HG21 ' HB2' ' A' ' 32' ' ' ALA . 14.0 p -53.44 -55.52 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.458 0.171 . . . . 0.0 110.842 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.589 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.09 -43.03 79.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.549 0.214 . . . . 0.0 110.926 179.208 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 13.4 tt0 -58.57 -47.0 85.72 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.731 0.3 . . . . 0.0 110.971 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.663 ' HG ' HD22 ' A' ' 76' ' ' LEU . 1.6 mm? -54.44 -20.43 7.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.9 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.765 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.57 41.72 0.93 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.554 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.765 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.3 OUTLIER -173.89 110.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.42 . . . . 0.0 111.288 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.408 ' O ' ' CA ' ' A' ' 1' ' ' MET . 38.6 t70 -61.38 163.63 6.43 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.375 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.98 ' HB2' HG21 ' A' ' 25' ' ' VAL . . . -145.39 174.8 10.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -131.85 109.02 9.81 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.99 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 18.7 m-85 -100.85 108.84 20.73 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.503 0.668 . . . . 0.0 112.018 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.419 ' O ' HD13 ' A' ' 37' ' ' ILE . 68.1 tt0 -119.77 131.17 55.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.94 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.499 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -80.3 141.94 35.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.006 0.431 . . . . 0.0 110.646 -179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.755 HG13 ' CE1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -116.76 70.62 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.481 -179.335 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.41 75.39 1.91 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.18 -179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.54 ' O ' HG13 ' A' ' 43' ' ' ILE . 1.3 mt-10 174.85 119.78 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.699 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.497 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 17.0 ptp -53.05 -27.76 21.39 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.467 0.175 . . . . 0.0 110.927 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.446 ' O ' HD23 ' A' ' 44' ' ' LEU . 4.5 m-20 -51.55 -39.87 58.6 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.49 ' HB3' HG21 ' A' ' 37' ' ' ILE . 1.9 mm-40 -87.74 -35.53 17.85 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.531 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.058 HG22 HD21 ' A' ' 48' ' ' LEU . 11.7 mt -62.06 -54.91 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.154 0.502 . . . . 0.0 111.216 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -58.88 -32.33 69.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.209 179.836 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' N ' HD23 ' A' ' 44' ' ' LEU . 1.6 tt0 -59.38 -38.65 81.06 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 1.034 ' HB1' HD21 ' A' ' 60' ' ' LEU . . . -68.71 -40.67 79.88 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.59 178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.46 26.0 55.53 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.447 -0.797 . . . . 0.0 113.116 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.058 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -47.19 -87.43 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 117.25 0.525 . . . . 0.0 111.061 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.495 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 1.5 m 147.67 -25.52 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.563 0.745 . . . . 0.0 109.4 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.62 ' HB3' ' N ' ' A' ' 64' ' ' GLY . . . -122.15 -166.79 1.45 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.838 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.557 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -83.7 -59.52 0.36 Allowed Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.575 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.565 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 11.9 Cg_exo -70.06 57.76 1.64 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.5 2.133 . . . . 0.0 112.524 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -81.44 139.45 20.27 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.699 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.919 HD11 HG23 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -137.03 110.77 8.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.723 0.297 . . . . 0.0 110.944 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -99.55 123.27 43.66 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.035 179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.031 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -115.48 137.21 49.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.307 0.575 . . . . 0.0 111.836 -179.116 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 46.62 27.45 0.65 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.738 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.8 33.41 37.6 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.315 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -148.27 97.88 2.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.863 0.363 . . . . 0.0 111.081 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.034 HD21 ' HB1' ' A' ' 46' ' ' ALA . 2.0 mp -60.74 134.64 57.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.03 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 2.52 1.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.775 HG21 ' HA ' ' A' ' 66' ' ' VAL . 3.9 mp -137.78 127.6 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.632 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.46 ' CG ' ' HB2' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -147.34 126.79 13.18 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.678 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.62 ' N ' ' HB3' ' A' ' 50' ' ' ALA . . . 77.06 4.57 83.63 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.317 -0.944 . . . . 0.0 113.506 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 178.36 108.27 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.741 0.271 . . . . 0.0 110.504 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.919 HG23 HD11 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -59.54 139.12 19.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.659 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.659 ' HB3' HD13 ' A' ' 17' ' ' LEU . . . -63.93 168.2 5.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.811 0.339 . . . . 0.0 111.346 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.4 t -103.28 -174.77 2.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.148 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.867 ' HA ' HD12 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -60.39 -57.26 13.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.137 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -53.46 -33.96 56.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.143 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.515 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 0.4 OUTLIER -63.87 -37.71 88.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 69' ' ' LYS . 8.2 mt -64.98 -55.07 22.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.977 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 -34.41 72.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -74.1 -31.66 62.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.947 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.3 mm -76.14 -36.46 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.293 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.663 HD22 ' HG ' ' A' ' 28' ' ' LEU . 0.3 OUTLIER -74.69 -31.78 61.99 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.003 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.4 t . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.909 -179.899 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.433 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 2.6 mtm . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.616 0.246 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.529 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -76.45 113.32 13.93 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.987 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -69.29 118.59 12.37 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.411 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.713 HG21 ' CD2' ' A' ' 34' ' ' PHE . 7.4 mt -129.18 119.59 49.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.078 0.466 . . . . 0.0 112.117 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.492 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -112.0 123.89 51.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.333 178.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.517 ' C ' HD11 ' A' ' 37' ' ' ILE . 2.9 mp -101.74 111.82 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.661 0.267 . . . . 0.0 111.32 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.937 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 98.2 m-85 -95.17 108.59 20.72 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 121.073 0.463 . . . . 0.0 111.525 -179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.678 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 140.47 -82.3 0.24 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.468 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.504 HG23 ' HD3' ' A' ' 36' ' ' LYS . 10.8 m 69.68 -68.71 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 0.0 111.397 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.15 -92.39 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.635 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.6 m -54.47 -28.73 46.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.786 0.327 . . . . 0.0 111.129 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.678 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -90.62 117.21 29.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.149 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -76.24 15.71 0.54 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.9 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.5 p -57.53 -19.92 28.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.742 0.306 . . . . 0.0 111.419 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -47.39 -28.79 2.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.572 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -60.29 3.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.73 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.688 HD22 ' OD1' ' A' ' 20' ' ' ASN . 0.5 OUTLIER -59.45 -37.84 79.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.383 179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -54.37 -36.06 63.47 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.883 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -71.48 -52.45 18.3 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.531 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.688 ' OD1' HD22 ' A' ' 17' ' ' LEU . 28.4 p30 -62.68 -33.01 74.21 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.782 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' N ' ' OD1' ' A' ' 20' ' ' ASN . . . -58.89 -44.47 91.2 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.081 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.574 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 13.1 mtp180 -58.32 -52.64 64.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.292 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.41 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 2.7 pp20? -68.06 -50.12 57.15 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.378 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.634 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -60.87 -51.53 68.93 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.878 HG11 ' HB3' ' A' ' 32' ' ' ALA . 3.9 p -53.66 -55.64 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.883 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.525 ' N ' HG13 ' A' ' 25' ' ' VAL . 7.1 mttt -66.41 -50.25 64.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.689 0.28 . . . . 0.0 111.441 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 0.8 OUTLIER -57.68 -41.48 81.68 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.384 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.67 HD21 ' HG2' ' A' ' 73' ' ' LYS . 1.7 mm? -53.57 -19.15 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.914 0.387 . . . . 0.0 110.899 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.76 26.23 3.96 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.409 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -156.5 112.25 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 0.0 110.785 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.433 ' O ' ' CA ' ' A' ' 1' ' ' MET . 2.3 m-20 -61.67 159.89 12.56 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.878 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -152.03 153.72 34.57 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -114.91 114.97 26.18 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.218 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.713 ' CD2' HG21 ' A' ' 4' ' ' ILE . 18.1 m-85 -98.75 108.94 21.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.361 0.601 . . . . 0.0 111.431 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -110.76 110.73 21.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.1 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.504 ' HD3' HG23 ' A' ' 9' ' ' THR . 0.1 OUTLIER -82.37 137.54 34.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.877 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.78 HG13 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -102.9 176.58 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.666 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.458 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 4.3 pttt -160.1 75.49 0.6 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.883 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.506 ' O ' HG13 ' A' ' 43' ' ' ILE . 1.4 mt-10 158.14 128.53 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.564 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.533 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -56.58 -29.81 62.47 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 121.366 -0.134 . . . . 0.0 110.867 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.422 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -51.46 -36.37 43.92 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -86.67 -36.94 18.45 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.95 178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.937 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 40.4 mt -58.95 -55.49 23.02 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.106 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.731 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.4 OUTLIER -61.35 -36.74 81.04 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.631 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.603 ' H ' HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -55.79 -25.39 40.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.019 0.438 . . . . 0.0 110.335 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.711 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -70.93 -34.84 71.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.792 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.39 -17.87 9.57 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.745 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.81 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -83.2 169.35 15.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.936 0.398 . . . . 0.0 111.324 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 57.4 p -124.07 -30.1 3.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.91 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.423 ' HB1' ' HA2' ' A' ' 64' ' ' GLY . . . -68.2 -178.62 1.08 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.216 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.595 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.5 mp -86.39 -63.59 0.22 Allowed Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.658 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.892 ' O ' HD12 ' A' ' 62' ' ' ILE . 17.0 Cg_exo -66.27 63.92 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.033 1.822 . . . . 0.0 111.709 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -104.04 145.52 16.11 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.098 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.853 ' HB3' HD11 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -150.33 129.8 13.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.0 0.429 . . . . 0.0 110.165 179.572 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.741 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -103.55 125.03 49.85 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.021 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.852 HG13 HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -112.62 135.45 52.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.194 0.521 . . . . 0.0 111.45 -179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 48.12 27.35 1.23 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.257 -179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.75 38.64 31.12 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.344 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -154.98 99.52 2.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.827 0.346 . . . . 0.0 111.148 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.741 ' CD1' ' HB2' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -43.79 126.93 4.91 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.057 179.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.518 ' HE2' HD13 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -117.95 -17.68 9.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.91 -179.336 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.946 HD13 HG12 ' A' ' 66' ' ' VAL . 1.3 pt -137.33 140.42 42.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.068 0.461 . . . . 0.0 112.103 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.461 ' HG3' ' HB2' ' A' ' 48' ' ' LEU . 1.6 ttm -145.98 114.63 6.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.606 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.573 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 88.75 -14.26 60.58 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 119.688 -1.244 . . . . 0.0 112.866 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -178.44 114.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.648 0.261 . . . . 0.0 110.355 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.946 HG12 HD13 ' A' ' 62' ' ' ILE . 28.8 m -54.21 -173.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.12 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.94 143.21 30.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.92 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.2 m -65.9 162.43 19.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -47.59 84.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -67.14 -29.91 69.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.508 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.507 ' O ' HD12 ' A' ' 75' ' ' ILE . 2.4 tp10 -74.03 -42.0 60.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.067 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.563 HD13 HD21 ' A' ' 17' ' ' LEU . 1.1 tt -73.74 -48.47 39.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.346 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.67 ' HG2' HD21 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -59.94 -39.7 86.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.384 -179.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -74.08 -27.83 61.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.978 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.518 HD13 ' HE2' ' A' ' 61' ' ' LYS . 32.2 mt -75.71 -36.79 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.12 0.486 . . . . 0.0 109.997 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.511 HD21 HG23 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -75.15 -30.77 60.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.943 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.321 -0.847 . . . . 0.0 110.967 -179.974 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 6.2 mtp . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.652 0.263 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.529 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 0.3 OUTLIER -73.26 115.46 12.64 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.68 179.588 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.09 106.65 2.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.98 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.925 HG12 HG12 ' A' ' 56' ' ' VAL . 3.5 mt -122.45 124.88 71.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.743 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.438 ' HB2' ' CE2' ' A' ' 7' ' ' TYR . 2.5 mm-40 -110.75 138.9 46.57 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.856 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.512 ' C ' HD11 ' A' ' 37' ' ' ILE . 22.4 mt -114.24 104.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.193 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.944 ' CD1' ' HA ' ' A' ' 43' ' ' ILE . 94.5 m-85 -92.78 109.27 20.7 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.986 0.422 . . . . 0.0 111.369 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.529 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 134.55 -44.16 1.21 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.679 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 36' ' ' LYS . 82.4 p 52.73 -85.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 8' ' ' GLY . . . -94.71 -52.4 1.82 Allowed Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.709 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 7.8 m -53.1 -26.38 16.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 111.098 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.529 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -111.55 147.23 35.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.143 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -76.29 15.32 0.6 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.953 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.451 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.3 p -57.3 -19.88 24.82 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.707 0.289 . . . . 0.0 111.493 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.62 -32.08 7.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.403 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 4.8 mtt -63.31 -62.08 1.92 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.559 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.756 HD22 HD13 ' A' ' 54' ' ' LEU . 4.0 tt -63.92 -19.81 65.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.644 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -59.35 -54.13 50.32 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.56 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -71.9 -40.23 69.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.262 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.2 m-20 -64.54 -41.69 96.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.195 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HB2' HD23 ' A' ' 17' ' ' LEU . . . -62.49 -45.89 90.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.814 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.511 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -57.39 -42.52 82.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.617 0.246 . . . . 0.0 111.238 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 14.9 pt-20 -73.88 -49.22 25.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.321 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.8 -50.4 69.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.863 HG11 ' HB3' ' A' ' 32' ' ' ALA . 4.2 p -53.57 -52.84 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 121.08 -0.248 . . . . 0.0 110.357 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.486 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.23 -41.83 80.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.724 0.297 . . . . 0.0 110.742 178.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.421 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 1.1 tp10 -62.07 -43.79 98.07 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.418 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.968 HD22 HD21 ' A' ' 76' ' ' LEU . 0.7 OUTLIER -52.0 -19.49 1.87 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.791 0.329 . . . . 0.0 111.027 179.898 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.52 44.58 0.7 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.8 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 26' ' ' LYS . 1.2 tt 175.88 121.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.264 0.554 . . . . 0.0 111.158 179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.43 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 3.6 t0 -62.53 163.81 8.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.849 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.863 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -151.09 152.51 33.52 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.549 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -112.72 118.39 34.87 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.317 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.888 ' CE2' HD12 ' A' ' 4' ' ' ILE . 22.2 m-85 -101.78 109.39 21.14 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.339 0.59 . . . . 0.0 111.707 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -105.42 114.67 28.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.003 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.569 ' HB3' HG22 ' A' ' 9' ' ' THR . 11.7 mttt -82.11 139.17 34.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.089 0.471 . . . . 0.0 110.813 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.799 HG13 ' CD1' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -104.49 175.91 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.682 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 39' ' ' GLU . 7.0 ptmt -160.36 75.32 0.57 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.017 0.437 . . . . 0.0 110.916 179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.514 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER 157.63 127.88 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.405 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.559 ' HA ' HD12 ' A' ' 43' ' ' ILE . 17.7 mtp -54.77 -28.51 49.3 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 121.265 -0.174 . . . . 0.0 110.987 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.462 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.8 OUTLIER -51.34 -37.82 49.9 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -86.95 -36.52 18.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.952 178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.944 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 25.9 mt -60.01 -55.26 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.116 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.767 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -61.79 -34.5 76.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.719 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -60.64 -21.91 63.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 0.0 110.084 179.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.792 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -71.9 -34.76 69.39 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.615 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.22 -20.42 7.07 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.874 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.901 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -83.32 176.69 8.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 111.026 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.3 m -126.59 -34.94 2.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.223 0.535 . . . . 0.0 110.486 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.11 -173.11 0.35 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.707 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.582 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.4 mp -92.48 -63.55 0.16 Allowed Pre-proline 0 C--N 1.328 -0.361 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.456 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.628 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 28.6 Cg_exo -60.78 63.64 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.218 1.945 . . . . 0.0 112.645 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 51' ' ' LEU . . . -103.84 147.17 16.56 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.973 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.756 HD13 HD22 ' A' ' 17' ' ' LEU . 5.6 tt -144.58 118.26 9.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.827 0.346 . . . . 0.0 110.862 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.658 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . . . -99.57 122.65 42.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.037 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.925 HG12 HG12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -116.49 136.35 53.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.511 -179.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 46.75 28.17 0.78 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.898 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.47 30.39 58.46 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.433 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -142.97 103.95 4.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.892 0.377 . . . . 0.0 110.949 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.776 HD21 ' O ' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -54.98 127.32 28.35 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.06 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.752 ' O ' HD12 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -129.68 -9.15 4.52 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.787 -179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.752 HD12 ' O ' ' A' ' 61' ' ' LYS . 1.6 mp -134.4 127.73 50.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.573 0.225 . . . . 0.0 110.408 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 19.2 tmm? -146.81 116.51 7.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.83 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.628 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 70.19 3.27 44.82 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.121 -1.038 . . . . 0.0 113.651 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.97 96.6 0.21 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.919 0.359 . . . . 0.0 110.504 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.632 HG22 ' CB ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -68.27 129.62 32.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.813 -179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.522 ' HB3' ' CD1' ' A' ' 17' ' ' LEU . . . -63.79 166.04 7.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.793 0.33 . . . . 0.0 111.345 -179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.9 m -98.29 173.02 7.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.853 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -57.06 -47.34 81.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.159 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.79 -36.12 76.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.966 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.42 -38.18 90.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.038 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.634 HD11 HD11 ' A' ' 17' ' ' LEU . 45.0 mm -61.63 -55.17 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.185 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -52.48 -34.82 50.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.255 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.5 mtpp -74.2 -41.5 61.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.236 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -76.01 -24.46 16.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 0.0 110.872 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.968 HD21 HD22 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -95.73 -26.98 15.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.065 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.816 -179.955 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 2.4 mpp? . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.432 0.158 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.868 ' O ' HD12 ' A' ' 4' ' ' ILE . 2.1 ttt -80.05 112.5 17.41 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.861 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -69.78 114.69 8.21 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.638 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.027 HG13 HG12 ' A' ' 56' ' ' VAL . 2.3 mp -123.24 120.7 61.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.674 -179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -110.83 128.28 55.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.321 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.476 HD13 ' HG3' ' A' ' 18' ' ' GLU . 1.0 OUTLIER -113.39 109.0 26.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.683 0.277 . . . . 0.0 111.474 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.919 ' CD2' ' HA ' ' A' ' 43' ' ' ILE . 40.2 m-85 -93.69 119.2 32.39 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.952 0.406 . . . . 0.0 110.636 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.629 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . -173.71 -85.77 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.498 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.7 m 56.61 77.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 0.0 110.794 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.02 117.66 3.54 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.068 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 78.89 -56.97 0.44 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.69 0.281 . . . . 0.0 110.934 -179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.629 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -54.73 122.08 9.92 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.916 0.389 . . . . 0.0 111.053 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -76.38 20.87 0.2 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.171 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.458 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.3 p -52.15 -25.98 10.26 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.004 0.43 . . . . 0.0 111.181 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -31.93 72.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.643 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.5 mtp -63.52 -62.67 1.52 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.307 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.799 HD23 ' O ' ' A' ' 67' ' ' ALA . 1.1 tm? -67.79 -21.48 65.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.8 0.333 . . . . 0.0 110.629 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.476 ' HG3' HD13 ' A' ' 6' ' ' ILE . 7.4 tt0 -57.81 -48.3 80.14 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.229 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -71.54 -46.41 59.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.768 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -59.28 -36.27 75.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.149 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.512 ' HB2' HD13 ' A' ' 17' ' ' LEU . . . -66.86 -50.4 62.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.108 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.51 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 20.8 ttt180 -55.66 -37.83 68.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.519 0.199 . . . . 0.0 111.406 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 23.7 pt-20 -74.24 -48.31 29.57 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.111 -0.236 . . . . 0.0 111.229 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.77 -50.95 67.02 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.842 HG21 ' HB2' ' A' ' 32' ' ' ALA . 8.9 p -53.8 -55.42 13.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.717 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.572 ' N ' HG13 ' A' ' 25' ' ' VAL . 5.6 mtpm? -66.94 -49.49 65.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.108 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.454 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 45.6 tp10 -56.29 -43.77 79.19 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.843 0.354 . . . . 0.0 110.762 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.817 HD22 ' HB3' ' A' ' 76' ' ' LEU . 22.7 tp -53.11 -22.12 5.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.557 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.65 44.73 0.75 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.442 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.0 tt 179.76 124.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.308 0.575 . . . . 0.0 111.505 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -67.66 165.22 17.57 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.472 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.86 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -146.12 178.26 8.35 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.78 106.39 8.66 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.861 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.935 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 66.0 m-85 -99.4 109.0 21.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.424 0.63 . . . . 0.0 111.947 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.36 136.48 54.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.556 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.813 ' C ' HD13 ' A' ' 37' ' ' ILE . 4.9 ttpm? -89.37 153.64 20.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.12 0.486 . . . . 0.0 111.112 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.813 HG13 ' CE2' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -126.47 83.76 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.307 -179.073 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.55 75.35 9.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.138 0.494 . . . . 0.0 111.636 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.6 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER 173.07 118.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.789 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.506 ' HA ' ' CG1' ' A' ' 43' ' ' ILE . 6.2 ptt? -53.53 -35.31 60.56 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 121.238 -0.185 . . . . 0.0 110.945 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.445 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -51.42 -35.78 40.77 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -86.63 -35.2 19.52 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.98 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.935 HG22 HD21 ' A' ' 48' ' ' LEU . 23.3 mt -60.32 -55.9 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.553 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -64.02 -34.35 77.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.2 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -60.21 -21.26 61.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.406 . . . . 0.0 110.155 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.801 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -72.61 -38.38 67.81 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.704 179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.35 -14.62 7.76 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.473 179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.935 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -74.02 158.0 35.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.364 0.582 . . . . 0.0 111.119 -179.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.5 t -107.42 -10.33 15.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.04 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.471 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -102.51 -175.28 2.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.304 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.588 ' N ' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -89.64 -54.49 0.31 Allowed Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.614 -0.434 . . . . 0.0 111.616 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.649 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 11.1 Cg_exo -70.29 52.16 1.14 Allowed 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 122.626 2.218 . . . . 0.0 112.414 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -71.95 156.9 52.78 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.253 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.552 HD12 HG23 ' A' ' 66' ' ' VAL . 0.7 OUTLIER -154.36 101.49 2.37 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.844 0.354 . . . . 0.0 110.779 179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.523 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -100.3 126.09 46.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.809 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.027 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -118.05 140.62 40.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.141 0.496 . . . . 0.0 111.572 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 44.91 27.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.252 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.75 34.68 30.47 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.443 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.32 99.84 3.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.639 HD21 ' O ' ' A' ' 46' ' ' ALA . 0.6 OUTLIER -69.9 131.31 44.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.019 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -146.09 11.45 1.2 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.719 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' A' ' 66' ' ' VAL . 3.2 mp -133.31 123.92 48.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.557 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 2.4 mtm -146.62 123.51 11.32 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.649 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 70.81 7.33 61.59 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.825 178.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.55 100.43 0.06 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.868 0.366 . . . . 0.0 110.588 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.712 HG22 ' CB ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -56.34 141.84 12.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.96 -179.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.799 ' O ' HD23 ' A' ' 17' ' ' LEU . . . -63.66 172.35 2.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.902 0.382 . . . . 0.0 111.152 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -109.43 157.81 18.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.7 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -55.09 -41.18 71.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.206 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -60.14 -40.77 90.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.755 ' O ' HD12 ' A' ' 75' ' ' ILE . 1.1 mt-10 -64.6 -37.45 87.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.649 HD11 HD11 ' A' ' 17' ' ' LEU . 39.2 mm -59.72 -54.86 28.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.984 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -57.21 -33.31 67.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.033 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -68.52 -40.21 80.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.028 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.755 HD12 ' O ' ' A' ' 71' ' ' GLU . 2.2 mt -75.98 -38.2 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.362 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.817 ' HB3' HD22 ' A' ' 28' ' ' LEU . 43.6 mt -94.3 10.62 33.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.454 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.201 -0.904 . . . . 0.0 111.149 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.442 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 15.2 mmt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.463 0.173 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.955 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -81.31 112.36 18.54 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.836 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.42 ' CG ' ' HA ' ' A' ' 57' ' ' ASP . 17.3 ptpt -68.72 115.05 7.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.992 0.425 . . . . 0.0 110.583 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.931 HG13 HG12 ' A' ' 56' ' ' VAL . 1.5 mt -121.23 121.97 66.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.45 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.693 ' O ' HD22 ' A' ' 54' ' ' LEU . 2.5 mt-30 -110.54 134.87 51.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.604 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.538 HG22 ' SG ' ' A' ' 14' ' ' CYS . 1.6 mp -119.93 113.71 41.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.398 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.891 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 48.9 m-85 -104.27 116.59 32.43 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.578 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 138.42 -78.36 0.31 Allowed Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.493 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m 69.27 -66.41 0.26 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 111.209 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.58 -96.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.708 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.6 m -63.73 -46.14 86.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.79 0.329 . . . . 0.0 111.187 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.578 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -54.44 118.99 4.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.285 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -76.34 14.91 0.66 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.989 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.538 ' SG ' HG22 ' A' ' 6' ' ' ILE . 2.3 p -57.36 -19.83 25.33 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.755 0.312 . . . . 0.0 111.511 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.04 -35.5 34.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.194 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.4 mmt -63.84 -62.07 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.793 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.792 HD13 ' O ' ' A' ' 17' ' ' LEU . 3.3 tm? -60.25 -30.03 69.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.66 179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -54.7 -47.75 73.31 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.149 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.4 ttmt -65.04 -39.78 93.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.481 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.467 ' HB2' HD22 ' A' ' 17' ' ' LEU . 1.2 m-20 -60.14 -51.04 71.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.753 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.708 ' HB3' ' HE2' ' A' ' 34' ' ' PHE . . . -54.01 -37.54 64.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.201 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.63 ' HA ' ' CZ ' ' A' ' 34' ' ' PHE . 2.6 mtm-85 -59.92 -50.4 73.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.785 0.326 . . . . 0.0 111.207 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.472 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 10.8 pt-20 -71.67 -47.75 52.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.075 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.13 -51.93 67.01 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.703 HG21 ' HB2' ' A' ' 32' ' ' ALA . 4.5 p -53.24 -55.54 12.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.684 0.278 . . . . 0.0 110.737 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.541 ' N ' HG13 ' A' ' 25' ' ' VAL . 7.5 mttm -67.51 -49.59 62.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.305 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 4.9 tt0 -53.99 -48.03 70.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.355 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -51.0 -22.47 2.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.867 0.365 . . . . 0.0 110.671 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.63 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.57 34.64 1.7 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.648 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 29' ' ' GLY . 7.8 pt -161.98 112.85 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.872 0.368 . . . . 0.0 111.574 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.442 ' O ' ' CA ' ' A' ' 1' ' ' MET . 4.2 t70 -61.51 164.24 6.02 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.955 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -150.44 178.14 9.33 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -128.75 114.67 16.88 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.127 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.715 ' HE1' ' HB3' ' A' ' 32' ' ' ALA . 0.2 OUTLIER -102.06 109.34 21.03 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.209 0.528 . . . . 0.0 111.218 -178.738 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -116.09 115.72 26.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.035 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.454 ' HG2' HD13 ' A' ' 6' ' ' ILE . 20.6 mtpt -90.19 140.32 29.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.975 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.891 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -111.98 179.14 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.477 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' N ' HG12 ' A' ' 37' ' ' ILE . 2.7 tmtt? -157.25 75.56 0.81 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.138 0.494 . . . . 0.0 110.452 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 43' ' ' ILE . 0.7 OUTLIER 160.43 128.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.064 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.5 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -52.49 -27.41 16.2 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 121.25 -0.18 . . . . 0.0 110.831 -179.826 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.488 ' O ' HD23 ' A' ' 44' ' ' LEU . 2.6 m-20 -51.7 -39.27 58.04 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -86.54 -37.7 17.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.024 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.975 HG22 HD21 ' A' ' 48' ' ' LEU . 16.4 mt -58.98 -55.36 23.92 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.098 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.094 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.63 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -61.24 -40.97 96.02 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.702 179.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.63 ' H ' HD23 ' A' ' 44' ' ' LEU . 36.8 tt0 -53.02 -26.13 14.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.972 0.415 . . . . 0.0 110.372 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.737 ' O ' HD11 ' A' ' 60' ' ' LEU . . . -70.36 -36.57 74.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.753 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.3 -13.37 16.15 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.907 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.975 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -78.3 162.96 26.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.904 0.352 . . . . 0.0 111.124 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.63 -17.83 11.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 111.67 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -87.48 175.61 7.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.654 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.611 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.7 mt -79.64 -63.88 0.35 Allowed Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.962 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 11.0 Cg_exo -70.04 58.91 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.278 1.985 . . . . 0.0 111.919 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -79.01 147.75 30.83 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.475 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.693 HD22 ' O ' ' A' ' 5' ' ' GLN . 0.3 OUTLIER -139.85 104.01 4.78 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.409 -0.219 . . . . 0.0 110.409 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.99 ' HB2' HD23 ' A' ' 60' ' ' LEU . . . -98.47 124.72 43.35 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.975 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.931 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -120.68 139.51 47.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 121.182 0.515 . . . . 0.0 112.218 -179.267 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.42 ' HA ' ' CG ' ' A' ' 3' ' ' LYS . 1.8 m-20 43.03 28.3 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.687 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.29 32.95 37.05 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.714 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -148.48 98.56 2.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.921 0.391 . . . . 0.0 110.468 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.99 HD23 ' HB2' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -70.2 133.75 47.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.827 -179.6 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.729 ' O ' HD12 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -141.29 6.68 1.93 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.72 -179.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.729 HD12 ' O ' ' A' ' 61' ' ' LYS . 1.2 mp -127.88 125.78 65.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.662 0.268 . . . . 0.0 110.94 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.466 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 7.8 mtt -146.51 116.16 7.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.652 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.563 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 88.98 -13.24 63.65 Favored Glycine 0 C--N 1.334 0.437 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.134 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.6 ttm-85 179.46 114.42 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' ' 14' ' ' CYS . 3.6 m -52.11 179.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.392 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.722 ' HB2' HD11 ' A' ' 62' ' ' ILE . . . -91.71 177.31 6.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.1 p -99.67 158.49 15.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.806 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.3 ptmt -52.64 -39.32 61.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.118 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -67.37 -38.78 85.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.01 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.47 -32.29 72.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.048 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 25.2 mm -71.08 -52.63 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.078 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -34.25 73.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.833 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.86 -33.34 66.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.76 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 75' ' ' ILE . 9.0 mm -76.05 -36.8 32.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.227 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -72.56 -30.9 64.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 83.9 p . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.815 179.938 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.512 ' HA ' ' HA ' ' A' ' 32' ' ' ALA . 10.8 mtt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.316 0.103 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.816 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 33.2 mmm -83.5 111.12 18.78 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.163 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.05 100.8 2.58 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.154 0.502 . . . . 0.0 110.44 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.662 HG21 ' CD2' ' A' ' 34' ' ' PHE . 1.7 mp -99.86 114.64 38.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.998 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.415 ' CA ' HD11 ' A' ' 37' ' ' ILE . 0.8 OUTLIER -101.64 119.67 39.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.466 179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.587 ' N ' HD11 ' A' ' 37' ' ' ILE . 26.3 mm -104.59 101.63 12.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-O 120.697 0.284 . . . . 0.0 111.574 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.737 ' CE1' HG13 ' A' ' 37' ' ' ILE . 79.4 m-85 -90.6 103.23 15.95 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.046 0.451 . . . . 0.0 110.739 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.879 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 160.39 -84.55 0.12 Allowed Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.986 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 t 40.44 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.928 0.394 . . . . 0.0 112.001 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.07 -62.3 0.29 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.138 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 t -87.79 -30.79 19.99 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.98 0.419 . . . . 0.0 110.545 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.879 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -111.17 134.89 52.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.811 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.22 15.09 0.61 Allowed 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.502 ' SG ' HG22 ' A' ' 6' ' ' ILE . 3.7 p -57.85 -20.13 34.06 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.67 0.271 . . . . 0.0 111.524 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.58 -20.99 36.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.534 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.2 mtt -63.31 -62.43 1.7 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.771 0.319 . . . . 0.0 110.858 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.709 HD13 ' C ' ' A' ' 67' ' ' ALA . 4.0 tp -64.08 -22.45 66.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.34 . . . . 0.0 110.581 179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.407 ' CG ' HG13 ' A' ' 6' ' ' ILE . 47.1 tt0 -56.18 -54.17 48.36 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.354 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.55 -46.73 78.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.95 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -54.78 -51.32 66.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.868 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.401 ' CB ' ' HE2' ' A' ' 34' ' ' PHE . . . -56.62 -36.73 69.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.806 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.533 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 44.2 mtp180 -57.26 -48.0 79.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.847 0.356 . . . . 0.0 111.117 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 8.0 tt0 -72.39 -50.26 27.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.183 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.546 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -60.05 -51.08 71.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.609 HG11 ' HB3' ' A' ' 32' ' ' ALA . 2.4 p -53.64 -55.41 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.59 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.5 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 6.0 mttm -67.22 -50.36 61.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.681 0.277 . . . . 0.0 111.113 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 8.8 tt0 -52.01 -45.63 64.64 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.381 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.546 HD23 ' O ' ' A' ' 24' ' ' ALA . 2.6 mm? -52.99 -19.33 2.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.882 0.372 . . . . 0.0 110.608 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.872 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 113.37 21.31 5.89 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.599 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.872 HD13 ' O ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER -147.76 110.88 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.861 0.363 . . . . 0.0 110.899 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.2 OUTLIER -64.92 162.81 15.69 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.345 179.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.816 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -149.27 -169.33 3.35 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -142.42 113.96 7.88 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.048 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.662 ' CD2' HG21 ' A' ' 4' ' ' ILE . 11.8 m-85 -105.75 109.13 20.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.569 0.699 . . . . 0.0 112.249 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -127.65 134.87 49.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.456 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.837 ' C ' HD13 ' A' ' 37' ' ' ILE . 0.0 OUTLIER -79.24 155.71 28.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.022 0.439 . . . . 0.0 110.905 -179.387 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.837 HD13 ' C ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -126.21 80.34 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.663 -178.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 9.3 tptt -82.21 75.56 9.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.087 0.47 . . . . 0.0 111.143 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.545 ' O ' HG13 ' A' ' 43' ' ' ILE . 3.0 mm-40 173.52 121.7 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.67 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.543 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 1.6 tpt -53.88 -31.58 50.32 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.843 -0.162 . . . . 0.0 111.059 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.435 ' O ' HD23 ' A' ' 44' ' ' LEU . 0.5 OUTLIER -51.57 -37.96 52.19 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.443 ' CB ' HG22 ' A' ' 37' ' ' ILE . 47.9 mm-40 -86.9 -34.21 19.48 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.192 178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.844 HG22 HD21 ' A' ' 48' ' ' LEU . 47.5 mt -59.76 -55.21 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.107 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.348 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.664 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.3 OUTLIER -63.16 -38.37 90.9 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.048 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.664 ' H ' HD23 ' A' ' 44' ' ' LEU . 2.7 tt0 -56.11 -24.3 39.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.535 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.735 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -74.22 -34.78 63.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.974 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.43 -6.43 31.86 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.613 -0.803 . . . . 0.0 113.198 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.852 HD13 HD21 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -79.53 160.44 26.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.161 0.48 . . . . 0.0 111.643 -179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.51 HG22 ' HE2' ' A' ' 63' ' ' MET . 10.0 t -112.06 -30.09 7.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.743 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.447 ' CB ' ' N ' ' A' ' 64' ' ' GLY . . . -77.58 -177.78 4.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.229 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.582 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.3 mp -87.98 -62.47 0.22 Allowed Pre-proline 0 C--N 1.327 -0.376 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.912 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 16.9 Cg_exo -67.38 59.66 0.71 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.264 1.976 . . . . 0.0 112.255 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.8 139.52 17.92 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.574 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.647 ' CD1' HG23 ' A' ' 4' ' ' ILE . 16.3 tp -129.58 103.13 6.69 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.61 ' HB2' HD22 ' A' ' 60' ' ' LEU . . . -100.79 125.33 47.27 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.698 -0.401 . . . . 0.0 111.321 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.515 ' CG1' HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -114.92 139.38 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.338 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.078 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 47.06 26.94 0.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.587 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.61 34.79 48.47 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.325 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -144.7 103.31 3.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.91 0.386 . . . . 0.0 111.197 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.852 HD21 HD13 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -46.31 133.32 9.68 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.234 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.431 ' O ' HG23 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -118.63 -23.7 6.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.532 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.618 HD13 ' HA ' ' A' ' 66' ' ' VAL . 2.8 pp -154.62 154.91 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.638 ' HG2' ' HB2' ' A' ' 48' ' ' LEU . 2.0 mtp -146.78 129.13 15.81 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.432 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.472 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 94.41 -20.51 47.77 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.123 -1.037 . . . . 0.0 113.369 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -179.79 112.18 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.785 0.326 . . . . 0.0 110.364 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.618 ' HA ' HD13 ' A' ' 62' ' ' ILE . 15.8 m -51.29 161.54 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.278 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.709 ' C ' HD13 ' A' ' 17' ' ' LEU . . . -64.1 -166.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.954 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.9 t -118.94 171.17 8.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.962 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -55.57 -56.64 17.92 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.066 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -59.77 -30.54 68.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.822 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -61.89 -46.38 89.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.654 HG22 HD12 ' A' ' 76' ' ' LEU . 43.5 mm -59.71 -54.25 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.882 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -58.76 -33.27 70.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -71.84 -36.78 70.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.3 mt -75.83 -38.36 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.34 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.654 HD12 HG22 ' A' ' 72' ' ' ILE . 35.4 mt -88.07 0.05 56.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.452 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.6 t . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.975 -179.967 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.437 ' CA ' ' O ' ' A' ' 31' ' ' ASP . 4.8 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.523 0.201 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.83 ' O ' HD12 ' A' ' 4' ' ' ILE . 5.2 mmt -77.56 113.51 15.46 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.986 0.422 . . . . 0.0 110.808 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.81 100.51 1.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.084 0.468 . . . . 0.0 110.52 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.93 HG13 HG12 ' A' ' 56' ' ' VAL . 2.8 mp -109.24 128.79 64.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.933 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.735 ' O ' HD13 ' A' ' 54' ' ' LEU . 13.3 mm-40 -110.89 142.45 42.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.878 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.513 HG12 HD11 ' A' ' 54' ' ' LEU . 19.9 mt -122.09 115.0 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.196 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.863 ' HA ' ' CD1' ' A' ' 37' ' ' ILE . 86.6 m-85 -106.1 110.82 23.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.302 0.572 . . . . 0.0 112.134 -178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 155.78 -78.61 0.19 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.235 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 p 49.22 33.3 4.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.791 0.329 . . . . 0.0 111.584 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.38 -71.81 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.39 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.08 27.96 8.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.832 0.349 . . . . 0.0 110.737 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.416 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -124.57 130.05 51.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.083 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.5 m-20 -76.36 20.46 0.21 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.756 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.62 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.6 p -55.45 -19.86 10.68 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.796 0.332 . . . . 0.0 111.557 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.03 -41.47 47.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.787 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 5.0 mtp -63.74 -62.39 1.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.764 0.316 . . . . 0.0 111.218 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.059 HD21 HD11 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -59.47 -31.85 69.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.825 -179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.414 ' HG3' ' CD1' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -58.42 -40.05 81.45 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.636 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -73.28 -46.93 46.95 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.653 HD21 HD22 ' A' ' 17' ' ' LEU . 34.4 p30 -69.17 -34.3 74.74 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.151 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.495 ' HB1' ' HE2' ' A' ' 34' ' ' PHE . . . -63.06 -47.33 83.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.467 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.491 ' HA ' ' CE1' ' A' ' 34' ' ' PHE . 0.1 OUTLIER -57.69 -47.5 82.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.712 0.291 . . . . 0.0 111.294 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.442 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 22.2 tp10 -72.75 -50.45 24.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.42 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.58 -49.1 76.61 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.783 HG11 ' HB3' ' A' ' 32' ' ' ALA . 3.8 p -53.36 -54.66 16.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 121.001 -0.279 . . . . 0.0 110.451 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.495 ' N ' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -68.52 -43.43 76.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.619 0.247 . . . . 0.0 110.702 178.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 35.3 tt0 -57.28 -43.92 83.56 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.154 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.551 ' HB3' HD11 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -52.7 -19.12 2.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.8 0.333 . . . . 0.0 110.769 179.599 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.552 ' O ' HG23 ' A' ' 30' ' ' ILE . . . 113.91 25.91 4.03 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.671 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.552 HG23 ' O ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER -159.64 117.0 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.943 0.401 . . . . 0.0 111.443 179.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.452 ' HA ' ' CG ' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -61.46 164.79 5.35 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.242 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.783 ' HB3' HG11 ' A' ' 25' ' ' VAL . . . -148.78 165.74 30.53 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -125.13 110.05 13.64 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.546 -0.461 . . . . 0.0 110.042 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.842 ' CZ ' HD13 ' A' ' 4' ' ' ILE . 30.3 m-85 -97.08 108.94 21.78 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.253 0.549 . . . . 0.0 111.418 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -112.97 115.58 28.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.809 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 136.62 33.66 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.032 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.863 ' CD1' ' HA ' ' A' ' 7' ' ' TYR . 0.0 OUTLIER -101.66 -178.24 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.291 -179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.486 ' N ' HG12 ' A' ' 37' ' ' ILE . 3.3 ptmt -158.5 75.37 0.72 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.168 0.509 . . . . 0.0 110.651 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 38' ' ' LYS . 0.2 OUTLIER 155.37 131.68 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.886 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 0.523 ' HA ' ' HB ' ' A' ' 43' ' ' ILE . 3.1 mpp? -52.61 -25.11 9.72 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.2 -0.2 . . . . 0.0 111.136 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.483 ' O ' HD23 ' A' ' 44' ' ' LEU . 1.6 t0 -51.51 -39.82 58.39 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -86.54 -36.4 18.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.037 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.843 ' HA ' ' CD1' ' A' ' 7' ' ' TYR . 17.4 mt -59.67 -54.96 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.324 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -62.88 -38.58 91.45 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.835 179.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.556 ' H ' HD23 ' A' ' 44' ' ' LEU . 1.6 tp10 -55.63 -24.61 34.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.99 0.424 . . . . 0.0 110.294 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.793 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -72.62 -35.31 67.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.771 179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.639 ' HA3' HD21 ' A' ' 60' ' ' LEU . . . 113.0 -11.76 24.67 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.973 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.79 HD21 HG22 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -81.48 161.72 23.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 117.076 0.438 . . . . 0.0 111.36 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.6 p -114.32 -25.48 8.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.16 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.84 ' HB3' ' CB ' ' A' ' 63' ' ' MET . . . -77.88 171.92 14.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.579 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.617 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.5 mp -77.99 -64.12 0.42 Allowed Pre-proline 0 C--N 1.332 -0.188 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.486 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.617 ' HD3' ' CB ' ' A' ' 51' ' ' LEU . 14.8 Cg_exo -67.9 58.13 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.239 1.959 . . . . 0.0 112.365 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.626 ' O ' HD22 ' A' ' 54' ' ' LEU . . . -84.26 137.69 16.23 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.926 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.735 HD13 ' O ' ' A' ' 5' ' ' GLN . 2.6 mm? -129.06 103.83 7.22 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.744 ' HB2' HD12 ' A' ' 60' ' ' LEU . . . -97.82 121.7 40.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.026 0.441 . . . . 0.0 111.422 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.93 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -112.95 139.16 39.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.826 179.725 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 47.96 26.41 0.96 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.553 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.13 33.16 50.51 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.502 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -145.09 102.27 3.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.827 0.346 . . . . 0.0 111.158 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.744 HD12 ' HB2' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -48.78 126.56 12.25 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.856 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -115.6 -21.9 9.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.7 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.496 HD13 ' H ' ' A' ' 67' ' ' ALA . 0.1 OUTLIER -154.95 133.65 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.284 -179.392 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.84 ' CB ' ' HB3' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.88 138.02 25.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.355 178.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.509 ' N ' ' HB1' ' A' ' 50' ' ' ALA . . . 81.54 -3.54 77.94 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.816 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 179.61 100.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.34 . . . . 0.0 110.482 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' A' ' 14' ' ' CYS . 0.3 OUTLIER -65.5 141.3 18.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.961 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.496 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -63.93 -173.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.23 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -120.02 179.96 4.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.825 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.7 -46.19 87.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.212 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.61 -41.76 95.43 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.018 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.406 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 67.5 mm-40 -56.85 -44.05 81.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.075 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.059 HD11 HD21 ' A' ' 17' ' ' LEU . 40.3 mm -64.86 -55.1 22.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.154 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.57 -36.21 73.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.935 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -74.4 -31.77 62.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.031 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.0 mt -75.51 -37.54 37.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.284 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.3 mt -87.42 -29.32 21.55 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.9 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 1.441 ' CE ' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 1 N--CA 1.362 -4.861 0 N-CA-C 113.763 1.023 . . . . 2.66 113.763 . . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 1.381 ' CE ' ' CG ' ' A' ' 2' ' ' MET . 1.7 mtt -80.54 113.76 18.96 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.594 -0.442 . . . . 1.73 110.938 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -70.72 107.89 4.17 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-O 121.142 0.496 . . . . 2.22 110.406 179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.72 HG13 HG12 ' A' ' 56' ' ' VAL . 3.6 mt -114.65 122.68 69.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.124 0.487 . . . . 0.66 111.535 -179.274 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.1 133.67 52.7 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 115.867 -0.606 . . . . 1.82 110.632 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.445 ' CD1' ' CB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -115.03 108.91 26.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 120.832 0.349 . . . . 1.44 111.188 -179.915 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 1.419 ' CZ ' ' CD1' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -96.09 113.91 25.56 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.281 0.562 . . . . 1.25 111.591 -179.383 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.734 ' HA3' ' HB3' ' A' ' 12' ' ' ALA . . . 154.79 -83.8 0.15 Allowed Glycine 1 C--O 1.114 -7.378 0 CA-C-N 115.833 -0.621 . . . . 0.71 113.678 -179.865 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 1.284 ' O ' ' CA ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER 61.18 69.21 0.68 Allowed 'General case' 2 C--O 0.484 -39.237 1 CA-C-O 149.367 13.937 . . . . 1.97 111.866 179.918 . . . . . . . . 5 4 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 1.284 ' CA ' ' O ' ' A' ' 9' ' ' THR . . . 142.4 -71.18 0.41 Allowed Glycine 3 C--N 0.807 -28.808 3 O-C-N 50.769 -44.957 . . . . 1.42 115.301 179.83 . . . . . . . . 4 3 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.234 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 1.1 m -90.58 -20.82 22.17 Favored 'General case' 2 C--N 1.078 -11.201 2 O-C-N 108.323 -8.751 . . . . 1.88 111.781 -179.946 . . . . . . . . 4 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.734 ' HB3' ' HA3' ' A' ' 8' ' ' GLY . . . -89.86 129.9 36.17 Favored 'General case' 1 C--N 1.184 -6.624 1 O-C-N 115.274 -4.641 . . . . 0.49 111.247 179.969 . . . . . . . . 4 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 1.388 ' OD1' ' CB ' ' A' ' 13' ' ' ASN . 68.6 m-20 -76.36 17.9 0.34 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 112.36 0.504 . . . . 1.66 112.36 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.56 ' HB2' HG22 ' A' ' 6' ' ' ILE . 2.0 p -54.7 -23.21 16.56 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.286 0.565 . . . . 0.7 111.936 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.478 ' HG2' ' N ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -52.85 -33.89 51.69 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.811 -0.631 . . . . 1.56 111.799 -179.85 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 1.586 ' CG ' ' CE ' ' A' ' 16' ' ' MET . 0.0 OUTLIER -64.38 -59.14 4.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.161 0.505 . . . . 2.28 110.889 -179.978 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.493 ' CD2' ' CB ' ' A' ' 17' ' ' LEU . 2.7 tm? -64.57 -25.8 68.13 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.187 0.517 . . . . 1.75 110.907 179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.515 ' HG3' HD13 ' A' ' 6' ' ' ILE . 3.5 tt0 -57.56 -48.95 77.94 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.981 -0.554 . . . . 1.78 110.623 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 1.471 ' CD ' ' NZ ' ' A' ' 19' ' ' LYS . 25.6 tttt -69.05 -47.81 64.4 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.113 0.482 . . . . 2.32 111.316 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -43.81 92.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.086 -0.506 . . . . 1.92 111.176 -179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.407 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -58.94 -42.71 90.45 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.123 -0.489 . . . . 0.36 111.714 -179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 1.126 ' NE ' ' CG ' ' A' ' 22' ' ' ARG . 0.5 OUTLIER -57.68 -45.62 85.38 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.816 0.341 . . . . 2.7 111.467 -179.638 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.457 ' O ' ' CB ' ' A' ' 27' ' ' GLU . 0.6 OUTLIER -71.9 -49.33 38.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.407 -0.36 . . . . 2.18 111.296 -179.636 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.563 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -62.4 -50.43 71.57 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.877 0.325 . . . . 0.48 111.877 -179.515 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.727 HG11 ' HB3' ' A' ' 32' ' ' ALA . 5.4 p -53.72 -54.86 16.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.643 0.258 . . . . 0.52 110.743 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 1.359 ' CE ' ' CG ' ' A' ' 26' ' ' LYS . 21.7 mttm -67.55 -47.23 70.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.734 0.302 . . . . 2.35 110.995 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' A' ' 23' ' ' GLU . 86.1 tt0 -57.12 -43.88 82.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.826 0.346 . . . . 1.95 111.35 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -52.39 -20.94 3.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.997 0.427 . . . . 2.0 110.903 179.551 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.92 36.22 1.41 Allowed Glycine 0 C--O 1.22 -0.738 0 C-N-CA 120.798 -0.715 . . . . 0.65 112.474 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 1.549 ' CB ' ' CD1' ' A' ' 30' ' ' ILE . 17.7 pt -170.37 117.12 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-O 121.117 0.484 . . . . 1.76 111.434 179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 1.423 ' OD1' ' CB ' ' A' ' 31' ' ' ASP . 0.4 OUTLIER -62.4 163.61 8.39 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.937 -0.574 . . . . 1.62 110.228 179.379 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.747 ' HB1' ' O ' ' A' ' 2' ' ' MET . . . -149.43 164.7 34.26 Favored 'General case' 0 C--O 1.188 -2.167 0 N-CA-C 109.584 -0.525 . . . . 0.6 109.584 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -122.0 113.15 19.17 Favored 'General case' 0 C--N 1.281 -2.398 0 O-C-N 121.008 -1.057 . . . . 2.18 110.17 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 1.431 ' CZ ' ' CD1' ' A' ' 34' ' ' PHE . 22.3 m-85 -98.93 109.4 22.16 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.398 0.618 . . . . 1.28 111.824 -178.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 1.473 ' CD ' ' CB ' ' A' ' 35' ' ' GLU . 1.8 mt-10 -115.64 122.9 46.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.169 -0.923 . . . . 2.3 110.278 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 1.412 ' CD ' ' NZ ' ' A' ' 36' ' ' LYS . 14.7 mttt -84.42 144.95 28.44 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.437 -0.347 . . . . 2.26 110.507 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 1.036 HD13 ' N ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -115.01 136.57 51.27 Favored 'Isoleucine or valine' 1 C--O 0.985 -12.837 0 CA-C-O 123.872 1.796 . . . . 1.81 110.205 -179.568 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.714 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 53.1 pttt -124.71 75.3 1.41 Allowed 'General case' 1 C--N 1.132 -8.889 2 O-C-N 109.725 -8.11 . . . . 3.21 110.94 -179.98 . . . . . . . . 4 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER 163.4 128.29 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.339 -0.846 . . . . 2.44 110.7 179.839 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . 1.347 ' CE ' ' CG ' ' A' ' 40' ' ' MET . 0.0 OUTLIER -56.21 -26.52 51.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.573 0.225 . . . . 2.59 111.065 -179.871 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 1.165 ' OD2' ' CB ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -51.5 -38.7 55.28 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.899 -0.778 . . . . 1.7 108.899 178.645 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 1.079 ' CD ' ' CB ' ' A' ' 42' ' ' GLN . 6.3 mm-40 -87.02 -34.95 19.04 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.093 -0.958 . . . . 1.98 110.302 178.316 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.729 HG13 ' HA ' ' A' ' 40' ' ' MET . 5.2 mt -62.61 -52.76 55.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-O 121.108 0.48 . . . . 1.11 111.375 -179.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.523 HD23 ' H ' ' A' ' 45' ' ' GLU . 0.2 OUTLIER -63.38 -36.85 85.08 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 115.97 -0.559 . . . . 0.7 110.866 179.877 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 1.088 ' CD ' ' CB ' ' A' ' 45' ' ' GLU . 24.5 tt0 -57.14 -25.61 59.16 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.348 -0.387 . . . . 2.01 110.17 179.297 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.553 ' HB2' ' CZ ' ' A' ' 7' ' ' TYR . . . -74.72 -38.07 62.39 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 115.951 -0.568 . . . . 0.89 109.75 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.43 -3.48 28.0 Favored Glycine 0 C--O 1.195 -2.293 0 C-N-CA 120.773 -0.727 . . . . 0.78 114.867 179.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.728 ' H ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -74.03 160.19 31.63 Favored 'General case' 1 C--O 0.896 -17.525 0 CA-C-O 121.69 0.757 . . . . 1.17 112.073 179.96 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 1.305 ' CG2' ' CA ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -115.55 -17.56 11.14 Favored 'General case' 2 C--N 1.111 -9.768 3 O-C-N 109.08 -8.513 . . . . 1.82 112.481 179.761 . . . . . . . . 5 4 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -97.01 -172.71 2.51 Favored 'General case' 1 C--N 1.208 -5.549 0 O-C-N 117.698 -3.126 . . . . 0.56 110.348 179.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 1.33 ' CD1' ' CB ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -89.01 -63.65 0.2 Allowed Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 112.13 0.419 . . . . 1.47 112.13 -179.572 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.601 ' HD2' ' HA2' ' A' ' 64' ' ' GLY . 6.3 Cg_exo -67.78 59.68 0.84 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.239 1.959 . . . . 0.59 112.829 -179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 62' ' ' ILE . . . -86.9 144.44 19.47 Favored Glycine 0 C--O 1.21 -1.355 0 C-N-CA 120.642 -0.79 . . . . 0.46 112.862 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.483 ' CD1' ' CB ' ' A' ' 54' ' ' LEU . 0.9 OUTLIER -136.73 109.22 7.4 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 122.52 -0.4 . . . . 1.72 110.708 179.889 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 60' ' ' LEU . . . -101.02 125.15 47.62 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.909 0.385 . . . . 0.42 111.269 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.72 HG12 HG13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -116.82 139.12 45.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.073 -0.512 . . . . 0.51 111.306 -179.91 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 1.3 ' OD1' ' CB ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER 47.11 27.06 0.73 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.605 -0.725 . . . . 1.59 110.715 -179.575 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 77.58 32.89 44.86 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.864 -0.684 . . . . 0.62 112.527 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.267 ' CD ' ' CB ' ' A' ' 59' ' ' GLU . 3.9 mt-10 -145.75 102.27 3.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.856 0.36 . . . . 2.21 111.041 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.481 HD21 ' O ' ' A' ' 46' ' ' ALA . 2.1 mm? -58.92 131.95 52.53 Favored 'General case' 0 CA--C 1.482 -1.668 0 CA-C-N 116.094 -0.503 . . . . 1.82 111.32 179.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.47 -8.71 3.69 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 114.678 1.362 . . . . 2.47 114.678 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.518 ' O ' ' HA2' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -142.08 130.78 22.18 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.908 0 C-N-CA 120.253 -0.579 . . . . 2.17 111.795 -179.881 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 1.251 ' CG ' ' SD ' ' A' ' 63' ' ' MET . 0.0 OUTLIER -146.62 131.04 17.63 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 112.742 0.645 . . . . 2.28 112.742 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.601 ' HA2' ' HD2' ' A' ' 52' ' ' PRO . . . 77.46 -2.93 60.93 Favored Glycine 0 C--O 1.192 -2.512 0 C-N-CA 120.297 -0.954 . . . . 0.65 113.676 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 1.538 ' CD ' ' CB ' ' A' ' 65' ' ' ARG . 1.7 ttp180 -177.21 101.9 0.05 Allowed 'General case' 0 C--O 1.2 -1.549 0 CA-C-N 117.48 0.64 . . . . 3.53 112.7 -179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 1.18 ' CG2' ' CA ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -57.95 148.58 5.51 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 116.579 -0.282 . . . . 1.28 111.476 -179.666 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.54 167.44 21.89 Favored 'General case' 0 C--O 1.19 -2.047 0 CA-C-O 120.816 0.341 . . . . 0.73 111.511 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 1.132 ' OG ' ' HB3' ' A' ' 68' ' ' SER . 0.5 OUTLIER -97.21 170.72 8.91 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 122.085 -0.384 . . . . 1.61 111.297 -179.989 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 1.468 ' CB ' ' CD ' ' A' ' 69' ' ' LYS . 2.7 pttt -57.54 -46.5 83.8 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.405 -0.361 . . . . 2.8 111.125 -179.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 74' ' ' LYS . 1.4 tt0 -64.7 -34.95 79.52 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.88 0.371 . . . . 2.42 111.135 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -45.05 81.31 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.2 -0.454 . . . . 1.95 110.921 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -50.54 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 116.098 -0.501 . . . . 1.64 111.086 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 1.462 ' CE ' ' CG ' ' A' ' 73' ' ' LYS . 17.6 tttt -59.26 -35.03 72.98 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 116.295 -0.411 . . . . 2.32 110.836 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 1.493 ' NZ ' ' CD ' ' A' ' 74' ' ' LYS . 4.8 tttt -71.8 -33.12 68.3 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.42 -0.354 . . . . 2.62 111.136 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 1.251 ' CD1' ' CB ' ' A' ' 75' ' ' ILE . 0.7 OUTLIER -76.3 -34.28 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 116.177 -0.465 . . . . 1.54 110.414 179.686 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.526 ' CD2' ' CB ' ' A' ' 76' ' ' LEU . 0.4 OUTLIER -79.16 -35.53 41.85 Favored 'General case' 0 C--O 1.162 -3.517 0 CA-C-N 116.167 -0.47 . . . . 2.61 111.678 -179.926 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 1.22 ' CB ' ' N ' ' A' ' 77' ' ' SER 1.471 0.0 OUTLIER . . . . . 2 C--O 0.09 -59.94 2 N-CA-C 166.842 20.682 . . . . 2.77 166.842 179.996 . . . . . . . . 5 3 . 1 stop_ save_